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Abstract 
Breast cancer is a major health problem and exposure to oestrogen is a main risk factor. Many 
environmental chemicals with oestrogenic activity are known to enter the human breast from 
exposure through diet, the domestic environment and personal care products. In this study, six 
chemicals, used to absorb ultraviolet light (UV screens) in consumer products and known to 
be detectable in human milk, have been studied for their effects on proliferation and 
migration of MCF-7, T-47-D and MDA-MB-231 human breast cancer cells. The six 
chemicals were benzophenone-1 (Bp1), benzophenone-2 (Bp2), benzophenone-3 (Bp3), 
octylmethoxycinnamate (OMC), 3-(4-methylbenzilidene) camphor (4MBC) and homosalate 
(HS).  All six of these UV screens at 10
-5
M could induce luciferase activity from an ERE-
LUC reporter gene stably transfected into MCF-7 cells. Dose-response experiments on 
proliferation of oestrogen-responsive MCF-7 and T-47-D cells showed increased proliferation 
following the exposure to the UV screens but not OMC, which had no effect on proliferation 
of MCF-7 cells except when cells are seeded on a laminin matrix. No effect on MDA-MB-
231 cell proliferation was recorded. Although the oestrogenic activity of these chemicals has 
been shown to influence proliferation, this is only one of the hallmarks of cancer cells. 
Another important hallmark is activation of invasion and metastasis which is relevant for 
breast cancer where mortality arises not from growth of the primary tumour but from 
metastatic tumour spread. Effects of these UV screens have therefore been studied on 
migration and invasion of MCF-7, T-47-D and MDA-MB-231 cells following prior (2 weeks) 
or (up to 30 weeks) exposure using a wound healing assay, time-lapse microscopy or 
xCELLigence technology. 2 weeks of exposure to10
-5
M OMC, 4MBC and HS increased the 
motility of MCF-7 cells as determined by xCELLigence technology or time-lapse 
microscopy. 21 weeks of exposure to 10
-5 
M Bp1, Bp3, to 10
-7
M concentrations of OMC, 
4MBC and HS increased the motility of MCF-7 cells. Results using western immunoblotting 
suggest a decrease in E-cadherin mRNA levels by 10
-5 
M Bp1, Bp3, OMC, 4MBS and HS 
and protein levels of cells exposed to 10
-5 
M Bp1 and HS.10
-5
M Bp1 also increased the 
secretion of MMP-9 as measured by zymography and the protein levels of pro-MMP-14 as 
measured by western immunoblotting. β-catenin protein was reduced in MCF-7 cells 
following the exposure to 10
-5
M OMC, which also reduced the mRNA levels of other two 
molecular markers of motility (PIK3R1 and BMP7). T-47-D cells exposed to 10
-5
M of the 
UV screens have shown an increase in motility as determined by xCELLigence but only Bp1 
increased the migration as determined by wound healing. MDA-MB-231 cells showed no 
increase in motility following 2 weeks of exposure to the UV screens. However, 8 weeks of 
exposure to 10
-7 
M Bp2, Bp3, 4MBC and HS increased the cells motility as determined by the 
xCELLigence and 15 weeks of exposure to 10
-7 
M of the UV screens increased the motility of 
MDA-MB-231 cell as measured by the time-lapse microscopy. OMC and 4MBC increased 
the secretion of MMP-2 by MDA-MB-231 cells. Overall, these results demonstrate for the 
first time that these six UV screens can influence not only proliferation but also migration of 
human breast cancer cells. 
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Chapter 1   Introduction 
1.1 Introduction  
Breast cancer is the leading cancer of women and causes the death of 517,000 women 
worldwide annually (World Health Organization, 2008). It is worth noting that incidence of 
breast cancer is higher in developed countries than in developing countries (Key et al., 2001). 
The UK’s Office for National Statistics published that the incidence rate per 100.000 of 
female breast cancer in England was 163.6 in 2005 (Office for National Statistics, 2016), 
while in Saudi Arabia the documented incidence rate in the same year was 21.6 (Al-Kuraya et 
al., 2005). However, even if the incidence rate of breast cancer is relatively lower than in the 
UK, breast cancer represents the highest type of cancer among Saudi females. Interestingly, 
the eastern region of Saudi Arabia has the highest rate of the disease along with a high 
incidence rate in other neighbouring Arabian Gulf countries including Bahrain, Kuwait and 
Oman (Al-Eid et al., 2004). The reasons for the increasing incidence of breast cancer in the 
eastern region of Saudi Arabia are not published, but this part of the country is distinguished 
by oil industry activities (Price, 1993), which might correlate with the incidence of the 
disease. 
Oestrogen is a main risk factor for breast cancer (Key et al., 2001) and therefore exposure to 
environmental pollutants, which mimic the action of oestrogen, may play a role in breast 
cancer development (Byford et al., 2002; Darbre and Charles, 2010) by mirroring the role of 
oestrogen in initiating (Russo and Russo, 2006) or influencing some of the hallmarks of 
breast cancer including proliferation (Darbre and Daly, 1989) or metastasis (Planas-Silva and 
Waltz, 2007; Chakravarty et al., 2010; Li et al., 2010; Chaudhri et al., 2012; Ganapathy et al., 
2012; Ogba et al., 2014; Zhou et al., 2016; Saha Roy and Vadlamudi, 2012). 
UV screens are widely used in cosmetics and other household products (Shaath, 2010; Darbre 
and Charles, 2010). The oestrogenicity of some of these chemicals has been reported through 
evidence of their influence on endocrine disruption of fish (Weisbrod et al., 2007), 
uterotrophic activity in rodents and proliferation of oestrogen responsive breast cancer cells in 
vitro (Schlumpf et al., 2001). A number of the UV screens have been measured in human 
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milk (Schlumpf et al., 2010), so they are presented in human breast and their effect on breast 
cancer development is plausible. Since mortality from breast cancer mainly results when the 
cancer cells metastasise (Solomayer et al., 2000; Schairer et al., 2004; Manders et al., 2006; 
Saha Roy and Vadlamudi, 2012), this study has focused on the potential effect for UV screens 
to increase migration and invasion of breast cancer cells in vitro.  
1.2 Introduction to breast cancer 
1.2.1 The biology of normal breast 
A typical mature female breast contains milk-producing glands (lobules), which are 
connected to ducts that end in the nipple (Figure 1 (A)). These lobules consist of acini, 
formed of two cell types, the luminal epithelial cells and the myoepithelial cells (Figure1 (B)) 
which are separated by the basement membrane from the surrounding connective and fatty 
tissues (Cichon et al., 2010; Zhu and Nelson, 2013; Liu and Gartner, 2012). The breast is 
supplied with blood vessels and surrounded by the lymphatic system (Russo and Russo, 
2014).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure ‎1.1 Human female breast biology. 
Figure 1.1 represents (A) Cross section of human female breast, adapted from (Zhu and 
Nelson, 2013). (B) Diagram showing cross-section of an acini of a lobule, adapted from 
(Liu and Gartner, 2012) . (C) Lobule types (Russo and Russo, 1994). 
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Figure ‎1.2 The hallmarks of cancer. 
This scheme represents the original six hallmarks of cancer proposed by Hanahan and 
Weinberg in 2000 (unshaded boxes)(Hanahan and Weinberg, 2000) and the new emerged 
markers proposed in 2011 (shaded boxes). Adapted from (Hanahan and Weinberg, 2011). 
The human breast is a hormone-responsive organ which is mainly controlled by ovarian 
hormones. These regulate development of the lobules through puberty, pregnancy and 
lactation. The undifferentiated lobule type 1 is found in childhood but the influence of 
oestrogen and progesterone enables a more branched and differentiated lobule type 2/3 during 
puberty. In pregnancy and lactation, lobule type 4 is present, a more branched and larger 
lobule. Following cessation of lactation, lobules regress into type 3 (Russo et al., 2000) 
(Figure 1.1 (C)).  
1.2.2 The hallmarks of cancer 
For cancer to develop, cell processes undergo multiple physiological alterations which 
transform normal cells to malignant ones. The proposal of the hallmarks of cancer defines the 
malignancy as extubating 8 hallmarks which are shared in diverse cancers as illustrated in 
(Figure 1.2) (Hanahan and Weinberg, 2011) and driven by 2 underlying characteristics; 
genome instability and mutations and the tumour promoting inflammation (Hanahan and 
Weinberg, 2011). Breast cancer starts when normal breast cells develops the hallmarks of 
cancer, especially sustained uncontrolled cell proliferation and/or the ability for cell migration 
and invasion (Allred et al., 2001; Hanahan and Weinberg, 2011), both hallmarks will be 
studied in this work. 
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1.2.3 Classification of breast cancer 
Breast cancer starts with an excessive uncontrolled proliferation of cells in the lobules or 
ducts which results in the production of atypical hyperplasia, a form of benign tumour which 
can progress into carcinoma. Based on the location of the disrupted epithelial cells, breast 
cancer is classified into ductal carcinoma in situ (DCIS), lobular carcinoma in situ (LCIS) or 
invasive ductal carcinoma (IDC). In DCIS and LCIS, the cells over-proliferate and lose 
typical characteristics but remain within the breast ducts (DCIS) or lobules (LCIS). In an 
advanced stage, a large number of the cancer cells will start to infiltrate into the local 
environment resulting in invasive carcinoma (IC). IC is classified into different types 
according to architectural features and origin of the cancer (Allred et al., 2001; Malhotra et 
al., 2010). In addition, breast cancer is divided into different sub-types based on the gene 
expression profile and some of the molecular features. Peruo and his colleagues have initially 
classified breast cancer cells into 4 types including luminal, basal-like, enriched epidermal 
growth factor receptor 2 (HER2) and normal breast-like (Peruo et al., 2000). Based on the 
expression of oestrogen receptor (ER), the luminal cells were later classified into luminal A 
and luminal B (Sorlie et al., 2001). More recently, specific mutations and signalling pathways 
were found to be subtype associated and that suggested heterogeneity within the major 4 
types of breast cancer (Perou and Network, 2012). Other molecular features including 
Claudin-3/4/7 (Herschkowitz et al., 2007), progesterone receptor (PR), E-cadherin and 
vimentin were used to classify breast cancer (Andre and Pusztai, 2006; Malhotra et al., 2010; 
Holliday and Speirs, 2011) (Table 1.1). In addition to the 4 types which were suggested by 
Peruo and colleagues in 2000, other groups have suggested the addition of interferon-
regulated (Hu et al., 2006) or apocrine androgen receptor enriched subtype, which is ER and 
PR negative (Farmer et al., 2005). This heterogeneity categorization has also been used to 
classify the existing in vitro models of human breast cancer cell lines (Peruo et al., 2000; 
Holliday and Speirs, 2011) as illustrated in Table ‎1.1.  
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Table ‎1.1 Breast cancer classification based on variation in molecular features and 
related examples of commonly used human breast cancer cell lines in vitro (Adapted from  
(Peruo et al., 2000; Sorlie et al., 2001; Herschkowitz et al., 2007; Malhotra et al., 2010; 
Holliday and Speirs, 2011; Eroles et al., 2012) 
 
1.2.4 Risk factors for breast cancer 
Several risk factors have been related to the development of breast cancer. In addition to the 
inherited susceptibility through loss of tumour suppressor genes, several epidemiological 
studies have shown that a westernized lifestyle has a major impact on the development of the 
disease. Hormone disruption and environmental pollution are also crucial players in the 
development of the breast cancer (Key et al., 2001; Hulka and Moorman, 2001).  
1.2.4.1 Family history 
Inheritance of genetic factors increase the susceptibility in up to 10% of breast cancer 
(McPherson et al., 2000). Familial risk of breast cancer has been reported to increase the risk 
of having the disease 2-fold when a first-degree relative is affected (Pharoah et al., 1997). The 
loss of function of BRCA1 (Hall et al., 1990) or BRCA2 (Wooster et al., 1994) are the main 
links between breast cancer incidence and inherited risk factors (Claus et al., 1998).  Loss of 
Breast cancer type Molecular characteristics Cell line 
Luminal A ERα 
high
 and Her2 
low
 MCF-7 and T-47-D 
Luminal B ERα 
low
 and Her2 
low
 ZR-75-1 
Claudin low ERα
-
, Claudin-3/4/7
low
, E-cadherin 
low
 and 
vimentin
+
 
MDA-MB-231 
Basal  ERα
-
, PR
-
, Her2
-
 and EGFR
+
 MDA-MB-468 
HER2 enriched HER2
+
 and ERα- SKBR3 
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these genes is associated with defects in several crucial biological functions of the cell 
including loss of DNA repair and cell cycle check points regulation (Venkitaraman, 2002).  
1.2.4.2 The influence of lifestyle 
There is a noticeable relation between lifestyle and becoming a breast cancer patient. An 
interesting point of view has emerged from different epidemiological studies in linking breast 
cancer and westernized lifestyle (Hortobagyi et al., 2005; Youlden et al., 2012). Migrating 
into high risk countries such as the USA can increase the risk of breast cancer within the 
migrants who come from low risk countries such as Japan (Ziegler et al., 1993). Different 
lifestyle choices and practices can add to the risk of breast cancer, including bearing children 
at a late age, avoiding breast feeding and having high alcohol consumption (Snedeker and 
Diaugustine, 1996; McPherson et al., 2000; Key et al., 2001; Boyle, 2005; Anand et al., 
2008).  
1.2.4.3 Hormones and breast cancer 
An elevation of the main female sex hormones (oestrogens) have been found to correlate with 
the development of breast cancer, especially in postmenopausal women (Missmer et al., 2004; 
Trehan et al., 2012).  
Oestrogen levels naturally change in the female body throughout different life stages, notably 
through the menstrual cycle, during pregnancy and after menopause (Wright et al., 1999; 
Darbre, 2015). Perturbations to the balanced hormone system through use of hormone 
replacement therapy (HRT) has been linked to an increased risk of development of invasive 
breast cancer within 1.7 % of HRT users after 2.6 years (Beral, 2003), and use of oral 
contraceptives has also been found to cause an increase in breast cancer incidence 
(Collaborative Group on Hormonal Factors in Breast Cancer, 1996). 
1.2.4.4 Environmental pollution and environmental oestrogens 
The environment is now thought to play a crucial role in carcinogenesis and cancer 
progression in the breast through the exposure to either radiation and/or chemical pollutants 
caused by different human activities (McPherson et al., 2000; Key et al., 2001; Darbre, 2006). 
A study conducted in the United States of America to measure the effect of radiation on 
women who worked as radiological technologists before 1940 found a high mortality of 
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breast cancer among participants and these deaths were believed to be connected to the high 
dosage of radiation (Mohan et al., 2002). Furthermore, high radiation exposure was found to 
be correlated with increased breast cancer incidence from the Japan atomic bomb survivors 
(Tokunaga et al., 1979). 
In addition, other studies have demonstrated the effect of chemical pollutants on human 
health and on cancer incidence. In 2009, Landau-Ossondo and his colleagues found a linear 
relationship between the usage of organochlorine (OCs) pesticides and an increase of both 
prostate and breast cancer among the people who live on the island of Martinique (Landau-
Ossondo et al., 2009). In another study, OCs were measured in the adipose tissue of females 
from Long Island, New York, where it is a high risk region for breast cancer (Stellman et al., 
2000) and a correlation between high concentration of OCs and breast cancer has been 
reported (Muscat et al., 2003).  
Among the various chemical pollutants in the environment, multiple chemicals of natural or 
artificial origins can manipulate the human hormonal system by mimicking specific natural 
hormones and interfering with their natural signalling pathways (Olea and Fernandez, 2007); 
compounds which interfere in oestrogen action are called “environmental oestrogens’’  
(Darbre, 2006).   
Organic or inorganic environmental oestrogens can enter the human body from activities of 
daily life. It can enter through diet and water, through consumption of phytoestrogens (plant-
derived xenoestrogens) and through exposure to different domestic and cosmetic products 
including lotions, hair sprays, shampoos, underarm deodorant/ antiperspirant see Figure ‎1.3 
below (Darbre, 2006; Darbre and Charles, 2010; Darbre, 2015).  
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Although the sources of these chemicals might vary between different individual lifestyles, 
entry of these chemicals into the human body has been confirmed by several studies that 
measured their existence either in human breast tissue (Darbre et al., 2004; Waliszewski et 
al., 2005; Barr et al., 2012; Exley et al., 2007), in human milk samples (Chao et al., 2007; 
Schlumpf et al., 2010; Toms et al., 2011) (Table 1.2) or in human blood within hours of 
dermal application (Janjua et al., 2004; Janjua et al., 2007). This has led to taking into 
consideration the influence of several factors on the action of these chemicals including the 
concentration of these chemicals, the additive effect of their mixtures, the exposure route and 
time (Olea and Fernandez, 2007; Kortenkamp, 2007; Darbre and Charles, 2010). 
Even if some of these chemicals have a very weak oestrogenic activity or might be detected 
in low concentrations, they might cause an oestrogenic effect after exposure as mixtures 
(Charles and Darbre, 2013), and disrupt the natural state and elevate the level of oestrogen 
related activities, which might be correlated to breast cancer progression (Darbre and 
Fernandez, 2013; Darbre, 2015). 
Figure ‎1.3 Types and examples of environmental oestrogens. 
Adapted from (Payne et al., 2001; Darbre, 2006) 
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Table ‎1.2 Chemical components of cosmetics which possess oestrogenic activity. 
(Adapted from Darbre, 2006) 
Chemical 
component 
Function in 
cosmetics 
Evidence indicating entry to human breast 
Parabens Preservative 
Measured in human breast tissue (85.5 ng/g tissue) (Barr 
et al., 2012). 
Sunscreens 
Absorb or 
reflect UV light 
Measured in human milk (19- 117 ng/g lipid) (Schlumpf 
et al., 2010). 
Phthalates Plasticizer 
Measured in human milk (1.12-34.06 ng/g lipid) 
(Schlumpf et al., 2010). 
Aluminium 
salts 
Antiperspirant 
Measured in human breast tissue (4-437 nmol/g dry 
wt.)(Exley et al., 2007). 
Triclosan Antimicrobial 
Measured in human milk (<20-300 µg/kg lipid weight) 
(Adolfsson-Erici et al., 2002). 
Musks 
Fragrance 
chemicals 
Measured in human milk (2.93-6.17 ng/g lipid) 
(Schlumpf et al., 2010). 
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1.3 The role of oestrogens in the development of breast cancer 
Oestrogens are the main endogenous female hormones that regulate multiple important 
physiological processes related to the function of the reproductive system and the 
development of the secondary sex characteristics (Delemarre et al., 2008). There are three 
types of oestrogens: oestrone, oestradiol and oestriol and the most potent physiological type is 
17β-oestradiol (Alonso and Rosenfield, 2002), as illustrated in Figure ‎1.4 below. Oestrogen is 
secreted mainly by the ovaries in premenopausal women and this change after menopause to 
lower secretion from adipose tissue and the adrenal cortex. The precursor of oestrone is 
androstenedione, which is converted to oestradiol and then oestriol by aromatase (Nelson and 
Bulun, 2001). The enzyme aromatase also converts testosterone to oestradiol (Thomas and 
Potter, 2013), as shown in Figure ‎1.5. 
The relationship between breast cancer and oestrogen was first recorded in 1896 by Beatson. 
He showed that breast tumour growth was reduced by surgical removal of the ovaries in 
premenopausal breast cancer patients (Beatson, 1896). In addition to the increasing risk of 
breast cancer which has been observed following the use of oral contraceptives and HRT  
(Key et al., 2001) as described in 1.2.4.3, further evidence for the role of oestrogen in 
affecting breast cancer cell proliferation was found from in vitro and in vivo models (Nandi et 
al., 1995; Harvell et al., 2000; Mense et al., 2008).  In Darbre et al.’s study in 1983, oestrogen 
was shown to increase proliferation of the human breast cancer cell line ZR-75-1 in a dose 
dependent manner (Darbre et al., 1983). Based on the involvement of oestrogen in breast 
cancer development, therapeutic strategies against hormone-dependent breast cancer target 
the effect of oestrogen on breast cancer cells either by inhibiting oestrogen from binding to its 
cellular receptors using anti-oestrogenic drugs such as tamoxifen (Jordan, 2006), by down-
regulating the oestrogen receptor protein levels using fulvestrant (Wakeling, 1995) or by 
preventing oestrogen synthesis using aromatase inhibitors (Manders and Gradishar, 2005).  
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Figure ‎1.4 The structure of oestradiol, oestrone and oestriol. 
Adapted from (Thomas and Potter, 2013). 
Oestrone 
Oestriol 
Oestradiol 
Figure ‎1.5  Biosynthesis of oestrogens in the ovary and the liver. 
The precursors of oestrogens (androstenedione and testosterone) are biosynthesised in the 
theca interna and converted in the granulosa cells to oestrogens by the enzyme aromatase. 
(Adapted from (Cheng et al., 2001; Thomas and Potter, 2013; Darbre, 2015)). 
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1.3.1 Molecular action of oestrogen    
Although the lipophilic nature of oestrogens allow them to diffuse passively through the cell 
membrane (Beato and Klug, 2000), their biological functions require the presence of 
intracellular oestrogen receptor proteins ERα and ERβ (Nelson and Bulun, 2001). After the 
binding of oestrogen to ER, molecular mechanisms of action may be genomic or  non-
genomic (Katzenellenbogen et al., 2000; Cheskis et al., 2007; McDevitt et al., 2008; Darbre, 
2012).  
1.3.1.1 Oestrogen receptors  
In the late 1960s the mechanism of action of oestrogen was confirmed to be dependent on its 
interaction with cellular receptor proteins (Toft and Gorski, 1966). The cDNA for oestrogen 
receptor α (ERα) was first cloned in 1985 (Walter et al., 1985). Eleven years later the 
oestrogen receptor β (ERβ) was cloned (Mosselman et al., 1996). ERα and ERβ share a close 
structural homology although they are produced from two separate genes. ERα is localized on 
the human chromosome 6q24-q27 (Gosden et al., 1986), while ERβ is localized on 
chromosome 14q22-q24 (Enmark et al., 1997). Both proteins are composed of 5 functional 
domains (A-F). The first is located at the N-terminal (A/B) region and encodes the hormonal 
independent transcriptional activation function 1 (AF1). The second domain is region C, 
called the DNA binding domain (DBD). DBD is responsible for the specific binding of 
oestrogen-ER dimers to enhancer elements termed oestrogen response elements (ERE) in the 
region of the target genes through zinc finger motifs. The third domain (the hinge) in region 
D facilitates the receptor conformational changes and dimerization. The fourth domain is the 
region E, known as the ligand binding domain (LBD) and is where the oestrogen binds into a 
specific binding pocket to the ER. The final domain is region F and contains the hormone-
dependent transcriptional activation function 2 (AF2) (Figure 1.6) (Nilsson et al., 2001; 
Osborne et al., 2001; Ascenzi et al., 2006; Darbre, 2012). 
Although 17β-oestradiol has the highest binding affinity to the ER in comparison with other 
oestrogens (Zhu et al., 2006) (Figure 1.7), oestrogen receptors binding affinity is known for 
its high plasticity. Along with oestrogens, these receptors can accommodate phyto-oestrogens 
or synthetic chemicals (environmental oestrogens) of quite different sizes and structures 
(Kiyama and Wada-Kiyama, 2015) and activate subsequent oestrogenic responses (Jordan et 
al., 1985; Katzenellenbogen, 1995; Oostenbrink et al., 2000). One key binding requirement 
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seems to be a p-hydroxy phenyl ring group together with a hydrophobic region, which can 
then bind into LBD in an analogous manner to 17β-oestradiol (Katzenellenbogen, 1995; Fang 
et al., 2001) (Figure 1.7). 
Oestrogen receptors are present not only in the breast but also in other tissues such as the 
ovaries, uterus, bones, and brain. These tissues vary in the levels of ERα and ERβ (Nilsson et 
al., 2001; Gustafsson, 2003; Heldring et al., 2007; Pearce and Jordan, 2004) and together with 
varied levels of coactivators or corepressors this leads to a tissue specific response to 
oestrogens (Katzenellenbogen et al., 1996; Nilsson et al., 2001; Heldring et al., 2007).  In 
breast cancer cells both ERα and ERβ are present (Jarvinen et al., 2000; Pearce and Jordan, 
2004; Hartman et al., 2009) with higher levels of ERα in ER-positive breast cancer tumours 
(Miyoshi et al., 2010). It has been shown that induced expression of ERβ works as a negative 
modulator of ERα in cells that express both receptors and reduces the 17β-oestradiol 
proliferative response of MCF-7 cells (Paruthiyil et al., 2004) and T-47-D cells (Strom et al., 
2004).  
 
 
 
 
 
 
 
 
 
 
 
Figure ‎1.6 Schematic representation of the functional domains of the human 
oestrogen receptors ERα and ERβ. 
AF1= activating function 1; AF2= activating function 2; DBD= DNA binding domain; 
LBD= ligand binding domain. The relative amino acid homology between corresponding 
domains is shown. Adapted from (Osborne et al., 2001; Darbre, 2012). 
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Figure 1.7 Crystal structure of the ligand binding of 17β-oestradiol to oestrogen receptor 
alpha.  
Figure 1.7 illustrates the hydrogen bonding (dotted lines) between 17-β oestradiol and specific 
amino acids of the ligand binding domain of the oestrogen receptor and water molecules. Glu 
353, Arg 394 and His 524 (histidine 542) are the key polar amino acids in the ER pocket 
(coloured in red) (from (Brzozowski et al., 1997)). 
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1.3.1.2 Genomic action of oestrogen  
In the absence of ligand, oestrogen receptors remain inactive as a result of binding to receptor 
associated proteins (RAPs). However, binding of ER to oestrogen in a 1:1 ratio causes the 
phosphorylation of ER and the dissociation of RAPs (Pratt, 1992; Klinge et al., 1997). 
Oestrogen binds to the LBD of the ER, which results in a change of conformation of the ER 
and dimerization of the oestrogen-ER complexes. Dimers translocate to the nucleus and bind 
to specific nucleotide sequences in the DNA, a sequence called oestrogen response elements 
(ERE). Coactivators or corepressors will then be recruited and transactivation results in 
modulation of cellular gene expression (as reviewed by (Nilsson et al., 2001; Darbre, 2015)). 
Many genes are known to be regulated through the direct genomic action of oestrogen. One 
early oestrogen-regulated gene was the Trefoil factor 1 (TFF1) isolated as pS2 (Masiakowski 
et al., 1982; Brown et al., 1984; Jakowlew et al., 1984) (Figure 1.8 (1)). TFF1 protein is 
predominantly expressed in the gastrointestinal tract (Rio et al., 1988), where it stimulates 
epithelial cells restitution and migration (Marchbank et al., 1998). The biological role off 
TFF1 protein in breast cancer was unknown (May and Westley, 1997) until the stimulation of 
MCF-7 and MDA-MB-231 breast cancer cells migration by TFF1 protein was documented 
(Prest et al., 2002). Many hundreds of other genes are regulated by oestrogen, more of which 
are downregulated than upregulated (Frasor et al., 2003). Among the molecular actions of 
oestrogen, the genomic action is the most considered in the context of breast cancer 
tumourigenicity and progression and as consequence was targeted therapeutically using 
tamoxifen (Jordan, 2006) and fulvestrant (Wakeling, 1995). 
1.3.1.3 Indirect genomic action of oestrogen 
Molecular action of the dimerized oestrogen-ER complexes is not always through binding 
directly to DNA. The complex can act also as a coactivator by interacting with other specific 
transcription factors, such as Fos/Jun AP-1 complex (Webb et al., 1999), leading to 
modifications of gene expression which are not mediated by the ERE (Umayahara et al., 
1994; Darbre, 2012) (Figure 1.8 (2)).  
1.3.1.4 Non-genomic action of oestrogen 
Non-genomic mechanisms of action occur when the oestrogen binds to oestrogen receptors in 
the cellular membrane which can generate cytosolic signalling cascades (Razandi et al., 2002; 
Darbre, 2012; Kow and Pfaff, 2016). One mode of action involves the modulation of ion 
16 
 
channels (Picotto et al., 1999; Kow and Pfaff, 2016). Another mode of 17β-oestradiol action 
is to mediate signalling pathways through the binding of E-ER complexes to tyrosine kinase 
receptors (Filardo et al., 2002) or through binding of oestrogen to G-protein-coupled estrogen 
receptor 1 (GPER) (Filardo et al., 2000). The interaction of 17β-oestradiol with the cell 
membrane receptors resulting in activation of mitogen-activated protein kinase (MAPK) 
(Filardo et al., 2002; Song et al., 2002b) and phosphatidyl-inositol 3-kinase (PI3K)/Akt 
signalling pathways (Haynes et al., 2000) in oestrogen responsive cells and therefore 
regulates cell proliferation and migration (Figure 1.8 (3)). 
 
Figure ‎1.8  Molecular mechanisms of action of oestrogen.  
(1) Direct genomic action via the interaction between oestrogen (E), oestrogen receptor (ER) 
and the oestrogen responsive element (ERE) (DNA-protein interaction). (2) Indirect genomic 
action by interacting of E-ER complex with transcription factors (TF) (protein-protein 
interaction). (3) Non-genomic interaction, E binds to membrane ER or transmembrane GPER 
and initiates signalling cascades which activates different cellular pathways and physiological 
responses. Adapted from (Heldring et al., 2007; Darbre, 2012; Arevalo et al., 2015; Contrò et 
al., 2015). 
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1.3.2 Oestrogen and breast epithelial cell proliferation    
One of the hallmarks of cancer is the ability of malignant cells to keep sustained uncontrolled 
proliferation, which can result in changing of the normal tissue structure and losing the 
physiological functions of the organ (Hanahan and Weinberg, 2011). As described in 
section  1.2.1 above, oestrogen has an important role in normal breast development and 
growth (Russo et al., 2000). However, evidence has now been gathered to show it can also 
stimulates the proliferation of oestrogen responsive breast cancer cells (Lippman and 
Dickson, 1989). The profound effect of oestrogen on cell proliferation can occur through 
alteration to growth factor signalling pathways (Lippman and Dickson, 1989) and cell cycle-
regulated proteins (Sutherland et al., 1998; Darbre, 2012).  
Growth factors act by binding to specific growth factor receptors which act through signal 
transduction pathways to influence cellular processes such as proliferation and differentiation 
(Bafico and Aaronson, 2003). In breast cancer, oestrogen can cross talk with several growth 
factor signalling pathways such as the transforming growth factor α (TGF-α), epidermal 
growth factor (EGF), insulin- like growth factors (IGF) and platelet derived growth factor 
(PDGF) (Lippman and Dickson, 1989). Oestrogen can cross-talk with growth factor 
signalling pathways either by influencing the levels of the growth factors (Lippman et al., 
1987), their receptors (Lee et al., 1999; Maor et al., 2006), their binding proteins (Matsuda et 
al., 2001) or by increasing the sensitivity of breast cancer cells towards their regulation 
(Stewart et al., 1990). Moreover, some of the growth factors can phosphorylate and activate 
the oestrogen receptors in the absence of ligand (Bunone et al., 1996). 
Oestrogen and the growth factors have been found to increase oestrogen responsive cell 
proliferation through influencing cell cycle regulation (Dufourny et al., 1997; Mawson et al., 
2005). To achieve this effect, oestrogen regulates c-myc, a nuclear transcriptional factor that 
is known to enhance oestrogen responsive cell proliferation via the alteration of cell cycle 
proteins (Dubik et al., 1987; Watson et al., 1991; Sutherland et al., 1998; Doisneau-Sixou et 
al., 2003). Oestrogen can increase cyclin D1 expression (Altucci et al., 1996) and activate 
cyclin E as well as increasing its expression (Planas-Silva and Weinberg, 1997; Niu et al., 
2015). Both of those cell cycle proteins mediate G1/S progression (Musgrove et al., 1994; 
Prall et al., 1998; Doisneau-Sixou et al., 2003). Oestrogen can also reduce the recruitment of 
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cell cycle kinase inhibitors and their ability to bind to the cyclin proteins (Sutherland et al., 
1998). 
1.3.3 Oestrogen and breast cancer cell metastasis 
Breast cancer motility arises mainly when the breast cancer cells migrate from the primary 
tumour site, invade and localize in other distant organs in a process known as breast cancer 
metastasis (Weigelt et al., 2003; Redig and McAllister, 2013). The main distant organs 
affected by breast cancer metastasis are the bone, liver, lung and brain (Nguyen et al., 2009).  
Cancer cell metastasis is a complex process which involves modulating interaction of cells 
with their extracellular matrix (ECM) and with other surrounding cells (Timar et al., 2001; 
Martin et al., 2013). In order to achieve metastasis, cancer cells have to undergo multiple 
changes in their morphology and adhesion properties to enable their mobility (Ridley et al., 
2003). Then cancer cells have to invade surrounding barriers including the basement 
membrane and ECM components in order to reach the lymph nodes and the blood stream 
(intravasation) to be carried to the new site. Finally, they invade the new tissue 
(extravasation) and return to their non-motile form and start colonizing and proliferating in 
the new site (Nguyen et al., 2009; Hanahan and Weinberg, 2011).  
Breast cancer cells migrate both individually (van Zijl et al., 2011; Y.-C. Chen et al., 2015) or 
collectively (Planas-Silva and Waltz, 2007; van Zijl et al., 2011; Cheung et al., 2013). Both 
migration types include similar mechanisms but the process of migration that is found in 
single cell migration will extend across the entire cell sheet with maintenance of cell-cell 
adhesion (Friedl and Gilmour, 2009; Friedl et al., 2012). 
The role of oestrogen and its receptors in breast cancer metastasis remains to be fully 
understood. While several studies have documented the negative effect of oestrogen and its 
receptors on breast cancer cell metastasis (Rochefort et al., 1998; Sisci et al., 2004; Ma and 
Gollahon, 2016), other studies have recorded a positive effect (Planas-Silva and Waltz, 2007; 
Chakravarty et al., 2010; Li et al., 2010; Chaudhri et al., 2012; Ganapathy et al., 2012; Ogba 
et al., 2014; Zhou et al., 2016). The following sections focus on some of the biological 
characteristics and molecular markers influenced by oestrogen in breast cancer cell 
metastasis. 
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1.3.3.1 Mechanisms of breast cells; polarity, adhesion, motility and 
epithelial to mesenchymal transition (EMT) 
The architecture of breast epithelial cells is disrupted in malignancy (Bazzoun et al., 2013). 
Normal epithelial cells have an apical-basal polarity where the apical part is directed toward 
the lumen and the opposite edge (the base) is adhered to the basement membrane or the ECM. 
This architecture is achieved by the presence of tight junctions that separate the apical area 
from the lateral sides between the cells, by the sufficient cohesive intracellular adhesion on 
the lateral sides, by the maintenance of base adhesion to the ECM and by the preservation of 
the polarized distribution of the cytoskeleton (Rodriguez-Boulan and Nelson, 1989). 
Intracellular adhesion (cell-cell adhesion) is mediated by tight junctions in the apical domain, 
adherens junctions, desmosomes and gap junctions on the lateral sides of the cells (Bazzoun 
et al., 2013; Martin et al., 2013). Many proteins are involved in cell-cell adherens junctions 
including E-cadherin, β-catenin and α-catenin of which E-cadherin binds directly to the 
cytoskeletal actin (Ratheesh and Yap, 2012; Martin et al., 2013) (Figure 1.9). 
E-cadherin (135 kDa) (Vestweber and Kemler, 1984) is a transmembrane protein (Takeichi, 
1991) encoded by the CDH1 gene (Berx et al., 1995). The N-terminal portion of E-cadherin 
extends into the extracellular environment of the cells. This N-terminal region of the protein 
is formed of 5 domains of cadherin sequence repeats of 110 amino acids separated by Ca
++
 
binding sites (Patel et al., 2003; Parisini et al., 2007), which facilitate the homophilic binding 
with E-cadherin from neighbouring cells (Takeichi, 1991). The intracellular part of E-
cadherin is linked to the actin cytoskeleton (Ozawa et al., 1989) via the catenin proteins 
(Kemler, 1993)(β-catenin, γ-catenin, α-catenin and P120-catenin) to strengthen cell-cell 
adhesion, and mediates signalling through catenins (Vestweber, 2015).   
β-catenin and γ-catenin serve as anchor between the E-cadherin intracellular domain 
(Nagafuchi and Takeichi, 1989; Kemler, 1993; Zhurinsky et al., 2000) and α-catenin which 
binds to the actin filaments (Rimm et al., 1995; Yonemura, 2011; C.-S. Chen et al., 2015). 
P120-catenin binds to the intracellular domain of E-cadherin including the juxtamembrane 
region and is believed to have a role in E-cadherin clustering at the adherens junctions (Yap 
et al., 1998). 
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β-catenin (92 kDa) (Ozawa et al., 1989) is encoded by the CTNNB1 gene (van Hengel et al., 
1995). Alongside localization in adherens junctions, this protein was also found to serve as a 
nuclear transcriptional coactivator when unengaged with E-cadherin. Initially the free β-
catenin cytoplasmic pool increases when β-catenin is stabilized by activation of the Wnt 
signalling pathway (Papkoff et al., 1996; Novak and Dedhar, 1999). Then β-catenin re-
localizes to the nucleus where it complexes with lymphoid enhancer factor-1/T-cell factor 
transcription factors (LEF/TEF) (Behrens et al., 1996; Hsu et al., 1998) and trans-activates 
LEF/TEF targeted genes (Eastman and Grosschedl, 1999). It is worth noting that the β-
catenin/Wnt pathway also increases cancer cell proliferation (Tan et al., 2016). One of the 
possible explanations is that β-catenin transactivates LEF/TEF to increase the expression of c-
myc (He et al., 1998) and cyclin D1 (Shtutman et al., 1999; Lin et al., 2000) which are both 
regulators of cancer cell proliferation (see section  1.3.2 above). In addition,  some of the 
downstream targets of the β-catenin/Wnt signalling pathway are also involved in cancer cell 
metastasis through inducing activators of epithelial-mesenchymal (EMT) transition (Prasad et 
al., 2008) such as Twist and Snail (Yook et al., 2006; Kahlert et al., 2012). Knock down of β-
catenin (Xu et al., 2015) or suppressing the β-catenin/Wnt signalling pathway (Tsai et al., 
2013; Fan and Guo, 2015; Hu and Xie, 2015) also impairs breast cancer cell metastasis 
capability.   
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Figure ‎1.9 Schematic representation of epithelial cell-cell adhesion mediated by E-
cadherin. 
The adherens junction is formed by homophilic binding of the extracellular tail of E-cadherin 
from neighbouring cells. The intracellular part of E-cadherin is linked to the actin 
cytoskeleton through binding to β-catenin and α-catenin. P120-catenin binds E-cadherin to 
the juxtamembrane sites. Adapted from (Pecina-Slaus, 2003; Wheelock et al., 2008; 
Vestweber, 2015). 
 
In order to maintain the apical-base polarity, epithelial cells maintain cell-ECM adhesion. The 
extracellular matrix or the basement membrane consists of different macromolecules 
including laminin, collagen and fibronectin (Yurchenco et al., 2004). Epithelial cell-ECM 
adhesion can be achieved mechanically through focal adhesion (Burridge et al., 1988). Part of 
the focal adhesion is the integrin family, which are transmembrane adhesion receptors 
(Calderwood et al., 2000) that directly affect cell polarization through  coupling to the actin 
cytoskeleton (Burridge and Chrzanowska-Wodnicka, 1996; Ciobanasu et al., 2013). The 
interaction between the ECM and focal adhesion molecules can fire a cascade of signalling 
pathways (Burridge and Chrzanowska-Wodnicka, 1996) and influence cell proliferation and 
metastasis (Larsen et al., 2006; Tilghman and Parsons, 2008). 
The initial step in epithelial cell migration is the loss of the apical-basal polarity (Drasin et al., 
2011). In a subsequent step, there is an alteration of adhesion between cells and/or between 
cells and the ECM (Ridley et al., 2003). Cells then show front-back end polarity by being 
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directed towards a leading edge, where protrusions are formed to reach a new site and new 
adhesions occur. On the opposite side of the cell is a trailer edge where detachment of 
adhesion occurs (Ridley et al., 2003; Steeg, 2006). The cell will cause an actin-myosin fibre 
contraction within the cytoskeleton, which will move the cell forwards (Morton and Parsons, 
2011). 
Breast cancer cells exhibit morphological changes during metastasis which are associated 
with the acquisition of mesenchymal or fibroblast spindle-like morphology in a process called 
epithelial-mesenchymal transition (EMT)(Drasin et al., 2011). At a molecular level, multiple 
transcription factors are involved in EMT such as Twist, Snail and zinc-finger-E-box-binding 
(ZEB) (Lamouille et al., 2014). During EMT, epithelial cells lose cell-cell adhesion through 
suppression of the expression of E-cadherin and cytokeratins, and obtain mesenchymal 
properties such as overexpression of N-cadherin and vimentin which together results in more 
motile and invasive cell behaviour (Christiansen and Rajasekaran, 2006; Kalluri and 
Weinberg, 2009; Sanchez-Tillo et al., 2012). When arriving at the new site, cancer cells 
regain the epithelial characteristics (Bukholm et al., 2000) in a process known as 
mesenchymal-epithelial transition (Yao et al., 2011; Heerboth et al., 2015).  
The mode of tumour motility varies between different cancer cell types (Friedl and Wolf, 
2003; Clark and Vignjevic, 2015) from individual amoeboid or mesenchymal cell motility to 
collective cell migration (Friedl and Alexander, 2011). Although  EMT was reported to play a 
crucial role in cancer metastasis (Thiery, 2002; Xue et al., 2003; de Herreros et al., 2010; May 
et al., 2011), some reports suggest that some of the epithelial cells can gain motility in a 
manner independent of EMT (Pinkas and Leder, 2002) or partially acquire some of the 
mesenchymal cell markers besides retaining epithelial cell morphology and markers such as 
the expression of E-cadherin (Boyer et al., 1992; Klymkowsky and Savagner, 2009; de 
Herreros et al., 2010; Uchino et al., 2010; Gao et al., 2014), producing a transit status known 
as metastable phenotype  (Lee et al., 2006; Klymkowsky and Savagner, 2009). In addition, in 
collective migration the expression of  E-cadherin remains essential for motility of cell sheets 
(Hwang et al., 2012). The plasticity of cancer cells contributes to the varied routes of cancer 
cell metastasis and invasion (Friedl and Alexander, 2011).  
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1.3.3.2 Oestrogen regulation of breast cancer cell morphology and 
EMT   
Oestrogen was found to enhance breast cancer cell migration through influencing several 
morphological and molecular characteristics of the epithelial breast cancer cells. One of the 
earliest studies was conducted by Sapino et.al in 1986 in which they noted that exposure to 
oestrogen caused rearrangement of the cytoskeleton of MCF-7 cells and increased the 
pseudopodial protrusions where adhesion areas were mostly localized (Sapino et al., 1986).  
Also, the F-actin cytoskeleton of MCF-7 cells was found to be rearranged after exposure to 
oestrogen. This change in the cytoskeleton was marked by the presence of active 
lamellipodial structures beneath the cell clusters with the presence of E-cadherin cell-cell 
adhesion (DePasquale, 1999). Later, Song and his colleagues reported that oestrogen 
increases the ruffling and pseudopodia formation in the membrane of MCF-7 cells, both of 
which are characteristic features of migratory cells (Song et al., 2002b).  In another study 
oestrogen was found to enhance a spindle-like elongated cell morphology in both  MCF-7 and 
ZR-75-1 human breast cancer cells and enhance collective migration of a subset of MCF-7 
cell clusters which retained the expression of E-cadherin (Planas-Silva and Waltz, 2007). 
Since E-cadherin was not lost entirely in the presence of oestradiol, EMT and subsequent 
motility caused by oestrogen in MCF-7 cells is suggested to be through the down-regulation 
of  E-cadherin expression (Oesterreich et al., 2003), the alteration of localization of associated 
proteins such as β-catenin (Planas-Silva and Waltz, 2007) or alteration of localization of E-
cadherin (DePasquale, 1999).  
However, oestrogen was also found to influence other signalling pathways during the 
observed increase in breast cancer cell motility. It has been documented that oestrogen 
increases the motility of T-47-D cells via interacting with PI3K and MAPK signalling 
pathways , which activate focal adhesion kinase, paxilllin and c-Src (Li et al., 2010). Recently 
Ho and his colleagues have reported that oestrogen influences the phosphorylation of the 
PI3K/Akt  signalling pathway in MCF-7 cells via the interaction of ERα and integrin β4 
resulting in enhanced cell motility (Ho et al., 2016). 
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1.3.3.3 Oestrogen regulation of matrix metalloproteinases (MMPs) in 
breast cancer cell migration and invasion  
Degradation of the ECM components and surrounding tissue is an essential process in cancer 
cell metastasis. This process is influenced mainly by the secretion of matrix 
metalloproteinases (MMPs) (Stamenkovic, 2000) which results in targeting and releasing 
several growth factors from the surrounding microenvironment (Song et al., 2007; 
Kessenbrock et al., 2010; Sbardella et al., 2012) and disrupting the ECM structure 
(Stamenkovic, 2000).  
MMPs are a family of endopeptidases expressed in both normal and cancer cells and 
controlled by the tissue inhibitors of matrix metalloproteinases (TIMP) (Gomez et al., 1997; 
Nagase and Woessner, 1999). MMPs are either secreted extracellularly (Stamenkovic, 2000) 
or remained anchored to the cells as transmembrane proteins (Sato et al., 1994; Takino et al., 
1995). They are subdivided into different subclasses depending on their ability to degrade 
different substrates such as gelatin and collagen (Stamenkovic, 2000). The activation of the 
latent form of the MMPs can be initiated by interaction with several modulators and by auto 
activation between the family members (Stamenkovic, 2000). For example, the regulation of 
MMP-2 was found to be activated via the interaction with the membrane anchored MMP-14 
(Atkinson et al., 1995). Several members of the MMPs family were found to be highly 
expressed in primary human breast cancers in comparison to non-cancerous controls 
(Kohrmann et al., 2009). MMP-2 and MMP-9 were found to be expressed in human breast 
cancer tissue in a greater amount than normal breast tissue (Garbett et al., 2000), and have 
also been reported in breast cancer cells in vitro (Kohrmann et al., 2009) and the membrane 
attached MMP-14 (Devy et al., 2009). The ability of MMPs to induce EMT in breast cancer 
cells enables them to move through the breast stroma in the process of metastasis (Radisky 
and Radisky, 2010). 
In breast cancer patients, the high expression of MMP-9 and MMP-11 was found to correlate 
with distant metastasis (Vizoso et al., 2007) which supports the findings from the in vitro 
studies showing a correlation of MMPs activity and the metastatic ability of breast cancer 
cells. In MDA-MB-231 cells, MMP-14 was found to be a key enzyme in the formation of 
functional invadopodia that degrade the gelatin matrix (Artym et al., 2006). Moreover, it was 
found that TIMP-4 transfection can inhibit the MMPs activity and impair invasion activity of 
25 
 
the MDA-MB-435 cells (Wang et al., 1997). In vivo the survival rate of nude mice which 
were injected with TIMP-2 transfected MDA-MB-231 cells was higher than the mice injected 
with the wild type of non-transfected  MDA-MB-231 cells (Yoneda et al., 1997). 
The non-genomic action of oestradiol in MCF-7 cells was found to activate the MAPK 
signalling pathway by activating a linear sequences of events including MMP-2 and MMP-9 
(Song et al., 2007). Furthermore, oestradiol was found to increase the expression of MMP-9 
mRNA expression in MCF-7, MDA-MB-231 and ZR-75-1 cell lines (Kousidou et al., 2008). 
In contrast, others reported a reducing effect of oestradiol on the activity of MMP-2/MMP-9 
in MCF-7 cells (Nilsson et al., 2007). 
1.4 Breast cancer and UV screens  
1.4.1 Introduction to UV screens  
Ultraviolet rays (UVR) are a component of the solar radiation waves that reach the earth (Rai 
et al., 2012). Different sub-types of these UVR negatively affect the integrity of industrial 
products (Yousif and Hasan, 2015). Further, they are able to cause skin damage to humans. 
For these reasons,  use of sunscreen products which absorb, scatter or reflect the UVR has 
increased over recent decades (Rai et al., 2012). UV screens are either organic compounds 
(used to absorb UVR) or inorganic agents (used to scatter or reflect UVR) (Shaath, 2010; 
Latha et al., 2013), and due to their different mechanisms of action a mixture from each group 
is usually used to achieve full sun protection of both user and product  (Serpone et al., 2007; 
Rai et al., 2012; Latha et al., 2013). A wide range of products contain various UV screens 
including adhesives, plastics (Wypych, 2015), furnishing, clothes (Hoffmann et al., 2001) and 
cosmetics (Serpone et al., 2007; Darbre, 2006; Manová et al., 2013; Yousif and Hasan, 2015). 
Extensive use of the UV screens in consumer products has resulted in the wash out of these 
chemicals into waste water systems (Poiger et al., 2004; Brooke et al., 2008) and due to their 
stability, they are accumulating in the environment with measurable levels in water and in soil 
(Poiger et al., 2004; Brooke et al., 2008; Zhang et al., 2011; Jurado et al., 2014; Careghini et 
al., 2015) and in tissues of aquatic species (Balmer et al., 2005; Buser et al., 2006; Gago-
Ferrero et al., 2015). Furthermore, UV screens can now be measured in human tissue as 
discussed in the section 1.4.2 below.  
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Among the different UV screens, fifty five chemicals are approved for use in various different 
countries but only 10 of them are approved for global use (Shaath, 2010). For this thesis, 6 
organic UV screens (detailed in tables 1.3-1.4) known to be used in cosmetics were chosen 
for investigation based on the current knowledge of their levels and stable presence in the 
environment and the aquatic species (Poiger et al., 2004; Balmer et al., 2005; Buser et al., 
2006; Brooke et al., 2008; Zhang et al., 2011; Jurado et al., 2014; Careghini et al., 2015; 
Gago-Ferrero et al., 2015), their absorbance by the human skin, their existence in human 
samples (section 1.4.2) and their reported oestrogenicity (section 1.4.3). Other reflective 
compounds were not selected due to time and physical limitations. 
Table ‎1.3 Selected benzophenones used in this study.  
Benzophenones absorb two sub-types of the UVR (UVA and UVB). Information from 
Shaath, 2010; Krause et al., 2012 and the structures from http://pubchem.ncbi.nlm.nih.gov.  
UV screen 
Chemical name 
(CAS number) 
Chemical structure and Relative 
binding affinity to ER (RBA) 
Approval 
for use 
Benzophenone-
1 (Bp1) 
2,4-dihydroxy-
benzophenone 
( CAS 131-56-6) 
 
 
 
 
RBA to ER = 0.002 % (IC50  3.65 X 
10
–5
 M ± 0.45 x 10
–5 
M) (Blair et al., 
2000) 
Japan 
 And  
South Africa 
Benzophenone-
2 (Bp2) 
2,2',4,4'-tetrahydroxy-
benzophenone 
(CAS 131-55-5) 
 
 
 
 
RBA to ER = information not available  
Australia/ 
New 
Zealand-  
Japan-South 
Africa 
Benzophenone-
3 (Bp3) 
2-Hydroxy-4-
methoxybenzophenone 
(CAS 131-57-7) 
 
 
 
 
RMA to ER = low 
(IC50  > 1.00 X 10-4 M) (Blair et al., 
2000) 
Worldwide 
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Table ‎1.4  Other selected UV screens used in this study. 
Both octyl methoxycinnamate (OMC) and homosalate (HS) absorb UVB, while 4-
methylbenzylidene camphor (4MBC) absorbs UVA. Information from Shaath, 2010; 
Krause et al., 2012 and the structures from http://pubchem.ncbi.nlm.nih.gov.   
UV screen 
Chemical name 
(CAS number) 
Chemical structure  
and (RBA) 
Approval for use 
Octyl 
methoxycinnamate 
(OMC) 
2-Ethylhexyl-p-
methoxycinnamate 
(CAS 5466-77-3) 
RBA to ER = information 
not available  
Worldwide 
4-Methylbenzylidene 
camphor (4MBC) 
3-(4-
Methylbenzylidene)ca
mphor 
(CAS 36861-47-9) RBA to ER = 0.006 % 
ERβ binding IC50= 3.53 × 
10
−5
 ± 2.04 × 10
−5
 M 
(Schlumpf et al., 2004a) 
EU- Australia/ 
New Zealand- 
Japan- South 
Africa 
Homosalate (HS) 
3,3,5-Trimethyl-
cyclohexyl- salicylate  
(CAS 118-56-9) 
RBA to ER = information 
not available  
Worldwide 
Limited published work has documented the binding affinity of some of the 6- UV screens 
under investigation and the ER. Blair and co-workers have documented Bp1, Bp2 and Bp3 
binding affinity to ER by using the rat uterus ER binding competitive assay of 3H-
oestradiol with the benzophenones (Blair et al., 2000), while among the other UV screens 
only 4-MBC binding affinity to human ERβ was documented by Schlumpf and her 
28 
 
1.4.2 Human exposure and tissue levels 
Humans are exposed to UV screens through the dermal application of cosmetic products that 
contain these chemicals. Penetration of these chemicals into the human body has been 
demonstrated (Hayden et al., 1997; Jiang et al., 1999; Janjua et al., 2004; Schlumpf et al., 
2010), and varies according to the lipophilic characteristics of the UV screen and the product 
formulation (Chatelain et al., 2003; Kim et al., 2014). Dermal application of a commercial 
sunscreen lotion containing Bp3 6% (w/v), OMC 7.5% (w/v), octyl salicylate 5% (w/v) and 
octocrylene 7% (w/v), resulted in the detection of Bp3 in the urine samples of nine human 
volunteers after 48 hours (Hayden et al., 1997). Janjua and his colleagues detected three of 
the commonly used UV screens (4MBC, OMC or Bp3) in human plasma and urine after two 
weeks of daily dermal application on males and post-menopausal women (Janjua et al., 
2004). In a following study, similar findings were obtained but after only 4 days of repetitive 
whole body application of 4MBC, OMC and Bp3; these three chemicals were detected in 
plasma after 2 hours of application and in the urine with higher concentrations after 96 hour 
of the application than after 24 hours (Janjua et al., 2008). Some of the UV screens have been 
detected in animal blood/plasma following topical application such as HS (Kim et al., 2014) 
and Bp2 in rat plasma (Schlecht et al., 2008). 
Evidence of human exposure to the UV screens in the general population was obtained from 
several reports, which measured these chemicals in human urine, blood/serum, milk and 
placenta. This is documented in Table ‎1.5 below. A large scale study was conducted to test 
urine and blood samples of Chinese participants who were not known to have a work-related 
exposure to Bp1, Bp2 and Bp3. In that study, 101 urine samples were tested and Bp1, Bp2 
and Bp3 were detected in 57%, 5% and 25% of the samples respectively. Moreover, Bp3 was 
detected in 83% of the analysed adult blood samples. However, Bp1 was only detected in two 
blood samples and Bp2 was never observed in the blood (Zhang et al., 2013). In Korea, the 
colleagues (Schlumpf et al., 2004a). Further Kerdivel and colleagues have conducted a 
docking analysis of the interaction between benzophenone compounds including Bp1, Bp2 
and Bp3 and the ER. Results have showed that benzophenones phenolic A-ring with a 
hydroxyl group interacts with Arg-394, Glu-353 or Phe-404 of the ligand-binding pocket of 
ERα (Kerdivel et al., 2013). The oestrogenic effects of the 6 selected UV screens are 
further detailed in section 1.4.3. 
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linear association between the use of different cosmetic products and the high concentration 
of Bp3 in the urine samples was recently documented (Ko et al., 2016).  
The presence of HS, 3-benzylidene camphor (3-BC) and 4MBC in the human placenta was 
reported in 2013 (Jimenez-Diaz et al., 2013). In a more recent study, Valle-Sistac and his 
colleagues have measured Bp1, Bp2, Bp3 and benzophenone-4 (Bp4) in 12 human placenta 
samples. However, Bp3 could not be observed in the tissue while its largest metabolite (Bp1) 
was observed in all of the samples. In the same study, Bp2 was measured in only one sample 
but Bp4 was measured in all of the samples (Valle-Sistac et al., 2016).   
1.4.2.1 UV screens in human milk 
Concentrations of the UV screens in human breast tissue have not yet been measured but 
levels have been measured in human milk and measurement in milk is reflective of levels in 
the breast. A significant correlation with the use of dermally applied cosmetics that contain 
UV screens and the presence of these chemicals in human milk was reported by Schlumpf 
and her colleagues in 2010. Eight of the UV screens (Bp2, Bp3, OMC, 4MBC, HS, 
octocrylene, 3-BC and octyl-dimethyle PABA (OD-PABA)) were chosen to be investigated, 
and 54 milk samples were collected along with detailed questionnaires regarding the use of 
cosmetics from every participant. Notably, 85.2% of the milk samples contained one of the 
eight UV screens included in this study except for Bp2 which was not detected in the milk 
samples. Moreover,  4MBC and octocrylene were found to be correlate significantly with the 
use of cosmetic products (Schlumpf et al., 2010). In addition, Bp1 was recently detected in 
nine of ten samples collected from lactating women from Spain, and Bp3 was found in a 
higher concentration than Bp1 in the same study (Rodriguez-Gomez et al., 2015). However, it 
is noteworthy that Bp1 is a metabolite of BP3 that was measured in rats (Jeon et al., 2008), 
after in vitro incubation of Bp3 with isolated rat hepatocytes (Nakagawa and Suzuki, 2002), 
and in human urine after 4 hours of topical application of Bp3 (Felix et al., 1998). Thus even 
if Bp1 is not used in cosmetics in the EU, it might be generated from the metabolism of the 
world-wide approved Bp3. Concentrations of UV screens in human milk are documented in 
Table ‎1.5 below. 
The evidence of the presence of UV screens in human tissues is important in the context that 
these chemicals are considered to be endocrine disruptors with an ability to mimic the action 
of oestrogen. This is discussed in more detail in the next section.  
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Table ‎1.5  Measurement of UV screens in human samples and the recommended 
maximal amount in cosmetics in The European Union (EU).  
U
V
 S
u
n
sc
r
ee
n
 Concentration (Range) in Amount in 
cosmetics (EU 
Directive 
76/768/EEC from 
Brook et.al, 2008) 
Human urine 
Human plasma/ 
blood  
Human milk  
Human tissue 
(placenta)  
Bp1 
0.07 - 14.6 ng/ml ( 2.8 
X 10-10 M - 6.8 X 10-8 
M) (Zhang et al., 2013) 
0.06 - 0.15 ng/ml ( 2.8 
X 10-10 M  - 7  X 10-10 
M) (Zhang et al., 2013) 
0.61 ng/ml (2.8 X 10-9 
M) (Rodriguez-Gomez 
et al., 2015) 
* 0.02-0.07 ng/g fw ( 
9.3 X 10-11 M  - 2.8 X 
10-10 M )  (Valle-Sistac 
et al., 2016) 
* 0.5-9.8 ng/g  ( 2.3  X 
10-9  M  -  4.6  X 10-8 
M ) (Vela-Soria et al., 
2011) 
Not listed in 
the  EU 
Directive 
76/768/EEC   
Bp2 -- -- 
Not detected. 
Participants reported 
no usage of Bp2 
(Schlumpf et al., 2010) 
* 0.05 ng/g fw ( 2  X 
10-10 M) (Valle-Sistac 
et al., 2016) 
* 0 - 8.9 ng/g ( 0 M  -  
3.6 X 10-8 M ) (Vela-
Soria et al., 2011) 
Not listed in 
the  EU 
Directive 
76/768/EEC   
Bp3 
* 0 - 468 ng/ml ( 0 M  
- 2.8 X 10-6 M ) (Janjua 
et al., 2008) 
* 0.11 - 46.1 ng/ml ( 
4.8  X 10-10  M  -  2  X 
10-7 M ) (Zhang et al., 
2013) 
* 28 - 392 ng/ml ( 1.2  
X 10-7   M  -  1.7  X 10-
6 M ) (Janjua et al., 
2008) 
* 0.41 - 3.38 ng/ml ( 
1.7  X 10-9  M  -  1.4  X 
10-10 M ) (Zhang et al., 
2013) 
* 7.3 - 121.4 ng/g 
Lipid (1.14  X 10-9 M - 
2 X 10-8 M) (Schlumpf 
et al., 2010) 
* 4.5-15.7 ng/ml (7.8  
X 10-10 M - 2.95 X 10-9 
M) (Rodriguez-Gomez 
et al., 2015) 
* Not detected (Valle-
Sistac et al., 2016) 
* Not detected (Vela-
Soria et al., 2011) 10% 
OMC 
1 - 39 ng/ml ( 3.4  X 
10-9  M  -  1.3  X 10-7 
M ) (Janjua et al., 
2008) 
0 - 40 ng/ml ( 0  M  -  
1.4  X 10-7 M ) 
(Janjua et al., 2008) 
2.1 - 79.85 ng/g Lipid  
( 3 X 10-10 M to 1 X 
10-8 M)  (Schlumpf et 
al., 2010) 
-- 10% 
4MBC 
0 - 32 ng/ml (0  M  -  
1.25  X 10-7 M ) 
(Janjua et al., 2008) 
0 - 39 ng/ml ( 0  M  -  
1.5  X 10-7 M ) (Janjua 
et al., 2008) 
6.7 - 48.37 ng/g Lipid 
(1 X 10-9 M  - 7.6 X 
10-9 M) (Schlumpf et 
al., 2010) 
2 - 73 ng/g ( 7.8  X 10-
9  M  -  2.8  X 10-7 M ) 
(Jimenez-Diaz et al., 
2013) 
4% 
HS -- -- 
11.4 - 61.2  ng/g  
Lipid (1.7 X 10-9 M - 
9.33 X 10-9 M) 
(Schlumpf et al., 2010) 
2.1- 73 ng/g (8  X 10-9  
M  -  2.8  X 10-7 M ) 
(Jimenez-Diaz et al., 
2013) 
10% 
(--) No information available 
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1.4.3 The oestrogenic action of UV screens in vitro and in vivo   
1.4.3.1 In vitro oestrogenic activity of UV screens 
In vitro oestrogenic activity of these chemicals can be measured in terms of their ability to 
bind to oestrogen receptor and to regulate oestrogen responsive gene expression. It can also 
be measured in terms of the ability to stimulate proliferation of oestrogen responsive human 
breast cancer cells (Darbre, 2015). 
1.4.3.1.1 Reporter gene assays 
The oestrogenic activity of OMC, 4MBC, HS and Bp3 was studied in vitro using reporter 
gene assays. The ERE–luciferase assay (ERE-LUC) was conducted on either ERα or ERβ 
stably transfected HEK293 kidney cells after exposure to UV screens for 24 hours. All tested 
chemicals activated ERα transcription, although to different extents. The EC50 (the 
concentration which caused 50 % of the maximal effect of the chemical) of hERα 
transcriptional activity for each UV screen was 2.8 X 10
-5 
M Bp3, 6.2 X 10
-6 
M 4MBC and 
1.6 X 10
-6 
M  HS while the transcriptional activity for OMC dose-response was beyond 42 %. 
OMC was the only tested chemical not to activate ERβ mediated transcriptional activity 
(Schreurs et al., 2005). Gomez and co-workers confirmed Schreurs work. In their study they 
used transfected HeLa cervical cells and reported an oestrogenic ERα transcriptional activity 
in the presence of 10
-5
 M OMC, 3 X 10
-6 
M 4MBC and 10
-6
 M HS (Gomez et al., 2005). 
Using a reporter gene assay, Kerdivel and his colleagues measured the effect of Bp1, Bp2 and 
Bp3 (in concentrations from 10
-8 
M to 10
-6 
M) on the luciferase activity of oestrogen 
responsive targets in MCF-7 cells transfected with ERE-LUC. Both 10
-6 
M Bp1 and 10
-7 
M 
Bp2 significantly increased the transactivation activity of ERE and the effect was decreased 
using the antioestrogen fulvestrant at 10
-7 
M concentration. However, no significant change in 
the transactivation activity was observed following the exposure to Bp3 (Kerdivel et al., 
2013).   
1.4.3.1.2 Endogenous oestrogen regulated genes 
The oestrogen mimicking activity of the UV screens has also been investigated using 
endogenous oestrogen-regulated genes in MCF-7 cells. The radioimmunoassay for TFF1 
protein was performed to measure the secretion of TFF1 by MCF-7 cells in the culture media 
following 3 days of exposure to 5 X 10
-5 
M of OMC, 4MBC, HS and Bp3, which resulted in 
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significant elevation of TFF1 protein expression when compared to the control. The highest 
levels were measured following exposure to 4MBC, HS and Bp3 respectively but no effect of 
OMC was found (Schlumpf et al., 2001).  A further effect of the UV screens on TFF1 mRNA 
transcription levels was reported by Heneweer and his colleagues who found a dose response 
increase in TFF1 gene transcription in MCF-7 cells after 24 hours exposure to Bp1, Bp3, 
OMC or 4MBC, at concentrations ranging from 10
-8 
M to 10
-5
 M. In the same study, a 
mixture of equipotent components, which individually showed no significant effect in 
comparison to 17β-oestradiol at C50 (the concentration of which the UV screen increased 
50% of the basal TFF1 gene transcription), induced TFF1 gene expression to a similar levels 
of that of 17β-oestradiol (Heneweer et al., 2005).  
More oestrogen regulated genes were studied by Kerdivel and his colleagues. The effect on 
TFF1 gene expression was documented following MCF-7 cell exposure, Bp1, Bp2 and Bp3 at 
concentrations of 10
-8
 M to 10
-6
 M or 10
-8
 M 17β-oestradiol. The cells were deprived of 
serum for 24 hours and then incubated with oestradiol, Bp1, Bp2 and Bp3 in the presence of 
2.5% dextran-charcoal treated serum for 48 hours. Among the treatments, oestradiol induced 
the highest effect on TFF1 mRNA expression followed by 10
-6 
M Bp2 and 10
-6 
M Bp3 
respectively. The effect on the TFF1 gene by oestradiol and these chemicals was decreased by 
using the antioestrogen fulvestrant. While 10
-6
 M
 
Bp1 did not increase the expression of TFF1 
gene in MCF-7 cells, it increased the expression of progesterone receptor (PR) mRNA which 
is another oestrogen regulated gene, and a similar effect was found after exposure to 10
-6
 M 
Bp2. The induction of CXCL12 and amphiregulin expressions were achieved after exposure 
to 10
-6
 M Bp2 (Kerdivel et al., 2013).   
1.4.3.1.3 The recombinant yeast assay 
The recombinant yeast assay was used to measure the ability of UV screens to activate ERE 
in vitro. This technique is performed with transfecting two different plasmids in yeast, the 
first is the expression plasmid which is integrated with human cDNA that produces ER and 
the second is the reporter plasmid which is consisted of ERE reporter gene upstream of β-
galactosidase structural gene. Once the compounds binds to ER and activated the receptors, 
the dimerized ERs consequently activates the ERE reporter gene, which activate the release 
of β-galactosidase in the medium (Coldham et al., 1997). Kunz and colleagues measured the 
effect of Bp1, Bp2, Bp3, OMC, 4MBC or HS on recombinant yeast carrying human ERα. In 
their study a high potency was detected following incubation with 2.59 X 10
-10
 M 17β-
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oestradiol, 1.15 X 10
-6
 M Bp1 and 1.09 X 10
-5
 M Bp2. Mild potency was achieved by the 
presence of 1.86 X 10
-5
 M Bp3 and no oestrogenic effect was detected after the exposure to 
OMC, 4MBC or HS (Kunz et al., 2006). Miller and his colleagues studied 73 different 
compounds used in cosmetics of which 18 were UV screens. Using yeast transfected with 
human ERα gene, the oestrogenic potency relative to 17β-oestradiol of Bp1 was (1/3,000) and 
of Bp2 was (1/7,000) while Bp3 showed even weaker potency (1/100,000). Furthermore, they 
have suggested that the UV screens with oestrogenic activity (Bp1 and Bp2) have an 
unhindered phenolic ring with OH in a para configuration and an appropriate molecular size 
(140 - 250 kDa) which allows the chemical to fit and bind in the ERα site (Miller et al., 2001) 
(see section 1.3.1.1 and see Table 1.3). 
1.4.3.1.4 Proliferation of oestrogen responsive human breast cancer 
cells 
Several studies have shown the oestrogenic activity of UV sunscreens on cell proliferation in 
vitro. In 2001, Schlumpf and her colleagues reported an increase in MCF-7 cell proliferation 
after 6 days of exposure to different concentrations of Bp3, OMC, 4MBC and HS. Significant 
increase in MCF-7 cell proliferation was reported following the exposure to 5 X 10
-6
 M Bp3, 
5 X 10
-6
 M OMC, 5 X 10
-5
 M 4MBC and 1 X 10
-6
 M HS (Schlumpf et al., 2001). Further 
studies reported an increase in MCF-7 cell proliferation after exposure to 10
-6
 M
 
Bp2 
(Kerdivel et al., 2013) and 10
-8
 M Bp1 (Nakagawa and Suzuki, 2002). Similar positive effects 
on MCF-7 cell proliferation after exposure to 4MBC or HS were reported by Jimenez-Diaz et 
al., (2013). In contrast with the reported positive effect of Bp1 or Bp3 on MCF-7 cell 
proliferation, Kerdivel and his colleagues did not observe similar results and neither Bp3 nor 
Bp1 at concentrations from 10
-8
 M to 10
-6
 M increased MCF-7 cell proliferation in their 
studies (Kerdivel et al., 2013). The most likely explanation for the differences lies in the 
variation of the oestrogen responsiveness of MCF-7 cells between different laboratories, and 
the diverse experimental conditions (Osborne et al., 1987; Shaw et al., 2006). 
1.4.3.2 In vivo oestrogenic activity of UV screens 
In addition to the in vitro oestrogenic activity of UV screens, multiple in vivo studies have 
been conducted which demonstrate oestrogenic activity in rodents. One of the first 
experiments to measure the oestrogenic effect of the UV screens using the uterotrophic assay 
in immature rats was conducted by Schlumpf and her colleagues in 2001. The dermal 
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application of olive oil containing  5 % and 7.5 % 4MBC on immature rats caused an 
increased uterine weight after 6 days of applying the chemical twice a day (Schlumpf et al., 
2001). This effect on immature rat uterus was confirmed by another research group who 
administrated 4MBC as either a subcutaneous injection or oral inoculation (Tinwell et al., 
2002). However, Mueller and co-workers have suggested that the increase in the uterine 
weight in rat after exposure to 4MBC might not be mediated through an oestrogenic pathway 
because of the weak transcriptional activity of ERα and ERβ after the exposure to 4MBC in 
transiently transfected human endometrial Ishikawa cells (Mueller et al., 2003). The 
uterotrophic assay was also used to measure the effect of orally introduced UV screens 
including OMC, HS, Bp1, Bp2 or Bp3, and a positive increase in the uterine weight was 
detected following the treatment for all but HS (Schlumpf et al., 2004). 
The endocrine disruption in fish after exposure for 14 days to Bp1 and Bp2 was found by 
measuring the endocrine disruptor marker Vitellogenin (VGA) using ELISA, and no effect 
was found after exposure to Bp3, OMC, 4MBC or HS (Kunz et al., 2006). On the other hand, 
VGA mRNA expression was induced following the exposure to OMC or 4MBC in another 
fish species (Inui et al., 2003). However, different in vivo results might be caused by different 
species (Kunz et al., 2006). 
The endocrine disruption of some of these chemicals was further demonstrated in vivo in the 
literature. Disruption has been recorded on the endocrine system in rats including effects on 
the pituitary gland (Klammer et al., 2005), measured by the reduction of luteinising hormone 
synthesis (Jarry et al., 2004), by interference with thyroid hormone production (Seidlová-
Wuttke et al., 2006; Klammer et al., 2007; Schmutzler et al., 2007), and by interference with 
lipid metabolism (Jarry et al., 2004; Seidlová-Wuttke et al., 2006). Moreover, some UV 
screens were associated with a delay in puberty in male rats due to their androgenic effects 
(Schlumpf et al., 2004), and disturbance to the reproductive ability of fish species (Fathead 
Minnows) (Weisbrod et al., 2007). 
Since UV screens possess oestrogen mimicking properties and their entry to the human body 
is documented, further investigation should be carried out to in order to explore their probable 
influence through endocrine disruption to related human health concerns. 
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1.5 Underlying hypothesis 
The evidence of the UV screens entry to the human body along with their oestrogen 
mimicking properties as indicated in both in vitro and in vivo models as well as the previously 
elaborated evidence of the role of oestrogen on breast cancer progression, make the 
hypothesis of the possible effect of the UV screens on breast cancer progression biologically 
plausible and applicable to this research. For this reason, the hypothesis was tested that UV 
screens might enable multiple hallmarks of cancer and might increase not only proliferation 
but also migration/invasion of human breast cancer cells. 
1.6 Aims of project 
The overall aims of this research were to investigate the effects of six UV screens on the 
proliferation, migration and invasion of human breast cancer cells, using different times of 
exposure.  
The first aim was to study the oestrogenic effect of six UV screen (Bp1, Bp2, Bp3, OMC, 
4MBC and HS) on MCF-7 human breast cancer cells by: 
1- The ERE-LUC reporter gene assay in stably transfected MCF-7 human breast 
cancer cells.  
2- Evaluate the effect of exposure to the six UV screens on TFF1 mRNA levels 
using RT-PCR. 
3- Evaluate the effect of exposure to the six UV screens on ERα protein levels in 
MCF-7 cells. 
4- MCF-7 human breast cancer cell proliferation in monolayer culture using plastic 
culture dishes and in 3D culture using plates coated with fibronectin or laminin. 
A second aim was to investigate the effect of the exposure to the benzophenones (Bp1, Bp2 
or Bp3) and the other group of the selected UV screens (OMC, 4MBC or HS) on migration of 
MCF-7 human breast cancer cells after different times of exposure, using time-lapse 
microscopy, wound healing assays and xCELLigence technology, and on invasion of MCF-7 
human breast cancer cells using xCELLigence technology plates coated with matrigel. 
Further research investigated some potential molecular mechanisms underlying any changes 
in the migration and invasion of MCF-7 cells using western immunoblotting, zymography 
and on Reverse Transcriptase Polymerase Chain Reaction (RT-PCR). The focus was mainly 
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directed toward the markers of EMT (E-cadherin, β-catenin, Twist-1and snail), and other 
markers of motility including bone morphogenetic protein 7 (BMP7), phosphoinositide-3-
kinase regulatory subunit 1 (PIK3R1), MMP-2, MMP-9 and MMP-14.   
The third aim was to validate the findings obtained using the MCF-7 cell line by using a 
second oestrogen responsive (ER+) human breast cancer cell line, the T-47-D human breast 
cell line. 
Finally, the fourth aim was to investigate the effect of the UV screens on the proliferation, 
migration and invasion of oestrogen unresponsive human breast cancer cells using the MDA-
MB-231 cell line. The effect of the UV screens on the molecular level of this cell line was 
carried on by investigating the effects on MMPs using western immunoblotting and 
zymography. 
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Chapter 2  Materials and Methods 
2.1 Culture of human breast cancer cells  
2.1.1 Culture of stock MCF-7 human breast cancer cells 
MCF-7 McGrath human breast cancer cells were provided by C.K. Osborne in 1987 at 
passage number 390 (Osborne et al., 1987). Cells were maintained as monolayer cultures in 
9-cm tissue culture dishes (63.6 cm
2
 culture area per dish) (Nunc, Denmark) in a humidified 
atmosphere of 10% carbon dioxide in air at 37°C. Stock culture medium consisted of 
Dulbecco's modified Eagle's medium (DMEM) (containing phenol red) (Invitrogen, Paisley, 
UK), 5% (v/v) foetal calf serum (FCS) (Invitrogen), 10
-8 M 17β-oestradiol (Steraloids, 
Croydon, UK), streptomycin (100µg/ml) , penicillin (100U/ml) (Invitrogen) and insulin 
(10µg/ml) (Sigma, Poole, UK) (Darbre and Daly, 1989). Oestradiol was dissolved in ethanol 
as a 10
-4
 M stock solution and diluted 1/10,000 in culture medium. Insulin (bovine pancreas) 
was purchased at 10mg/ml from Sigma (10516-5ml) and diluted 1/1000 in culture medium. 
2.1.2 Culture of stock T-47-D human breast cancer cells 
T-47-D human breast cancer cells were provided by the originator (Keydar et al., 1979). 
These cells were grown as a monolayer cultures in 9-cm tissue culture dishes (63.6 cm
2 
culture area per dish) (Nunc, Denmark) in a humidified atmosphere of 10% carbon dioxide in 
air at 37°C. Stock culture medium consisted of Dulbecco's modified Eagle's medium 
(DMEM) (containing phenol red) (Invitrogen, Paisley, UK), 5% (v/v) foetal calf serum (FCS) 
(Invitrogen), 10
-8
 M 17β-oestradiol (Steraloids, Croydon, UK), streptomycin (100µg/ml) and 
penicillin (100U/ml) (Invitrogen). 
2.1.3 Culture of stock MDA-MB-231 human breast cancer cells 
MDA-MB-231 human breast cancer cells were obtained from The American Tissue Culture 
Collection at passage 28. Cells were maintained as monolayer cultures in 9-cm tissue culture 
dishes (63.6 cm
2
 culture area per dish) (Nunc, Denmark) in a humidified atmosphere of 10% 
carbon dioxide in air at 37°C. Stock culture medium consisted of Dulbecco's modified Eagle's 
medium (DMEM) (containing phenol red) (Invitrogen, Paisley, UK), 10% (v/v) foetal calf 
serum (FCS) (Invitrogen), streptomycin (100µg/ml) and penicillin (100U/ml) (Invitrogen). 
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2.1.4 Sub culturing of stock human breast cancer cells  
Stock cells were sub-cultured at weekly intervals. The cells in monolayer were washed twice 
with 2 ml of Hanks’ balanced salt solution (HBSS) (Invitrogen). Then cells were incubated in 
2ml of HBSS containing 0.06% trypsin (w/v), 0.02% EDTA, pH7.3 (Invitrogen) in a 
humidified atmosphere of 10% carbon dioxide in air at 37°C for 2 minutes. The cells were 
suspended and then added to relevant culture medium and re-plated at 1/10th dilution into 9-
cm tissue culture dishes (Nunc, Denmark). 
2.1.5 Maintenance of human breast cancer cells with UV screens  
MCF-7 and T-47-D human breast cancer cells were maintained as separate stock cultures in 
phenol red-free DMEM (Invitrogen) containing 5% (v/v) dextran-charcoal stripped FCS 
(DCFCS) (Darbre et al., 1983), 2 mM L-glutamine, 100 µg/ml streptomycin and 100 U/ml 
penicillin (Invitrogen, Paisley, UK) with no further addition or with the relevant 
concentration of UV screens in a humidified atmosphere of 10% carbon dioxide in air at 
37°C. DC treatment of sera was carried out by incubating FCS (Invitrogen) with 1 % charcoal 
(Sigma) and 0.1 % dextran T-70 (Pharmacia, Sweden) with rotation for 35 minutes at 55°C 
(Darbre et al., 1983). Then DCFS was filter sterilized and aliquots were stored at -20°C. 2,4-
dihydroxybenzophenone (Bp1) (CAS 131-56-6) with purity of 99% , 2,2',4,4'-tetrahydroxy-
benzophenone (Bp2) (CAS 131-55-5) with purity of 97%, 2-Hydroxy-4-
methoxybenzophenone (Bp3) (CAS 131-57-7) with purity of 98%, 2-Ethylhexyl-p-
methoxycinnamate (OMC) (CAS 5466-77-3) with purity of 98%, 3-(4-
Methylbenzylidene)camphor (4MBC) (CAS 36861-47-9) with purity of 98% and 3,3,5-
Trimethyl-cyclohexyl- salicylate (HS) (CAS 118-56-9) with purity of 99.9% were purchased 
from Sigma-Aldrich (UK). Stock concentrations of the UV screens were made in ethanol and 
diluted 1/10,000 in cell culture media. Controls contained the same volume of ethanol. 
Experiments contained final concentrations of each UV screen at concentrations of 10
-8
 M to 
10
-5
 M (Table ‎2.1). Media were changed routinely every 3-4 days. 
The same methodology was used for maintaining MDA-MB-231 human breast cancer cells 
except that the DMEM contained phenol red and 10% FCS (Invitrogen, Paisley, UK). 
Experiments were conducted on cells exposed to different treatments for 1-2 weeks, while 
longer-term exposure experiments were carried out on the cells treated for 7-40 weeks. 
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Table ‎2.1 Final concentration of UV screens in media for short and long-term exposure 
experiments 
Human breast 
cancer cells 
Proliferation 
experiments 
Migration and motility experiments 
1 week Short-term exposure Long-term exposure 
MCF-7 cells 
10
-8 
M, 10
-7 
M,  
10
-6 
M and 10
-5 
M 
10
-7 
M, 10
-6 
M and 10
-5 
M 
(2 weeks) 
10
-7 
M, 10
-6 
M and 10
-5 
M 
(7 - 13 - 31 weeks) 
T-47-D cells 
10
-8 
M, 10
-7 
M,  
10
-6 
M and 10
-5 
M  
10
-5 
M 
(2 - 3 weeks) 
10
-5 
M 
(7- 13 - 20 - 40 weeks) 
MDA-MB-231 
cells 
10
-5 
M  10
-7 
M and 10
-5 
M 
(2 weeks) 
10
-7 
M and 10
-5 
M   
 (8 - 15 weeks) 
 
2.1.6 Sub culturing of human breast cancer cells exposed to UV 
screens  
Long-term exposed human breast cancer cells were maintained in 6-well plates. Cells were 
sub cultured at weekly intervals. 0.8ml of HBSS was used to wash the cell monolayer twice. 
And cells were incubated in in a humidified atmosphere of 10% carbon dioxide in air at 37°C 
for 2 minutes in 0.8 ml of HBSS containing 0.06% trypsin (w/v) and 0.02% EDTA pH 7.3. 
After that cells were re-plated at 1/5
th
 dilution in relevant media into 6-well plates.  
2.2 Measurement of cell proliferation 
Cell proliferation was determined by either using the Coulter counter in order to count the 
number of nuclei released from adherent cells in a monolayer or by monitoring the change in 
electrical impedance, which is correlated with the increase of proliferation as determined by 
the xCELLigence technology.  
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2.2.1 Measurement of cell proliferation using a ZBI Coulter counter  
2.2.1.1 Measurement of cell proliferation on non-coated plates using a 
Coulter counter  
Cells were suspended from stock dishes by treatment with trypsin-EDTA solution as 
described above and seeded at 0.2 × 10
5
 cells per ml in phenol-red-free-DMEM containing 
5% DCFCS in 0.5 ml aliquots into 4-well (2.01 cm
2 
culture
 
area per well (1.6 cm diameter)) 
and 24-well (2.01 cm
2 
culture
 
area per well) plastic tissue culture dishes (Nunc). The medium 
was replenished after 24h to contain the required concentration of UV screen, an ethanol 
vehicle control or 10
-8 
M 17β-oestradiol as a positive control. Medium was changed routinely 
every 3-4 days. 
Cell number was measured by counting cell nuclei on a ZBI Coulter counter. Cells in a 4-well 
plate were lysed on day zero and cells in monolayer in 24-well plates were lysed after 7 or 14 
days of incubation. To achieve nuclei release, cells were washed with 0.9% (w/v) NaCl in 
water and lysed in 0.01 M HEPES/ 1.5 mM MgCl2 plus two drops of Zap-oglobin II (lytic 
reagent used to lyse the cells and release the nuclei) (Beckman Coulter) for 20 minutes. 
According to the manufacturer, Zap-ogloben II active ingredients include organic quaternary 
ammonium salt, potassium cyanide, sodium Nitrate and sodium nitroferricyanide. Released 
nuclei were counted in isoton (Beckman Coulter) in triplicate on a ZBI Coulter counter 
(Beckman Coulter). Cell counts were done in triplicate and cell numbers are the average of 
triplicate wells for each treatment ± standard error (SE). The results were calculated using 
Microsoft Excel 2010 package and plotted using GraphPad Prism software version-6.01 
(GraphPad Software Inc.). 
2.2.1.2 Measurement of cell proliferation on coated plates using a 
Coulter counter  
In order to study the effect of the UV screens on cells seeded on coated plates, (2.01 cm
2 
culture
 
area per well) and 24-well (2.01 cm
2 
culture
 
area per well) tissue culture plates (Nunc) 
were used uncoated or coated with 6.5 µg/cm
2
 laminin or with 6.5 µg/cm
2
 fibronectin. 
Laminin (Engelbreth-holm-swarm murine sarcoma basement membrane Sigma, Poole, UK) 
[1mg/ml in Tris buffered NaCl] was received suitable for tissue culture and was diluted in 
HBSS in sterilized conditions. 
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Wells were coated with 6.5 µg/cm
2
 laminin for each well. Then the tissue culture plates were 
incubated 2 hours at 37°C in the incubator and 1 hour at room temperature. Excess laminin 
was removed and the wells were washed 3X with HBSS. Plates were kept at 4°C for 24 hours 
prior to the seeding experiment. 
Fibronectin from human plasma (Sigma, Poole, UK) was received dry and was dissolved in 
sterilized ddH2O by incubating the mixture at 37°C using the water bath. Wells were coated 
with of 6.5 µg/cm
2
 of fibronectin diluted in HBSS and then left at room temperature in the 
hood to dry for 1 hour. Excess fibronectin was removed and the wells were washed 3X with 
HBSS. Plates were kept at 4°C for 24 hours prior to the seeding experiment. 
The coated plates were washed with phenol-red-free-DMEM containing 5% DCFCS in 0.5 ml 
aliquots prior to seeding of MCF-7 cells. Cells were suspended from stock dishes by 
treatment with trypsin-EDTA solution as described above (section 2.1.4) and seeded at 0.2 × 
10
5
 cells per ml in phenol-red-free-DMEM containing 5% DCFCS in 0.5 ml aliquots into the 
coated and uncoated plates. The medium was replenished after 24h to contain the required 
concentration of UV screen, an ethanol vehicle control or 10
-8
 M 17β-oestradiol as a positive 
control. Medium was changed routinely every 3-4 days and the cell counting experiment was 
carried out on day 7 using the ZBI Coulter counter as previously described (in section 
2.2.1.1). 
2.2.2 Measurement of cell proliferation using xCELLigence technology 
For measurement of MDA-MB-231 cell proliferation, aliquots of 100 µl of phenol-red-
DMEM containing 10% FCS were added to each of 16 wells in an E-plate (ACEA 
Biosciences, USA), incubated for one hour and then assembled into the cradle of the 
xCELLigence machine (Figure ‎2.1 and Figure ‎2.2) according to manufacturer’s instructions 
(ACEA Biosciences, USA). Stock cells were added to the required volume of phenol-red-
DMEM containing 10% FCS at a concentration of 0.2 × 10
5
 cells per ml and 100 µl aliquots 
added to each of the 16 wells of the E-plate. After 24 hours, the medium was replaced to 
contain the required concentration of UV screen or ethanol control. The culture medium was 
changed routinely every 3-4 days and the electrical impedance (cell index) monitored every 
hour for one week. Cell index after 7 days of exposure was determined by RTCA-DP 
software 1.2.1 (ACEA Biosciences, USA) and results were plotted using GraphPad Prism 
software version-6.01 (GraphPad Software Inc.).  
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Figure ‎2.1 xCELLigence real-time cell analysis (RCTA) instrument. 
The instrument is placed inside the incubator and was externally controlled via a cable 
connection to the RCTA system on a laptop computer.  
Figure ‎2.2 The E-plate 16.  
E-Plate 16 was used to measure cell proliferation by 
monitoring the live change in the electrical impedance of 
the microelectrode in the bottom of wells using the 
xCELLigence technology. 
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2.3 Ligand ability to increase expression of ERE-LUC reporter gene in 
MCF-7 cells  
The ability of each chemical to regulate an oestrogen-responsive gene was tested using a 
stably transfected oestrogen regulated ERE-LUC reporter gene in MCF-7 cells. The 
oestrogen-inducible ERE-LUC vector consisted of the oestrogen response element (ERE)-
containing nucleotide sequence from the vitellogenin A2 gene from -331 to -295 bp (5’- 
CTAGAAAGTCAGGTCACAGTGACCTGATCAAT –3’) (Klein-Hitpass et al., 1986) 
cloned into the multiple cloning site of the pGL3promoter vector containing the coding 
sequence for firefly luciferase (Promega). Oestrogen regulation of transiently transfected 
oestrogen-inducible ERE-LUC reporter gene in MCF-7 cells was published in 2006 (Shaw et 
al., 2006). However, a line of MCF-7 cells stably transfected with the same ERE-LUC 
reporter gene has been produced but not validated by prior publication.  
Transfected MCF-7 stocks were maintained in the same stock medium as MCF-7 cells 
(section 2.1.1) plus G418 sulphate (100 µg/ml) (Invitrogen). For reporter assays cells were 
seeded at 0.2 × 10
5
 cells per ml in phenol-red-free-DMEM containing 5% DCFCS in 0.5 ml 
aliquots into 24-well (2.01 cm
2
 culture
 
area
 
per well) plastic tissue culture dishes (Nunc) and 
grown for 6 days with a change of medium after 3 days. After 6 days, the medium was 
changed again but to contain the required concentration of the relevant UV screen, an ethanol 
vehicle control or 10
-8
 M 17β-oestradiol and cells grown for a further 24 hours. Six wells 
were used for each treatment. Three wells were used for cell counts and three wells were used 
for luciferase assays. For cell counts, each well was washed twice with isotonic saline and 
cell counts were performed using a ZBI Coulter counter as described (in section 2.2.1). 
Luciferase assays were performed using a commercial assay kit (Promega). For this, each 
well was washed twice with isotonic saline, cells were lysed using 50 µl of Promega passive 
lysis buffer and assays were performed without delay according to the manufacturer’s 
instructions (Promega). Cell extracts from each well were assayed in triplicate by mixing 4 µl 
of cell extract and 20 µl of luciferase reagent (Promega) in a 96-well white luminometer plate 
(Nunc) and measuring the luminescence within 10 minutes using an Anthos Lucy 1 
microplate luminometer. Results were calculated as average units of luminescence per 24 
hours for the triplicate assays. Results are presented as average luminescence units per 10,000 
cells ± standard error for the triplicate wells.  
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2.4 Cell migration and motility assays  
Three different techniques were used to study the effect of short-term and long-term exposure 
to UV screens on motility or migration of human breast cancer cells in this study. In order to 
detect the effect on the collective migration of MCF-7 and T-47-D human breast cancer cells, 
wound healing assays were performed.  To observe a live change in cell motility, time-lapse 
microscopy was carried out for both MCF-7 and MDA-MB-231 cell lines. To achieve a live 
monitoring of the effect of UV screens on chemotaxis driven migration of human breast 
cancer cells, the xCELLigence technology was used.  
2.4.1 Wound healing assay 
MCF-7 and T-47-D cells were seeded in phenol-red-free DMEM supplemented with 5% 
DCFCS, penicillin (100 U/ml), streptomycin (100 µg/ml) in 2.5 ml aliquots into 12-well (3.14 
cm
2 
culture area per well) plastic tissue culture dishes (Nunc) with the required concentrations 
of the UV screen, 10
-8
 M 17β-oestradiol or ethanol control. Triplicate wells were prepared for 
each treatment. Cells were grown to confluence and wounds were made down the centre of 
each well using a sterile 200µl plastic pipette tip (Liang et al., 2007). The cells were washed 
with HBSS (Invitrogen) to remove detached cells. Medium was replenished with the same 
test media plus mitomycin-C (Calbiochem, Merck Biosciences, Nottingham, UK) to inhibit 
cell proliferation. Mitomycin-c is an anticancer drug (Bradner, 2001), which stops the 
proliferation of cells by acting as DNA cross-linker and impairs DNA replication (Szybalski 
and Iyer, 1964). Mitomycin-C was dissolved in autoclaved distilled water to make a stock 
solution of 0.5 mg/ml and further diluted 1/1000 into cell culture media to give a 
concentration of 0.5 µg/ml. A minimum of five images (×4 objective) per well were taken 
along the length of the wound at 0 hour and 24 hours using an Axion inverted microscope 
attached to a Nikon-Ds-Fi2 camera and running NIS-elements AR4.10 software and equipped 
with a digital camera. The area of the wound at 0 hour was taken as 100% to assess cellular 
migration at 24 hours.  
2.4.1.1  Analysis of cell migration from wound healing assay 
Analysis of wound closure was conducted using Image J (version 1.47) open source software, 
obtained from the National Institutes of Health (NIH, USA).  Wound area was selected using 
the freehand selection tool for 0 and 24 hour pictures and the measurements were exported to 
Excel sheets to calculate the percentage of the closure of the wound area of three replicates ± 
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SE. The percentage values of wound closure were plotted using GraphPad Prism version-6.01 
software (GraphPad Software, La Jolla, CA). 
2.4.2 Cell motility assay as measured by time-lapse microscopy  
Cells were incubated in phenol-red-free DMEM supplemented with 5% DCFCS (for MCF-7 
cells) or phenol-red DMEM supplemented with 10% FCS (for MDA-MB-231 cells), 
penicillin (100 U/ml), streptomycin (100 µg/ml) and the required concentration of UV screen, 
10
-8
 M 17β-oestradiol or ethanol alone for 2, 13 or 22 weeks prior to the experiment. 48 hours 
prior to microscopy, cells were trypsinised and seeded at 0.2 x 10
5 
cells/ml in relevant media 
containing the required concentration of treatment in 0.5ml aliquots into 12-well (3.14 cm
2 
culture area per well) plastic tissue culture dishes (Nunc). After 48 hours, the medium was 
changed to contain mitomycin-C (0.5 µg/ml) and the dishes were placed on a microscope 
stage in a chamber heated to 37
o
C in an atmosphere of 5% carbon dioxide in air. Cell 
migration was observed over 24 hours by using a Nikon Eclipse TiE inverted microscope 
running NIS-elements AR4.10 software and equipped with a digital camera.  
2.4.2.1 Analysis of cell motility as measured by time-lapse microscopy 
Time-lapse videos were generated by capturing specific points of the 12-well (3.14 cm
2
 
culture area per well) plates every 15 minutes for 24 hours. Ten cells per field of view (three 
fields per well) were tracked for the entire period by using Image J software and MTrackJ 
plugin to calculate the total length of travel of each cell (cumulative length) and the 
percentage of motile cells. Results were calculated from the average value for 10 cells per 
field of view and then the average of three fields per well. Results are shown as mean ± SE 
for three wells. Results were plotted using GraphPad Prism version-6.01 software (GraphPad 
Software, La Jolla, CA). 
2.4.3 Cell migration using xCELLigence technology  
Cells were incubated in either phenol-red-free DMEM supplemented with 5% DCFCS (for 
MCF-7 and T-47-D) or phenol-red DMEM supplemented with 10% FCS (For MDA-MB-231 
cells), penicillin (100 U/ml), streptomycin (100 µg/ml) with the required concentration of UV 
screen, 10
-8
 M 17β-oestradiol or ethanol alone as vehicle control for 2 weeks and beyond 
prior to the experiment. Experiments were set up in an uncoated CIM-plate16 according to 
the manufacturer’s instructions (ACEA Biosciences, USA). The CIM-plate16 consists of two 
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chambers separated by a polyethylene terephthalate membrane with 8 µ pore size. The 
motility of cells from the upper to the lower chambers induces change in the electrical 
impedance of integrated gold microelectrodes on the underside of the membrane (Figure 2.3).  
 
 
 
 
 
 
 
 
 
 
 
According to the manufacturer’s instructions, 160µl of phenol-red-free DMEM with 5% 
DCFCS and the relevant concentration of 17β-oestradiol, UV compounds or ethanol control 
was added to fill lower chamber completely. In the upper chamber 30 µl of relevant medium 
lacking serum was added and the plate was incubated for 1 hour in the incubator and the 
background was set before seeding the cells.  
Cells were trypsinized as described above and counted by using a haemocytometer. After that 
the cells were pelleted by centrifugation for 2 minutes at 800 rpm (87xg) (Eppendorf 
centrifuge 5810) and re-suspended at the required density in relevant media lacking serum in 
order to generate a chemotactic signal towards the lower chamber. In each well the cell 
Figure ‎2.3 The CIM-plate16. 
The CIM-plate16 consists of upper chamber (A), lower chamber (B) separated by a 
polyethylene terephthalate membrane with 8 µ pore size (C) and integrated with gold 
microelectrodes (D). Red arrows demonstrate the cell migration from top chamber to the 
lower chamber through the membrane and onto the electrodes. 
 
(A) 
(B) 
(C) 
(D) 
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density was 40,000 cells / 100 µl. The real time change of the electrical impedance (cell 
index) was then determined by the xCELLigence analyser system (RTCA-DP, ACEA 
Biosciences, USA) every 5 minutes for 24 hours.  
2.4.3.1 Analysis of cell migration using xCELLigence technology 
Results were obtained as curves that represent the average of cell index values for each time 
point for independent duplicate/triplicate wells as indicated for each experiment using RTCA 
software 1.2.1 (RTCA-DP, ACEA Biosciences, USA). Traces are the average of duplicate or 
triplicate wells. Cell index at 24 hours was plotted using GraphPad Prism version-6.01 
software (GraphPad Software, La Jolla, CA). Error bars represent mean average ±SE of 
triplicate wells. 
2.5 Cell invasion using xCELLigence technology 
Wells of CIM-16 plates (ACEA Biosciences, USA) were coated with a solution of growth-
factor-reduced-matrigel (BD Biosciences) in serum-free DMEM (lacking phenol red) (20µl 
1:40-diluted matrigel per well on the upper surface only). The CIM-plate16 was incubated in 
a humidified atmosphere of 10% carbon dioxide in air at 37°C for 4 hours prior to the 
experiment. Experimental steps were carried on as described above (section  2.4.3. 
and  2.4.3.1) but the real time change of the electrical impedance (cell index) was determined 
by the xCELLigence analyser system (RTCA-DP, ACEA Biosciences, USA) every 5 minutes 
for 48 hours. 
2.6 Real-Time Reverse Transcriptase Polymerase Chain Reaction 
(RT-PCR) 
2.6.1 Preparation of total cellular RNA  
2.6.2 Total cellular RNA extraction after 1 week of exposure to the UV 
screens 
In order to obtain the same cell density at collection time after short term exposure to UV 
screens, MCF-7 human breast cancer cells were trypsinized from stock dishes and were 
plated in 9-cm (63.6 cm
2 
culture area per well) and 4-well (2.01 cm
2 
culture area per well) 
tissue culture dishes (Nunc) at different densities based on different effects of UV screens on 
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the proliferation rate of MCF-7 human breast cancer cells (Table ‎2.2). Cells were seeded in 
phenol-red-free DMEM (Invitrogen) containing 5% DCFCS, 2mM L-glutamine, 100 µg/ml 
streptomycin and 100 U/ml penicillin (Invitrogen). After 24 hours, the medium was 
replenished with fresh medium containing 10
-5
 M of the UV screens, 10
-8
 M 17β-oestradiol or 
ethanol. After 7 days, 4-well (2.01 cm
2 
culture area per well) tissue culture dishes were 
counted as described (in section ‎2.2.1) to provide the cell density at the time of harvest. From 
the 9-cm dishes, MCF-7 cells were collected after washing twice with 2 ml of 0.9% (w/v) 
NaCl in water and scraped off the dish using a rubber scraper. Cells were pelleted by 
centrifugation at 1000 rpm (113 xg) (Eppendorf centrifuge 5810) for 2 minutes and cell 
pellets were stored at -80
0
C. 
Table ‎2.2 Densities of MCF-7 cells seeded in relation to the proliferation rate. 
Cell proliferation rate UV screen Seeding density 
Low  10
-5 
M Bp3, 10
-7 
M Bp3, 10
-5 
M OMC, 10
-7 
M OMC, 10
-7 
M 4MBC and 10
-7 
M HS or 
ethanol control 
5 x 10
5 
cells/ml 
Medium  10
-7 
M Bp1, 10
-7 
M Bp2, 10
-5 
M 4MBC or  
10
-5 
M HS 
2.5 x 10
5 
cells/ml 
High  10
-8 M 17β-oestradiol and 10-5 M Bp1 or 10-
5 
M
 
Bp2.  
0.8 x 10
5 
cells/ml 
 
2.6.3 Total cellular RNA extraction after 24-25 weeks of exposure to 
UV screens 
Prior to the RNA extraction MCF-7 human breast cancer cells were long-term exposed (24-25 
weeks) to 10
-5 
M of each of the six UV screens, 10
-8 M 17β-oestradiol or ethanol control. 
Cells were maintained in phenol red-free DMEM (Invitrogen) containing 5% DCFCS, 2mM 
L-glutamine, 100 µg/ml streptomycin, 100 U/ml penicillin (Invitrogen) and the relevant 
treatment or ethanol control. MCF-7 human breast cancer cells were trypsinized from stock 
dishes and 16 ml of suspended cells were plated in 9-cm dishes (63.6 cm
2
 culture area per 
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dish) at 0.8 x 10
5 
cells/ml in relevant media. After 7 days, cells were collected after washing 
twice with 2 ml of 0.9% (w/v) NaCl in water and scraped off the dish using a rubber scraper. 
In 15ml tubes, cells were pelleted by centrifugation at 1000 rpm (113 xg) (Eppendorf 
centrifuge 5810) for 2 minutes. The pellets were kept at -80°C until the RNA extraction 
procedure. 
2.6.4 Total cellular RNA extraction 
MCF-7 whole cell RNA was produced using the Qiagen RNeasy® kit with on-column DNase 
treatment. According to the manufacturer, 600 µl RLT buffer and 6 µl β-merceptoethanol 
were added to each cell pellet and mixed by vortexing. The lysate was then passed through a 
QIA shredder spin column (Qiagen) by centrifuging for 2minutes at maximum speed. The 
flow-through represents the homogenized cell lysate. To precipitate the DNA, 1 volume (600 
µl) of 70% ethanol [prepared in RNase-free water (Qiagen)] was added to the cell lysate and 
mixed by pipetting. Then 700 µl of that mix was transferred onto an RNeasy spin column 
placed in a 2 ml collection tube and spun for 15 seconds at 8000 xg. The flow-through was 
discarded and the same step was repeated for the remaining ethanol-cell lysate mix. 
Subsequently, 700 µl of buffer RW1 was added to the column and then centrifuged for 15 
seconds at 8000 xg. The flow-through was discarded. Then 500 µl of buffer RPE was added 
to the column and spun for 15 seconds at 8000 xg. This step was repeated another time using 
an increased centrifugation time of 2 minutes. The column was placed in a new 2 ml 
collection tube and spun on full speed (13000 xg) for 1 minute. To elute the RNA, the column 
was placed into a 1.5 ml collection tube and 50µl of RNase-free water was added to the 
column. Finally, the column was spun for 1 minute at 8000 xg, and the eluate containing the 
RNA was collected and stored at -80
0
C. The concentration of RNA was assessed from the 
OD at 260 nm and the purity of the sample was revealed using the ratio of OD values 260/280 
nm using a NanoDrop 2000 spectrophotometer (Thermo Scientific, USA). 
2.6.5 cDNA synthesis  
First strand cDNA was synthesised using the QuantiTect® Reverse Transcription Kit 
(Qiagen). Before starting the procedure, RNA samples and the kit components were thawed 
on ice. In order to eliminate the genomic DNA, 2 µl of gDNA buffer was added to 1 µg of 
RNA sample in a 0.5 ml microcentrifuge and RNase-free water was added to complete the 
final reaction volume to 14 µl. According to Qiagen technical support, gDNA buffer contains 
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a double strand specific endonuclease and the buffer conditions are optimised to allow the 
removal of residual DNA without the removal of ssDNA or RNA. The tubes were incubated 
for 2 minutes at 45
o
C and then placed immediately on ice. Next the reverse transcription 
reaction mixture was prepared by mixing 1 µl of Quantiscript Reverse Transcriptase, 4 µl of 
Quantiscript RT buffer, 1 µl RT Primer mix and 14 µl of the RNA template, which was 
prepared in the previous step. The reaction components were mixed by pipetting and then 
incubated for 15 minutes at 45
o
C and then 3 minutes at 95
o
C to inactivate the Quantiscript 
Reverse Transcriptase. cDNA samples were diluted (1 in 20) in RNase-free water and stored 
in -80
o
C. 
2.6.6 PCR assay  
QuantiTect primers (Table ‎2.3) were supplied as bioinformatically validated by Qiagen. Each 
primer was supplied dry and reconstituted in 1.1 ml TE buffer [1M Tris pH 8.0 and 0.05 M 
EDTA in RNase-free water] and then were stored at -20
o
C. The PCR reaction mix was 
prepared by mixing 7 µl of QuantiTect SYBR Green PCR Master Mix (Qiagen, UK), 1.4 µl 
of QuantiTect primer and 0.6 µl RNase-free water. The PCR assay was carried out in a 
volume of 14 µl including 9 µl of the reaction mix –described above- and 5 µl of cDNA (1/20 
dilution) or 5 µl RNase-free water (negative control) in 96-well optical reaction plate (1900 
High speed low profile PCR plate, Thermo Scientific, UK). Then the plates were sealed using 
optical adhesive cover (MicroAmp, Applied Biosystems). Subsequently, the 96-well plate 
was vortexed and spun to remove bubbles using Perfect Spin-P (PEQLAB, USA) before 
loading the PCR plates into the StepOne™ Plus real-time PCR instrument (Applied 
Biosystems, Life Technologies Ltd.). The thermal profile for all reactions was 95
o
C for 15 
minutes, followed by 94
o
C for 15 seconds and 60
o
C for 1 minute (50 cycles). All reactions 
were performed in triplicate and β-actin was used as an endogenous housekeeping gene.  
2.6.7 RT-PCR analysis 
The relative gene expression quantification method was used to compare the gene expression 
of the control sample with the gene expression of 17β-oestradiol or UV screen exposed 
samples. Ct values of the endogenous control β-actin and from different targeted genes were 
used to calculate the fold change in relative gene expression using the  2
-ΔΔC
T method (Livak 
and Schmittgen, 2001). Each reaction was all carried out in triplicate and results are shown as 
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the average ± SE of biological replicates from separate cell cultures. The results were plotted 
using Graph Pad Prism version-6.01 software (GraphPad Software, La Jolla, CA).  
 
 
Table ‎2.3 The QuantiTect primers (Qiagen) and their GeneGlobe specifications 
QuantiTect Primer 
(product number) 
Species Gene 
ID 
Amplicon 
length 
Detected transcript 
TFF1 (QT00209608) Homo sapiens 7031 75 bp NM_003225 (508 bp) 
E-cadherin (CDH1) 
(QT00080143) 
Homo sapiens 999 84 bp NM_004360 (4815 bp) 
β-catenin  
(CTNNB1) 
(QT00077882) 
Homo sapiens 1499 130 bp NM_001098209 (3415bp) 
TWIST1(QT00011956) Homo sapiens 7291 127 bp NM_000474 (1669 bp) 
Snail 1 (QT00010010) Homo sapiens 6615 131 bp NM_005985 (1722 bp) 
PIK3R1(QT00023100) Homo sapiens 5295 117 bp NM_001242466  (5554 
bp) 
BMP7 (QT00068936) Homo sapiens 655 128 bp NM_001719 (4049 bp) 
β-actin (ACTB) 
(QT-01680476) 
Homo sapiens 60 bp 104 bp NM_001101 (1852 bp) 
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2.7 Western immunoblotting  
2.7.1 Preparation of whole cell lysates  
2.7.1.1 Preparation of MCF-7 whole cell lysates after exposure to the 
UV screens  
In order to prepare MCF-7 whole cell lysates, the same procedures (in sections ‎2.6.2 
and  ‎2.6.3) were performed to collect the appropriate number of MCF-7 cells after 1 week and 
21-23 weeks of exposure to 10
-5 
M of the UV screens, 10
-8 
M 17β-oestradiol or ethanol 
control. 
2.7.1.2  Protein extraction 
 Lysis buffer was prepared freshly [50 mM Tris-HCl pH7.4, 250 mM NaCl, 5 mM EDTA, 
0.3% Triton X-100, 0.3 mM AEBSF (4-2 aminoethylbenzenesulfonyl fluoride), 10 µg/ml 
leupeptin and 2 µg/ml aprotinin] and the required amount for each cell pellet (prepared in 
section ‎2.7.1) was calculated based on the cell count for each stock to obtain a final 
concentration of 1 x 10
5 
cells/µl. The cell pellet was mixed with the lysis buffer and kept on 
ice for 30 minutes. The cell lysate was moved to an autoclaved 1.5 ml microcentrifuge tube 
then the lysate was passed through needles of decreasing size from 19G (7 times) to 25G (7 
times). The tubes were centrifuged at 13,000 rpm (MSE, Jencons-Pls, UK) for 2 minutes and 
the supernatant was collected and aliquoted into labelled 0.5 ml microcentrifuge tubes and 
kept at -80ºC until required. 
2.7.2 Protein assay using the Pierce BCA reagent 
Protein assays were performed using the Pierce BCA reagent kit (Pierce, USA). In 0.5 ml 
microcentrifuge tubes, standards of bovine serum albumin (BSA) (Sigma) were prepared over 
a range of concentrations from 0-16 µg/µl and 2 µl of the lysis buffer was added to each tube. 
The final volume of each microcentrifuge tube was made to 10 µl by adding double distilled 
water. 2 µl of cell lysate samples were added to 8µl of double distilled water in 0.5 ml 
microcentrifuge tubes in triplicates. According to the manufacturer instructions, 5ml of 
Reagent A was mixed with 0.1 ml of reagent B and 200 µl of the reagent mixture was added 
to each microcentrifuge tube. The tubes were incubated in the oven (hybridization/shaker 
oven, Amersham Life Science) at 60ºC for 30 minutes. 150 µl aliquots of the standards and 
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samples were then transferred into the wells of a 96-well plate (Falcon, USA). The 
absorbance was then read at a wavelength of 540 nm using an EMax precision microplate 
reader (Molecular Devices, USA). The concentrations of the cell lysate were then calculated 
from the standard curve of the BSA samples of known concentration. 
2.7.3 Sodium Dodecyl Sulphate-polyacrylamide gel electrophoresis 
(SDS-PAGE) 
Prior to the SDS-PAGE, protein samples were denatured and reduced by mixing the sample 
1:1 with 2x Lamaelli buffer (Bio-Rad) supplemented with  2-mercaptoethanol (50 µl in 950 
µl) (Sigma-Aldrich) and incubated for 3 minutes at 100ºC. Gradient (4-15%) or 10% precast 
TGX stain-free mini PAGE gels (Bio-Rad, Hertfordshire, UK) were used to separate the 
protein samples according to their molecular weight. After removing the comb, the gel was 
placed into the electrophoresis tank and washed with running buffer [25 mM Tris pH 8.3, 
0.1% (w/v) SDS, 192 mM glycine].  6 µl of Precision plus protein unstained protein standard 
(marker) in the range of 10-250 kDa (Bio-Rad) was loaded as a marker in each gel and 25 µg 
of protein samples were loaded per gel track. The gel was run at 200 volts for 30 minutes. 
Stain-free gels are designed to facilitate obtaining the volume of total protein in each gel track 
after blotting the protein onto the membrane. In order to estimate the amount of total protein 
the gel was activated by using the Gel Doc EZ imager (Bio-Rad) on the stain-free tray for five 
minutes. 
2.7.4 Protein transfer 
Proteins were transferred from the gels onto 0.2 µm PVDF by semi-dry western blotting 
using Trans-Blot turbo transfer pack (Bio-Rad), which contains 0.2 µm PVDF membrane and 
the Whatman papers soaked with transfer buffer and ready to use (Trans-Blot turbo transfer 
pack, Bio-Rad). The membrane and the gel were set up into the Trans-Blot Turbo transfer 
system (Bio-Rad) and the transfer was set up at 2.5 A constant current for 3minutes. The Gel 
Doc EZ imager was then used to scan the membrane and image the total protein in each track 
on the PVDF membrane. Later the total protein level was determined using Image Lab 
software (version 5.0, Bio-Rad) (Figure 2.4). This total protein was used as a loading control. 
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2.7.5 Immunostaining of protein 
The membrane was blocked with 5% (w/v) dried milk in TBS-T [0.1 % Tween-20, 150 mM 
NaCl, 2 mM KCl and 50 mM Tris pH 7.4] at room temperature for one hour with gentle 
rocking. The membrane was then washed three times for 5 minutes each with 15 ml of TBS-
T. In order to avoid stripping the membrane, the membrane was cut to have the loading 
control (actin) immunostained separately from targets of interest. Membranes were incubated 
in a heat sealable bag with appropriate primary antibody at the required concentration (Table 
2.4) diluted in 5% w/v BSA (Sigma) in TBS-T at 4ºC overnight on a rotating drum. The 
following day, the membrane was washed three times with TBS-T for 5 minutes each and 
then incubated with appropriate HRP-linked secondary antibody (Table 2.4) at a dilution of 
1:2000 and the marker conjugate (Precision Plus protein StrepTactin-HRP conjugate) at a 
dilution of 1:5000 both diluted in TBS-T and 5% w/v dried milk for 1 hour at room 
temperature. The membrane was washed again 3 times for 5 minutes each in TBS-T. 
The ECL-Prime western blotting detection reagent (GE Healthcare) was prepared according 
to the manufacturer’s instructions and the membrane was incubated in the reagent for 3 
minutes. The membrane was covered with Saranwrap and imaged on a luminescent image 
analyser (Image Quant LAS4000mini, GE Healthcare). Exposure time was optimized for 
band detection.  
(B) 
(A) 
Figure ‎2.4 Bio-Rad Gel Doc EZ imager and the turbo transfer system. 
This image illustrates Bio-Rad Gel Doc EZ imager (A) and the Trans-Blot Turbo transfer system (B).  
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Table ‎2.4  List of antibodies used for immunoblotting 
Primary Antibody 
Manufacturer -
Product number 
Source Dilution 
Oestrogen‎receptor‎α Cell Signalling - 6844 Rabbit 1:1000 
E-cadherin Cell Signalling - 3195 Rabbit 1:1000 
β-catenin Cell Signalling - 9582 Rabbit 1:1000 
MMP14 Cell Signalling - 13130 Rabbit 1:1000 
β-actin Cell Signalling - 8457 Rabbit 1:1000 
Secondary Antibody Manufacturer Source Dilution 
HRP-linked, anti-rabbit  Cell Signalling - 7074 Goat 1:2000 
Precision Plus protein 
StrepTactin-HRP conjugate 
Bio-Rad - 1:5000 
 
2.7.6  Quantitation of protein and data analysis 
Quantification of each protein band was performed by quantitating the relative intensity of 
each band present on the digital image acquired by Image Quant LAS4000min (GE 
Healthcare). The Image was analysed using Image J software and gel analyser plugin. The 
intensity of each band was obtained in numerical form. Results were expressed as a ratio to 
the relevant loading control (β-actin or total protein). The results were expressed as mean ± 
standard error (SE) from at least three independent cell cultures. 
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2.8 Gelatin zymography 
Zymography is a semi-quantitative technique used to detect the activity of matrix 
metalloproteinases (MMPs). Different substrates can be used in this technique and the 
selection of the substrate depends on the group of MMPs under investigation. In order to 
detect MMP-2 and MMP-9 activity, SDS gelatin gels were chosen (Hu and Beeton, 2010). 
2.8.1 Conditioned media collection 
MMP-2 and MMP-9 are secreted by human breast cancer cells and were therefore assayed by 
collection of serum free media (Das et al., 2008). Prior to the collection, MCF-7 cells were 
exposed to 10
-5
 M UV screens in the presence of 5% DFCS for 35-37 weeks and MDA-MB-
231 cells were exposed to 10
-7
 M UV in the presence of 10% FCS for 15 weeks. 
After 35 weeks of exposure with 10
-5
 M of UV screens, 10
-8
 M 17β-oestradiol or ethanol 
control, MCF-7 human breast cancer cells were trypsinized from long-term maintained dishes 
and were plated at 0.8 x 10
5
 cells/ml (16 ml/dish) in 9-cm (63.6 cm
2
 culture area per dish) and 
4-well (2.01 cm
2
 culture area per well) tissue culture dishes (Nunc) (0.5 ml/well). Cells were 
seeded in phenol red-free DMEM (Invitrogen) containing 5% DCFCS, 2mM L-glutamine, 
100 µg/ml streptomycin, 100 U/ml penicillin (Invitrogen) and the 10
-5
 M of UV screen, 10
-8 
M 17β-oestradiol or ethanol.  
On day 7, dishes were washed two times. Firstly, with 2 ml of HBSS (Invitrogen) and 
secondly with 2 ml of serum free media [phenol red-free DMEM (Invitrogen), 2 mM L-
glutamine, 100 µg/ml streptomycin and 100 U/ml penicillin (Invitrogen)] in the presence of 
different treatments or control. After the washing steps, 4 ml of serum free media were added 
to each 9-cm dish and 0.25 µl volume in the 4-well plates. The plates were incubated in a 
humidified atmosphere of 10% carbon dioxide in air at 37°C for 24 hours.  
Then, the 4 ml conditioned media samples were collected and concentrated using ultra-4 
centrifugal-filter units (10,000 NMWL) (Milipore, USA). The units were spun at 3000 xg for 
20 minutes and the yield of samples was between 250-400 µl. simultaneously, cells in 4-well 
tissue culture dishes were counted as described in section ‎2.2.1 to provide the cell density at 
the time of conditioned media collection. 
The same procedure was carried out in order to collect conditioned media from MDA-MB-
231 cell lines exposed to 10
-7
 M UV screens or control for 15 weeks. However, the media 
57 
 
used for long-term maintenance of MDA-MB-231 was phenol-red DMEM supplemented 
with 10% FCS 100 µg/ml streptomycin and 100U/ml penicillin with relative UV screen or 
ethanol, and the conditioned media consisted of [phenol-red DMEM,100 µg/ml streptomycin 
and 100 U/ml penicillin] with the relative UV screen or ethanol, and the MDB-MB-231 cells 
were collected to prepare protein lysate as described (in section ‎2.7.1.2). 
2.8.2 Loading and running zymography SDS gelatin gels 
The volume of concentrated conditioned media from 10
5
 cells was mixed with an equal 
amount of zymogram loading buffer (Bio-Rad). Then the samples were kept at room 
temperature for 10 minutes and vortexed prior to loading in each gel track.  
Precast 10% polyacrylamide-SDS gels with gelatin (Bio-Rad) were used to run the prepared 
samples at 125 V for 1 hour 20 minutes. Before loading the samples, the gels were washed 
with the running buffer [25 mM Tris pH 8.3, 0.1% (w/v) SDS, 192 mM glycine]. 
2.8.3 Developing the zymogram 
After running the samples, the proteases were renatured by incubating the gel in renaturation 
buffer [2.5% Triton-X-100]. Then the protease activity was developed by initially incubating 
the gels with 100 ml developing buffer [100 mM Tris-Base, 399 mM Tris-HCL, 2 M NaCl, 
66.6 mM CaCl2 and 0.2% Brij35] for 30 minutes at room temperature with gentle shaking. 
After discarding the buffer, another fresh 100 ml of the developing buffer was added and the 
gels were incubated at 37°C in an oven for 24 hours. 
2.8.4 Staining and destaining of zymography SDS gelatin gel 
Prior to the staining step, the developed gels were washed 3 times with ddH2O with gentle 
shaking. Later the gels were stained with 50 ml of 0.5% Coommassie blue R-250 (Bio-Rad) 
for 30 minutes with gentle shaking. After that, the stained gels were destained using 20 ml of 
destaining solution [40% methanol, 10% glacial acetic acid] for 15 minutes and replacing the 
destaining solution every 30 minutes for 1 and 1/2 hour. 
2.8.5 Quantifying the proteinases activity and data analysis 
The MMP-2 and MMP-9 activities showed as white bands (representing the gelatinase 
activity) against a blue background. By using the BioRad Gel Doc imager (white light tray), 
images of the gels were obtained, and then Image J software, was used to convert the image 
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Figure ‎2.5  Bio-Rad Gel Doc imager trays 
This figure shows the white tray used for zymogram gel imaging (A) and the stain-free tray 
used to activate the stain-free western blot gels and to obtain the total protein image from the 
PVDF membrane (B). 
(A) (B) 
into grayscale and to quantify the band area (Hu and Beeton, 2010). Results were normalized 
against the negative control. All results show the average ± SE of three biological replicates 
(n=3). The results were plotted using Graph Pad Prism version-6.01 software (GraphPad 
Software, La Jolla, CA). 
 
 
 
 
 
 
 
 
 
2.9 Data Analysis 
Statistical differences involving 2 groups were subjected to t-Test assuming unequal variance, 
but those involving more than 2 groups were analysed by one-way analysis of variance 
(ANOVA) with Dunnett’s post-hoc test to compare the result of each treatment to a single 
control or Tukey’s post-hoc test to compare pairs of means within the tested group. In an 
experiment where cells were subjected to two variances, data were analysed by two-way 
analysis of variance (Two-way-ANOVA) with Bonferroni post-hoc test. Statistics were 
conducted using Minitab 17 statistics package or GraphPad Prism version-6.01 software 
(GraphPad Software, La Jolla, CA). A value of p-value ≤ 0.05 was considered statistically 
significant and the results were plotted using GraphPad Prism version-6.01 software 
(GraphPad Software, La Jolla, CA). 
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Chapter 3 The oestrogenic activity of UV screens in oestrogen 
responsive MCF-7 human breast cancer cells 
3.1 Introduction 
17β-oestradiol, the endogenous female hormone responsible for reproductive processes 
including the growth of female breasts (Russo and Russo, 2014), has been linked to breast 
cancer development due to its positive influence on breast epithelial cell proliferation (Russo 
and Russo, 2006; Yue et al., 2010). In order to investigate the mechanistic processes related 
to the role of oestrogen in breast cancer, in vitro model systems have been developed.  
The MCF-7 human breast cancer cell line has been the most widely used cell line in the field 
of breast cancer research (Lippman et al., 1977; Burdall et al., 2003). Among the in vitro 
models, MCF-7 cells have been used to study the effects of oestrogen on breast cancer cells 
because it is oestrogen responsive in culture when phenol red is removed from the culture 
medium (Berthois et al., 1986). Oestrogens bind to oestrogen receptor in MCF-7 cells 
(Brooks et al., 1973). Both ERα and ERβ are expressed in this cell line with high 
predominance of ERα (Shaw et al., 2006; Nadal-Serrano et al., 2012). Once ER is activated 
by oestrogen, the proliferation of MCF-7 cells increases (Darbre and Daly, 1989; Dupont and 
Le Roith, 2001; Lai et al., 2001; Liao et al., 2014) and the use of the pure antioestrogen 
fulvestrant decreases the proliferative response of MCF-7 cells towards 17β-oestradiol (Shaw 
et al., 2006). Exposure to 17β-oestradiol not only increases the proliferation of MCF-7 cells 
but it also influences oestrogen-regulated gene expression such as the TFF1 (pS2) gene, 
which increases following MCF-7 cell exposure to 17β-oestradiol (Masiakowski et al., 1982; 
Brown et al., 1984; Jakowlew et al., 1984; May and Westley, 1986; Kida et al., 1989). 
These properties of the MCF-7 cell line have made it a useful starting point to evaluate the 
endocrine disruptive capabilities of the environmental chemicals in vitro (Soto et al., 1995). 
Among the many of the endocrine disruptors that have entered human tissues, are the UV 
screens (Hayden et al., 1997; Jiang et al., 1999; Janjua et al., 2004; Schlumpf et al., 2010; 
Valle-Sistac et al., 2016). Although human use of UV screens is very high, only few studies 
have explored their effect on breast cancer cell proliferation, TFF1 gene expression and 
reporter gene assays (see section 1.4.3.1.). In this chapter, 6 UV screens benzophenone-1  
(Bp1), benzophenone-2 (Bp2), benzophenone-3 (Bp3), octyl-methoxycinnamate (OMC), 4-
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methylbenzylidene camphor (4MBC) and homosalate (HS) have been investigated for their 
comparative oestrogenic activity. 
Previous studies have examined the effect of some of these UV screens on the proliferation of 
MCF-7 cells (Schlumpf et al., 2001; Nakagawa and Suzuki, 2002; Jimenez-Diaz et al., 2013; 
Kerdivel et al., 2013). Among different laboratories the MCF-7 human breast cancer cell line 
has been found to exhibit variation in some biological properties including the proliferation 
rate (Osborne et al., 1987) and the sensitivity towards oestrogen (Darbre and Daly, 1989; 
Villalobos et al., 1995; Hamelers et al., 2003). For these reasons, this work investigated the 
effects of these 6 UV screens on proliferation using MCF-7 cells from our laboratory, prior to 
investigating their potential influence on other hallmarks of cancer.  
Moreover, previous in vitro proliferation studies have only considered the effect of these 
chemicals on MCF-7 cells growing on plastic. However, breast cancer cells seeded on coated 
plates with extracellular matrix (ECM) components have shown different responses towards 
different treatments (Sonohara et al., 1998; Woodward et al., 2000; Korah et al., 2004; 
Ohbayashi et al., 2008; Pontiggia et al., 2012), which offers a more realistic model of cancer 
cell growth in vivo in the human body. The changes caused by cell-extracellular matrix 
interactions via the integrins (a family of transmembrane heterodimeric glycoproteins) initiate 
several signalling pathways and subsequently affect several biological processes such as cell 
proliferation and differentiation (Schwartz et al., 1995; Longhurst and Jennings, 1998). It is 
noteworthy that the sensitivity of MCF-7 cells towards 17β-oestradiol was found to be 
different in the presence of different coating materials. In contrast to the increase in 
sensitivity toward 17β-oestradiol by cells seeded on a fibronectin coating, the sensitivity was 
found to be reduced by laminin (Woodward et al., 2000). To date, no studies have shown the 
effect of the dual presence of extracellular matrix proteins and the UV screens on the 
proliferation of MCF-7 cells.  
3.2 Experimental aims 
The overall aims of this chapter were to compare the oestrogenic effect of six UV screens 
(benzophenone-1(Bp1), benzophenone-2 (Bp2), benzophenone-3 (Bp3), octyl-
methoxycinnamate (OMC), 4-methylbenzylidene camphor (4MBC) and homosalate (HS)) 
using the MCF-7 human breast cancer cell line in our laboratory by measuring ERE-LUC 
reporter gene expression, ERα protein levels, TFF1 gene expression and stimulation of cell 
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proliferation.  Since oestrogen is present in vivo in the female body in the range of 10
-11
 M to 
10
-10
 M  (Wright et al., 1999), the influence of different concentrations of 17β-oestradiol with 
the UV screens was studied on the proliferation of  MCF-7 cells.  
Another aim of this chapter was to compare the influence of fibronectin or laminin coating on 
the proliferation of MCF-7 cells following the exposure to 17β-oestradiol or UV screens. 
3.3 Results 
3.3.1 Effects on ERE-LUC reporter gene expression 
To assess the oestrogenic effect of UV screens on MCF-7 cells, an oestrogen responsive 
reporter gene assay was performed (as described in section 2.3). Oestrogen regulation of a 
transiently transfected oestrogen-inducible ERE-LUC reporter gene in MCF-7 cells was 
published in 2006 (Shaw et al., 2006). However, a line of MCF-7 cells stably transfected with 
the same ERE-LUC reporter gene has been produced but not validated by publication. Before 
assessing the effect of UV screens on the ERE-LUC reporter gene in these cells, validation of 
the assay was needed. 
3.3.1.1 Validation of the stably transfected ERE-LUC reporter gene in 
MCF-7 cells 
MCF-7 cells stably transfected with the ERE-LUC reporter gene were kept in stock media 
supplemented with G418 sulphate (100 µg/ml)   for two weeks. Cells were re-plated in 24 
well plates into experimental medium lacking any treatments for 6 days prior to the 
experiment. Cells were then exposed to 10
-8
 M 17β-oestradiol or ethanol control for 24 hours 
prior to the luciferase assay. 10
-8
 M 17β-oestradiol induced luciferase gene expression from a 
control value of 0.77 ± 0.12 to a value of 2.89 ± 0.56 (Figure ‎3.1) (p-value ≤ 0.01). This 
experiment is the result of 3 independent biological replicates. 
3.3.1.2 Effects of UV screens on ERE-LUC reporter gene expression 
MCF-7 cells stably transfected with the ERE-LUC reporter gene were used to evaluate the 
ability of UV screens to induce luciferase activity. 10
-5
 M Bp1 was found to induce luciferase 
activity significantly from a control value of 0.63 ± 0.04 to a value of 2.14 ± 0.15 (Figure 3.2 
(A)) (p-value ≤ 0.0001) and comparison with 10-8 M 17β-oestradiol (Figure 3.2 (G)) revealed 
that 10
-5
 M Bp1 caused a greater induction of luciferase activity than 10
-8
 M 17β-oestradiol 
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(Figure 3.2 (H)) (p-value ≤ 0.05). Among the UV screens under the study, 10-5 M Bp2 was 
found to induce the highest luciferase activity from a control value of 0.63 ± 0.04 to a value 
of 3.42 ± 0.32. It is also noteworthy that the luciferase activity induced by 10
-5 
M Bp2 (Figure 
3.2(B)) (p-value ≤ 0.0001) was greater than that by 10-8 M 17β-oestradiol (Figure 3.2 (H)) (p-
value ≤ 0.0001). A lower induction of the luciferase activity from a control value of 0.63 ± 
0.04 was detected following the exposure to 10
-5 
M Bp3 to a value of 1.57 ± 0.12 (Figure 3.2 
(C)) (p-value ≤ 0.0001), 10-5 M OMC to a value of 1.07 ± 0.11 (Figure 3.2 (D)) (p-value ≤ 
0.05), 10
-5 
M 4MBC to a value of 0.79 ± 0.06 (Figure 3.2 (E)) (p-value ≤ 0.01) and 10-5 M HS 
to a value of 0.793 ± 0.06 (Figure 3.2 (F)) (p-value ≤ 0.01). No significant difference in 
Luciferase activity was found between 10
-5 
M Bp3 and 10
-8
 M 17β-oestradiol. However, 
effects of 10
-5 
M OMC, 10
-5 
M 4MBC and 10
-5 
M HS were significantly lower than the effect 
caused by 10
-8
 M 17β-oestradiol (Figure 3.2 (H)). 
Dose response experiments were then carried using a range of concentrations for each of the 
UV screens. Increased luciferase activities were observed in line with the increase in molar 
concentration (Figures 3.3-3.8). Although some effects on the luciferase activity were 
detected following exposure to 10
-5 
M of OMC, 4MBC or HS, lower concentrations of these 
chemicals were not found to show more effect than the activities following exposure to 10
-5 
M.  The dose response curve of luciferase activities following exposure to either OMC 
(Figure 3.6) or HS (Figure 3.8) showed an increase in luciferase activities with increasing 
molar concentrations. However, 10
-7 
M, 10
-6 
M and 10
-5 
M 4MBC concentrations were found 
to induce similar luciferase activity from a control value of 0.54 ± 0.02 to a value of 0.77 ± 
0.04, 0.77 ± 0.03 and 0.79 ± 0.09, suggesting lower molar concentrations need to be studied 
(Figure 3.7). 
3.3.1.3 Effect of fulvestrant on induction of ERE-LUC reporter gene by 
UV screens 
Fulvestrant (ICI 182,780) (AstraZeneca, Macclesfield, UK) is an oestrogen receptor 
antagonist, which reduces oestrogen action through the ER (Wakeling et al., 1991). In order 
to investigate whether Bp1 and Bp2 induce ERE-LUC reporter gene expression via an ER-
mediated pathway, cells were incubated with 10
-7
 M fulvestrant and 10
-5
 M Bp1 or 10
-5
 M 
Bp2.  
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The effect of 10
-8
 M 17β-oestradiol on the luciferase activity was decreased from a value of 
4.052 ± 1.31 to a value of 0.685 ± 0.42 using 10
-7 
M fulvestrant (p-value ≤ 0.01). In the same 
experiment, 10
-7 
M fulvestrant decreased the luciferase activity following the exposure to 10
-5 
M Bp1 from a value of 3.15 ± 0.21 to a value of 1.01 ± 0.07 (p-value ≤ 0.001) and to 10-5 M 
Bp2 from a value of 4.39 ± 0.52 to a value of 1.96 ± 0.16 (p-value ≤ 0.001) (Figure ‎3.9). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure ‎3.1 Regulation of a stably transfected oestrogen-inducible ERE-LUC reporter 
gene in MCF-7‎ human‎breast‎ cancer‎ cells‎ following‎ exposure‎ to‎ 17β-oestradiol or 
ethanol control. 
MCF-7 cells were plated at 0.2 x 10
5 
cells/well in 24 well plates and grown in phenol-red-free-
DMEM containing 5% DCFCS for 6 days prior to the experiment. Media were replenished on day 
1 and day 4. On day 7 media was replenished with fresh media plus 10
-8
 M 17β-oestradiol (+E) or 
ethanol control (-E). Luciferase assay was conducted after 24 hours of exposure. Results were 
calculated as the average luciferase activity per 10,000 cells. Each experiment was conducted in 
triplicate. Values are the average ±SE of 3 independent experiments (n=3). ** p-value ≤ 0.01 
versus no addition by t-Test. 
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Figure ‎3.2 Regulation of a stably transfected oestrogen-inducible ERE-LUC reporter 
gene in MCF-7 human breast cancer cells following exposure to 10
-5
M of UV screens, 10
-
8M‎of‎17β-oestradiol or ethanol. 
Stably transfected MCF-7 cells were plated at 0.2 x 10
5 
cells/well in 24 well plates and grown in 
phenol-red-free-DMEM containing 5% DCFCS for 6 days prior to the experiment. Media were 
replenished on day 1 and day 4. On day 7 media was replenished with fresh media plus 10
-5 
M Bp1 
(Bp1 (-5M)) (A), 10
-5 
M Bp2 (Bp2 (-5M)) (B), 10
-5 
M Bp3 (Bp3 (-3M)) (C), 10
-5 
M OMC (OMC (-
5M)) (D), 10
-5 
M 4MBC (4MBC (-5M)) (E), 10
-5 
M HS (Hs (-5M)) (F), 10
-8 M 17β-oestradiol (+E) 
(G) or ethanol control (-E). Comparisons between the UV screens and +E (green asterisk) is present in 
(H). Luciferase assay was conducted after 24 hours of exposure. Results were calculated as the 
average luciferase activity per 10,000 cells. Values are the average ±SE of three wells from three 
independent experiments for Bp1 and Bp2 (n=3) and two independent experiments for Bp3, OMC, 
4MBC and HS (n=2). * p-value ≤ 0.01, ** p-value ≤ 0.001 and **** p-value ≤ 0.0001 versus no 
addition (black asterisks) or +E (green asterisks) by t-Test.  
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Figure ‎3.3 Regulation of a stably transfected oestrogen-inducible ERE-LUC reporter 
gene in MCF-7 human breast cancer cells following exposure to increasing doses of Bp1. 
MCF-7 cells were plated at 0.2 x 10
5
 cells/well in 24 well plates and grown in phenol-red-free-DMEM 
containing 5% DCFCS for 6 days prior to the experiment. Media were replenished on day 1 and day 4. 
On day 7 media was replenished with fresh media without or with 10
-8
 M 17β-oestradiol (+E) (A) or 
with indicated concentrations of Bp1 (B). Luciferase assay was conducted after 24 h of exposure. 
Results were calculated as average luciferase activity per 10,000 cells. Values are the average ±SE of 
3 independent wells. * p-value ≤ 0.05 and **** p-value ≤ 0.0001 versus no addition by t-Test (A) or 
by one-way ANOVA Dunnett’s test (B). 
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Figure ‎3.4 Regulation of a stably transfected oestrogen-inducible ERE-LUC reporter 
gene in MCF-7 human breast cancer cells following exposure to increasing doses of Bp2.  
MCF-7 cells were plated at 0.2 x 10
5
 cells/well in 24 well plates and grown in phenol-red-free-DMEM 
containing 5% DCFCS for 6 days prior to the experiment. Media were replenished on day 1 and day 4. 
On day 7 media was replenished with fresh media without or with 10
-8
 M 17β-oestradiol (+E) (A) or 
with indicated concentrations of Bp2 (B). Luciferase assay was conducted after 24 hours of exposure. 
Results were calculated as average luciferase activity per 10,000 cells. Values are the average ±SE of 
3 independent wells. ** p-value ≤  0.01, *** p-value ≤ 0.001 and **** p-value ≤ 0.0001 versus no 
addition by t-Test (A) or by one-way ANOVA Dunnett’s test (B). 
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Figure ‎3.5 Regulation of a stably transfected oestrogen-inducible ERE-LUC reporter 
gene in MCF-7 human breast cancer cells following exposure to increasing doses of Bp3.  
MCF-7 cells were plated at 0.2 x 10
5
 cells/well in 24 well plates and grown in phenol-red-free-DMEM 
containing 5% DCFCS for 6 days prior to the experiment. Media were replenished on day 1 and day 4. 
On day 7 media was replenished with fresh media without or with 10
-8
 M 17β-oestradiol (+E) (A) or 
with indicated concentrations of Bp3 (B). Luciferase assay was conducted after 24 hours of exposure. 
Results were calculated as average luciferase activity per 10,000 cells. Values are the average ±SE of 
3 independent wells. **** p-value ≤ 0.0001 versus no addition by t-Test (A) or by one-way ANOVA 
Dunnett’s test (B).  
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Figure ‎3.6 Regulation of a stably transfected oestrogen-inducible ERE-LUC reporter 
gene in MCF-7 human breast cancer cells following exposure to increasing doses of 
OMC. 
MCF-7 cells were plated at 0.2 x 10
5
 cells/well in 24 well plates and grown in phenol-red-free-DMEM 
containing 5% DCFCS for 6 days prior to the experiment. Media were replenished on day 1 and day 4. 
On day 7 media was replenished with fresh media without or with 10
-8
 M 17β-oestradiol (+E) (A) or 
with indicated concentrations of OMC (B). Luciferase assay was conducted after 24 hours of 
exposure. Results were calculated as average luciferase activity per 10,000 cells. Values are the 
average ±SE of 3 independent wells. ** p-value ≤ 0.01 and *** p-value ≤ 0.001 versus no addition by 
t-Test (A) or by one-way ANOVA Dunnett’s test (B).  
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Figure ‎3.7 Regulation of a stably transfected oestrogen-inducible ERE-LUC reporter 
gene in MCF-7 human breast cancer cells following exposure to increasing doses of 
4MBC. 
MCF-7 cells were plated at 0.2 x 10
5
 cells/well in 24 well plates and grown in phenol-red-free-DMEM 
containing 5% DCFCS for 6 days prior to the experiment. Media were replenished on day 1 and day 4. 
On day 7 media was replenished with fresh media without or with 10
-8
 M 17β-oestradiol (+E) (A) or 
with indicated concentrations of 4MBC (B). Luciferase assay was conducted after 24 hours of 
exposure. Results were calculated as average luciferase activity per 10,000 cells. Values are the 
average ±SE of 3 independent wells. ** p-value ≤ 0.01 and *** p-value ≤ 0.001 versus no addition by 
t-Test (A) or by one-way ANOVA Dunnett’s test (B).  
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Figure ‎3.8 Regulation of a stably transfected oestrogen-inducible ERE-LUC reporter 
gene in MCF-7 human breast cancer cells following exposure to increasing doses of HS.  
MCF-7 cells were plated at 0.2 x 10
5
 cells/well in 24 well plates and grown in phenol-red-free-DMEM 
containing 5% DCFCS for 6 days prior to the experiment. Media were replenished on day 1 and day 4. 
On day 7 media was replenished with fresh media without or with 10
-8
 M 17β-oestradiol (+E) (A) or 
with indicated concentrations of HS (B). Luciferase assay was conducted after 24 hours of exposure. 
Results were calculated as average luciferase activity per 10,000 cells. Values are the average ±SE of 
3 independent wells. * p-value ≤ 0.05, ** p-value ≤ 0.01 and **** p-value ≤ 0.0001 versus no 
addition by t-Test (A) or by one-way ANOVA Dunnett’s test (B).   
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Figure ‎3.9 Effect of fulvestrant on induction of ERE-LUC reporter gene by exposure to 
Bp1,‎Bp2,‎17β-oestradiol or ethanol control. 
MCF-7 cells were plated at 0.2 x 10
5
 cells/well in 24 well plates and grown in phenol-red-free-DMEM 
containing 5% DCFCS for 6 days prior to the experiment. Media were replenished on day 1 and day 4. 
On day 7 media was replenished with fresh media plus 10
-5
 M Bp1 (Bp1(-5M)), 10
-5
 M Bp1 and 10
-7
 
M fulvestrant (Bp1(-5M+Fulv)), 10
-5
 M Bp2 (Bp2(-5M)), 10
-5
 M Bp2 and 10
-7
 M fulvestrant (Bp2(-
5M+Fulv)), 10
-10
 M 17β-oestradiol (+E), 10
-10
 M 17β-oestradiol and 10
-7
 M fulvestrant (+E(Fulv)) , 
ethanol control (-E) or ethanol control and 10
-7
 M fulvestrant (-E(Fulv)) . Luciferase assay was 
conducted after 24 hours of exposure. Results were calculated as the average luciferase activity per 
10,000 cells. Values are the average ±SE of three independent wells. * p-value ≤ 0.05, ** p-value ≤ 
0.01, *** p-value ≤ 0.001 and **** p-value ≤ 0.0001 versus no addition (-E) (black asterisks) or to 
compare the effect of fulvestrant on the treatment (red asterisk) by one-way ANOVA Tukey’s test. 
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3.3.2 Effects of exposure to UV screens on ERα protein levels 
Levels of ERα protein were measured using western immunoblotting (as described in section 
2.7). MCF-7 cells were grown in phenol-red-free-DMEM containing 5% DCFCS with 10
-8
 M 
17β-oestradiol, 10-5 M of UV screens, 10-7 M of UV screens or ethanol control for 7 days and 
three biological replicate cell lysates were prepared. Calculated averages of replicates 
normalized to total protein showed that relative levels of ERα protein were reduced by 0.62 ± 
0.05 following 1 week of exposure to 10
-8
 M 17β-oestradiol (Figure 3.10). Levels of ERα 
protein were also reduced by 10
-7
 M Bp1, 10
-5
 M Bp2, 10
-7
 M Bp2 (Figure 3.10), 10
-5
 M 
4MBC and 10
-5
 M HS (Figure 3.11). 
3.3.3 Effects of exposure to UV screens on TFF1 mRNA levels 
Effects of short and long-term exposure to UV screens were investigated on levels of TFF1 
mRNA by RT-PCR (as described in 2.6). MCF-7 cells were grown in phenol-red-free-
DMEM containing 5% DCFCS with 10
-8
 M 17β-oestradiol, 10-5 M of UV screens, or ethanol 
control for 7 days and 24-25 weeks and three biological replicate cell lysates were prepared 
for each treatment. Using real time RT-PCR, increased levels of TFF1 mRNA were observed 
after the 1 week and 24-25 weeks of exposure to 10
-8
 M 17β-oestradiol (p-value ≤ 0.01) and 
(p-value ≤ 0.0001) respectively (Figure 3.12).  Although an increased level of TFF1 mRNA 
was observed following one week of exposure to 10
-5
 M Bp1 (5.26 ± 2.43) and 10
-5
 M Bp2 
(4.34 ± 1.98), statistics showed no significant difference compared to the control. In addition, 
no significant effect on TFF1 mRNA level was recorded following the exposure to 10
-5
 M of 
the other UV screens after one week of exposure (Figure 3.12 (A)). However, increased levels 
of TFF1 mRNA were observed after 24-25 weeks of exposure to 10
-5
 M 4MBC (p-value ≤ 
0.05) and 10
-5
 M HS (p-value ≤ 0.01) (Figure 3.12 (B)). 
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Figure ‎3.10 Effect of 1 week of exposure to oestradiol or benzophenones on the 
expression‎level‎of‎oestrogen‎receptor‎α.  
MCF-7 human breast cancer cells were grown for the 1 week in phenol-red-free DMEM with 5% 
DCFCS, without (-E) or with 10
-8
 M 17β-oestradiol (+E), 10
-5
 M Bp1 (Bp1 (-5M)), 10
-7
 M Bp1 (Bp1 
(-7M)), 10
-5
 M Bp2 (Bp2 (-5M)), 10
-7
 M Bp2 (Bp2 (-7M)), 10
-5
 M Bp3 (Bp3 (-5M)) or 10
-7
 M Bp3 
(Bp3(-7M)). Media were replenished on day 1 and day 4. Total cellular protein was loaded at 25µg 
per track and immunoblotted with an antibody against ERα (A). The same membrane was imaged 
prior to the immunoblotting using BioRad stain-free technology on the Gel Doc EZ imager to obtain 
the total protein as a control for loading (B). The bar diagram shows levels of ERα relative to total 
protein (C) and expressed as a fold change from control (-E). Error bars are the SE± of three 
independent experiments (n=3). * p-value ≤ 0.05 versus no addition by t-Test. 
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Figure ‎3.11 Effect of 1 week of exposure to oestradiol, OMC, 4MBC or homosalate on 
the‎expression‎level‎of‎oestrogen‎receptor‎α. 
MCF-7 human breast cancer cells were grown for 1 week in phenol-red-free DMEM with 5% 
DCFCS, without (-E) or with 10
-8
 M 17β-oestradiol (+E), 10
-5
 M OMC (OMC (-5M)), 10
-7
 M OMC 
(OMC (-7M)), 10
-5
 M 4MBC (4MBC (-5M)), 10
-7
 M 4MBC (4MBC (-7M)), 10
-5
 M homosalate (HS 
(-5M)) or 10
-7
 M homosalate (HS (-7M)). Media were replenished on day 1 and day 4. Total cellular 
protein was loaded at 25µg per track and immunoblotted with an antibody against ERα (A). The same 
membrane was imaged prior to the immunoblotting using BioRad stain-free technology on the Gel 
Doc EZ imager to obtain the total protein as a control for loading (B). The bar diagram shows levels 
of ERα relative to total protein (C) and expressed as a fold change from control (-E). Error bars are the 
SE± of three independent experiments (n=3).  * p-value ≤ 0.05 versus no addition by t-Test. 
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Figure ‎3.12 Effect of UV screens on the relative levels of TFF1 mRNA in MCF-7 cells 
after 7 days and 24 weeks of exposure. 
MCF-7 cells were plated at 0.2 x 10
5
cells/well in 24 well plates and grown in phenol-red-free-DMEM 
containing 5% DCFCS with 10
-8
M 17β-oestradiol (+E), 10-5M Bp1 (Bp1), 10-5 M Bp2 (Bp2), 10-5 M 
Bp3 (Bp3), 10
-5 
M OMC (OMC), 10
-5 
M 4MBC (4MBC) or homosalate (HS) for 7 days (media were 
replenished on day 1 and day 4.) (A) Or 24-25 weeks (media was replenished every 3-4 days) (B) 
prior to RNA isolation. For each RT-PCR assay, TFF1 values were normalised to β-actin values, 
expressed as fold change from control cells grown without the UV screens by 2
-ΔΔC
T method and the 
average SE of three independent experiments (n=3) taken from cells grown for 1week or 24- 25 weeks 
of culture. Fold change for cell grown with 17β-oestradiol or UV screens are shown in the bar graph 
compared to the negative control. * p-value ≤ 0.05 and ** p-value  ≤ 0.01 and **** p-value ≤ 0.0001 
versus no addition (-E) by t-Test. 
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3.3.4 Effects of UV screens on proliferation of MCF-7 human breast 
cancer cells  
17β-oestradiol induces the proliferation of MCF-7 human breast cancer cells in a dose 
response manner. Doses of 10
-12
 M 17β-oestradiol and above simulated the proliferation of 
MCF-7 cells with maximum simulation between 10
-10
 M and 10
-6
 M after 14 days (Figure 
3.13). In this section, the effect of UV screens (materials and methods Table 2.1) on the 
proliferation of MCF-7 human breast cancer cells was investigated after 14 days of exposure. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure ‎3.13 Effect‎ of‎ 17β-oestradiol on proliferation of MCF-7 human breast cancer 
cells in monolayer culture. 
Cells were grown for 14 days in phenol-red-free-DMEM containing 5% DCFCS with ethanol control 
only (0) or with indicated molar concentrations of 17β-oestradiol. Media were replenished every 3-4 
days. Values are the average ±SE of triplicate independent wells. ** p-value ≤ 0.01 and **** p-value 
≤ 0.0001 versus no addition by one-way ANOVA Dunnett’s test.   
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3.3.4.1 Effects of UV screens on MCF-7 human breast cancer cell 
proliferation in a monolayer culture on an uncoated surface 
MCF-7 human breast cancer cells were grown in phenol-red-free-DMEM containing 5% 
DCFCS with 10
-8
 M 17β-oestradiol or with increasing concentrations of UV screens (from 10-
8
 M to 10
-5
 M for 7 days and the cell count measured by counting cell nuclei on a ZBI Coulter 
counter (as described in 2.2.1.1). Cell growth experiments showed that among the tested UV 
screens, 10
-5 
M Bp1 and 10
-5 
M Bp2 had the highest simulation effect on the proliferation of 
MCF-7 cells and the proliferation was stimulated significantly by 10
-6 
M Bp1 (Figure 3.14) 
and 10
-6 
M Bp2 (Figure 3.15). Concentrations of 10
-8 
M to 10
-5 
M Bp3 and OMC did not 
stimulate the proliferation of MCF-7 cells (Figures 3.16 and 3.17). Proliferation of MCF-7 
cells was stimulated by 4MBC at 10
-7 
M and the maximal effect was found at 10
-6 
M (Figure 
3.18). A similar pattern in proliferation was found on MCF-7 cells after exposure to HS and 
maximal effect was observed at 10
-5 
M (Figure 3.19). 
3.3.4.2 Effects of fulvestrant on proliferation of MCF-7 human breast 
cancer cells after exposure to17β-oestradiol or UV screens 
In order to verify that 10
-5 
M Bp1 and 10
-5 
M Bp2 were inducing MCF-7 cell proliferation via 
interaction with oestrogen receptors, 10
-7
M fulvestrant was used. Fulvestrant (ICI 182,780) 
(AstraZeneca, Macclesfield, UK) is an oestrogen receptor antagonist, which reduces 
oestrogen action through the ER (Wakeling et al., 1991).  
MCF-7 cells were grown in phenol-red-free-DMEM containing 5% DCFCS with no addition 
or with 10
-8 M 17β-oestradiol, 10-5 M Bp1, 10-5 M Bp2 with or without 10-7 M fulvestrant for 
7 days. The addition of 10
-7 
M fulvestrant to 10
-5 
M Bp1 or 10
-5 
M Bp2 reduced the 
stimulation of MCF-7 cell proliferation caused by both chemicals without the addition of 
fulvestrant and the cell numbers were close to the negative control (Figure 3.20). 
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Figure ‎3.14 Effect of Bp1 on proliferation of MCF-7 human breast cancer cells in 
monolayer culture. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8
 M 17β-oestradiol (+E), with 10-8 M Bp1 (Bp1 (-8M)), 10-7 M Bp1 (Bp1 (-7M)), 10-6 M Bp1 (Bp1 
(-6M)) or 10
-5 
M Bp1 (Bp1 (-5M)) for 14 days. Media were replenished every 3-4 days. Values are the 
average ±SE of triplicate independent wells. Where no bars are seen, error was too small to be 
visualized. *** p-value ≤ 0.001 versus no addition by one-way ANOVA Dunnett’s test. Three 
replicate experiments showed similar results (n=3). 
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Figure ‎3.15 Effect of Bp2 on proliferation of MCF-7 human breast cancer cells in 
monolayer culture. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 
M 17β-oestradiol (+E), with 10-8 M Bp2 (Bp2 (-8M)), 10-7 M Bp2 (Bp2 (-7M)), 10-6 M Bp2 (Bp2 
(-6M)) or 10
-5 
M Bp2 (Bp2 (-5M)) for 14 days. Media were replenished every 3-4 days. Values are the 
average ±SE of triplicate independent wells. Where no bars are seen, error was too small to be 
visualized. * p-value ≤ 0.05 and *** p-value ≤ 0.001 versus no addition by one-way ANOVA 
Dunnett’s test. Three replicate experiments showed similar results (n=3). 
 
 
-E +
E
B
p
2 (
-8
M
)
B
p
2 (
-7
M
)
B
p
2 (
-6
M
)
B
p
2 (
-5
M
)
1 0 3
1 0 4
1 0 5
1 0 6
T r e a tm e n t
C
e
ll
s 
p
e
r
 w
e
ll
*
***
***
80 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure ‎3.16 Effect of Bp3 on proliferation of MCF-7 human breast cancer cells in 
monolayer culture. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 
M 17β-oestradiol (+E), with 10-8 M Bp3 (Bp3 (-8M)), 10-7 M Bp3 (Bp3 (-7M)), 10-6 M Bp3 (Bp3 
(-6M)) or 10
-5 
M Bp3 (Bp3 (-5M)) for 14 days. Media were replenished every 3-4 days.  Values are 
the average ±SE of triplicate wells. Where no bars are seen, error was too small to be visualized. **** 
p-value ≤ 0.0001 versus no addition by one-way ANOVA Dunnett’s test. Three replicate experiments 
showed similar results (n=3). 
 
 
-E +
E
B
p
3 (
-8
M
)
B
p
3 (
-7
M
)
B
p
3 (
-6
M
)
B
p
3 (
-5
M
)
1 0 4
1 0 5
1 0 6
T r e a tm e n t
C
e
ll
s
 p
e
r
 w
e
ll
****
81 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure ‎3.17 Effect of OMC on proliferation of MCF-7 human breast cancer cells in 
monolayer culture. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 M 17β-oestradiol (+E), with 10-8 M OMC (OMC (-8M)), 10-7 M OMC (OMC (-7M)), 10-6 M 
OMC (OMC (-6M)) or 10
-5 
M OMC (OMC (-5M)) for 14 days. Media were replenished every 3-4 
days. Values are the average ±SE of triplicate wells. Where no bars are seen, error was too small to be 
visualized. **** p-value ≤ 0.0001 versus no addition by one-way ANOVA Dunnett’s test. Three 
replicate experiments showed similar results (n=3). 
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Figure ‎3.18 Effect of 4MBC on proliferation of MCF-7 human breast cancer cells in 
monolayer culture. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 
M 17β-oestradiol (+E), with 10-8 M 4MBC (4MBC (-8M)), 10-7 M 4MBC (4MBC (-7M)), 10-6 M 
4MBC (4MBC (-6M)) or 10
-5 
M 4MBC (4MBC (-5M)) for 14 days. Media were replenished every 3-4 
days. Values are the average ±SE of triplicate wells. Where no bars are seen, error was too small to be 
visualized. *** p-value ≤ 0.001 and **** p-value ≤ 0.0001 versus no addition by one-way ANOVA 
Dunnett’s test. Three replicate experiments showed similar results (n=3).  
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Figure ‎3.19 Effect of HS on proliferation of MCF-7 human breast cancer cells in 
monolayer culture. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 
M 17β-oestradiol (+E), with 10-8M homosalate (HS (-8M)), 10-7 M homosalate (HS (-7M)), 10-6 M 
homosalate (HS (-6M)) or 10
-5 
M homosalate (HS (-5M)) for 14 days. Media were replenished every 
3-4 days. Values are the average ±SE of triplicate wells. Where no bars are seen, error was too small 
to be visualized. * p-value ≤ 0.05 and *** p-value ≤ 0.001 versus no addition by one-way ANOVA 
Dunnett’s test. Three replicate experiments showed similar results (n=3). 
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Figure ‎3.20 Effect of fulvestrant on the proliferation of MCF-7 human breast cancer 
cells‎proliferation‎following‎exposure‎to‎Bp1,‎Bp2,‎17β-oestradiol or ethanol control. 
MCF-7 cells were plated at 0.2  x 10
5 
cells/well in 24 well plates and grown in phenol-red-free-
DMEM containing 5% DCFCS for 7 days with 10
-5 
M Bp1 (Bp1 (-5M)), 10
-5 
M Bp1 and 10
-7 
M 
fulvestrant (Bp1 (-5M+Fulv)), 10
-5 
M Bp2 (Bp2  (-5M)), 10
-5 
M Bp2 and 10
-7 
M fulvestrant (Bp2 (-
5M+Fulv)), 10
-8 M 17β-oestradiol (+E), 10-8 M 17β-oestradiol and 10-7 M fulvestrant (+E (Fulv)) , 
ethanol control (-E) or ethanol control and 10
-7 
M fulvestrant (-E (Fulv)). Media were replenished on 
day 1 and day 4.  Values are the average ±SE of triplicates independent wells. Where no bars are seen, 
error was too small to be visualized. *** p-value ≤ 0.001 versus no addition (-E) (black asterisks) or to 
compare the effect of fulvestrant on the treatment (red asterisks) by one-way ANOVA Tukey’s test. 
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3.3.4.3 Effects of UV screens on MCF-7 human breast cancer cell 
proliferation in the presence of 17β-oestradiol 
Oestrogens are physiologically present in premenopausal female in a range of 10
-11 
M to 10
-10 
M (Wright et al., 1999). Thus, the effect of UV screens on proliferation of MCF-7 cells in the 
presence of different concentrations of 17β-oestradiol was investigated. MCF-7 cells were 
grown in phenol-red-free-DMEM containing 5% DCFCS with different concentrations of 
17β-oestradiol alone or mixed with 10-5 M of UV screens for 7 days. Increase in MCF-7 cells 
proliferation with 10
-5 
M Bp1 and 10
-5 
M Bp2 was not affected by the presence of different 
concentrations of 17β-oestradiol (Figure 21 (A and B)). 
Among the other tested UV screens 10
-5 
M Bp3 and 10
-5 
M 4MBC have a small yet 
significant antagonist effect on cells exposed to higher doses of 17β-oestradiol (10-11 M and 
10
-10 
M) (Figure 21 (C and D)). In contrast, 10
-5 
M OMC and 10
-5 
M HS seemed to have no 
effect on the proliferation of MCF-7 cells in a mixture with different concentrations of 17β-
oestradiol (data not shown). 
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Figure ‎3.21 Effect of Bp1, Bp2, Bp3 or 4MBC on the proliferation of MCF-7 human 
breast‎cancer‎cells‎in‎the‎presence‎and‎absence‎of‎17β-oestradiol in monolayer culture.  
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with 17β-oestradiol only 
(control, blue curves) at the indicated concentrations or with 10
-5 
M Bp1 (A, green curve), 10
-5 
M Bp2 
(B, green curve), 10
-5 
M Bp3 (C, green curve) or 10
-5 
M 4MBC (D, green curve) for 7 days. Media 
were replenished on day 1 and day 4. Values are the average ±SE of triplicate independent wells. 
Where no bars are seen, error was too small to be visualized. * p-value ≤ 0.05 and **** p-value ≤ 
0.0001 versus relative 17β-oestradiol concentration by one-way ANOVA Tukey’s test.  
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3.3.4.4 Effect of UV screens on the proliferation of MCF-7 human 
breast cancer cells on laminin or fibronectin coated plates 
MCF-7 cells were grown in phenol-red-free-DMEM containing 5% DCFCS on uncoated 
plates or plates coated with 6.5 µg/cm
2
 fibronectin or 6.5 µg/cm
2
 laminin (as described in 
2.2.1.2.) in the presence of 10
-8M 17β-oestradiol or increasing concentrations of UV screens 
(from 10
-8 
M to 10
-5 
M) for 7 days. Initially, the effect of different coating materials was 
investigated on adhesion, proliferation and morphology of MCF-7 cells.  
No significant difference was recorded in the number of cells adhered to fibronectin 
compared to the number of cells adhered to plastic after 24 hours of seeding as indicated by 
counting the adhered cells using a ZBI Coulter counter (Figure 3.22 (A)). Nor was any 
change observed on MCF-7 cell monolayer islands morphology when seeded on fibronectin 
(Figure 3.22 (C and D)). By contrast, MCF-7 cells showed significantly lower adhesion on 
laminin (p-value ≤ 0.0001) in comparison with adhesion on plastic or fibronectin, and 
exhibited colony formation (Figure 3.22 (A and E)). After 7 days of incubating MCF-7 cells 
on 6.5 µg/cm
2
 fibronectin or 6.5 µg/cm
2
 laminin, cells were counted to estimate the 
proliferation using the ZBI Coulter counter. Both fibronectin and laminin significantly 
increased the proliferation of MCF-7 cells (p-value ≤ 0.01) in comparison with cells seeded 
on plastic (Figure 3.22 (B)). 
The effect of coating with fibronectin or laminin on the proliferative response of MCF-7 cells 
to 10
-8 M 17β-oestradiol was then studied. 10-8 M 17β-oestradiol significantly increased 
MCF-7 cell proliferation on all surfaces. However, the presence of 6.5 µg/cm
2
 fibronectin 
caused a significantly greater increase in MCF-7 cell proliferation in comparison with plastic. 
On the other hand, coating with 6.5 µg/cm
2
 laminin significantly reduced the proliferative 
response of MCF-7 cells compared to both plastic and fibronectin coating (p-value ≤ 0.0001) 
(Figure 3.23).  
A similar pattern was observed following cell exposure to10
-5 
M Bp1 (Figure 3.24). Likewise, 
laminin coating reduced the proliferative effect of 10
-5 
M Bp2 on MCF-7 cells but no 
significant increase was recorded in the presence of fibronectin coating with this chemical 
(Figure 3.25). 
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Interestingly, 10
-5 
M OMC significantly increased the proliferation of MCF-7 cells on 6.5 
µg/cm
2
 laminin coated 24 well plates (Figure 3.26). Moreover, laminin and fibronectin both 
significantly increased the proliferation of MCF-7 cells following one week of exposure to 
10
-5
 4MBC (Figure 3.27). However, no effect of different coating materials were recorded on 
the proliferation of MCF-7 cells following one week exposure to lower concentrations of 
Bp1, Bp2, OMC, 4MBC, Bp3 (Figure 3.28) or HS (Figure 3.39). 
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Figure ‎3.22 Effect of different coated surfaces on adhesion (A), proliferation (B) and 
morphology (C-E) of MCF-7 human breast cancer cells. 
MCF-7 cells were plated at 0.2 x 10
5 
cells/well in 24 well plates. The wells were either uncoated (plastic), 
coated with 6.5 µg fibronectin or coated with 6.5 µg laminin. Cells were grown in phenol-red-free-DMEM 
containing 5% DCFCS for 24 hours or 1week. Bar-graph represents the cell count per well as measured by 
a ZBI Coulter counter after 24 hours of incubation (A) or after 1 week of incubation (media replenished on 
day 1 and day 4) (B). Values are the average ±SE of three independent wells. Where no bars are seen, error 
was too small to be visualized. ** p-value ≤ 0.01 and **** p-value ≤ 0.0001 versus plastic by one-way 
ANOVA Dunnett’s test. Images are representative phase contrast microscopy images of the appearance of 
MCF-7 cells grown for 24 hours on plastic (C), fibronectin (D) or laminin (E). 
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Figure ‎3.23 Effect of different coated surfaces on MCF-7 human breast cancer cell 
proliferation‎after‎treatment‎with‎17β-oestradiol. 
MCF-7 cells were plated at 0.2 x 10
5 
cells/well in 24 well plates. The wells were either uncoated 
(plastic), coated with 6.5 µg fibronectin or coated with 6.5 µg laminin. Cells were grown in phenol-
red-free-DMEM containing 5% DCFCS for 7 days with 10
-8
 M 17β-oestradiol (+E) or with ethanol 
vehicle (-E). Media were replenished on day 1 and day 4. Bar-graph represents the cell count per well 
as measured by the Coulter counter. Values are the average ±SE of three independent experiments. 
Where no bars are seen, error was too small to be visualized. **** p-value ≤ 0.0001 versus plastic 
(black asterisks), compared between different coating material for the same treatment (red asterisks) 
or compared to no addition (-E) with relative coating material (green asterisks) by two-way ANOVA 
Bonferroni test. 
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Figure ‎3.24 Effect of Bp1 on proliferation of MCF-7 human breast cancer cells on 
different coated surfaces. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8
 M 17β-oestradiol (+E), with 10-8 M Bp1 (Bp1 (-8M)), 10-7 M Bp1 (Bp1 (-7M)), 10-6 M Bp1 (Bp1 
(-6M)) or 10
-5 
M Bp1 (Bp1 (-5M)) for 7 days. Media were replenished on day 1 and day 4. Prior to the 
experiment, the wells were either uncoated (plastic), coated with 6.5 µg fibronectin or coated with 6.5 
µg laminin.  Values are the average ±SE of triplicate independent wells. Where no bars are seen, error 
was too small to be visualized. **** p-value ≤ 0.0001 compared to plastic (black asterisks), compared 
between different coating material for the same treatment (red asterisks) or compared to no addition (-
E) with relative coating material (green asterisks) by two-way ANOVA Bonferroni test. 
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Figure ‎3.25 Effect of Bp2 on proliferation of MCF-7 human breast cancer cells on 
different coated surfaces. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 
M 17β-oestradiol (+E), with 10-8 M Bp2 (Bp2 (-8M)), 10-7 M Bp2 (Bp2 (-7M)), 10-6 M Bp2 (Bp2 
(-6M)) or 10
-5 
M Bp2 (Bp2 (-5M)) for 7 days. Media were replenished on day 1 and day 4. Prior to the 
experiment, the wells were either uncoated (plastic), coated with 6.5 µg fibronectin or coated with 6.5 
µg laminin.  Values are the average ±SE of triplicate independent wells. Where no bars are seen, error 
was too small to be visualized. **** p-value ≤ 0.0001 compared to plastic (black asterisks), compared 
between different coating material for the same treatment (red asterisks) or compared to no addition (-
E) with relative coating material (green asterisks) by two-way ANOVA Bonferroni test. 
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Figure ‎3.26 Effect of Bp3 on proliferation of MCF-7 human breast cancer cells on 
different coated surfaces. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 M 17β-oestradiol (+E), with 10-8 M Bp3 (Bp3 (-8M)), 10-7 M Bp3 (Bp3 (-7M)), 10-6 M Bp3 (Bp3 
(-6M)) or 10
-5 
M Bp3 (Bp3 (-5M)) for 7 days. Media were replenished on day 1 and day 4. Prior to the 
experiment, the wells were either uncoated (plastic), coated with 6.5 µg fibronectin or coated with 6.5 
µg laminin.  Values are the average ±SE of triplicate independent wells. Where no bars are seen, error 
was too small to be visualized. * p-value ≤ 0.05, ** p-value ≤ 0.01, *** p-value ≤ 0.001 and **** p-
value ≤ 0.0001 compared to plastic (black asterisks), compared between different coating material for 
the same treatment (red asterisks) or compared to no addition (-E) with relative coating material 
(green asterisks) by two-way ANOVA Bonferroni test. 
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Figure ‎3.27 Effect of OMC on proliferation of MCF-7 human breast cancer cells on 
different coated surfaces. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 
M 17β-oestradiol (+E), with 10-8 M OMC (OMC (-8M)), 10-7 M OMC (OMC (-7M)), 10-6 M 
OMC (OMC (-6M)) or 10
-5 
M OMC (OMC (-5M)) for 7 days. Media were replenished on day 1 and 
day 4. Prior to the experiment, the wells were either uncoated (plastic), coated with 6.5 µg fibronectin 
or coated with 6.5 µg laminin.  Values are the average ±SE of triplicate independent wells. Where no 
bars are seen, error was too small to be visualized. *** p-value ≤ 0.001 and **** p-value ≤ 0.0001 
compared to plastic (black asterisks), compared between different coating material for the same 
treatment (red asterisks) or compared to no addition (-E) with relative coating material (green 
asterisks) by two-way ANOVA Bonferroni test. 
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Figure ‎3.28 Effect of 4MBC on proliferation of MCF-7 human breast cancer cells on 
different coated surfaces. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8
 M 17β-oestradiol (+E), with 10-8 M 4MBC (4MBC (-8M)), 10-7 M OMC (4MBC (-7M)), 10-6 M 
4MBC (4MBC (-6M)) or 10
-5
 M 4MBC (4MBC (-5M)) for 7 days. Media were replenished on day 1 
and day 4. Prior to the experiment, the wells were either uncoated (plastic), coated with 6.5 µg 
fibronectin or coated with 6.5 µg laminin.  Values are the average ±SE of triplicate independent wells. 
Where no bars are seen, error was too small to be visualized. * p-value ≤ 0.05, *** p-value ≤ 0.001 
and **** p-value ≤ 0.0001 compared to plastic (black asterisks), compared between different coating 
influence on the same treatment (red asterisks) or compared to no addition (-E) with relative coating 
material (green asterisks) by two-way ANOVA Bonferroni test. 
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Figure ‎3.29 Effect of HS on proliferation of MCF-7 human breast cancer cells on 
different coated surfaces. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 
M 17β-oestradiol (+E), with 10-8 M HS (HS (-8M)), 10-7 M HS (HS (-7M)), 10-6 M HS (HS (-6M)) 
or 10
-5 
M HS (HS (-5M)) for 7 days. Media were replenished on day 1 and day 4. Prior to the 
experiment, the wells were either uncoated (plastic), coated with 6.5 µg fibronectin or coated with 6.5 
µg laminin. Values are the average ±SE of triplicate independent wells. Where no bars are seen, error 
was too small to be visualized. * p-value ≤ 0.05, *** p-value ≤ 0.001 and **** p-value ≤ 0.0001 
compared to plastic (black asterisks), compared between different coating influence on the same 
treatment (red asterisks) or compared to no addition (-E) with relative coating material (green 
asterisks) by two-way ANOVA Bonferroni test. 
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3.3.5 Comparisons between the effects of different UV screens on MCF-
7 human breast cancer cells  
Comparisons between the effects on MCF-7 human breast cancer cells produced by the 
exposure to the UV screens or 17β-oestradiol using the different end points are summarized 
in Tables 3.1 and 3.2. 
To enable the statistical comparison between the different UV screens and their effects on 
ERE luciferase activity or MCF-7 proliferation, a summary figure was produced (Figure 
3.30). In comparison with the six UV screens, the highest ERE-Luciferase activity was 
caused by the exposure to 10
-5
 M Bp2. 10
-5
 M Bp2 increased the luciferase activity to a 
greater extent than 10
-5
 M Bp1 (p-value ≤ 0.0001), greater than 10-5 M Bp3 (p-value ≤ 
0.0001), greater than 10
-5
 M OMC, 4MBC and HS (p-value ≤ 0.0001) (Figure 3.30 (A)). No 
significant difference was found by comparing the effects of 10
-5
 M Bp1 and 10
-5
 M Bp3 or 
10
-5
 M Bp3 and 10
-5
 M OMC. In addition, differences of luciferase activity of 10
-5
 M OMC, 
10
-5
 M 4MBC and 10
-5
 M HS was not found statistically significant. However, the ERE-
luciferase activity increased by 10
-5
 M Bp3 was found greater than 10
-5
 M 4MBC (p-value ≤ 
0.01) and 10
-5
 M HS (p-value ≤ 0.05).  
The proliferation experiments revealed that 10
-5
 M Bp1 caused the highest proliferation 
among the 6 UV screens. It increased MCF-7 cell proliferation to a greater extent than 10
-5
 M 
Bp2 (p-value ≤ 0.05), 10-5 M Bp3, 10-5 M OMC, 10-5 M 4MBC and 10-5 M HS (p-value ≤ 
0.0001). Bp2 was found to increase the proliferation of MCF-7 cells statistically significant in 
comparisons with 10
-5
 M Bp3, 10
-5
 M OMC and 10
-5
 M 4MBC (p-values ≤ 0.05) but not HS. 
No statistical significant difference was recorded in comparing the effects of 10
-5
 M Bp1, 10
-5
 
M Bp2 and 10
-8
 M 17β-oestradiol on MCF-7 cells proliferation (Figure 3.30 (B)). 
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Table ‎3.1  Summary table of the oestrogenic action of 10
-5
M UV screens on MCF-7 
human breast cancer cells in comparison to 10
-8M‎17β-oestradiol. 
Treatments The evaluation tools used to determine the oestrogenic activity 
ERE-LUC 
reporter assay 
TFF1 gene 
expression 
ERα protein 
levels 
Proliferation experiments 
on plastic 
17β-oestradiol ↑ **** ↑ ** ↓ * ↑ *** 
Bp1 ↑ **** n.s. ↓ * ↑ *** 
Bp2 ↑ **** n.s. ↓ * ↑ *** 
Bp3 ↑ **** n.s. n.s. n.s. 
OMC ↑ * n.s. n.s. n.s. 
4MBC ↑ ** ↑ *  
After 24-25 weeks 
of exposure 
↓ * ↑ *** 
HS ↑ ** ↑ ** 
After 24-25 weeks 
of exposure 
↓ * ↑ *** 
Arrows indicate increase (↑) or decrease (↓). * p-value ≤ 0.05, ** p-value ≤ 0.01, *** p-value ≤ 0.001 
and **** p-value ≤ 0.0001 versus negative control and (n.s.) indicates no significant effect. 
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Table ‎3.2  Summary table showing the comparative effects of different coating materials 
on proliferation of 10
-5
M UV screens on MCF-7 human breast cancer cells in 
comparison to 10
-8M‎17β-oestradiol. 
Treatments Proliferation experiments 
On plastic  Laminin coating Fibronectin coating 
17β-oestradiol ↑ ***  
versus no addition 
↓ ****  
versus growth on plastic 
↑ ****  
versus growth on plastic 
Bp1 ↑ *** 
versus no addition 
↓ **** 
versus growth on plastic 
↑ **** 
versus growth on plastic 
Bp2 ↑ *** 
versus no addition 
↓ **** 
versus growth on plastic 
n.s. 
versus growth on plastic 
Bp3 n.s. 
versus no addition 
n.s. 
versus growth on plastic 
n.s. 
versus growth on plastic 
OMC n.s. 
versus no addition 
↑ **** 
versus growth on plastic 
n.s. 
versus growth on plastic 
4MBC ↑ *** 
versus no addition 
↑ **** 
versus growth on plastic 
↑ *** 
versus growth on plastic 
HS ↑ *** 
versus no addition 
n.s. 
versus growth on plastic 
n.s. 
versus growth on plastic 
Arrows indicates increase (↑) or decrease (↓). * p-value ≤ 0.05, ** p-value ≤ 0.01, *** p-value ≤ 0.001 
and **** p-value ≤ 0.0001 versus negative control (no addition) or versus growth on plastic and (n.s.) 
indicates no significant effect. 
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Figure ‎3.30 Statistical comparison and summary of the varying effect of the UV screens on 
oestrogen-inducible ERE-LUC reporter gene in stably transfected MCF-7 human breast 
cancer cells (A) and proliferation of MCF-7 human breast cancer cells in monolayer culture 
(B). Stably ERE-LUC transfected MCF-7 cells (0.2 x 105 cells/well) were exposed to 10
-8
 M 17β-
oestradiol (+E), 10
-5
 M Bp1 (Bp1 (-5M)), 10
-5
 M Bp2 (Bp2 (-5M)), 10
-5
 M Bp3 (Bp3 (-5M)), 10
-5
 M OMC 
(OMC (-5M)), 10
-5
 M 4MBC (4MBC (-5M)) or 10
-5
 M HS (HS (-5M)) or ethanol control (-E) in phenol-
red-free DMEM and 5% DCFS for 24 hours prior to the measurement (A). Monolayers of MCF-7 cells 
(0.2 x 10
5
 cells/well) were exposed to the same treatments and media for 14 days (B). (A)Values are the 
average ±SE of 3 independent experiments for Bp1 and Bp2 (n=3) and 2 independent experiments for Bp3, 
OMC and HS.  (B) Values are the average ±SE of 3 independent wells (n=3). * p-value ≤ 0.05, ** p-value 
≤ 0.01 and **** p-value ≤ 0.0001 versus no addition ( black asterisks), 17β-oestradiol (green asterisks), 
Bp1 (blue asterisks), Bp2 (purple asterisks), Bp3 (lime asterisks) by one-way ANOVA Tukey’s test. 
  
(A) 
(B) 
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3.4 Discussion 
Overall six UV screens have been found to have effects on gene expression and proliferation 
of oestrogen responsive MCF-7 human breast cancer cells. The six chemicals were, 
benzophenone-1(Bp1), benzophenone-2 (Bp2), benzophenone-3(Bp3), octyl-
methoxycinnamate (OMC), 4-methylbenzylidene camphor (4MBC) and homosalate (HS). In 
order to evaluate the oestrogenic potency of these chemicals, 4 methods were conducted; 
ERE-LUC reporter gene assay, measuring the levels of ERα protein by western 
immunoblotting, TFF1 gene expression by RT-PCR and effects on cell proliferation. The 
results are summarized in Table 3.1.  
UV screens increases the ERE-LUC activity. The ERE-LUC reporter gene assay results have 
shown a significant increase in the luciferase activity following the exposure of the stably 
transfected MCF-7 cells to all of the UV screens albeit to different extents. 10
-5
M Bp2 
induced the highest luciferase activity followed by 10
-5
M Bp1 and then 10
-5 
M Bp3. Three of 
the six UV screens (10
-5 
M OMC, 10
-5 
M 4MBC and 10
-5 
M HS) have shown positive effects 
compared to the control but their effects on the ERE-LUC activity were statistically lower 
than the benzophenones. Dose response curves for each of the chemicals has shown that the 
lowest observed effect concentrations (LOEC) were 10
-7 
M Bp2, 10
-6 
M Bp1, 10
-7 
M 4MBC, 
10
-6 
M HS, 10
-5 
M Bp3 and 10
-5 
M OMC. These findings are consistent with three published 
studies using ERα or ERβ stably transfected HEK293 kidney cells, the ERE activity 
following exposure to Bp3, OMC, 4MBC and HS were similar to our findings (Schreurs et 
al., 2002). Gomez and colleagues showed similar results of oestrogenic activity obtained from 
ERα transfected HeLa cervical cells following exposure to OMC, 4MBC and HS (Gomez et 
al., 2005). Induction of ERE-LUC activity in transiently transfected MCF-7 cells following 
exposure to Bp1 and Bp2 has been reported by Kerdivel and colleagues but they did not find 
any significant effect of Bp3 (Kerdivel et al., 2013). The Kerdivel group used 10
-6
 M as the 
highest concentration of Bp3 which is in line with our finding using the same concentration. 
However, the results here reported a significant effect of 10
-5 
M. The Kerdivel group has also 
investigated the effects on non-oestrogen responsive promotors and found a significant 
increase in transactivation activity of stimulating protein 1-luciferase (SP1-LUC) and 
complement 3-luciferase (C3-LUC) caused by 10
-6 
M Bp1 and 10
-7 
M Bp2, suggesting a 
possible effects on MCF-7 cells via other pathways besides the ER mediated ones (Kerdivel 
et al., 2013). 
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The ERE-luciferase activity induced by Bp1 and Bp2 was decreased using 10
-7 
M fulvestrant 
in our study and in the Kerdivel work (Kerdivel et al., 2013), which suggests the dependency 
on ER as a mechanism of action of these chemicals in activating the ERE-reporter gene. In 
this work, 10
-7 
M fulvestrant have been found to successfully reduce the effects of 10
-5 
M Bp1 
and Bp2 in increasing ERE-LUC activity. Further work is to be conducted to confirm if the 
other UV screens have increased ERE-LUC activity via ER mediated pathway. 
Other supporting evidence for the in vitro oestrogenic potency of these chemicals on gene 
expression have been published using  ER-ELISA and yeast two-hybrid assay (Morohoshi et 
al., 2005), recombinant yeast assay carrying human ER (Miller et al., 2001; Kunz and Fent, 
2006) and ER binding assay (Schlumpf et al., 2004). Whereas some of the reports report high 
oestrogenic potency of Bp1 and Bp2, the partial potency of Bp3 has also been described 
(Miller et al., 2001; Kunz and Fent, 2006).  Some reports have shown no oestrogenic potency 
of OMC, 4MBC (Morohoshi et al., 2005; Kunz and Fent, 2006) and HS (Kunz and Fent, 
2006). 
ERα protein levels in MCF-7 cells are reduced following one week exposure to the UV 
screens. Levels of ERα protein are known to be reduced by the addition of oestradiol (Saceda 
et al., 1988; Borras et al., 1994). The change of ERα protein level as determined by western 
blot was carried out therefore to verify the extent of the oestrogenic profile of the UV screens. 
MCF-7 cells were exposed to 10
-7 
M and 10
-5 
M of the UV screens for 1 week prior to the 
lysate preparations. 10
-7 
M Bp1, 10
-7 
M Bp2, 10
-5 
M Bp2, 10
-5 
M 4MBC and 10
-5 
M HS all 
gave a reduction in ERα levels but Bp3 and OMC did not. Kerdivel and his colleagues have 
not found an effect on ERα levels following exposure to 10-6M Bp1, 10-6M Bp2 and 10-6 M 
Bp3 but it is noteworthy that they also have not recorded a reduced level of ERα after 
exposure to 17β-oestradiol (Kerdivel et al., 2013). The investigation of the effect of these UV 
screens on the protein levels of ERβ was not carried out in this research. This will be 
interesting future research because others  documented the ability of Bp3, HS (Schreurs et al., 
2002) and 4MBC (Schlumpf et al., 2004) to interact with ERβ. However, the endogenous 
levels of ERβ in MCF-7 cells are much lower than ERα protein levels (Shaw et al., 2006; 
Holbeck et al., 2010; AL-Bader et al., 2011; Ford et al., 2011; Nadal-Serrano et al., 2012; Ma 
and Gollahon, 2016). Thus the effects of the UV screens on ERβ levels have not been carried 
out in this work. 
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TFF1 mRNA levels are increased after 24 weeks of exposure to 4MBC and HS. The 
induction of TFF1(pS2)-mRNA by 17β-oestradiol (Jakowlew et al., 1984) makes it a suitable 
biomarker for the oestrogenic activity  in MCF-7 cells (Jørgensen et al., 2000; Jung et al., 
2012). Therefore, it has been used to confirm the oestrogenicity of many endocrine disrupters 
such as bisphenol A (Olsen et al., 2003), triclosan (Huang et al., 2014) and parabens (Byford 
et al., 2002). Schlumpf and co-workers have recorded an induction in TFF1 protein secretion 
following exposure of MCF-7 cells to Bp3, 4MBC and HS but not OMC (Schlumpf et al., 
2001). Moreover, Heneweer and co-workers have described the induction of the TFF1 gene in 
MCF-7 cells after 24 hours of exposure to Bp1, Bp3, OMC and HS (Heneweer et al., 2005). 
In another recent study, TFF1-mRNA was significantly increased by the exposure to Bp2 and 
Bp3 but not by Bp1(Kerdivel et al., 2013). Results in this study were not similar after 1 week 
of exposure to the same chemicals. The main reason is the variation in the experimental 
designs, mRNA samples of this work was collected after one week of exposure, without prior 
hormone deprivation (or in this case UV screen deprivation), while the other groups collected 
the mRNA samples following 1 day of hormone deprivation and 24 hours (Heneweer et al., 
2005) or 48 hours (Kerdivel et al., 2013) of exposure to the UV screens.  
After 23-24 weeks of exposure TFF1-mRNA was found to be increased significantly by 10
-5 
M 4MBC and 10
-5 
M HS. In comparison with previous studies, Schlumpf  had measured the 
secreted TFF1 protein after 6 days of exposure and not the mRNA expression while the other 
two studies measured the TFF1-mRNA after 24 and 48 hours of exposure respectively 
(Heneweer et al., 2005; Kerdivel et al., 2013). Such differences in the experiments might 
explain these contradictory findings.  
However, lack of the induction of TFF1 gene expression by the six UV screens despite their 
ability to induce the ERE-luciferase reporter gene expression might be explained by the 
difference in experimental design. While the ERE-LUC reporter gene assay was conducted 
using stably transfected MCF-7 cells after 24 hours of exposure, measuring the TFF1-mRNA 
was carried out by collecting the RNA of MCF-7 cells after 7 days or longer (23-24 weeks) 
exposure. Although the oestrogenicity results obtained from the ERE-LUC activity after 
exposure to Bp1, Bp2, Bp3 and OMC have not been confirmed by the induction of the TFF1 
gene, the possible effect of these chemicals on other oestrogen responsive genes should now 
be studied because the activation of ER generates alteration to hundreds of oestrogen target 
genes (Frasor et al., 2003; Gruber et al., 2004). The variation of the ability of Bp1, Bp2 and 
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Bp3 to induce the expression of the TFF1 gene and other oestrogen responsive genes was 
published by Kerdivel and his colleagues and their investigation included PR, CXCL12 and 
amphiregulin (Kerdivel et al., 2013). Only Bp2 induced the expression of all of these 
oestrogen responsive genes and the TFF1 gene. In contrast, neither Bp1 nor Bp3 were able to 
induce the expression of all of the other 3 genes collectively whereas they have both induced 
the TFF1 gene and only Bp1 induced PR (Kerdivel et al., 2013). It is noteworthy that our 
positive control (17β-oestradiol) has significantly increased the luciferase activity as well as 
induced the TFF1-mRNA expression.  
UV screens increase MCF-7 cell proliferation. As is well known, the oestrogen responsive 
proliferation of MCF-7 cells (Berthois et al., 1986) enables the use of this cell line as a tool to 
estimate the oestrogenic potency of endocrine disruptors (Soto et al., 1995). This application 
of MCF-7 cells helped in revealing many of the oestrogenic compounds (Soto et al., 1994; 
Jones et al., 1998; Olsen et al., 2003; Charles and Darbre, 2013). Among the tested UV 
screens, Bp2 gave the greatest effect on proliferation of MCF-7 cells, with Bp1 a close second 
and less increase in MCF-7 cell proliferation was achieved by 4MBC and HS. These findings 
are in agreement with previous studies (Schlumpf et al., 2001; Nakagawa and Suzuki, 2002; 
Jimenez-Diaz et al., 2013). However, in contrast to Schlumpf’s work, our data showed no 
significant effect following the exposure to Bp3 or OMC. Similar findings of no effect of Bp3 
on MCF-7 cell proliferation was published by Kerdivel and his colleagues, who also 
disagreed with the effect of Bp1 on MCF-7 cell proliferation (Kerdivel et al., 2013). Such 
differences could be explained by differences in experimental methods and in experimental 
conditions such as the concentration of DCFCS, the time of exposure, the concentrations of 
the UV screens and the source of MCF-7 cells (Osborne et al., 1987). Since Bp1 and Bp2 
were the most potent compounds on MCF-7 cell growth the addition of the antioestrogen 
fulvestrant was tested on the compounds and the proliferative response was significantly 
downregulated by 10
-7 
M fulvestrant, which suggests that the proliferation caused by Bp1 and 
Bp2 was ER mediated. Whether the effect of 4MBC and HS on the proliferation of MCF-7 
cells is ER mediated is yet to be confirmed by the same assay in future work. 
Variation of the oestrogenic effects of the UV screens in relation to their molecular 
structure and their binding affinity to ER. Throughout this chapter, the six UV screens have 
shown different effects on the points under investigation. Miller and colleagues have studied 
the effect of 73 oestrogenic chemicals on the recombinant yeast assay and documented that 
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oestrogenic chemicals with a phenolic ring with para-hydroxyl group and with a molecular 
weight of 140-250 are able to activate ER (Miller et al., 2001). Among the tested UV screens, 
Bp2 induced the highest luciferase activity and second highest increase in proliferation after 
Bp1. The molecular structure of Bp2 (246.218 MW) has 4 hydroxyl groups of which two are 
para-hydroxy phenolic groupings (see structure table 1.3), which is consistent with Millers 
suggestions of the requirements of oestrogenic chemicals to activate ER. Further, Kerdivel 
and co-workers have conducted a docking analysis to study Bp2 and other benzophenones 
binding to the ER ligand binding pocket. In their study, the hydroxyl groups of Bp2 formed 
hydrogen bonds with Arg-394 and Glu-353 but with no interaction with His-524 (Kerdivel et 
al., 2013). These interactions are important in the conformation of ER after binding with 17β-
oestradiol as shown by the crystal structure of the ligand binding of 17β-oestradiol and ERα 
(Brzozowski et al., 1997) (see Figure 1.7). 
Bp1 (214.22 MW) had the highest effect in increasing the proliferation of MCF-7 cells and 
the second in increasing the luciferase activity with a molecular structure that consists of 1 
phenolic ring with ortho- and para- hydroxyl groups (see structure Table 1.3), which also is 
consistent with Millers suggestions and is related to the documented binding affinity of Bp1 
to ERα (Blair et al., 2000). Among the benzophenones, Bp3 came in third place in increasing 
the luciferase activity and did not have any effect on MCF-7 cell proliferation. The low 
binding affinity of Bp3 to ER may explain the lower potency of Bp3 (Blair et al., 2000). 
Although the molecular weight of Bp3 (228.274 MW) is within the range suggested by Miller 
et al., (2001), the chemical structure of Bp3 has one ortho-hydroxyl group on the phenolic 
ring and no interaction of Bp3 with Arg-394, Glu-353 or His-524 was found in docking 
analysis, instead this chemical activates ER through the hydrophobic bounding (Kerdivel et 
al., 2013). 
No docking data was found for OMC, 4MBC and HS. The luciferase activity caused by these 
chemicals was lower than the ones caused by the benzophenones and only 4MBC and HS 
increased the proliferation of MCF-7. The molecular structures of these three chemicals (see 
Table 1.4) show that OMC and 4MBC do not have a phenolic ring. HS has one phenolic ring 
but the hydroxyl group is in the ortho position. It is worth noting that the molecular weights 
of OMC (290.403 MW), 4MBC (254.373 MW) and HS (262.349 MW) are larger than the 
range proposed by Miller et al. (2001) and that might be related also to the lower potency of 
these chemicals. 
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UV screens in combination with 17β-oestradiol influence MCF-7 cell proliferative 
response. Since 17β-oestradiol is an endogenous hormone in the human body, the interaction 
of 17β-oestradiol with the UV screens was considered. The influence of UV screens on the 
proliferation of MCF-7 cells was investigated in combination with different concentrations of 
17β-oestradiol. No significant difference was obtained by combining 10-12 M of 17β-
oestradiol with the no-observed-effect concentration (NOEC) of the UV screens on MCF-7 
cell proliferation in comparison with the effect of 10
-12 
M 17β-oestradiol alone (data are not 
shown). Thus, we investigated the effect of combining 17β-oestradiol at different doses (from 
10
-14
 M to 10
-10 
M) with Bp1, Bp2, 4MBC and HS in the range causing maximum 
proliferative effect (10
-5 
M). The use of 10
-5 
M concentration of these chemicals might be 
necessary to provoke their effect in vitro. One example is the requirement of using 10
-4
M 
parabens to induce the proliferation of MCF-7 cells (Byford et al., 2002). A down side of 
using the high concentration of the chemicals in a binary mixture model is the possibility of 
producing saturable effects. At the same time, further investigation was also conducted to 
observe the effect of Bp3 and OMC regardless of their failure to induce MCF-7 cell 
proliferation. The combinations of 10
-5 
M Bp1 or 10
-5 M Bp2 with 17β-oestradiol enhanced 
cell proliferation, while Bp3 and 4MBC showed an antagonist effect in combination with 
higher concentrations of 17β-oestradiol (10-11 M and 10-10 M). Similar experiments using the 
same UV screens were not found in literature. Although, the effect of binary mixtures of 17β-
oestradiol and other environmental oestrogens including bisphenol A and butylbenzyl 
phthalate on MCF-7 cell proliferation was previously studied (Suzuki et al., 2001). Mixtures 
of Bp1, Bp2, Bp3 and other UV screens in combination with 17β-oestradiol showed a 
synergistic effect on the recombinant yeast assay carrying hERα (Kunz and Fent, 2006). The 
ability of these chemicals to interact with the effect of 17β-oestradiol on MCF-7 cell 
proliferation might point out of other possible actions within the human body. 
Proliferative response of MCF-7 cells to UV screens is affected by the use of laminin and 
fibronectin coating. Using another approach, we have studied the effects of UV screens on 
the proliferative response of MCF-7 cells on laminin or fibronectin coated surfaces in order to 
recapitulate in culture the responses to these chemicals in vivo. Studies on interactions of 
MCF-7 cells with extracellular matrix components (ECM) showed influence on their 
morphology (Kenny et al., 2007), proliferation (Nista et al., 1997; Li et al., 2014) and 
variation in their responses to 17β-oestradiol (Woodward et al., 2000). The decision to use 
laminin in this research was based on laminin being one of the major components of the 
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basement membrane (reviewed in (Colognato and Yurchenco, 2000)) which reduced the 
sensitivity of oestrogen responsive cells toward 17β-oestradiol (Woodward et al., 2000). The 
decision to use fibronectin was based on  its increased levels during the progression of breast 
cancer (Ioachim et al., 1997; Oskarsson, 2013) and its opposite action to those of laminin on 
MCF-7 cell growth response to 17β-oestradiol where it increases the proliferative response 
(Woodward et al., 2000; Xie and Haslam, 2008). To our knowledge, this was the first study 
that investigated the effect of coating with ECM components on the UV screen action on 
MCF-7 cell proliferation. Results of this work showed that both fibronectin and laminin 
increased the proliferation of MCF-7 cells after one week of exposure without the addition of 
17β-oestradiol and that is in line with previous studies (Nista et al., 1997; Li et al., 2014). 
After the addition of 17β-oestradiol, MCF-7 cells showed a significant increase in cell 
proliferation on fibronectin and reduced proliferation on laminin coated plates and these 
results have confirmed the published work by Woodwork and co-workers (Woodward et al., 
2000). In order to address the oestrogen mimicking properties’ of the six UV screens, the 
proliferative responses to the UV screens of MCF-7 cells on the same coating components 
was conducted. Among the tested chemicals, 10
-5 
M Bp1 was the only UV screen which 
showed a similar effect to 10
-8 
M 17β-oestradiol on MCF-7 cells seeded on the coating 
material and Bp2 had similar decrease in cell proliferation on laminin coated plates with no 
notable increase in the proliferation on fibronectin coated plates. Interestingly, in contrast to 
the non-significant effect of 10
-5 
M OMC on MCF-7 cell proliferation on plastic, 10
-5 
M OMC 
significantly increased the proliferation of MCF-7 cell proliferation on laminin. Further, 10
-5 
M 4MBC exhibited an increase in the proliferation on both fibronectin and laminin coated 
plates. However, Bp3 and HS did not exhibit any increase in proliferation on coated plates. 
Further investigations using this methodology might provide new insights into the effect of 
other environmental oestrogens in vitro. Whether the molecular mechanisms for the UV 
screens are similar to those of oestrogen on coated plates remains to be clarified for each UV 
screen individually in future work. 
In summary, using a combination of different techniques to estimate the possible oestrogen 
mimicking ability of these UV screens served in overcoming any technical limitations, which 
might be caused by the weak oestrogenic effect of these UV screens. Indeed, the oestrogenic 
activities of these chemicals were far less than the effects observed by the exposure to the 
endogenous hormone 17β-oestradiol. However, Bp1 and Bp2 have been found to mimic 17β-
oestradiol in most of the endpoints tested. Both chemicals were considered to possess more 
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oestrogenic potency as measured by the ERE-LUC reporter gene assay and proliferation in 
comparison to the other chemicals in this study. These activities are ER mediated, which were 
confirmed by knocking down the effects by the oestrogen receptor antagonist fulvestrant. 
However, lack of the induction of TFF1 gene expression by these two chemicals presents a 
missing gap in confirming the oestrogenic activity for Bp1 and Bp2, which can be explained 
by the different experimental design that was conducted in this research and was different 
than the one used to address the change in the levels of TFF1 mRNA (Heneweer et al., 2005 ; 
Kerdivel et al., 2013). Also, more biological replicates might reveal different findings on this 
matter and the interaction of these chemicals with other oestrogen-related genes should be 
investigated. 4MBC and HS gave significant differences in all of the endpoints except for the 
induction of TFF1 gene expression, which was only found after 24 weeks of exposure (see 
Table 3.1). 
In contrast to the reducing effect of laminin on MCF-7 cell proliferative response toward 17β-
oestradiol, 4MBC increased MCF-7 cell proliferation on laminin and proliferative response to 
HS was not influenced by the use of coating materials (Table 3.2). This variation in 
comparison with 17β-oestradiol suggests that 4MBC and HS might trigger other signalling 
pathways beside the ER-mediated mechanism. In comparison between 4MBC and HS, 
Schlumpf had found HS to induce higher in vitro oestrogenic activity than the one induced by 
4MBC. However, this was reversed in the in vivo model and 4MBC showed higher effect in 
increasing the uterine weight in immature rats (Schlumpf et al., 2001). The complexity of the 
interactions of these chemicals or their metabolites in vivo must be further investigated to 
provide a full profile of their oestrogenic abilities.  
Despite the ability of Bp3 and OMC to induce the ERE-LUC reporter gene activity, no other 
oestrogenic action on the other endpoints was documented. In contrast, OMC has induced the 
proliferation on laminin coated plates (see Table 3.2). Although Bp3 and OMC are considered 
to be partial agonists, they need further investigation because they are among the most 
detected UV screens in human samples and widely used in cosmetics (Janjua et al., 2008; 
Schlumpf et al., 2010; Zhang et al., 2013). Furthermore, since Bp1 is one of the metabolites 
of Bp3 (Jeon et al., 2008), which has shown high oestrogenic activity, further investigation of 
the effect of Bp3 and its metabolites remains important. 
While our model focused on the individual action of these chemicals, the additive effect of 
compound mixtures is another approach that can resemble their daily intake into the human 
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body and should be carried out in future studies. Mixtures of UV screens (Bp1, Bp3, OMC 
and 4MBC) (at IC50 concentrations) were found to induce TFF1 gene expression to similar 
levels caused by 17β-oestradiol (Heneweer et al., 2005). Thus, the possible effect of 
combinations of weaker environmental oestrogens should not be neglected. The effect of 
mixtures of other environmental oestrogens on MCF-7 cell proliferation was documented 
(Payne et al., 2001; Charles and Darbre, 2013) but further effects of UV screens in 
combination remains to be explored at the same concentration found in human milk or in 
human tissue. 
Although the oestrogenic activity of some of these chemicals has been shown to influence 
proliferation, this is only one of the hallmarks of cancer cells. Another important hallmark is 
activation of invasion and metastasis (Hanahan and Weinberg, 2011), which is relevant for 
breast cancer where mortality arises not from growth of the primary tumour but from 
metastatic tumour spread (Solomayer et al., 2000; Schairer et al., 2004; Manders et al., 2006). 
This hallmark is further investigated in the next chapters. 
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Chapter 4  Effects of the UV screens on migration and 
invasion of MCF-7 human breast cancer cells 
4.1 Introduction 
Proliferation of MCF-7 human breast cancer cells has been used as an in vitro model to 
demonstrate oestrogenicity of environmental chemicals (Soto et al., 1995) and their potential 
influence on breast cancer growth. However, mortality of breast cancer is mediated by the 
metastasis of cancer cells to distant organs (Solomayer et al., 2000; Schairer et al., 2004; 
Manders et al., 2006) and several reports document a supporting role of oestrogen on breast 
cancer cell migration in vitro (Saji et al., 2005; Malek et al., 2006; Planas-Silva and Waltz, 
2007; Giretti et al., 2008; Chakravarty et al., 2010; Li et al., 2010; Jimenez-Salazar et al., 
2014) and in vivo (Ganapathy et al., 2012; Ogba et al., 2014). It is therefore possible that 
environmental chemicals with oestrogenic activity might also influence motility and invasion 
of breast cancer cells through an ER-mediated mechanism. 
In 2012, Yao and his colleagues reported an increase in migration and invasion of human 
testicular embryonal carcinoma cells (NT2/D1) after being exposed to phthalate esters (Yao 
et al., 2012). In another study Khanna and colleagues (2014) have recorded an increase of 
MCF-7 and T-47-D human breast cancer cell migration and invasion after long-term exposure 
to parabens (Khanna et al., 2014). In view of the effect of the UV screens on MCF-7 cell 
proliferation described in the previous chapter, studies are described here of the ability of 
these chemicals to influence motility and invasion in MCF-7 cells and possible underlying 
molecular mechanisms have been investigated. 
The process of metastasis involves many alterations to cell morphology and metastasis-
related markers that facilitate the transition of non-motile epithelial MCF-7 cells into more 
motile cells. It was suggested that epithelial to mesenchymal transition (EMT) could be one 
of the possible mechanisms that underly the metastasis of epithelial cells (Guarino et al., 
2007). The morphological and cytoskeletal changes of the epithelial cells undergoing EMT is 
underlaid by several EMT-related molecular markers including loss of E-cadherin and β-
catenin and induced N-cadherin and vimentin (Micalizzi et al., 2010). It is noteworthy that 
loss of E-cadherin in breast cancer tissues was found to be correlated with poor prognosis in 
clinical studies (Gamallo et al., 1993; Oka et al., 1993; Siitonen et al., 1996; Jeschke et al., 
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2007). E-cadherin expression can be repressed by several regulators including elevated 
expression of the zinc-finger proteins (Snail) (Batlle et al., 2000) and the basic helix-loop-
helix transcription factor (Twist-1) (Yang et al., 2004; Vesuna et al., 2008), both of which 
were described as promotors of cancer metastasis (Nguyen et al., 2009). 
Other genes have also been linked to the promotion of cancer metastasis through EMT such 
as Phosphoinositide-3-Kinase Regulatory Subunit 1 (PIK3R1) and Bone morphogenetic 
protein 7 (BMP7). A correlation between EMT induction and down-regulation of BMP7 and 
PIK3R1 was described in vitro (Yang et al., 2005; Buijs et al., 2007; Lin et al., 2015). 
Furthermore, the depletion of PIK3R1 expression was correlated with poor breast cancer 
patient survival (Cizkova et al., 2013). Bone morphogenetic proteins are a sub-family of the 
transforming growth factor β (TGF-β) family, which are correlated with cell proliferation and 
differentiation (Ye and Jiang, 2015). BMP7 is detected in human breast cancer tissue 
(Schwalbe et al., 2003; Alarmo et al., 2006) and BMP7 mRNA expression was found to be 
elevated in MCF-7 cells and not expressed in the invasive motile MDA-MB-231 human 
breast cancer cells (Alarmo et al., 2007). Uchino and his colleagues have shown a link 
between the decrease in mRNA expression of BMP7 and PIK3R1 and the increase in motility 
and invasive activity of matrigel-selected MCF-7 cells (MCF-7-14). Moreover, they have 
shown similar down-regulated expression of both BMP7 and PIK3R1 in MCF-7-14 cells and 
MDA-MB-231 cells by microarray analysis. The same group has suggested that MCF-7-14 
cells have turned into a metastable phenotype  due to the retained  E-cadherin expression and 
elevated cell motility in comparison with parental MCF-7 cells (Uchino et al., 2010).  
Metastasis of cancer cells has also been reported to be influenced by the activity of matrix 
metalloproteases (MMPs). MMPs play a crucial role in degrading the ECM components in 
order to facilitate cancer invasion (Woodhouse et al., 1997; Roy et al., 2009). In the context 
of breast cancer, several MMPs have been linked to the induced metastasis of breast cancer 
cells including MMP-1, MMP-2, MMP-9 and the membrane-type MMP-14 (Deryugina et al., 
1997; Gupta et al., 2007; Kohrmann et al., 2009; Zarrabi et al., 2011). MMP-14 is an 
intracellular MMP, which is involved in the activation of pro-MMP-2 (Deryugina et al., 
2001). 17β-oestradiol was found to modulate MMP-2/MMP-9 activity in MCF-7 cells 
(Nilsson et al., 2007; Song et al., 2007). The effect of UV screens on MMP activities in MCF-
7 cells has therefore been investigated. 
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4.2 Experimental aims 
The MCF-7 human breast cancer cell line was found to give a proliferative response to some 
of the UV screens (see chapter3). The overall aims of this chapter are to investigate the effect 
of six UV screens (Bp1, Bp2, Bp3, OMC, 4MBC and HS) on motility and invasion of MCF-7 
cells after short-term (2 weeks) and long-term (24-31 weeks) exposure to these compounds 
and then to study molecular mechanisms that might underly any change in MCF-7 cell 
behaviour. These time points were suggested based on previous publications that have 
documented an increase in MCF-7 cell motility after long term exposure to environmental 
oestrogens. MCF-7 cell showed an increased motility after 20 ± 2 weeks exposure to parabens 
(Khanna et al., 2014), while exposure to aluminium increased MCF-7 cells motility after 32 
weeks (Darbre et. al, 2013).   
In order to achieve these aims the motility of MCF-7 cells was assessed using a wound 
healing assay, using live cell imaging by time-lapse microscopy and using the xCELLigence 
technology (see materials and methods chapter 2). 
Assessment of changes in MCF-7 cell invasive activity after exposure to the UV screens was 
carried out by monitoring cell migration through matrigel coated plates using the 
xCELLigence technology (see section 2.5). Investigation of the ability of these chemicals to 
alter MCF-7 cell invasive properties through alteration to MMPs was done by measuring 
changes in MMP-2 and MMP-9 secretion into the media using gelatin zymography (see 
section 2.8) and by measuring the levels of the intracellular MMP-14 using western 
immunoblotting (see section 2.7).  
Since motility of epithelial cells can be induced by EMT (Guarino et al., 2007), the work of 
this chapter examined the effect of short and long-term exposure of MCF-7 cells to the UV 
screens on two of EMT related markers; E-cadherin and β-catenin. mRNA levels were 
investigated by RT-PCR (see section 2.6) and protein levels by western immunoblotting (see 
section 2.7). mRNA levels of two of the upstream transcriptional regulators (Snail and Twist-
1) of E-cadherin were investigated using RT-PCR. Moreover, mRNA levels of BMP7 and 
PIK3R1 were measured as they are considered as molecular markers of cell motility (Yang et 
al., 2005; Buijs et al., 2007; Uchino et al., 2010; Lin et al., 2015).  
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4.3 Results 
4.3.1 Effects of Bp1 on migration of MCF-7 human breast cancer cells 
4.3.1.1 Effects of Bp1 on collective migration of MCF-7 human breast 
cancer cells as measured by wound healing 
The wound healing assay (as described in 2.4.1) was used to determine the effect of long term 
exposure to Bp1 on motility of MCF-7 human breast cancer cells. Results showed that after 7 
weeks of exposure to 10
-5
 M Bp1 the wound healing was higher than the negative control. 10
-
5 
M Bp1 closed 47.63 ± 5.36 % of the wound, while the closure percentage was 14.25 ± 1.77 
% in the negative control wells (Figure 4.1 (A)) (p-value ≤ 0.05). Longer exposure time of 13 
weeks showed that neither 10
-5 
M Bp1 nor 10
-7 
M Bp1 altered MCF-7 cell motility compared 
to the negative control (Figure 4.1 (B)). However, after 21 weeks of exposure to 10
-7 
M Bp1 
the wound healing activities of MCF-7 cells were found up-regulated to 68.11 ± 15.49 % in 
comparison to 24.75 ± 0.69 % in the negative control (Figure 4.1 (C)) (p-value ≤ 0.05). 
Represented images are illustrated in (Figure 4.2). 
4.3.1.2 Effects of Bp1 on migration of individual MCF-7 human breast 
cancer cells as measured by time-lapse microscopy 
MCF-7 human breast cancer cells were exposed for 2 weeks and 21 weeks to 10
-5 
M Bp1 or 
10
-7 
M Bp1. 48 hours prior to the experiment, cells were re-seeded in 12-well plates and cell 
migration was analysed using live cell imaging (time-lapse microscopy) (as described in 
section 2.4.2). 10 cells were tracked in 5 fields per well for 24 hours and the number of motile 
cells and cumulative length moved (total travelled length of cell) were measured for each 
treatment. 
A statistically significant % increase of motile cells (10.67 ± 2.40 %) was indicated in MCF-7 
cells exposed to 10
-5 
M Bp1 after 2 weeks (Figure 4.3 (A)) (p-value ≤ 0.05) compared to the 
control (4.00 ± 1.37 %). After the same period of exposure, MCF-7 cells exposed to 10
-7 
M 
Bp1 did not show any increase in % motile cells or cumulative length moved (Figure 4.3 (A 
and B)). However, the % increase of motile cells of MCF-7 cells exposed to 10
-7 
M Bp1 and 
10
-5 
M Bp1 were elevated after 21 weeks of exposure to 18.67 ± 1.764 % and 18.67 ± 6.360 
% respectively (Figure 4.3 (C)), although cumulative length was not significantly increased 
(Figure 4.3 (D)). 
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4.3.1.3 Effects of Bp1 on migration of MCF-7 human breast cancer cells 
as determined by xCELLigence technology 
Movement of cells through 8µm pores of a membrane towards a chemotaxis stimulus of FCS 
has also been investigated by using the xCELLigence technology. Cells were exposed to 10
-5 
M Bp1, 10
-6 
M Bp1, 10
-7 
M Bp1, 10
-8 M 17β-oestradiol or no addition for 2, 10 or 21 weeks 
prior to the experiment. Then the experiment was carried out according to the manufacturer’s 
instruction (as described in section 2.4.3). Results of short and long-term exposure to Bp1 at 
10
-7 
M and 10
-5 
M, suggested that Bp1 at 10
-5 
M triggered the migratory activity of MCF-7 
cells after 2 weeks of exposure with 0.22 cell index compared to 0.033 increase in cell index 
by the cells of the control (Figure 4.4) with a lower but similar pattern after 20 weeks of 
exposure (Figure 4.6). However, the effect of 10
-6 
M Bp1 on the migratory cells index was 
increasing throughout the different time points of the experiments. After 2, 10 and 20 weeks 
of exposure, 10
-6 
M Bp1 increased the cell index to 0.11, 0.14 and 0.22 respectively in 
comparison with no addition (with cell index 0.034, 0.084 and 0.044) (Figures 4.4-4.6). 
Whereas Bp1 at 10
-7 
M gave an increase in the cell motility after 2 weeks of exposure (cell 
index 0.18 compared to 0.03 of cells of no addition) (Figure 4.4), which shows similar pattern 
after 20 weeks of exposure (cell index 0.22 compared to 0.04 of cells of no addition) (Figure 
4.6). 
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Figure ‎4.1 Effect‎of‎exposure‎ to‎Bp1‎or‎17β-oestradiol on collective motility of MCF-7 
human breast cancer cells as measured by wound healing assay. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control (-E) only, 
10
-8 M 17β-oestradiol (+E), with 10-7 M Bp1 (Bp1 (-7M)) or with 10-5 M Bp-1 (Bp1 (-5M)) for 7 
weeks (A), 13 weeks (B) and 21 weeks (C) respectively. Media were replenished and cells were split 
every 3-4 days. Cells were then reseeded in 12-well plates and once the cells became ≥ 95% confluent, 
wound was made and mitomycin c (0.5µg/ml) was added.  Images were captured at 0 hour and 24 
hours. Cell migration was quantified by analysing 5 images from each well by using Image J software. 
(A) Values are the average ± SE of triplicate wells of three independent experiments (n=3). (B and C) 
Values are the average ± SE of triplicate independent wells. Where no bars are seen, error was too 
small to be visualized. * p-value ≤ 0.05 increase versus no addition. ## p-value ≤ 0.01 decrease versus 
no addition by one-way ANOVA Dunnett’s test. 
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Figure ‎4.2 Representative images of the effect of Bp1 on motility of MCF-7 human 
breast cancer cells as determined by wound healing assay. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control (-E) only or 
with 10
-7
M Bp1 for 13 and 21weeks.  Cells were then reseeded in 12-well plates and once the cells 
became ≥ 95% confluent, wound was made and mitomycin c (0.5 µg/ml) was added.  Images were 
captured at 0 hour and 24 hours. 
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Figure ‎4.3 Effect of exposure to Bp1 on motility of individual MCF-7 human breast 
cancer cells as determined by time-lapse microscopy. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control (0) only or 
with Bp1 at indicated concentrations for 2 (A, B) and 21 (C, D) weeks. . Media were replenished and 
cells were split every 3-4 days. 2 days prior to the experiment, cells were reseeded in 12-well plates at 
0.2 x 10
5 
cells/well. Time-lapse images of 5 fields per well were recorded. Results represent the 
percentage of motile cells (A, C) and cumulative length moved (B, D). Values are the average ±SE of 
triplicate independent wells. * p-value ≤ 0.05 versus no addition by one-way ANOVA Dunnett’s test. 
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Figure ‎4.4 Short-term‎ effect‎ of‎ Bp1‎ or‎ 17β-oestradiol on migration of MCF-7 human 
breast cancer cells using chemotaxis stimulus as determined by xCELLigence 
technology. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 M 17β-oestradiol (+E), 10-7 M Bp1 (Bp1 (-7M)), 10-6 M Bp1 (Bp1 (-6M)) or 10-5 M Bp1 (Bp1 (-
5M)) for 2 weeks. Media were replenished and cells were split every 3-4 days. (A) The relative 
change in cell index of duplicate wells as indicated by the changes in impedance caused by cell 
migration from upper chambers to lower ones through the pores of the polycarbonate membrane. Cell 
index was recorded every 5 minutes and monitored for 24 hours. (B) Bar graph represents the average 
of the end point measurements (Cell index) of cell migration of duplicate independent wells at 24 
hours.  
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Figure ‎4.5 Long-term‎ effect‎ of‎ Bp1‎ or‎ 17β-oestradiol on migration of MCF-7 human 
breast cancer cells using chemotaxis stimulus as determined by xCELLigence 
technology. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 M 17β-oestradiol (+E), 10-7 M Bp1 (Bp1 (-7M)), 10-6 M Bp1 (Bp1 (-6M)) or 10-5 M Bp1 (Bp1 (-
5M)) for 10 weeks. Media were replenished and cells were split every 3-4 days. (A) The relative 
change in cell index of duplicate wells as indicated by the changes in impedance caused by cell 
migration from upper chambers to lower ones through the pores of the polycarbonate membrane. Cell 
index was recorded every 5 minutes and monitored for 24 hours. (B) Bar graph represents the average 
of the end point measurements (Cell index) of cell migration of duplicate independent wells at 24 
hours.  
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Figure ‎4.6 Long-term‎ effect‎ of‎ Bp1‎ or‎ 17β-oestradiol on migration of MCF-7 human 
breast cancer cells using chemotaxis stimulus as determined by xCELLigence 
technology. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 M 17β-oestradiol (+E), 10-7 M Bp1 (Bp1 (-7M)), 10-6 M Bp1 (Bp1 (-6M)) or 10-5 M Bp1 (Bp1 (-
5M)) for 20 weeks. Media were replenished and cells were split every 3-4 days. (A) The relative 
change in cell index of duplicate wells as indicated by the changes in impedance caused by cell 
migration from upper chambers to lower ones through the pores of the polycarbonate membrane. Cell 
index was recorded every 5 minutes and monitored for 24 hours. (B) Bar graph represents the average 
of the end point measurements (Cell index) of cell migration of duplicate independent wells at 24 
hours. 
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4.3.1.4 Effects of Bp1 on invasion of MCF-7 human breast cancer cells 
as determined by xCELLigence technology 
MCF-7 cells exposed to Bp1 for 2 weeks, 11 weeks and 21 weeks were monitored for their 
invasive activity in real time using xCELLigence technology. According to the 
manufacturer’s instructions (ACEA Biosciences, USA), cells were seeded on matrigel (1:40 
dilution) in the upper chamber of a CIM-plate 16 (as described in section 2.5). The lower 
chamber of the plate was filled with phenol-red-free-DMEM without or with 10
-8 
M 17β-
oestradiol, 10
-7 
M Bp1, 10
-6 
M Bp1 or 10
-5 
M Bp1 supplemented with 5% DCFCS, while the 
upper chamber was filled with the same media without the serum. Invasion was monitored 
every 15 minutes for 48 hours as cells moved through the matrigel coated membrane onto the 
gold electrodes in lower chamber by chemotaxis stimulus of FCS. 
No effect on the invasive activities was observed after 2 weeks and 11 weeks of exposure to 
10
-7 
M Bp1, 10
-6 
M Bp1 or 10
-5 
M  Bp1 (data not shown). However, longer exposure time (31 
weeks) to 10
-5 
M Bp1 showed an increase in invasion (cell index 0.01) compared to cells with 
no addition (cell index -0.08) (Figure 4.7) (p-value ≤ 0.05).  
 
4.3.1.5 Summary of effects with Bp1 
Table 4.1 summarises all the results in section 4.3.1. The results are shown as determined by 
wound healing, time-lapse microscopy and the xCELLigence technology after 2 weeks and 
longer time points of exposure to concentrations of 10
-7 
M and 10
-5 
M Bp1. 
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Figure ‎4.7 Effect of 31 weeks of exposure to Bp1 or‎17β-oestradiol on invasion of MCF-7 
human breast cancer cells through matrigel using chemotaxis stimulus as determined by 
xCELLigence technology. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 M 17β-oestradiol (+E) or 10-5 M Bp1 (Bp1 (-5M)) for 31 weeks. Media were replenished and cells 
were split every 3-4 days. Cells were analysed for their invasive activity through matrigel (1:40) 
coated CIM-plate 16 in a real time invasion assay (xCELLigence RTCA device) (A) The relative 
change in cell index of triplicate wells as indicated by the changes in impedance caused by cell 
migration from upper chambers to lower ones through the pores of the polycarbonate membrane 
through matrigel. Cell index was recorded every 5 minutes and monitored for 48 hours. (B) Bar graph 
represents the cell index at 48 hours as calculated by the xCELLigence RTCA software. Values are 
the average ±SE of triplicate independent wells. * p-value ≤ 0.05 versus no addition (-E) by one-way 
ANOVA Dunnett’s test. 
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Table ‎4.1 Effects of Bp1 on motility and invasion of MCF-7 human breast cancer cells  
 
 Molar concentration  
Experiment 
10
-7
 M 10
-5 
M 
Incubation time prior 
to the experiment 
Wound healing 
-- * 7 weeks 
n.s. n.s. 13 weeks 
* n.s. 21 weeks 
Time-lapse 
n.s. 
(*) in percentage of 
motile cells 
2 weeks 
(*) in percentage of 
motile cells 
(*) in percentage of 
motile cells 
21 weeks 
Real-time monitoring 
of cell motility 
(xCELLigence) 
O. O. 2 weeks 
O. n.o. 10 weeks 
O. O. 21 weeks 
Real-time monitoring 
of cell invasion 
through matrigel 
 ( xCELLigence) 
n.s. n.s. 2 weeks and 11 weeks 
-- (*) 31 weeks 
(--) experiment was not conducted; * p-value ≤ 0.05 versus no addition; (n.s.) p-value < 0.05 
not significant; (O.) effect observed using duplicates only-no statistical analysis possible for 
duplicates; (n.o.) no effects observed using duplicates.  
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4.3.2 Effects of Bp2 on migration of MCF-7 human breast cancer cells 
4.3.2.1 Effects of Bp2 on collective migration of MCF-7 human breast 
cancer cells as measured by wound healing 
The wound healing assay was used to determine the effect of long term exposure to Bp2 on 
motility of MCF-7 human breast cancer cells. Results showed that after 7 weeks of exposure 
to 10
-5 
M Bp2 the wound healing was higher than the negative control. 10
-5 
M Bp2 closed 
39.28 ± 5.80 % of the wound, while the closure percentage was 14.64 ± 2.10 % in the 
negative control wells (Figure 4.8 (A)) (p-value ≤ 0.01). Longer exposure times have shown 
that after 13 weeks of exposure to 10
-5 
M Bp2, no statistically significant effect was observed 
at any of the concentrations tested. However, it is noteworthy that at 10
-5 
M Bp2 almost the 
same effect on wound closure (31.99 ± 2.21 %) was noted as after 7 weeks of exposure but 
the motility of the untreated cells (-E) (26.88 ± 2.27 %)  had risen (Figure 4.8 (B)). However, 
after 21 weeks of exposure to 10
-7 
M Bp2 MCF-7 cells have shown significant increase in the 
wound healing activities. Percentage of the wound closure in MCF-7 cells exposed to 10
-7
M 
Bp2 was 78.95 ± 2.22 % in comparison to 24.75 ± 0.68 % closure in the negative control 
(Figure 4.8 (C)) (p-value ≤ 0.001). 
4.3.2.2 Effects of Bp2 on migration of individual MCF-7 human breast 
cancer cells as measured by time-lapse microscopy 
MCF-7 human breast cancer cells were exposed for 2 weeks and 13 weeks to 10
-5 
M Bp2, 10
-7 
M Bp2 or no addition. 48 hours prior the experiment, cells were re-seeded in 12-well plates 
and cell migration was analysed using time-lapse microscopy. 10 cells were tracked in 5 
fields per well for 24 hours and the number of motile cells and cumulative length moved were 
measured for each treatment. Results showed no increase in percentage of motile cells (Figure 
4.9 (A)) but a statistically significant increase in cumulative length moved in MCF-7 cells 
exposed to 10
-7 
M Bp2 for 2 weeks (Figure 4.9 (B)) (p-value≤0.01). Longer exposure time (13 
weeks) to 10
-7 
M Bp2 did increase the percentage of motile cells significantly to 34.76 ± 5.21 
% in comparison to the negative control (5.33 ± 1.33 %) (Figure 4.9 (C)) (p-value ≤ 0.01) and 
increased the cumulative length moved by MCF-7 cells to 87.57 ± 16.05 microns in 
comparison to the control (27.92 ± 3.60 microns) (Figure 4.9 (D)) (p-value ≤ 0.01). The 
apparent difference in percentage of motile cells and cumulative length for cells exposed to 
10
-5 
M Bp2 were not significant (Figure 4.9 (C and D)). Due to technical problems the 
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collection of time-lapse videos to assess the effect of Bp2 on MCF-7 cells motility at 21 
weeks was not conducted.  
4.3.2.3 Effects of Bp2 on migration of MCF-7 human breast cancer cells 
as determined by xCELLigence technology 
MCF-7 cells were exposed to 10
-7 
M Bp2, 10
-6 
M Bp2, 10
-5 
M Bp2, 10
-8 M 17β-oestradiol or 
no addition for 2 weeks, 10 weeks or 21 weeks prior to the migration experiments. Minor 
increase was observed in the cell index of cells exposed to 10
-5 
M Bp2 for 2 weeks (cell index 
0.15) in comparison with the control cells (cell index 0.11) (Figure 4.10). Further increase in 
cell index was observed in cells exposed to 10
-7 
M Bp2 for 10 weeks (cell index 0.14) 
compared to cells of no addition (cell index 0.08) (Figure 4.11). No effect on MCF-7 motility 
was determined after 21 weeks of exposure to Bp2 (data not shown).  
4.3.2.4 Effects of Bp2 on invasion of MCF-7 human breast cancer cells 
as determined by xCELLigence technology 
The invasive activities of MCF-7 cells exposed to 10
-7 
M Bp2, 10
-6 
M Bp2 and 10
-5
 M Bp2 
were further investigated using the xCELLigence real-time as previously described (in section 
2.5). However, no observed effect on MCF-7 cells invasive activity was noted after 2, 10 and 
31 weeks of exposure (data not shown). 
4.3.2.5 Summary of effects with Bp2 
Table 4.2 summarises all the results in section 4.3.2. The results are shown as determined by 
wound healing, time-lapse microscopy and the xCELLigence technology after 2 weeks and 
longer time points of exposure to concentrations of 10
-7 
M and 10
-5 
M Bp2. 
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Figure ‎4.8 Effect‎of‎exposure‎ to‎Bp2‎or‎17β-oestradiol on collective motility of MCF-7 
human breast cancer cells as measured by wound healing assay. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control (-E) only, 
10
-8 M 17β-oestradiol (+E), with 10-7 M Bp2 (Bp2 (-7M) or with 10-5 M Bp2 (Bp2 (-5M)) for 7 weeks 
(A), 13 weeks (B) and 21 weeks (C). Media were replenished and cells were split every 3-4 days. 
Cells were then reseeded in 12-well plates and once the cells became ≥ 95% confluent, wound was 
made and mitomycin c (0.5 µg/ml) was added.  Images were captured at 0 hour and 24 hours. Cell 
migration was quantified by analysing minimum 5 images from each well. (A) Values are the average 
± SE of triplicate wells of three independent experiments (n=3). (B and C) Values are the average ± 
SE of triplicate independent wells.  ** p-value ≤ 0.01 and *** p-value ≤ 0.001 increase versus no 
addition. ### p-value ≤ 0.001 decrease versus no addition by one-way ANOVA Dunnett’s test. 
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Figure ‎4.9 Effect of exposure to Bp2 on motility of individual MCF-7 human breast 
cancer cells as determined by time-lapse microscopy. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control (0) only or 
with Bp2 at indicated concentrations for 2 (A, B) and 13 weeks (C, D). Media were replenished and 
cells were split every 3-4 days. 2 days prior to the experiment, cells were reseeded in 12-well plate at 
0.2 x 10
5 
cells/well. Time-lapse images of 5 fields per well were recorded. Results represent the 
percentage of motile cells (A, C) and cumulative length moved (B, D). Values are the average ±SE of 
triplicate independent wells. ** p-value ≤ 0.01 versus no addition (0) by t-Test (A and B) and one-way 
ANOVA Dunnett’s test (C and D).  
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Figure ‎4.10 Short-term‎effect‎of‎Bp2‎or‎17β-oestradiol on migration of MCF-7 human 
breast cancer cells using chemotaxis stimulus as determined by xCELLigence 
technology. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 M 17β-oestradiol (+E), 10-7 M Bp2 (Bp2 (-7M)), 10-6 M Bp2 (Bp2 (-6M)) or 10-5 M Bp2 (Bp2 (-
5M)) for 2 weeks. Media were replenished and cells were split every 3-4 days. (A) The relative 
change in cell index of duplicate wells as indicated by the changes in impedance caused by cell 
migration from upper chambers to lower ones through the pores of the polycarbonate membrane. Cell 
index was recorded every 5 minutes and monitored for 24 hours. (B) Bar graph represents the average 
of the end point measurements (Cell index) of cell migration of duplicate independent wells at 24 
hours. 
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Figure ‎4.11 Long-term‎effect‎of‎Bp2‎or‎17β-oestradiol on migration of MCF-7 human 
breast cancer cells using chemotaxis stimulus as determined by xCELLigence 
technology. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 M 17β-oestradiol (+E), 10-7 M Bp2 (Bp2 (-7M)), 10-6 M Bp2 (Bp2 (-6M)) or 10-5 M Bp2 (Bp2 (-
5M)) for 10 weeks. Media were replenished and cells were split every 3-4 days. (A) The relative 
change in cell index of duplicate wells as indicated by the changes in impedance caused by cell 
migration from upper chambers to lower ones through the pores of the polycarbonate membrane. Cell 
index was recorded every 5 minutes and monitored for 24 hours. (B) Bar graph represents the average 
of the end point measurements (Cell index) of cell migration of duplicate independent wells at 24 
hours.  
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Table ‎4.2 Effects of Bp2 on motility and invasion of MCF-7 human breast cancer cells  
 Molar concentration  
Experiment 
10
-7
 M 10
-5 
M 
Incubation time prior 
to the experiment 
Wound healing 
-- (**) 7 weeks 
n.s. n.s. 13 weeks 
(***) n.s. 21 weeks 
Time-lapse 
(*) in cumulative 
length moved 
-- 2 weeks 
(**) in cumulative 
length moved and in 
percentage of motile 
cells 
n.s. 21 weeks 
Real-time monitoring 
of cell motility 
(xCELLigence) 
n.o. O. 2 weeks 
O. n.o. 10 weeks 
n.o. n.o. 21 weeks 
Real-time monitoring 
of cell invasion 
through matrigel 
 ( xCELLigence) 
n.s. n.s. 2 weeks and 11 weeks 
-- n.s. 31 weeks 
(--) experiment was not conducted; * p-value ≤ 0.05 versus no addition; ** p-value ≤ 0.01 
versus no addition; *** p-value ≤ 0.001 versus no addition; (n.s.) p-value < 0.05 not 
significant; (O.) effect observed using duplicates only-no statistical analysis possible for 
duplicates; (n.o.) no effects observed using duplicates.  
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4.3.3  Effects of Bp3 on migration of MCF-7 human breast cancer cells 
4.3.3.1 Effects of Bp3 on collective migration of MCF-7 human breast 
cancer cells as measured by wound healing 
The wound healing assay was used to determine the effect of long term exposure to Bp3 on 
motility of MCF-7 human breast cancer cells. Results showed that after 8 and 13 weeks of 
exposure to Bp3 no increase in the percentage of wound closure in comparison to the negative 
control was indicated. After 8 weeks of exposure, 10
-5 
M Bp3 gave 20.38 ± 1.33 % closure of 
the wound compared to 19.80 ± 0.66 % in the negative control (Figure 4.12 (A)). After 13 
weeks of exposure to 10
-5 
M Bp3, 26.03 ± 2.78 % closure of the wound was recorded, while 
the closure percentage was 24.75 ± 2.10 % in the negative control (Figure 4.12 (B)). 
However, longer exposure time has shown that after 21 weeks of exposure to 10
-5
M Bp3 an 
increase in the wound healing activities (59.28 ± 5.39 %) in comparison to the negative 
control (24.75 ± 0.68 %) was recorded (Figure 4.12 (C)) (p-value ≤ 0.01). Similarly after 21 
weeks of exposure, 10
-7 
M Bp3 increased the wound closure to 35.26 ± 2.35 % (Figure 4.12 
(C)) (p-value ≤ 0.01) and that effect was not shown after 13 weeks of exposure. 
4.3.3.2 Effects of Bp3 on migration of individual MCF-7 human breast 
cancer cells as measured by time-lapse microscopy 
MCF-7 human breast cancer cells were exposed for 2 weeks and 21 weeks to 10
-5 
M Bp3, 10
-7 
M Bp3 or no addition. 48 hours prior the experiment, cells were re-seeded in 12-well plates 
and cell migration was analysed using time-lapse microscopy. 10 cells were tracked in 5 
fields per well for 24 hours and the number of motile cells and cumulative length moved were 
measured for each treatment. MCF-7 cells exposed to 10
-7
 M and 10
-5
 M Bp3 for 2 weeks did 
not show significant increase in motile cell number or in the cumulative length moved by 
cells (Figure 4.13 (A and B)). While longer exposure to 10
-7 
M Bp3 increased the number of 
motile cells statistically significantly up to 14.67 ± 0.33 % in comparison to the negative 
control (6.00 ± 2.08%) (Figure 4.13 (B)) (p-value < 0.05), although the average of cumulative 
length moved was not different from the control (Figure 4.13 (C and D)). 
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4.3.3.3 Effects of Bp3 on migration and invasion of MCF-7 human 
breast cancer cells as determined by xCELLigence technology 
MCF-7 cells were exposed to 10
-7 
M Bp3, 10
-6 
M Bp3, 10
-5 
M Bp3, 10
-8 M 17β-oestradiol or 
no addition for 3, 11, 21 and 23 weeks prior to the experiment. Results of 3 weeks of 
exposure to 10
-5 
M Bp3 showed an increase in the motility of MCF-7 cells (cell index 0.11) in 
comparison to the negative control (cell index 0.05) (Figure 4.14) and longer exposure times 
to 10
-5 
M Bp3 had a greater observed effect in increasing MCF-7 cells motility in comparison 
to the effect of 3 weeks of exposure (Figure 4.17). Similar increase in cell motility was 
observed after 11 and 21 weeks of exposure to 10
-7 
M Bp3 and 10
-6 
M Bp3 (Figures 4.15-
4.16). MCF-7 cells exposed to 10
-5 
M Bp3 showed an increase in cell motility (cell index 0.20 
± 0.03) in comparison to the negative control (cell index 0.09 ± 0.02) (Figure 4.17) (p-value ≤ 
0.05). 
According to ACEA application note no.6 (2013) and Roach technical support, lower cell 
index (negative signals) refers to lower dynamic range of cell behaviour (motility or cell 
adhesion). In figure 4.14, negative chemotactic cell index of 17β-oestradiol reflects the lower 
activity in migration. 
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Figure ‎4.12 Effect‎of‎exposure‎to‎Bp3‎or‎17β-oestradiol on collective motility of MCF-7 
human breast cancer cells as measured by wound healing assay. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control (-E) only, 
10
-8 M 17β-oestradiol (+E), with 10-7 M Bp3 (Bp3 (-7M)), or with 10-5 M Bp3 (Bp3 (-5M)) for 8 (A), 
13 weeks (B) and 21 weeks (C). Media were replenished and cells were split every 3-4 days. Cells 
were then reseeded in 12-well plates and once the cells became ≥ 95% confluent, wound was made 
and mitomycin c (0.5 µg/ml) was added.  Images were captured at 0 hour and 24 hours. Cell migration 
was quantified by analysing minimum 5 images from each well. (A) Values are the average ± SE of 
triplicate wells of three independent experiments (n=3). (B and C) Values are the average ± SE of 
triplicate independent wells. ** p-value ≤ 0.01 increase versus no addition. ## p-value ≤ 0.01 decrease 
versus no addition by one-way ANOVA Dunnett’s test.  
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Figure ‎4.13 Effect of exposure to Bp3 on motility of individual MCF-7 human breast 
cancer cells as determined by time-lapse microscopy. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control (0) only or 
with Bp3 at indicated concentrations for 2 (A, B) and 21 weeks (C, D). Media were replenished and 
cells were split every 3-4 days. 2 days prior to the experiment, cells were reseeded in 12-well plate at 
0.2 x 10
5 
cells/well. Time-lapse images of 5 fields per well were recorded. Results represent the 
percentage of motile cells (A, C) and cumulative length moved (B, D). Values are the average ±SE of 
triplicate wells. * p-value ≤ 0.05 versus no addition by t-Test (C and D). 
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Figure ‎4.14 Short-term‎effect‎of‎Bp3‎or‎17β-oestradiol on migration of MCF-7 human 
breast cancer cells using chemotaxis stimulus as determined by xCELLigence 
technology. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 M 17β-oestradiol (+E), 10-7 M Bp3 (Bp3 (-7M)), 10-6 M Bp3 (Bp3 (-6M)) or 10-5 M Bp3 (Bp3 (-
5M)) for 3 weeks. Media were replenished and cells were split every 3-4 days. (A) The relative 
change in cell index of duplicate wells as indicated by the changes in impedance caused by cell 
migration from upper chambers to lower ones through the pores of the polycarbonate membrane. Cell 
index was recorded every 5 minutes and monitored for 24 hours. (B) Bar graph represents the average 
of the end point measurements (Cell index) of cell migration of duplicate independent wells at 24 
hours.  
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Figure ‎4.15 Long-term‎effect‎of‎Bp3‎or‎17β-oestradiol on migration of MCF-7 human 
breast cancer cells using chemotaxis stimulus as determined by xCELLigence 
technology. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 M 17β-oestradiol (+E), 10-7 M Bp3 (Bp3 (-7M)), 10-6 M Bp3 (Bp2 (-6M)) or 10-5 M Bp3 (Bp3 (-
5M)) for 11 weeks. Media were replenished and cells were split every 3-4 days. (A) The relative 
change in cell index of duplicate wells as indicated by the changes in impedance caused by cell 
migration from upper chambers to lower ones through the pores of the polycarbonate membrane. Cell 
index was recorded every 5 minutes and monitored for 24 hours. (B) Bar graph represents the average 
of the end point measurements (Cell index) of cell migration of duplicate wells at 24 hours.  
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Figure ‎4.16 Long-term‎effect‎of‎Bp3‎or‎17β-oestradiol on migration of MCF-7 human 
breast cancer cells using chemotaxis stimulus as determined by xCELLigence 
technology. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 M 17β-oestradiol (+E), 10-7 M Bp3 (Bp3 (-7M)), 10-6 M Bp3 (Bp3 (-6M)) or 10-5 M Bp3 (Bp3 (-
5M)) for 21weeks. Media were replenished and cells were split every 3-4 days. (A) The relative 
change in cell index of duplicate wells as indicated by the changes in impedance caused by cell 
migration from upper chambers to lower ones through the pores of the polycarbonate membrane. Cell 
index was recorded every 5 minutes and monitored for 24 hours. (B) Bar graph represents the average 
of the end point measurements (Cell index) of cell migration of duplicate independent wells at 24 
hours.  
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Figure ‎4.17 Long-term‎effect‎of‎Bp3‎or‎17β-oestradiol on migration of MCF-7 human 
breast cancer cells using chemotaxis stimulus as determined by xCELLigence 
technology. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 M 17β-oestradiol (+E) or 10-5 M Bp3 (Bp3 (-5M)) for 23 weeks. Media were replenished and cells 
were split every 3-4 days. (A) The relative change in cell index of triplicate wells as indicated by the 
changes in impedance caused by cell migration from upper chambers to lower ones through the pores 
of the polycarbonate membrane. Cell index was recorded every 5 minutes and monitored for 24 hours. 
(B) Bar graph represents the average of the end point measurements (Cell index) of cell migration of 
triplicate wells at 24 hours. Values are the average ±SE of triplicate independent wells. * p-value ≤ 
0.05 versus no addition (-E) by one-way ANOVA Dunnett’s test. 
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4.3.3.4 Effects of Bp3 on invasion of MCF-7 human breast cancer cells 
as determined by xCELLigence technology 
Monitoring MCF-7 cell invasive activity in real-time using xCELLigence technology (as 
described previously in section 2.5) did show a clear increase in invasive activity of cells 
exposed to 10
-5 
M Bp3 after 2 weeks of exposure (cell index 0.47) in comparison to the 
control cells (cell index 0.028) (Figure 4.18), which continued in a similar pattern after 11 
weeks of exposure to 10
-7 
M, 10
-6 
M and 10
-5 
M Bp3 (Figure 4.19). However, MCF-7 cells 
exposed to 10
-5 
M Bp3 for 31 weeks showed no significant increase in invasive activity (data 
not shown). 
4.3.3.5 Summary of effects with Bp3 
Table 4.2 summarises all the results in section 4.3.3. The results are shown as determined by 
wound healing, time-lapse microscopy and the xCELLigence technology after 2 weeks and 
longer time points of exposure to concentrations of 10
-7 
M and 10
-5 
M Bp3. 
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Figure ‎4.18 Short-term‎ effect‎ of‎ Bp3‎ or‎ 17β-oestradiol on invasion of MCF-7 human 
breast cancer cells through matrigel using chemotaxis stimulus as determined by 
xCELLigence technology. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 M 17β-oestradiol (+E) or 10-5 M Bp3 (Bp3 (-5M)) for 2 weeks. Media were replenished and cells 
were split every 3-4 days. Cells were analysed for their invasive activity through matrigel (1:40) 
coated CIM-plate 16 in a real time invasion assay (xCELLigence RTCA device) (A) The relative 
change in cell index of duplicate wells as indicated by the changes in impedance caused by cell 
migration from upper chambers to lower ones through the pores of the polycarbonate membrane 
coated with matrigel. Cell index was recorded every 5 minutes and monitored for 48 hours. (B) Bar 
graph represents the average of the end point measurements (Cell index) of cell invasion of duplicate 
independent wells at 48 hours. 
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Figure ‎4.19 Long-term‎ effect‎ of‎ Bp3‎ or‎ 17β-oestradiol on invasion of MCF-7 human 
breast cancer cells through matrigel using chemotaxis stimulus as determined by 
xCELLigence technology. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 M 17β-oestradiol (+E), 10-7 M Bp3 (Bp3 (-7M)), 10-6 M Bp3 (Bp3 (-6M)) or 10-5 M Bp3 (Bp3 (-
5M)) for 11 weeks. Media were replenished and cells were split every 3-4 days. Cells were analysed 
for their invasive activity through  matrigel (1:40) coated CIM-plate 16 in a real time invasion assay 
(xCELLigence RTCA device) (A) The relative change in cell index of duplicate wells as indicated by 
the changes in impedance caused by cell migration from upper chambers to lower ones through the 
pores of the polycarbonate membrane coated with matrigel. Cell index was recorded every 5 minutes 
and monitored for 48 hours. (B) Bar graph represents the average of the end point measurements (Cell 
index) of cell invasion of duplicate independent wells at 48 hours. 
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Table ‎4.3  Effects of Bp3 on motility and invasion of MCF-7 human breast cancer cells  
 Molar concentration  
Experiment 
10
-7
 M 10
-5 
M 
Incubation time prior 
to the experiment 
Wound healing 
-- n.s. 7 weeks 
n.s. n.s. 13 weeks 
(**) (**) 21 weeks 
Time-lapse 
n.s. n.s. 2 weeks 
(*) in cumulative 
length moved  
-- 21 weeks 
Real-time monitoring 
of cell motility 
(xCELLigence) 
n.o. O. 2 weeks 
O. O. 11 weeks 
O. O. 21 weeks 
-- * 23 weeks 
Real-time monitoring 
of cell invasion 
through matrigel 
 ( xCELLigence) 
O. O. 11 weeks 
-- n.s. 31 weeks 
(--) experiment was not conducted; * p-value ≤ 0.05 versus no addition; ** p-value ≤ 0.01 
versus no addition; (n.s.) p-value < 0.05 not significant; (O.) effect observed using duplicates 
only-no statistical analysis possible for duplicates; (n.o.) no effects observed using duplicates.  
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4.3.4 Effects of OMC on migration of MCF-7 human breast cancer cells 
4.3.4.1 Effects of OMC on collective migration of MCF-7 human breast 
cancer cells as measured by wound healing 
The wound healing assay was used to determine the effect of long term exposure to OMC on 
motility of MCF-7 human breast cancer cells. Results showed that after 7 weeks of exposure 
to 10
-5 
M OMC the wound healing was higher than in the negative control. 10
-5 
M OMC 
closed 30.16 ± 2.57 % of the wound, while the closure percentage was 14.64 ± 2.10 % in the 
negative control (Figure 4.20 (A)) (p-value ≤ 0.001). Longer exposure times after 13 weeks of 
exposure to 10
-5 
M OMC and 10
-7 
M OMC had shown reduced wound closure in comparison 
with the negative control (Figure 4.20 (B)). However, after 21 weeks of exposure to 10
-5 
M 
OMC or 10
-7 
M OMC, MCF-7 cells have shown an increase in the wound healing activities. 
Closure percentage of the wound in MCF-7 cells exposed to 10
-7 
M OMC was 35.13 ± 0.79 % 
and to 10
-5 
M OMC was 37.42 ± 5.47 % in comparison to 24.75 ± 0.68 % closure in the 
negative control (Figure 4.20 (C)) (p-value ≤ 0.001). 
4.3.4.2 Effects of OMC on migration of individual MCF-7 human breast 
cancer cells as measured by time-lapse microscopy 
MCF-7 human breast cancer cells were exposed for 2 weeks and 21 weeks to 10
-5 
M OMC, 
10
-7 
M OMC or no addition. 48 hours prior the experiment, cells were re-seeded in 12-well 
plates and cell migration was analysed using time-lapse microscopy. 10 cells were tracked in 
5 fields per well for 24 hours and the number of motile cells and cumulative length moved 
were measured for each treatment. Results indicated a 14.00 ± 2.00 % increase in % motile 
cells (Figure 4.21 (A)) (p-value ≤ 0.05) but no difference in cumulative length moved in 
MCF-7 cells exposed to 10
-5 
M OMC or 10
-7 
M OMC after 2 weeks (Figure 4.21 (B)). 21 
weeks of exposure to 10
-7 
M OMC showed no difference in the percentage of motile cells or 
in cumulative length moved by MCF-7 cells (Figure 4.21 (C and B)). 
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4.3.4.3 Effects of OMC on migration of MCF-7 human breast cancer 
cells as determined by xCELLigence technology 
MCF-7 cells were exposed to 10
-5 
M OMC, 10
-6 
M OMC, 10
-7 
M OMC, 10
-8 M 17β-oestradiol 
or no addition for 2 weeks (Figure 4.22), 10 weeks (Figure 4.23), 21 weeks (Figure 4.24) or 
23 weeks (Figure 4.25) prior to the experiment. Results of 2 weeks of exposure to OMC 
suggested that 10
-6 
M OMC and 10
-5 
M OMC increased the motility of MCF-7 cells (with cell 
index 0.15 and 0.25 respectively) in comparison to the negative control (cell index 0.03), 
while no difference in cell motility was indicated for cells exposed to the lowest 
concentration used 10
-7 
M OMC (cell index 0.03) (Figure 4.22). However, results of 21 weeks 
of exposure to 10
-7 
M OMC increased MCF-7 cells motility in comparison to the control 
(Figure 4.24). Although longer exposure (23 weeks) to 10
-5
M OMC showed significant 
increase in cell motility (cell index 0.23 ± 0.01) in comparison to the control cells (cell index 
0.09 ± 0.02) (Figure 4.25) (p-value ≤ 0.01), the increase in cell index was similar to that of 
the cells exposed for 2 weeks to the same concentration of OMC (Figure 4.22). 
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Figure ‎4.20 Effect‎of‎exposure‎to‎OMC‎or‎17β-oestradiol on collective motility of MCF-7 
human breast cancer cells as measured by wound healing assay. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control (-E) only, 
10
-8 M 17β-oestradiol (+E), with 10-7 M OMC (OMC (-7M)) or with 10-5 M OMC (OMC (-5M)) for 7 
weeks (A), 13 weeks (B) and 21 weeks (C). Media were replenished and cells were split every 3-4 
days. Cells were then reseeded in 12-well plates and once the cells became ≥ 95% confluent, wound 
was made and mitomycin c (0.5 µg/ml) was added.  Images were captured at 0 hour and 24 hours. Cell 
migration was quantified by analysing minimum 5 images from each well. (A) Values are the average 
± SE of triplicate wells of three independent experiments (n=3). (B and C) Values are the average ± 
SE of triplicate independent wells. *** p-value ≤ 0.001 increase versus no addition and #### p-value 
≤ 0.0001 decrease versus no addition by one-way ANOVA Dunnett’s test. 
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Figure ‎4.21 Effect of exposure to OMC on motility of individual MCF-7 human breast 
cancer cells as determined by time-lapse microscopy. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control (0) only or 
with OMC at indicated concentrations for 2 (A, B) and 21 weeks (C, D). Media were replenished and 
cells were split every 3-4 days. 2 days prior to the experiment, cells were reseeded in 12-well plates at 
0.2x10
5
cells/well. Time-lapse images of 5 fields per well were recorded. Results represent the 
percentage of motile cells (A, C) and cumulative length moved (B, D). Values are the average ±SE of 
triplicate independent wells. * p-value ≤ 0.05 versus no addition by one-way ANOVA Dunnett’s test 
(A). 
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Figure ‎4.22 Short-term‎effect‎of‎OMC‎or‎17β-oestradiol on migration of MCF-7 human 
breast cancer cells using chemotaxis stimulus as determined by xCELLigence 
technology. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 M 17β-oestradiol (+E), 10-7 M OMC (OMC (-7M)), 10-6 M OMC (OMC (-6M)) or 10-5 M OMC 
(OMC (-5M)) for 2 weeks. Media were replenished every 3-4 days. (A) The relative change in cell 
index of duplicate wells as indicated by the changes in impedance caused by cell migration from 
upper chambers to lower ones through the pores of the polycarbonate membrane. Cell index was 
recorded every 5 minutes and monitored for 24 hours. (B) Bar graph represents the average of the end 
point measurements (Cell index) of cell migration of duplicate independent wells at 24 hours.  
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Figure ‎4.23 Long-term‎effect‎of‎OMC‎or‎17β-oestradiol on migration of MCF-7 human 
breast cancer cells using chemotaxis stimulus as determined by xCELLigence 
technology. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 M 17β-oestradiol (+E), 10-7 M OMC (OMC (-7M)), 10-6 M OMC (OMC (-6M)) or 10-5 M OMC 
(OMC (-5M)) for 10 weeks. Media were replenished and cells were split every 3-4 days. (A) The 
relative change in cell index of duplicate wells as indicated by the changes in impedance caused by 
cell migration from upper chambers to lower ones through the pores of the polycarbonate membrane. 
Cell index was recorded every 5 minutes and monitored for 24 hours. (B) Bar graph represents the 
average of the end point measurements (Cell index) of cell migration of duplicate independent wells at 
24 hours.  
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Figure ‎4.24 Long-term‎effect‎of‎OMC‎or‎17β-oestradiol on migration of MCF-7 human 
breast cancer cells using chemotaxis stimulus as determined by xCELLigence 
technology. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 M 17β-oestradiol (+E), 10-7 M OMC (OMC (-7M)), 10-6 M OMC (OMC (-6M)) or 10-5 M OMC 
(OMC (-5M)) for 21 weeks. Media were replenished and cells were split every 3-4 days. (A) The 
relative change in cell index of duplicate wells as indicated by the changes in impedance caused by 
cell migration from upper chambers to lower ones through the pores of the polycarbonate membrane. 
Cell index was recorded every 5 minutes and monitored for 24 hours. (B) Bar graph represents the 
average of the end point measurements (Cell index) of cell migration of duplicate independent wells at 
24 hours.  
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Figure ‎4.25 Long-term‎effect‎of‎OMC‎or‎17β-oestradiol on migration of MCF-7 human 
breast cancer cells using chemotaxis stimulus as determined by xCELLigence 
technology. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 M 17β-oestradiol (+E) or 10-5 M OMC (OMC (-5M)) for 23 weeks. Media were replenished and 
cells were split every 3-4 days. (A) The relative change in cell index of triplicate wells as indicated by 
the changes in impedance caused by cell migration from upper chambers to lower ones through the 
pores of the polycarbonate membrane. Cell index was recorded every 5 minutes and monitored for 24 
hours. (B) Bar graph represents the average of the end point measurements (Cell index) of cell 
migration of triplicate wells at 24 hours. Values are the average ±SE of triplicate independent wells. 
** p-value ≤ 0.01 versus no addition by one-way ANOVA Dunnett’s test. 
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4.3.4.4 Effects of OMC on invasion of MCF-7 human breast cancer cells 
as determined by xCELLigence technology 
Further investigation was carried out to observe the effect of OMC on the invasive activity of 
MCF-7 cells (as described in section 2.5). MCF-7 cells showed an increase in the invasive 
activity through matrigel after 2 weeks of exposure to 10
-5 
M OMC (cell index 0.13) 
compared to the activity shown by the negative control cells (cell index 0.03) (Figure 4.26) 
and kept a similar increase with a cell index 0.21 after 10 weeks of exposure in comparison to 
the no addition cells (cell index 0.01) (Figure 4.27) and further exposure to 10
-5 
M OMC for 
31 weeks significantly increased the cell index (0.18 ± 0.03) of MCF-7 cells compared to the 
no addition cells (-0.08 ± 0.02) (Figure 4.28) (p-value ≤ 0.01). Lower cell index (negative 
signals) refers to lower dynamic range of cell invasion (ACEA application note no.6, 2013 ; 
Eisenberg et al., 2011). In figure 4.28, negative chemotactic cell index of the control cells and 
17β-oestradiol reflects the lower invasion through matrigel. 
  
4.3.4.5 Summary of effects with OMC 
Table 4.2 summarises all the results in section 4.3.4. The results are shown as determined by 
wound healing, time-lapse microscopy and the xCELLigence technology after 2 weeks and 
longer time points of exposure to concentrations of 10
-7 
M and 10
-5 
M OMC. 
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Figure ‎4.26 Short-term‎effect‎of‎OMC‎or‎17β-oestradiol on invasion of MCF-7 human 
breast cancer cells through matrigel using chemotaxis stimulus as determined by 
xCELLigence technology. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 M 17β-oestradiol (+E) or 10-5 M OMC (OMC (-5M)) for 2 weeks. Media were replenished every 
3-4 days. Cells were analysed for their invasive activity through matrigel (1:40) coated CIM-plate 16 
in a real time invasion assay (xCELLigence RTCA device) (A) The relative change in cell index of 
duplicate wells as indicated by the changes in impedance caused by cell migration from upper 
chambers to lower ones through the pores of the polycarbonate membrane coated with matrigel. Cell 
index was recorded every 5 minutes and monitored for 48 hours. (B) Bar graph represents the average 
of the end point measurements (Cell index) of cell invasion of duplicate independent wells at 48 
hours. 
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Figure ‎4.27 Long-term‎effect‎of‎OMC‎or‎17β-oestradiol on invasion of MCF-7 human 
breast cancer cells through matrigel using chemotaxis stimulus as determined by 
xCELLigence technology. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 M 17β-oestradiol (+E), 10-7 M OMC (OMC (-7M)), 10-6 M OMC (OMC (-6M)) or 10-5 M OMC 
(OMC (-5M)) for 10 weeks. Media were replenished and cells were split every 3-4 days. Cells were 
analysed for their invasive activity through matrigel (1:40) coated CIM-plate 16 in a real time invasion 
assay (xCELLigence RTCA device) (A) The relative change in cell index of duplicate wells as 
indicated by the changes in impedance caused by cell migration from upper chambers to lower ones 
through the pores of the polycarbonate membrane coated with matrigel. Cell index was recorded every 
5 minutes and monitored for 48 hours. (B) Bar graph represents the average of the end point 
measurements (Cell index) of cell invasion of duplicate independent wells at 48 hours. 
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Figure ‎4.28 Long-term‎effect‎of‎OMC‎or‎17β-oestradiol on invasion of MCF-7 human 
breast cancer cells through matrigel using chemotaxis stimulus as determined by 
xCELLigence technology. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 M 17β-oestradiol (+E) or 10-5 M OMC (OMC (-5M)) for 31 weeks. Media were replenished and 
cells were split every 3-4 days. Cells were analysed for their invasive activity through matrigel (1:40) 
coated CIM-plate 16 in a real time invasion assay (xCELLigence RTCA device) (A) The relative 
change in cell index of triplicate wells as indicated by the changes in impedance caused by cell 
migration from upper chambers to lower ones through the pores of the polycarbonate membrane 
coated with matrigel. Cell index was recorded every 5 minutes and monitored for 48 hours. (B) Bar 
graph represents the average of the end point measurements (Cell index) of cell invasion of triplicate 
wells at 48 hours. Values are the average ± SE of triplicate independent wells. ** p-value ≤ 0.01 
versus no addition by one-way ANOVA Dunnett’s test. 
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Table ‎4.4 Effects of OMC on motility and invasion of MCF-7 human breast cancer cells  
 
 Molar concentration  
Experiment 
10
-7
 M 10
-5 
M 
Incubation time prior 
to the experiment 
Wound healing 
-- (***) 7 weeks 
(####) (####) 13 weeks 
(***) n.s. 21 weeks 
Time-lapse 
n.s. 
(*) in percentage of 
motile cells 
2 weeks 
n.s. -- 21 weeks 
Real-time monitoring 
of cell motility 
(xCELLigence) 
n.o. O. 2 weeks 
n.o. n.o. 10 weeks 
O. O. 21 weeks 
-- (**) 23 weeks 
Real-time monitoring 
of cell invasion 
through matrigel 
 ( xCELLigence) 
n.o. O. 2 and 10 weeks 
-- (**) 31 weeks 
(--) experiment was not conducted; * p-value ≤ 0.05 increase versus no addition; ** p-value ≤ 
0.01 increase versus no addition; *** p-value ≤ 0.001 increase versus no addition; #### p-
value ≤ 0.0001 decrease versus no addition; (n.s.) p-value < 0.05 not significant; (O.) effect 
observed using duplicates only-no statistical analysis possible for duplicates; (n.o.) no effects 
observed using duplicates.  
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4.3.5 Effects of 4MBC on migration of MCF-7 human breast cancer cells 
4.3.5.1 Effects of 4MBC on collective migration of MCF-7 human breast 
cancer cells as measured by wound healing 
The wound healing assay was used to determine the effect of long term exposure to 4MBC on 
motility of MCF-7 human breast cancer cells. Although 4MBC increased the wound closure 
to 47.02 ± 3.11 % significantly compared to no addition (19.80 ± 0.65 %) after 8 weeks of 
exposure (Figure 4.29 (A)) (p-value ≤ 0.001), results showed that 13 weeks of exposure to 10
-
5
 M 4MBC or 10
-7 
M 4MBC did not have the same effect on the wound healing in MCF-7 
cells (Figure 4.29 (B)). On the other hand, a longer exposure time showed that after 21 weeks 
of exposure to the same concentrations the wound healing in MCF-7 cells increased. The 
wound healing closure of MCF-7 cells exposed to 10
-5 
M 4MBC was increased significantly 
to 47.66 ± 4.98 % (p-value ≤ 0.001), while 10
-7 
M 4MBC had increased the wound healing 
closure to 42.61 ± 2.22 % in comparison to the negative control (24.75 ± 0.68 %)  (Figure 
4.29 (C)) (p-value ≤ 0.01).  
4.3.5.2 Effects of 4MBC on migration of individual MCF-7 human 
breast cancer cells as measured by time-lapse microscopy 
MCF-7 human breast cancer cells were exposed for 2 weeks and 21 weeks to 4MBC or no 
addition. 48 hours prior the experiment, cells were re-seeded in 12-well plates and cell 
migration was analysed using time-lapse microscopy. 10 cells were tracked in 5 fields per 
well for 24 hours and the number of motile cells and cumulative length moved were measured 
for each treatment. Although statistics did not show any significant increase in the percentage 
of motile cells after 2 weeks of exposure to 10
-5 M 4MBC (Figure 4.30 (A)), there was an 
indicated increase in the cumulative length moved by MCF-7 cells to 78.85 ± 22.10 microns 
in comparison to 19.51 ± 12.25 microns in the negative control (Figure 4.30 (B)) (p-value ≤ 
0.05). After a longer exposure time (21 weeks), 10
-7 M 4MBC significantly increased the 
percentage of motile cells to 13.33 ± 2.91 % almost double the percentage of that indicated in 
the negative control (6.00 ± 2.91 %) (Figure 4.30 (C)) (p-value ≤ 0.01), but no change in 
cumulative length was found in the same experiment (Figure 4.30 (D)). 
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4.3.5.3 Effects of 4MBC on migration of MCF-7 human breast cancer 
cells as determined by xCELLigence technology 
MCF-7 cells were exposed to 10
-7 M 4MBC, 10
-6 M 4MBC, 10
-5 M 4MBC, 10
-8 M 17β-
oestradiol or no addition for 2, 10, 20 and 23 weeks prior to the experiment. Results of 2 and 
10 weeks of exposure to 4MBC suggested only a minor effect of 10
-5 M 4MBC on MCF-7 
cell motility in comparison with the negative control (Figures 4.31 and 4.32). Results also 
showed a reduction of cell motility after 2 and 10 weeks of exposure to 10
-7 M 4MBC and 10
-
6 M 4MBC in comparison with no addition (Figures 4.31 and 4.32). However, longer 
exposure (20 weeks) showed an increase in cell motility for cells exposed to 10
-6 M 4MBC 
and 10
-5 M 4MBC (Figure 4.33) and after 23 weeks of exposure to 10
-5 M 4MBC the increase 
in cell index 0.22 ± 0.06 was found to be significantly greater than the cell index of no 
addition (0.091 ± 0.02) (Figure 4.34) (p-value ≤ 0.05). Lower cell index (negative signals) of 
the negative control in Figure 4.33 refers to lower dynamic range of cell motility as described 
by (ACEA application note no.6, 2013 ; Eisenberg et al., 2011). 
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Figure ‎4.29 Effect‎of‎exposure‎to‎4MBC‎or‎17β-oestradiol on collective motility of MCF-
7 human breast cancer cells as measured by wound healing assay. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control (-E) only, 
10
-8 M 17β-oestradiol (+E), with 10-7 M 4MBC (4MBC (-7M)) or with 10-5 M 4MBC (4MBC (-5M)) 
for 8 weeks (A) 13 weeks (B) and 21 weeks (C). Media were replenished and cells were split every 3-
4 days. Cells were then reseeded in 12-well plates and once the cells became ≥ 95% confluent, wound 
was made and mitomycin c (0.5 µg/ml) was added.  Images were captured at 0 hour and 24 hours. Cell 
migration was quantified by analysing minimum 5 images from each well. (A) Values are the average 
± SE of triplicate wells of three independent experiments (n=3). (B and C) Values are the average ± 
SE of triplicate independent wells. ** p-value ≤ 0.01 and *** p-value ≤ 0.001 increase versus no 
addition. #### p-value ≤ 0.0001 decrease versus no addition by one-way ANOVA Dunnett’s test. 
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Figure ‎4.30 Effect of exposure to 4MBC on motility of individual MCF-7 human breast 
cancer cells as determined by time-lapse microscopy. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control (0) only or 
with 4MBC at indicated concentrations for 2 (A, B) and 21 weeks (C, D). Media were replenished and 
cells were split every 3-4 days. 2 days prior to the experiment, cells were reseeded in 12-well plates at 
0.2 x 10
5 
cells/well. Time-lapse images of 5 fields per well were recorded. Results represent the 
percentage of motile cells (A, C) and cumulative length moved (B, D). Values are the average ±SE of 
triplicate independent wells. * p-value ≤ 0.05 and ** p-value ≤ 0.01 versus no addition by t-Test. 
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Figure ‎4.31 Short-term‎effect‎of‎4MBC‎or‎17β-oestradiol on migration of MCF-7 human 
breast cancer cells using chemotaxis stimulus as determined by xCELLigence 
technology. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 M 17β-oestradiol (+E), 10-7 M 4MBC (4MBC (-7M)), 10-6 M 4MBC (4MBC (-6M)) or 10-5 M 
4MBC (4MBC (-5M)) for 2 weeks. Media were replenished and cells were split every 3-4 days. (A) 
The relative change in cell index of duplicate wells as indicated by the changes in impedance caused 
by cell migration from upper chambers to lower ones through the pores of the polycarbonate 
membrane. Cell index was recorded every 5 minutes and monitored for 24 hours. (B) Bar graph 
represents the average of the end point measurements (Cell index) of cell migration of duplicate 
independent wells at 24 hours.  
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Figure ‎4.32  Long-term‎effect‎of‎4MBC‎or‎17β-oestradiol on migration of MCF-7 human 
breast cancer cells using chemotaxis stimulus as determined by xCELLigence 
technology. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 M 17β-oestradiol (+E), 10-7 M 4MBC (4MBC (-7M)), 10-6 M 4MBC (4MBC (-6M)) or 10-5 M 
4MBC (4MBC (-5M)) for 10 weeks. Media were replenished and cells were split every 3-4 days. (A) 
The relative change in cell index of duplicate wells as indicated by the changes in impedance caused 
by cell migration from upper chambers to lower ones through the pores of the polycarbonate 
membrane. Cell index was recorded every 5 minutes and monitored for 24 hours. (B) Bar graph 
represents the average of the end point measurements (Cell index) of cell migration of duplicate wells 
at 24 hours.  
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Figure ‎4.33 Long-term‎effect‎of‎4MBC‎or‎17β-oestradiol on migration of MCF-7 human 
breast cancer cells using chemotaxis stimulus as determined by xCELLigence 
technology. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 M 17β-oestradiol (+E), 10-7 M 4MBC (4MBC (-7M)), 10-6 M 4MBC (4MBC (-6M)) or 10-5 M 
4MBC (4MBC (-5M)) for 20 weeks. Media were replenished and cells were split every 3-4 days. (A) 
The relative change in cell index of duplicate wells as indicated by the changes in impedance caused 
by cell migration from upper chambers to lower ones through the pores of the polycarbonate 
membrane. Cell index was recorded every 5 minutes and monitored for 24 hours. (B) Bar graph 
represents the average of the end point measurements (Cell index) of cell migration of duplicate wells 
at 24 hours.  
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Figure ‎4.34 Long-term‎effect‎of‎4MBC‎or‎17β-oestradiol on migration of MCF-7 human 
breast cancer cells using chemotaxis stimulus as determined by xCELLigence 
technology. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 M 17β-oestradiol (+E) or 10-5 M 4MBC (4MBC (-5M)) for 23 weeks. Media were replenished and 
cells were split every 3-4 days. (A) The relative change in cell index of triplicate wells as indicated by 
the changes in impedance caused by cell migration from upper chambers to lower ones through the 
pores of the polycarbonate membrane. Cell index was recorded every 5 minutes and monitored for 24 
hours. (B) Bar graph represents the average of the end point measurements (Cell index) of cell 
migration of triplicate wells at 24 hours. Values are the average ±SE of triplicate independent wells. * 
p-value ≤ 0.05 versus no addition by one-way ANOVA Dunnett’s test. 
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4.3.5.4 Effects of 4MBC on invasion of MCF-7 human breast cancer 
cells as determined by xCELLigence technology 
MCF-7 cells were exposed to 10
-7 
M 4MBC, 10
-6 
M 4MBC, 10
-5 
M 4MBC, 10
-8 M 17β-
oestradiol or no addition for different exposure times prior to the experiment. The invasive 
activity of MCF-7 cells following the exposure to these concentrations was observed using 
the xCELLigence technology (as described in section 2.5). 10
-5 
M 4MBC increased the 
invasive activity after 2 weeks (Figure 4.35), 10 weeks (Figure 4.36) and significantly after 
31 weeks of exposure (Figure 4.37) (p-value ≤ 0.05). Lower cell index of the control cells and 
17β-oestradiol (negative signals) (Figure 4.37) refers to lower dynamic range of cell invasion 
according to (ACEA application note no.6, 2013; Eisenberg et al., 2011). 
4.3.5.5 Summary of effects with 4MBC 
Table 4.5 summarises all the results in section 4.3.5. The results are shown as determined by 
wound healing, time-lapse microscopy and the xCELLigence technology after 2 weeks and 
longer time points of exposure to concentrations of 10
-7 
M and 10
-5 
M 4MBC. 
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Figure ‎4.35 Short-term‎effect‎of‎4MBC‎or‎17β-oestradiol on invasion of MCF-7 human 
breast cancer cells through matrigel using chemotaxis stimulus as determined by 
xCELLigence technology. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 M 17β-oestradiol (+E) or 10-5 M 4MBC (4MBC (-5M)) for 2 weeks. Media were replenished and 
cells were split every 3-4 days. Cells were analysed for their invasive activity through matrigel (1:40) 
coated CIM-plate 16 in a real time invasion assay (xCELLigence RTCA device) (A) The relative 
change in cell index of duplicate wells as indicated by the changes in impedance caused by cell 
migration from upper chambers to lower ones through the pores of the polycarbonate membrane 
coated with matrigel. Cell index was recorded every 5 minutes and monitored for 48 hours. (B) Bar 
graph represents the average of the end point measurements (Cell index) of cell invasion of duplicate 
wells at 48 hours.  
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Figure ‎4.36 Long-term‎effect‎of‎4MBC‎or‎17β-oestradiol on invasion of MCF-7 human 
breast cancer cells through matrigel using chemotaxis stimulus as determined by 
xCELLigence technology. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 M 17β-oestradiol (+E), 10-5 M 4MBC (4MBC (-5M)), 10-6 M 4MBC (4MBC (-6M)) or 10-7 M 
4MBC (4MBC (-7M)) for 10 weeks. Media were replenished and cells were split every 3-4 days. 
Cells were analysed for their invasive activity through matrigel (1:40) coated CIM-plate 16 in a real 
time invasion assay (xCELLigence RTCA device) (A) The relative change in cell index of duplicate 
wells as indicated by the changes in impedance caused by cell migration from upper chambers to 
lower ones through the pores of the polycarbonate membrane. Cell index was recorded every 5 
minutes and monitored for 48 hours. (B) Bar graph represents the average of the end point 
measurements (Cell index) of cell invasion of duplicate wells at 48 hours.  
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Figure ‎4.37 Long-term‎effect‎of‎4MBC‎or‎17β-oestradiol on invasion of MCF-7 human 
breast cancer cells through matrigel using chemotaxis stimulus as determined by 
xCELLigence technology. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8
 M 17β-oestradiol (+E) or 10-5 M 4MBC (4MBC (-5M)) for 31 weeks. Media were replenished 
and cells were split every 3-4 days. Cells were analysed for their invasive activity through matrigel 
(1:40) coated CIM-plate 16 in a real time invasion assay (xCELLigence RTCA device) (A) The 
relative change in cell index of triplicate wells as indicated by the changes in impedance caused by 
cell migration from upper chambers to lower ones through the pores of the polycarbonate membrane. 
Cell index was recorded every 5 minutes and monitored for 48 hours. (B) Bar graph represents the 
average of the end point measurements (Cell index) of cell invasion of triplicate wells at 48 hours. 
Values are the average ±SE of triplicate independent wells. * p-value ≤ 0.05 versus no addition by 
one-way ANOVA Dunnett’s test. 
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Table ‎4.5 Effects of 4MBC on motility and invasion of MCF-7 human breast cancer cells  
 Molar concentration  
Experiment 
10
-7
 M 10
-5 
M 
Incubation time prior 
to the experiment 
Wound healing 
-- (**) 8 weeks 
n.s.  n.s. 13 weeks 
(**) (**) 21 weeks 
Time-lapse 
-- 
(*) in cumulative length 
moved by the cells 
2 weeks 
**↑ in percentage of 
motile cells 
-- 21 weeks 
Real-time monitoring 
of cell motility 
(xCELLigence) 
n.o. O. 2 weeks 
n.o. O. 10 weeks 
O. O. 21 weeks 
-- (*) 23 weeks 
Real-time monitoring 
of cell invasion 
through matrigel 
 ( xCELLigence) 
n.o. O. 2 and 10 weeks 
-- (*) 31 weeks 
(--) experiment was not conducted; * p-value ≤ 0.05 versus no addition; ** p-value ≤ 0.01 
versus no addition; (n.s.) p-value > 0.05 not significant; (O.) effect observed using duplicates 
only-no statistical analysis possible for duplicates; (n.o.) no effects observed using duplicates. 
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4.3.6 Effects of HS on migration of MCF-7 human breast cancer cells 
4.3.6.1 Effects of HS on collective migration of MCF-7 human breast 
cancer cells as measured by wound healing 
The wound healing assay was used to determine the effect of long term exposure to HS on 
motility of MCF-7 human breast cancer cells. Results showed that after 8 weeks of exposure 
to 10
-5 
M HS the wound healing of MCF-7 cells was increased significantly to 37.11 ± 4.74 % 
compared to 19.8 ± 0.66 % in the negative control (Figure 4.38 (A)) (p-value ≤ 0.01). After 
13 weeks of exposure to 10
-6 
M HS or 10
-7 
M HS did not increase the wound healing closure 
in MCF-7 cells (Figure 4.38 (B)). In contrast, after longer exposure time (21 weeks) the 
wound healing closure in MCF-7 cells exposed to 10
-6 
M HS was increased significantly to 
44.72 ± 6.91 % and to 10
-7 
M HS was increased to 52.00 ± 1.11 %  in comparison to the 
negative control (24.75 ± 0.68 %) (Figure 4.38 (C)) (p-value ≤ 0.05 and p-value ≤ 0.01).  
4.3.6.2 Effects of HS on migration of individual MCF-7 human breast 
cancer cells as measured by time-lapse microscopy 
MCF-7 human breast cancer cells were exposed for 2 weeks and 21 weeks to HS or no 
addition. 48 hours prior the experiment, cells were re-seeded in 12-well plates and cell 
migration was analysed using time-lapse microscopy. 10 cells were tracked in 5 fields per 
well for 24 hours and the number of motile cells and cumulative length moved were measured 
for each treatment. No significant increase in percentage of cell motility or cumulative length 
moved was indicated after 2 weeks of exposure to 10
-5 
M HS (Figure 4.39 (A and B)). 
However, after 21 weeks of exposure to 10
-7 
M HS results have shown a significant increase 
in the percentage of motile cells (27.33 ± 2.40 %) in comparison to the negative control 
(12.00 ± 4.16 %) (Figure 4.39 (C)) (p-value ≤ 0.05). In the same experiment the cumulative 
length moved was not increased significantly in comparison to the negative control (Figure 
4.39 (D)).  
4.3.6.3 Effects of HS on migration of MCF-7 human breast cancer cells 
as determined by xCELLigence technology 
The movement of MCF-7 cells through 8µm pores of a membrane towards a chemotaxis 
stimulus of FCS was observed following the exposure to 10
-5 
M HS, 10
-6 
M HS, 10
-7 
M HS, 
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10
-8 M 17β-oestradiol or no addition for 3, 11, 21 and 23 weeks prior to the experiment. 
Short-term exposure to 10
-5 
M HS showed no increase in cell index (0.051) in comparison to 
the negative control (cell index 0.050) (Figure 4.40). However, 23 weeks of exposure 
increased the motility of MCF-7 cells significantly (cell index 0.18 ± 0.03) in comparison to 
the negative control (cell index 0.09 ± 0.02) (Figure 4.41) (p-value ≤ 0.05). 
Observing the effects of the exposure to lower concentrations of HS (10
-6 
M HS and 10
-7 
M 
HS) was conducted at 11 and 20 weeks of exposure. Cells exposed to 10
-6 
M HS showed a 
minor increase in cell index in comparison to the negative control and no effect of exposure 
to 10
-7 
M HS was observed in both experiments (Figures 4.42 and 4.43). 
Although the effects of 10
-8
 M 17β-oestradiol at 10 weeks from independent experiments has 
shown irregular pattern of MCF-7 cells motility compared to no addition as indicated by 
chemotaxis (Figures 4.5, 4.11, 4.15, 4.23, 4.32 and 4.42), further statistical analysis using 
tow-way ANOVA Bonferroni’s test showed no significant difference in the pattern of MCF-7 
cells motility exposed to 10
-8
 M 17β-oestradiol in comparison to no addition. 
4.3.6.4 Effects of HS on invasion of MCF-7 human breast cancer cells as 
determined by xCELLigence technology 
MCF-7 Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol 
control only, 10
-8 M 17β-oestradiol or 10-5 M HS for 2, 11 and 31 weeks. Cells were analysed 
for their invasive activity through matrigel (1:40) coated CIM-plate 16 in a real time invasion 
assay using the xCELLigence technology. No effect on MCF-7 cell invasive activity was 
observed after 11 weeks of exposure to 10
-7 
M HS or 10
-6 
M HS (data not shown). However, 
short-term exposure to 10
-5
M HS induced the cell index to 0.092 in comparison to the 
negative control (cell index 0.03) (Figure 4.44) and long-term (31 weeks) exposure of MCF-7 
cells to 10
-5 
M HS significantly induced the cell index to 0.16 ± 0.08 in comparison to the 
control cells (cell index -0.08 ± 0.02) (Figure 4.45) (p-value ≤ 0.05). Lower cell index 
(negative signals) of the control cells and 17β-oestradiol reflects lower dynamic range of cell 
invasion through matrigel (ACEA application note no.6, 2013; Eisenberg et al., 2011). 
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Figure ‎4.38 Effect‎of‎exposure‎to‎HS‎or‎17β-oestradiol on collective motility of MCF-7 
human breast cancer cells as measured by wound healing assay. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control (-E) only, 
10
-8 M 17β-oestradiol (+E), with 10-7 M HS (HS (-7M)), 10-6 M HS (Hs (-6M)) or 10-5 M HS (Hs (-
5M)) for 8 weeks (A), 13 weeks (B) and 21 weeks (C). Media were replenished and cells were split 
every 3-4 days. Cells were then reseeded in 12-well plates and once the cells became ≥ 95% confluent, 
wound was made and mitomycin c (0.5 µg/ml) was added. Images were captured at 0 hour and 24 
hours. Cell migration was quantified by analysing minimum 5 images from each well. (A) Values are 
the average ± SE of triplicate wells of three independent experiments (n=3). (B and C) Values are the 
average ± SE of triplicate independent wells.* p-value ≤ 0.05 and ** p-value ≤ 0.01 increase versus no 
addition. ## p-value ≤ 0.01 decrease versus no addition by one-way ANOVA Dunnett’s test. 
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Figure ‎4.39 Effect of exposure to HS on motility of individual MCF-7 human breast 
cancer cells as determined by time-lapse microscopy. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control (0) only or 
with HS at indicated concentrations for 2 (A, B) and 21 weeks (C, D). Media were replenished and 
cells were split every 3-4 days. 2 days prior to the experiment, cells were reseeded in 12-well plates at 
0.2 x 10
5 
cells/well. Time-lapse images of 5 fields per well were recorded. Results represent the 
percentage of motile cells (A, C) and cumulative length moved (B, D). Values are the average ±SE of 
triplicate independent wells. * p-value ≤ 0.05 versus no addition by t-Test. 
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Figure ‎4.40 Short-term‎ effect‎ of‎HS‎ or‎ 17β-oestradiol on migration of MCF-7 human 
breast cancer cells using chemotaxis stimulus as determined by xCELLigence 
technology. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 M 17β-oestradiol (+E), 10-7 M HS (HS (-7M)) or 10-6 M HS (HS (-6M)) for 3 weeks. Media were 
replenished and cells were split every 3-4 days. (A) The relative change in cell index of duplicate 
wells as indicated by the changes in impedance caused by cell migration from upper chambers to 
lower ones through the pores of the polycarbonate membrane. Cell index was recorded every 5 
minutes and monitored for 24 hours. (B) Bar graph represents the average of the end point 
measurements (Cell index) of cell migration of duplicate independent wells at 24 hours.  
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Figure ‎4.41 Long-term‎ effect‎ of‎HS‎ or‎ 17β-oestradiol on migration of MCF-7 human 
breast cancer cells using chemotaxis stimulus as determined by xCELLigence 
technology. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 M 17β-oestradiol (+E) or 10-5 M HS (HS (-5M)). Media were replenished and cells were split 
every 3-4 days. (A) The relative change in cell index of triplicate wells as indicated by the changes in 
impedance caused by cell migration from upper chambers to lower ones through the pores of the 
polycarbonate membrane. Cell index was recorded every 5 minutes and monitored for 24 hours. (B) 
Bar graph represents the average of the end point measurements (Cell index) of cell migration of 
triplicate independent wells at 24 hours. * p-value ≤ 0.05 versus no addition by one-way ANOVA 
Dunnett’s test.  
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Figure ‎4.42 Long-term‎ effect‎ of‎HS‎ or‎ 17β-oestradiol on migration of MCF-7 human 
breast cancer cells using chemotaxis stimulus as determined by xCELLigence 
technology. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 M 17β-oestradiol (+E), 10-7 M HS (HS (-7M)) or 10-6 M HS (HS (-6M)) for 11 weeks. Media were 
replenished and cells were split every 3-4 days. (A) The relative change in cell index of duplicate 
wells as indicated by the changes in impedance caused by cell migration from upper chambers to 
lower ones through the pores of the polycarbonate membrane. Cell index was recorded every 5 
minutes and monitored for 24 hours. (B) Bar graph represents the average of the end point 
measurements (Cell index) of cell migration of duplicate independent wells at 24 hours.  
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Figure ‎4.43 Long-term‎ effect‎ of‎HS‎ or‎ 17β-oestradiol on migration of MCF-7 human 
breast cancer cells using chemotaxis stimulus as determined by xCELLigence 
technology. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 M 17β-oestradiol (+E), 10-7 M HS (HS (-7M)) or 10-6 M HS (HS (-6M)) for 20 weeks. Media were 
replenished and cells were split every 3-4 days. (A) The relative change in cell index of duplicate 
wells as indicated by the changes in impedance caused by cell migration from upper chambers to 
lower ones through the pores of the polycarbonate membrane. Cell index was recorded every 5 
minutes and monitored for 24 hours. (B) Bar graph represents the average of the end point 
measurements (Cell index) of cell migration of duplicate independent wells at 24 hours.  
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Figure ‎4.44 Short-term‎ effect‎ of‎ HS‎ or‎ 17β-oestradiol on invasion of MCF-7 human 
breast cancer cells through matrigel using chemotaxis stimulus as determined by 
xCELLigence technology. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 M 17β-oestradiol (+E) or 10-5 M HS (HS (-5M)) for 2 weeks. Media were replenished and cells 
were split every 3-4 days. Cells were analysed for their invasive activity through matrigel (1:40) 
coated CIM-plate 16 in a real time invasion assay (xCELLigence RTCA device) (A) The relative 
change in cell index of duplicate wells as indicated by the changes in impedance caused by cell 
migration from upper chambers to lower ones through the pores of the polycarbonate membrane 
coated with matrigel. Cell index was recorded every 5 minutes and monitored for 48 hours. (B) Bar 
graph represents the average of the end point measurements (Cell index) of cell invasion of duplicate 
independent wells at 48 hours. 
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Figure ‎4.45 Long-term‎ effect‎ of‎ HS‎ or‎ 17β-oestradiol on invasion of MCF-7 human 
breast cancer cells through matrigel using chemotaxis stimulus as determined by 
xCELLigence technology. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 M 17β-oestradiol (+E) or 10-5 M homosalate (HS (-5M)) for 31 weeks. Media were replenished 
and cells were split every 3-4 days. Cells were analysed for their invasive activity through matrigel 
(1:40) coated CIM-plate 16 in a real time invasion assay (xCELLigence RTCA device) (A) The 
relative change in cell index of triplicate wells as indicated by the changes in impedance caused by 
cell migration from upper chambers to lower ones through the pores of the polycarbonate membrane 
coated with matrigel. Cell index was recorded every 5 minutes and monitored for 48 hours. (B) Bar 
graph represents the average of the end point measurements (Cell index) of cell invasion of triplicate 
wells at 48 hours. Values are the average ±SE of triplicate independent wells. * p-value ≤ 0.05 versus 
no addition by one-way ANOVA Dunnett’s test. 
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4.3.6.5 Summary of effects with HS 
Table 4.6 summarises all the results in section 4.3.6. The results are shown as determined by 
wound healing, time-lapse microscopy and the xCELLigence technology after 2 weeks and 
longer time points of exposure to concentrations of 10
-7 
M and 10
-5 
M HS. 
Table ‎4.6 Effects of HS on motility and invasion of MCF-7 human breast cancer cells  
 Molar concentration  
Experiment 
10
-7
 M 10
-5 
M 
Incubation time prior 
to the experiment 
Wound healing 
-- (**) 8 weeks 
n.s.  n.s. 13 weeks 
(**) -- 21 weeks 
Time-lapse 
-- n.s. 2 weeks 
(*)in percentage of 
motile cells 
-- 21 weeks 
Real-time monitoring 
of cell motility 
(xCELLigence) 
-- n.o. 2 weeks 
n.o. -- 10 weeks 
n.o. -- 20 weeks 
-- (*) 23 weeks 
Real-time monitoring 
of cell invasion 
through matrigel 
 ( xCELLigence) 
n.o. O. 2 and 10 weeks 
-- (*) 31 weeks 
(--) experiment was not conducted; * p-value ≤ 0.05 versus no addition; ** p-value ≤ 0.01 
versus no addition; (n.s.) p-value > 0.05 not significant; (O.) effect observed using duplicates 
only-no statistical analysis possible for duplicates; (n.o.) no effects observed using duplicates. 
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4.3.7 Comparisons of effects among different UV screen and different 
exposure time points: 
In order to compare the effect of different UV screens on MCF-7 cells motility, collected data 
from the wound healing assays were statistically compared using one-way ANOVA Tukey’s 
test. Data from 7 weeks of exposure to 10
-5
 M UV screens has shown no significant different 
in the effects caused by exposure to these chemicals but an increase in MCF-7 cells motility 
was indicated after exposure to 10
-5
 M Bp2 and 10
-5
 M 4MBC compared to 10
-8
 M 17β-
oestradiol (Figure 4.46 (A)). However, after 21 weeks of exposure to 10
-5
 M UV screens Bp3 
has shown a significant increase in MCF-7 cells motility compared to no addition, 10
-8
 M 
17β-oestradiol and 10-5 M Bp1 (Figure 4.46 (B)). While 4MBC and HS has caused significant 
increase in MCF-7 cells motility compared to 10
-8
 M 17β-oestradiol (p-value ≤ 0.05) (Figure 
4.46 (B)). 
No different between the effects of 10
-7
 M of the UV screens was indicated fallowing 13 
weeks of exposure (data not shown). However, 21 weeks of exposure to 10
-7
 M Bp1 has 
caused a significant increase in wound healing compared to 10
-7
 M Bp3 and 10
-7
 M OMC (p-
value ≤ 0.05). Although no different was indicated after comparing the effects of 10-7 M Bp1 
and 10
-7
 M Bp2, the effects of Bp2 on wound healing was significant compared to three UV 
screens (10
-7
 M Bp3, 10
-7
 M OMC and 10
-7
 M 4MBC) (p-value ≤ 0.01) ( Figure 4.46 (C)). 
In order to address whether the indicated affects of the UV screens on MCF-7 cells motility 
as indicated by wound healing assays or the xCELLigence technology have varied through 
the different time points of exposure, another statistical analysis was conducted using two-
way ANOVA Bonferroni post-hoc test. The results of the motility of MCF-7 cells that were 
exposed to 10
-5
 M of the UV screens for 7-8 and 21 weeks of exposure have shown that only 
effects of exposure to 10
-5
 M Bp3 has increased significantly through the time line of the 
experiment as indicated by wound healing assay (Figure 4.47 (A)). However, the effects of 
the exposure to lower dose of the UV screens have shown a significant increase in MCF-7 
cells motility after 21 weeks of exposure compared to 13 weeks of exposure to 10
-7
 M Bp1 
(p-value ≤ 0.0001), 10-7 M Bp2 (p-value ≤ 0.0001), 10-7 M Bp3 (p-value ≤ 0.01), 10-7 M 
OMC, 10
-7
 M 4MBC  and 10
-7
 M HS (p-value ≤ 0.05) as indicated by wound healing assay 
(Figure 4.47 (B)).  
Results obtained of the chemotactic driven motility of MCF-7 cells by the xCELLigence have 
shown that the effect of exposure to 10
-7
 M, 10
-6
 M and 10
-5
 M Bp3 has increased through the 
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time line (Figurer 4.48 (A)), and 10
-6
 M OMC, 10
-7
 M OMC and 10
-6
 M 4MBC had shown a 
significant increase in motility after 21 weeks of exposure compared to 2 and 10 weeks of 
exposure (Figures 4.49 and 4.50). 
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Figure 4.46 Statistical comparison of the varying effect of the UV screens on MCF-7 human 
breast cancer cells collective motility as indicated by the wound healing assay.  
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control (-E) only, 10
-8 
M 17β-oestradiol (+E), with 10-5 M of the UV screens for 7-8 weeks (A), 21 weeks (B) and to 10-7 M UV 
screens for 21 weeks (C) respectively. Media were replenished and cells were split every 3-4 days. Cells 
were then reseeded in 12-well plates and once the cells became ≥ 95% confluent, wound was made and 
mitomycin c (0.5µg/ml) was added.  Images were captured at 0 hour and 24 hours. Cell migration was 
quantified by analysing 5 images from each well by using Image J software. Values are the average ±SE 
of 3 independent wells (n=3). * p-value ≤ 0.05, ** p-value ≤ 0.01 and **** p-value ≤ 0.0001 versus no 
addition (black asterisks), 17β-oestradiol (green asterisks), Bp1 (blue asterisks) and Bp2 (purple asterisks) 
by one-way ANOVA Tukey’s test. 
(A) 
(B) 
(C) 
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Figure ‎4.47 Statistical comparison of the effects of different times of exposure of MCF-7 
human breast cancer cells to the UV screens as indicated by the wound healing assay.  
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control (-E) only, 10
-
8 M 17β-oestradiol (+E), with 10-5 M of the UV screens for 7-8 and 21 weeks (A) and to 10-7 M UV 
screens for 13 and 21 weeks (B) respectively. Media were replenished and cells were split every 3-4 
days. Cells were then reseeded in 12-well plates and once the cells became ≥ 95% confluent, wound 
was made and mitomycin c (0.5µg/ml) was added.  Images were captured at 0 hour and 24 hours. Cell 
migration was quantified by analysing 5 images from each well by using Image J software. Values are 
the average ±SE of 3 independent wells (n=3). * p-value ≤ 0.05, ** p-value ≤ 0.01 and **** p-value ≤ 
0.0001 versus the different time point for the same chemical by two-way ANOVA Bonferroni test. 
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Figure ‎4.48 Effect of different exposure times to Bp3‎or‎17β-oestradiol on migration 
of MCF-7 human breast cancer cells using chemotaxis stimulus as determined by 
xCELLigence technology. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-
E), 10
-8 M 17β-oestradiol (+E), 10-7 M Bp3 (Bp3 (-7M)), 10-6 M Bp3 (Bp3 (-6M)) or 10-5 M Bp3 
(Bp3 (-5M)) for 3, 10 and 21 weeks. Media were replenished and cells were split every 3-4 days. 
The relative change in cell index of duplicate wells as indicated by the changes in impedance 
caused by cell migration from upper chambers to lower ones through the pores of the 
polycarbonate membrane was recorded every 5 minutes and monitored for 24 hours. The bar 
graph represents the normalised cell index values to the negative control at the end point of cell 
migration of duplicate independent wells at 24 hours. **** p-value ≤ 0.0001 versus the same 
concentration at 3 weeks (black asterisks) or 10 weeks ( blue asterisks) by two-way ANOVA 
Bonferroni test. 
.  
 
185 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
T im e  l in e
N
o
r
m
a
li
z
e
d
 c
e
ll
 i
n
d
e
x
 a
ft
e
r
 2
4
 h
o
u
r
s
2
 w
e
e
k
s
1
0
 w
e
e
k
s
2
1
 w
e
e
k
s
0
2
4
6
8
1 0
- E
+ E
O M C  (-7 M )
O M C  (-6 M )
O M C  (-5 M )
***
***
**
****
Figure ‎4.49  Effect of different exposure times to OMC or‎17β-oestradiol on migration 
of MCF-7 human breast cancer cells using chemotaxis stimulus as determined by 
xCELLigence technology. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 M 17β-oestradiol (+E), 10-7 M OMC (OMC (-7M)), 10-6 M OMC (OMC (-6M)) or 10-5 M OMC 
(OMC (-5M)) for 2, 10 and 21 weeks. Media were replenished and cells were split every 3-4 days. 
The relative change in cell index of duplicate wells as indicated by the changes in impedance caused 
by cell migration from upper chambers to lower ones through the pores of the polycarbonate 
membrane was recorded every 5 minutes and monitored for 24 hours. The bar graph represents the 
normalised cell index values to the negative control at the end point of cell migration of duplicate 
independent wells at 24 hours.** p-value ≤ 0.01, *** p-value ≤ 0.001 and **** p-value ≤ 0.0001 
versus the same concentration at 2 weeks (black asterisks) or 10 weeks (blue asterisks) by two-way 
ANOVA Bonferroni test. 
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Figure ‎4.50 Effect of different exposure times to 4MBC or‎17β-oestradiol on migration 
of MCF-7 human breast cancer cells using chemotaxis stimulus as determined by 
xCELLigence technology. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 M 17β-oestradiol (+E), 10-7 M 4MBC (OMC (-7M)), 10-6 M 4MBC (OMC (-6M)) or 10-5 M 
4MBC (OMC (-5M)) for 2, 10 and 21 weeks. Media were replenished and cells were split every 3-4 
days. The relative change in cell index of duplicate wells as indicated by the changes in impedance 
caused by cell migration from upper chambers to lower ones through the pores of the polycarbonate 
membrane was recorded every 5 minutes and monitored for 24 hours. The bar graph represents the 
normalised cell index values to the negative control at the end point of cell migration of duplicate 
independent wells at 24 hours.* p-value ≤ 0.05 versus the same concentration at 2 weeks (black 
asterisks) or 10 weeks (blue asterisks) by two-way ANOVA Bonferroni test. 
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4.3.8 Effects of the UV screens on molecular markers related to 
motility and invasion of MCF-7 human breast cancer cells  
Alterations in MCF-7 cell epithelial morphology including the production of protrusions and 
lamellipodia were noticed after 23 weeks of exposure to the UV screens (Figures 4.51 and 
4.52). Red arrows show cells which have changed to a more mesenchymal morphology by 
showing two morphological features; transiting to individual elongated cells or forming 
motility compartments including lamellipodial or filopodial protrusions. These morphological 
changes combined with changes in cell motility as described earlier, led to investigation of 
potential molecular mechanisms. The expression levels of two of the molecular markers 
involved in EMT (E-cadherin and β-catenin) were assessed using RT-PCR (as described in 
section 2.6) and western immunoblotting (as described in section 2.7). Also, the mRNA levels 
of Twist1 and Snail were assessed using RT-PCR. Further investigation also covered the 
effects of UV screens on the activity of MMP-2 and MMP-9 using zymography (as described 
in section 2.8). Moreover, this work examined the effects of UV screens on mRNA levels of 
two other genes (PIK3R1 and BMP7), which were found to be allied in both the metastable 
phenotype of MCF-7 cells and the mesenchymal breast cancer cell line MDA-MB-231 as 
described by Uchino et al. (2010). 
4.3.8.1 Effects of the UV screens on levels of E-cadherin in MCF-7 
human breast cancer cells  
Effects of UV screens on levels of E-cadherin mRNA and protein levels were investigated 
after 1 week and 20 weeks+ of exposure. In order to measure the levels of E-cadherin mRNA 
using RT-PCR, β-actin was selected to be used as an endogenous control. Levels of E-
cadherin mRNA were found to be significantly reduced in MCF-7 cells after 1 week of 
exposure to 10-5 M 4MBC and 10-5 M HS (Figure 4.53 (A)) (p-value ≤ 0.001). Also, longer 
exposure (24-25 weeks) to 10
-5 
M Bp1, 10
-5 
M Bp3, 10
-5 
M OMC, 10
-5 
M 4MBC or 10
-5 
M HS 
were found to reduce E-cadherin mRNA levels (Figure 4.53 (B)). 
E-cadherin was identified as 135 kDa band on western immunoblotting using molecular 
weight markers. After 1 week of exposure to 10
-5 
M of the UV screens, no change in E-
cadherin levels was indicated by western immunoblotting (data not shown). However, longer 
exposure time (24-25 weeks) to 10
-5 
M Bp1 and 10
-5 
M HS decreased the E-cadherin protein 
levels in comparison with the negative control (Figures 4.54 and 4.55) (p-value ≤ 0.05). 
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Figure ‎4.51 Representative images of the long-term effect of UV screens on morphology 
of MCF-7 human breast cancer cells. 
Phase contrast images of MCF-7 cells grown in phenol-red-free-DMEM containing 5% DCFCS with 
ethanol control (-E) only, with 10
-5 
M Bp1 (Bp1), 10
-5 
M Bp2 (Bp2) or with 10
-5 
M Bp3 (Bp3) or with 
10
-8 M 17β-oestradiol (+E) for 23 weeks. Red arrows show cells which have changed to a more 
mesenchymal morphology by becoming elongated individual cells (A) or showing the formation of 
motility compartments including lamellipodial or filopodial protrusions (B).
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Figure ‎4.52 Representative images of the long-term effect of UV screens on morphology 
of MCF-7 human breast cancer cells. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control (-E) only, 
with 10
-5 
M OMC (OMC), 10
-5 
M 4MBC (4MBC) or with 10
-5 
M homosalate (HS) or with 10
-8 M 17β-
oestradiol (+E) for 23 weeks. Red arrows show cells which have changed to a more mesenchymal 
morphology by becoming separated elongated individual cells (A) or showing the formation of 
motility compartments including lamellipodial or filopodial protrusions (B). 
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Figure ‎4.53 Effect of exposure to the UV screens on levels of E-cadherin mRNA in 
MCF-7 cells as determined using real-time RT-PCR. 
Cells were assayed after 1 week (media were replenished two times)(A) or 24-25 weeks (media were 
changed and cells were split each 3-4 days) (B), with ethanol control (-E), with 10
-8 M 17β-oestradiol 
(+E), with 10
-5 
M Bp1 (Bp1), with 10
-5 
M Bp2 (Bp2), with 10
-5 
M Bp3 (Bp3), with 10
-5
M OMC 
(OMC), with 10
-5 
M 4MBC (4MBC) or with 10
-5 
M HS (HS). For each RT-PCR assay, E-cadherin 
values were normalised to β-actin values, expressed as fold change from control cells grown without 
the UV screens by 2
-ΔΔC
T method and the average SE of three independent experiment (n=3) taken 
from cells grown for 1 week or 24-25 weeks from independent cultures. Fold change for cell grown 
with 17β-oestradiol or UV screens are shown in the bar graph compared to the negative control. # p-
value ≤ 0.05, ## p-value ≤ 0.01 and ### p-value ≤ 0.001 decrease versus no addition (-E) by t-Test. 
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Figure ‎4.54 Effect of long-term exposure to UV screens on the level of E-cadherin. 
MCF-7 human breast cancer cells were grown for 24-25 weeks in phenol-red-free-DMEM 
supplemented with 5% DCFCS, with or without 10
-8 M 17β-oestradiol or with 10-5 M Bp1 (Bp1 (-
5M)), with10
-5 
M Bp2 (Bp2 (-5M)) or with 10
-5 
M Bp3 (Bp3 (-5M)). Media were replenished and cells 
were split every 3-4 days. (A) Total cellular protein was loaded at 25 µg per track and immunoblotted 
with antibody against E-cadherin. (B) Total protein was measured by the z-imager (Bio-RAD) prior to 
the immunoblotting steps. (C) The bar graph shows the level of E-cadherin relative to total protein 
from three independent experiments (n=3). # p-value ≤ 0.05 decreased versus no addition by t-Test. 
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Figure ‎4.55 Effect of long-term exposure to UV screens on the level of E-cadherin. 
MCF-7 human breast cancer cells were grown for 24-25 weeks in phenol-red-free-DMEM 
supplemented with 5% DCFCS, with or without 10
-8 M 17β-oestradiol or with 10-5 M OMC (OMC), 
with 10
-5 
M 4MBC (4MBC) or with 10
-5 
M HS (HS). Media were replenished and cells were split 
every 3-4 days. (A) MDA-MB-231 cell lysate was used as a negative control. Total cellular protein 
was loaded at 25 µg per track and immunoblotted with antibody against E-cadherin. (B) Total protein 
was measured by the z-imager (Bio-RAD) prior to the immunoblotting steps. (C) The bar graph shows 
the level of E-cadherin relative to total protein for three independent experiments (n=3). # p-value ≤ 
0.05 decrease versus no addition by t-Test. 
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4.3.8.2 Effects of the UV screens on levels of β-catenin in MCF-7 human 
breast cancer cells  
Effects of UV screens on levels of β-catenin mRNA and protein levels were investigated after 
1 week and 24-25 weeks of exposure. Levels of β-catenin mRNA were found to be 
significantly reduced in MCF-7 cells after 1 week of exposure to 10-5 M HS (Figure 4.56 (A)) 
(p-value ≤0.05). Longer exposure (24-25 weeks) to 10
-5
M Bp2 or 10
-5 
M Bp3 was found to 
reduce β-catenin mRNA levels in MCF-7 cells (Figure 4.56 (B)). 
β-catenin was identified as a 92 kDa band on western immunoblotting using molecular weight 
markers. After 1 week of exposure, MCF-7 cells exposed to 10
-5 
M OMC or 10
-5 
M HS 
showed lower levels of β-catenin in comparison to the negative control (Figure 4.58) (p-value 
≤ 0.05) but no significant effects were found following exposure to the benzophenones or the 
other UV screens (Figures 4.57 and 4.58). 
Significant reduction was found on β-catenin protein levels in MCF-7 cells following longer-
term exposure (24-25 weeks) to 10
-5 
M OMC (Figure 4.59) (p-value ≤ 0.05).  
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Figure ‎4.56 Effect of exposure to the UV screens on levels of β-catenin mRNA in MCF-7 
cells as determined using real-time RT-PCR. 
Cells were assayed after 1 week (media were replenished two times)(A) or 24-25 weeks (media were 
changed and cells were split each 3-4 days) (B) with ethanol, with 10
-8 M 17β-oestradiol, with 10-5 M 
Bp1 (Bp1), with 10
-5 
M Bp2 (Bp2), with 10
-5 
M Bp3 (Bp3), with 10
-5 
M OMC (OMC), with 10
-5 
M 
4MBC (4MBC) or with 10
-5 
M HS (HS). For each RT-PCR assay, β-catenin values were normalised to 
β-actin values, expressed as fold change from control cells grown without the UV screens by 2-ΔΔCT 
method and the average SE of three independent experiments (n=3) taken from cells grown for 1 
weeks or 24-25 weeks of culture. Fold change for cell grown with 17β-oestradiol or UV screens are 
shown in the bar graph compared to the negative control. # p-value ≤ 0.05 and ## p-value ≤ 0.01 
versus no addition (-E) by t-Test. 
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Figure ‎4.57 Effect of short-term‎exposure‎to‎UV‎screens‎on‎the‎level‎of‎β-catenin. 
MCF-7 human breast cancer cells were grown for 1 week in phenol-red-free-DMEM supplemented 
with 5% DCFCS, with or without 10
-8 M 17β-oestradiol or with 10-5 M Bp1 (Bp1), with 10-5 M Bp2 
(Bp2) or 10
-5 
M Bp3 (Bp3). Media were replenished twice. (A)Total cellular protein was loaded at 25 
µg per track and immunoblotted with antibody against β-catenin. (B) The loading control β-actin. (C) 
The bar graph shows the level of β-catenin relative to β-actin. Values are means and bars indicate 
SEM (n=3 independent experiments) by t-Test. 
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Figure ‎4.58 Effect of short-term‎exposure‎to‎UV‎screens‎on‎the‎level‎of‎β-catenin. 
MCF-7 human breast cancer cells were grown for 1 week in phenol-red-free-DMEM supplemented 
with 5% DCFCS, with or without 10
-8 M 17β-oestradiol or with 10-5 M OMC (OMC), with 10-5 M 
4MBC (4MBC) or with 10
-5 
M HS (HS). Media were replenished twice. (A) Total cellular protein was 
loaded at 25 µg per track and immunoblotted with antibody against β-catenin. (B) β-actin the loading 
control. (C) The bar graph shows the level of β-catenin to β-actin. Values are means and bars indicate 
SEM (n=3 independent experiments). # p-value ≤ 0.05 decrease versus no addition by t-Test. 
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Figure ‎4.59 Effect of long-term‎exposure‎to‎UV‎screens‎on‎the‎level‎of‎β-catenin. 
MCF-7 human breast cancer cells were grown for 24-25 weeks in phenol-red-free-DMEM 
supplemented with 5% DCFCS, with or without 10
-8 M 17β-oestradiol or with 10-5 M OMC (OMC), 
with 10
-5 
M 4MBC (4MBC) or with 10
-5 
M HS (HS). Media were replenished and cells were split 
every 3-4 days. (A) Total cellular protein was loaded at 25 µg per track and immunoblotted with 
antibody against β-catenin. (B) Total protein was measured by the z-imager (Bio-RAD) prior to the 
immunoblotting steps. (C) The bar graph shows the level of β-catenin relative to total protein from 
three independent experiments (n=3). # p-value ≤ 0.05 decrease versus no addition (-E) by t-Test. 
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4.3.8.3 Effects of the UV screens on MMPs in MCF-7 human breast 
cancer cells. 
Three MMPs were selected to be investigated after long-term exposure (35-37 weeks) of 
MCF-7 cells to the UV screens. Secreted MMP-2 and MMP-9 were measured in the 
conditioned media (serum free media) via zymography (as described in section 2.8). In the 
case of the intracellular MMP-14 protein levels, the effects were measured using western 
immunoblotting (as described in section 2.7). 
4.3.8.3.1 Effects of the UV screens on MMP-2 and MMP-9 activity of 
MCF-7 human breast cancer cells as determined by 
zymography 
After 36-38 weeks of exposure to 10
-5 
M Bp1, 10
-5 
M Bp2, 10
-5 
M Bp3, 10
-5 
M OMC, 10
-5 
M 
4MBC or 10
-5 
M HS, conditioned media (serum free) which contained relevant concentration 
of each UV screen was added for 24 hours prior to collection. Then the collected media were 
concentrated using ultra-4 centrifugal-filter units (10,000 NMWL) (Milipore, USA). Samples 
were run on 10% gelatin gel and the zymogram was developed at 37
o
C for 24 hours. Gels 
were stained and de-stained. Images of the gels were captured using BioRad Gel Doc imager 
and the peak area of each band was quantified using Image J software. Results showed a 
significant increase in MMP-9 activity following long-term exposure to 10
-5 
M Bp1 (Figure 
4.60 (A and B)) (p-value ≤ 0.001) but no other benzophenones had an effect of either MMP-9 
or MMP-2 (Figure 4.60 (B and C)). Also, no significant effect on MMP-2 or MMP-9 
activities were detected following the long-term exposure to 10
-5 
M OMC, 10
-5 
M 4MBC or 
10
-5 
M HS (date not shown). 
4.3.8.3.2  Effects of the UV screens on levels of MMP-14 in MCF-7 
human breast cancer cells as determined by western blotting 
The Pro form of MMP-14 was identified as a 62 kDa band on western immunoblotting using 
molecular weight markers, while the active form of MMP-14 was identified as a 50 kDa 
band. The cell lysates were prepared (as described in section 2.7.2.1) from the same dishes 
prepared for conditioned media collection (section 2.8.1). No significant difference was found 
between the levels of pro and active forms of MMP-14. However, levels of pro-MMP-14 
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were found significantly elevated after 36-38 weeks of exposure to 10
-5 
M Bp1 compared to 
no addition (Figure 4.61) (p-value ≤ 0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure ‎4.60 Effect of benzophenones on secreted MMP-9 activity of MCF-7 human 
breast cancer cells as measured by gelatin zymography. 
MCF-7 Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only 
(-E), 10
-8 M 17β-oestradiol (+E), 10-5 M Bp5 (Bp5), 10-5 M Bp2 (Bp2) or 10-5 M Bp3 (Bp3) for 35-37 
weeks. Media were replenished and cells were split every 3-4 days. Cells were exposed to serum free 
media plus the relative chemicals for 24 hours prior collection. Collected media were concentrated 
using Amicon ultra centrifugal filters prior to gelatin gel zymography. (A) Representative scanned 
image showing the effect of the conditioned media on the activity of MMP-9 and MMP-2 on a 10% 
gelatin gel. (B) Bar graph represents the bands densities of MMP-9 and error bars are the standard 
error of triplicate independent experiments. (C) Bar graph represents the band densities of MMP-2 and 
error bars are the standard error of triplicate independent experiments (n=3). ** p-value ≤ 0.01 versus 
no addition (-E) by t-Test. 
M M P -9
-E + E B p 1 B p 2 B p 3
0
2
4
6
8
1 0
N
o
rm
al
iz
ed
 p
ea
k 
ar
ea **
M M P -2
-E + E B p 1 B p 2 B p 3
0 .0
0 .5
1 .0
1 .5
T r e a tm e n t
N
or
m
al
iz
ed
 p
ea
k 
ar
ea
-E +E Bp1 Bp2 Bp3 
MMP-9 
MMP-2 
(A) 
(B) 
(C) 
200 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure ‎4.61 Effect of long-term exposure to UV screens on the intracellular level of 
MMP-14 in MCF-7 cells. 
MCF-7 human breast cancer cells were grown for 35, 36 and 37 weeks in phenol-red-free-DMEM 
supplemented with 5% DCFCS, with or without 10
-8 M 17β-oestradiol or with 10-5 M Bp1 (Bp1), with 
10
-5 
M Bp2 (Bp2) or 10
-5 
M Bp3 (Bp3) and HeLa human cervical carcinoma (HeLa) cells lysate was 
used as a positive control. Media were replenished and cells were split every 3-4 days. Cells were 
exposed to serum free media plus the relative chemicals for 24 hours prior to the cell lysate collection. 
(A) Total cellular protein was loaded at 25 µg per track and immunoblotted with antibody against pro-
MMP-14 (62 kDa) and activated-MMP-14 (50 kDa). (B) Total protein was measured by the z-imager 
(Bio-RAD) prior to the immunoblotting steps. (C) The bar graph shows the level of pro and active 
MMP-14 relative to total protein. Values are means and bars indicate SEM (n=3 independent 
experiments). * p-value ≤ 0.05 versus no addition (-E) by t-Test. 
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4.3.8.4 Effect of the UV screens on molecular markers of EMT in MCF-7 
human breast cancer cells 
Further investigation was carried out in order to observe the effect of UV screens on mRNA 
expression levels of two markers related to EMT; (Snail and Twist-1) and two markers 
related to cell motility (PIK3R1 and BMP7). mRNA levels were measured using RT-PCR (as 
described in section 2.6). MCF-7 human breast cancer cells in phenol-red-free-DMEM 
(Invitrogen) containing 5% DCFCS, 2mM L-glutamine, 100µg/ml streptomycin, 100U/ml 
penicillin (Invitrogen) were exposed to 10
-8 
M 17β-oestradiol, 10-5 M of the UV screens or to 
ethanol for short-term (1 week) and long-term (24-25 weeks) prior to total RNA extraction, 
cDNA preparation and subsequent steps of RT-PCR assay. Results were normalised to β-actin 
values, expressed as fold change from control cells grown without the UV screens by the 2
-
ΔΔC
T method and the results are shown as average ±SE of 3 biological independent assays. 
Although Snail mRNA levels were increased after exposure to 10
-8 
M 17β-oestradiol for 24-
25 weeks (Figure 4.62 (B)) (p-value≤0.05), similar increases were not found in samples 
exposed to 10
-5 
M of the UV screens for the same time of exposure. However, 1 week 
exposure to 10
-5 
M Bp3 was found to increase Snail mRNA levels in MCF-7 cells (Figure 
4.62 (A)) (p-value ≤ 0.05). 
Short-term and long-term exposures to the UV screens have not shown an effect on Twist-1 
mRNA levels in MCF-7 cells (Figure 4.63 (A and B)).  
Levels of PIK3R1 mRNA were significantly reduced after 1 week of exposure to 10
-5 
M Bp2 
(p-value ≤ 0.05), 10-5 M OMC (p-value ≤ 0.01) and 10-5 M HS (p-value ≤ 0.01) in comparison 
with the negative control (Figure 4.64 (A)) and only to 10
-5
M Bp2 and 10
-5 
M OMC after 
longer-term exposure (24-25 weeks) (Figure 4.64 (B)) (p-value ≤ 0.05).  
Short-term exposure (1 week) to 10
-5 
M 4MBC was found to decrease BMP7 mRNA levels 
(Figure 4.65 (A)) (p-value ≤ 0.01). On the contrary, 24-25 weeks of exposure to 10-5 M 4MBC 
increased BMP7 mRNA levels (Figure 4.65 (B)) (p-value ≤ 0.01) and to 10-5 M Bp3 and 10-5 
M OMC decreased BMP7 mRNA levels in comparison with the negative control (Figure 4.65 
(B)) (p-value ≤ 0.01 and p-value ≤ 0.05 respectively). 
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4.3.8.5 Summary of the effects of UV screens on selected molecular 
markers 
In order to illustrate the effects of the UV screens on the targeted markers in MCF-7 cells 
after 1 week and 24-25 weeks of exposure, a summary table showing the significant effects of 
each of the UV screens on each marker was generated (see Table 4.7). 
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Figure ‎4.62 Effect of exposure to the UV screens on levels of Snail mRNA in MCF-7 cells 
as determined using real-time RT-PCR. 
Cells were assayed after 1 (media were replenished two times)(A) or 24-25 weeks (media were 
changed and cells were split each 3-4 days) (B) with ethanol, with 10
-8 M 17β-oestradiol, with 10-5 M 
Bp1 (Bp1), with 10
-5 
M Bp2 (Bp2), with 10
-5 
M Bp3 (Bp3), with 10
-5 
M OMC (OMC), with 10
-5 
M 
4MBC (4MBC) or with 10
-5 
M HS (HS). For each RT-PCR assay, Snail values were normalised to β-
actin values, expressed as fold change from control cells grown without the UV screens by 2
-ΔΔC
T 
method and the average SE of biological independent experiments assay (n=3) taken from cells grown 
for 1week or 24-25 weeks of culture. Fold change for cell grown with 17β-oestradiol or UV screens 
are shown in the bar graph compared to the negative control. * p-value ≤ 0.05 and ** p-value ≤ 0.01 
increase versus no addition (-E) by t-Test. # p-value ≤ 0.01 and ### p-value ≤ 0.01 decrease versus no 
addition (-E) by t-Test. 
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Figure ‎4.63 Effect of exposure to the UV screens on levels of Twist-1 mRNA in MCF-7 
cells as determined using real-time RT-PCR. 
Cells were assayed after 1 week (media were replenished two times)(A) or 24-25 weeks (media were 
changed and cells were split each 3-4 days) (B) with ethanol, with 10
-8 M 17β-oestradiol, with 10-5 M 
Bp1 (Bp1), with 10
-5 
M Bp2 (Bp2), with 10
-5 
M Bp3 (Bp3), with 10
-5 
M OMC (OMC), with 10
-5 
M 
4MBC (4MBC) or with 10
-5 
M HS (HS). For each RT-PCR assay, Twist-1 values were normalised to 
β-actin values, expressed as fold change from control cells grown without the UV screens by 2-ΔΔCT 
method and the average SE of biological independent experiments (n=3) taken from cells grown for 1 
week or 24-25 weeks of culture. Fold change for cell grown with 17β-oestradiol or UV screens are 
shown in the bar graph compared to the negative control (-E) by t-Test.  
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Figure ‎4.64 Effect of exposure to the UV screens on levels of PIK3R1 mRNA in MCF-7 
cells as determined using real-time RT-PCR. 
Cells were assayed after 1 week (media were replenished two times)(A) or 24-25 weeks (media were 
changed and cells were split each 3-4 days) (B) with ethanol, with 10
-8 M 17β-oestradiol, with 10-5 M 
Bp1 (Bp1), with 10
-5 
M Bp2 (Bp2), with 10
-5 
M Bp3 (Bp3), with 10
-5 
M OMC (OMC), with 10
-5 
M 
4MBC (4MBC) or with 10
-5 
M HS (HS). For each RT-PCR assay, PIK3R1 values were normalised to 
β-actin values, expressed as fold change from control cells grown without the UV screens by 2-ΔΔCT 
method and the average SE of biological independent experiments (n=3) taken from cells grown for 
1week or 24-25 weeks of culture. Fold change for cell grown with 17β-oestradiol or UV screens are 
shown in the bar graph compared to the negative control. # p-value ≤ 0.05 and ## p-value ≤ 0.01 
decrease versus no addition (-E) by t-Test.  
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Figure ‎4.65 Effect of exposure to the UV screens on levels of BMP7 mRNA in MCF-7 
cells as determined using real-time RT-PCR. 
Cells were assayed after 1 week (media were replenished two times)(A) or 24-25 weeks (media were 
changed and cells were split each 3-4 days) (B) with ethanol, with 10
-8 M 17β-oestradiol, with 10-5 M 
Bp1 (Bp1), with 10
-5 
M Bp2 (Bp2), with 10
-5 
M Bp3 (Bp3), with 10
-5 
M OMC (OMC), with 10
-5 
M 
4MBC (4MBC) or with 10
-5 
M HS (HS). For each RT-PCR assay, BMP7 values were normalised to β-
actin values, expressed as fold change from control cells grown without the UV screens by 2
-ΔΔC
T 
method and the average SE of biological independent experiments (n=3) taken from cells grown for 
1week or 24-25 weeks of culture. Fold change for cell grown with 17β-oestradiol or UV screens are 
shown in the bar graph compared to the negative control. * p-value ≤ 0.05 increase versus no addition. 
# p-value ≤ 0.05 and ## p-value ≤ 0.01 decrease versus no addition (-E) by t-Test. 
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Table ‎4.7  Summary table of the effects of UV screens on selected molecular markers. 
This table summarises the effects of exposure to UV screens on molecular markers in MCF-7 
cells. Fold numbers compared to control without UV screen. Purple shades represent decrease 
levels and green shades illustrate significant increase compared to control.  
(--) represent no significant effect.
UV screen 
E-cadherin β- catenin Snail Twist-1 PIK3R1 BMP7 
mRNA 
levels 
Protein 
levels 
mRNA 
levels 
Protein 
levels 
mRNA 
levels 
mRNA 
levels 
mRNA 
levels 
mRNA 
levels 
17β- 
oestradiol 
1 week -- -- -- -- -- -- -- -- 
24-25 
weeks 
-- -- -- -- 7.76 ± 1.62 -- -- -- 
Bp1 
1 week -- -- -- -- -- -- -- -- 
24-25 
weeks 
0.54 ± 0.17 0.74 ± 0.12 -- -- 0.52 ± 0.12 -- -- -- 
Bp2 
1 week -- -- -- -- -- -- 0.59 ± 0.09 -- 
24-25 
weeks 
-- -- 0.84 ± 0.04 -- -- -- 0.42 ± 0.09 -- 
Bp3 
1 week -- -- -- -- 1.16 ± 0.04 -- -- -- 
24-25 
weeks 
0.51 ± 0.11 -- 0.51 ± 0.07 -- -- -- -- 
0.58 ± 
0.03 
OMC 
1 week -- -- -- 0.73 ± .07 -- -- 0.57 ± 0.03  
24-25 
weeks 
0.60 ± 0.12 -- -- 
0.61 ± 
0.17 
0.55 ± 0.04 -- 0.47 ± 0.11 
0.43 ± 
0.13 
4MBC 
1 week 0.18 ± 0.06 -- -- -- -- -- -- 0.56 ± 0.07 
24-25 
weeks 
0.52 ± 0.15 -- -- -- -- -- -- 1.55 ± 0.12 
HS 
1 week 0.36 ± 0.01 -- 0.47 ± 0.21 0.54 ± 0.13 -- -- 0.51 ± 0.08 -- 
24-25 
weeks 
0.55 ± 0.17 0.79 ± 0.12 -- -- -- -- -- -- 
  
 
4.4 Discussion 
The acquisition of migratory and invasive activity by epithelial cells is one of the hallmarks 
of cancer (Hanahan and Weinberg, 2011). The role of UV screens in influencing breast 
cancer cell migration has not been investigated previously. Results in this study, report for the 
first time that UV screens increase the motility of MCF-7 human breast cancer cells as shown 
in Tables 4.1- 4.6.  
Strength of this study by using different methods. The use of three techniques strengthened 
the evaluation of the influence of UV screens on the motility of MCF-7 cells but there were 
variations in results obtained from each technique due to the different perspective that each 
technique provides in the context of cell motility. The wound healing assay measures 
collective cell migration in a monolayer for cells that expresses cell-cell adhesion and 
cohesion (Friedl et al., 2004) and this technique facilitates the quantitation of cell motility in 
one direction (Hulkower and Herber, 2011). Time-lapse microscopy helps to observe the 
motility of individual cells in any direction  (Jain et al., 2012). The xCELLigence technology 
monitors the motility of individual cells through pores of a membrane in real time towards the 
chemotactic effect of the serum (Limame et al., 2012).  
UV screens at 10
-5
M concentration increased cell migration. The evaluation of the effect of 
the UV screens using different techniques revealed that MCF-7 cells showed different types 
of motility in response to the different UV screens in this work. All of the six UV screens at 
10
-5
 M concentrations have increased MCF-7 cell collective motility after 7-8 weeks as 
determined by the wound healing. In the same time, increased MCF-7 cell motility towards 
chemotactic stimulus as determined by the xCELLigence technology was found for all the 
UV screens after 2 weeks of exposure except for HS. However, longer exposure times gave 
varied effects for the different chemicals. 
10
-5 
M Bp1 was found to increase MCF-7 cell motility towards the chemotactic effect with 
similar magnitude after 2 weeks and 21≥weeks of exposure by the xCELLigence technology. 
In addition, even with the absence of the chemotaxis stimulus of FCS in time-lapse 
microscopy, an increase in the percentage of motile MCF-7 cells was found after short-term 
exposure (2 weeks) to 10
-5 
M Bp1. While the collective migration of MCF-7 cells exposed to 
this chemical was only found after 7 weeks of exposure and not found after 21 weeks of 
exposure as assessed by the wound healing. Similar findings were found in MCF-7 cells 
exposed to 10
-5 
M Bp2 where 2 weeks of exposure showed increased MCF-7 cell motility 
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towards the chemotactic effect, while 21 weeks of exposure to 10
-5 
M Bp2 showed no effect 
on MCF-7 cell motility, which might be linked to the preservation of the oestrogenic 
properties by these chemicals compared to the more motile oestrogenic deprived cultures 
(Lewis-Wambi et al., 2008; Nguyen et al., 2015). 
While the increase in MCF-7 cell motility was observed after the exposure to 10
-5 
M Bp3 (2 
weeks and 21 weeks) as determined by xCELLigence, the increase in wound closure of MCF-
7 cells following exposure to 10
-5 
M Bp3 was not found after 7 weeks and 13 weeks of 
exposure and increased significantly after 21 weeks of exposure, which was significantly 
increased through the time line of the experiment, suggesting that the increase in collective 
motility of MCF-7 cells after long-term exposure to 10
-5
M Bp3 is accumulative. 
Concentrations of 10
-5 
M OMC and 10
-5 
M 4MBC were found to increase MCF-7 cell motility 
towards the chemotactic effect with similar magnitude after 2 weeks and 21≥weeks of 
exposure as determined by the xCELLigence technology. In addition, an increase in the 
percentage of motile MCF-7 cells was found after 2 weeks of exposure to 10
-5 
M OMC, and 
in cumulative length moved by cells exposed for 2 weeks to 10
-5 
M 4MBC as determined by 
the time-lapse. These findings of the effects of 21 weeks of exposure to 10
-5 
M 4MBC were 
supported by significant wound closure in the wound healing assay but not for OMC. 
Compared to the other chemicals, 10
-5 
M HS was the only chemical that showed no influence 
on MCF-7 cell motility after 2 weeks but increased cell motility after 23 weeks of exposure as 
determined by the xCELLigence. Previous reports regarding the effect of UV screens on 
breast cancer cells in vitro have only focused on the proliferative response of MCF-7 cells 
towards the UV screens (Schlumpf et al., 2001; Nakagawa and Suzuki, 2002; Jimenez-Diaz et 
al., 2013; Kerdivel et al., 2013) and cell motility was never investigated until 2015. As data 
for this work were collected, Sol-Ji In and his colleagues have indicated the influence of 10
-5 
M Bp1 in increasing the motility of MCF-7 human breast cancer cells after three days of 
exposure as assessed by the wound healing assay (In et al., 2015). Despite the differences in 
methodologies used by Sol-Ji In group and in this work, their finding is in line with the 
results obtained in this research after short-term (2 weeks) exposure to 10
-5 
M Bp1 by the 
xCELLigence technology. Nevertheless, they have decreased this induced motility by using 
the ERα antagonist fulvestrant, suggesting that the increase of MCF-7 cell motility is ER 
mediated (In et al., 2015). In a more recent study, Shin and his colleagues have found that 
Bp1 increased the motility of BG-1 ovarian cancer cells and in agreement with the work by 
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Sol-Ji In on MCF-7 cells, the influence of Bp1 on BG-1 cells motility was decreased by 
fulvestrant (Shin et al., 2016). 
UV screens at 10
-7
M concentration increased cell migration. 10
-7
 M of the UV screens did 
not increase MCF-7 cell motility after 2 weeks of exposure, but did increase their motility 
after 21 weeks of exposure as measured by the wound healing assay. This increase in 
collective motility was statistically linked to the effect of the long-time of exposure. A similar 
pattern of increase in MCF-7 cell motility towards chemotactic stimulus was observed after 
21 weeks of exposure to 10
-7
 M Bp1, 10
-7
 M Bp3, 10
-7
 M OMC and 10
-7
 M 4MBC as 
determined by the xCELLigence experiments. In addition, time-lapse analysis supported the 
influence of 10
-7
 M Bp1, 10
-7
 M Bp2, 10
-7
 M Bp3, 10
-7
 M 4MBC and 10
-7
 M HS in increasing 
MCF-7 cell motility after 21 weeks of exposure, where 10
-7
 M Bp2 and 10
-7
 M Bp3 increased 
the cumulative length moved by MCF-7 cells and increased the percentage in motile cells 
following the long-term exposure to 10
-7
 M Bp1, 10
-7
 M Bp2, 10
-7
 M 4MBC and 10
-7
 M HS. 
The effect of long-term exposure to environmental oestrogens at low concentration is a rising 
concern because it reflects the reality of the exposure to environmental oestrogens in daily 
life (Darbre and Fernandez, 2013) and the effects of the long-term, low-dose model 
represented by this work support these rising concerns.  
Effect of 17β-oestradiol and long-term oestrogen deprivation on cell migration. In line with 
previous reports regarding the influence of 10
-8 M 17β-oestradiol in increasing MCF-7 cell 
motility (Saji et al., 2005; Malek et al., 2006; Planas-Silva and Waltz, 2007; Jimenez-Salazar 
et al., 2014), 10
-8 M 17β-oestradiol in this work also increased MCF-7 cell motility in 
comparison with control cells after 2 weeks of exposure as measured using xCELLigence 
technology. However, longer term growth of cells with and without 17β-oestradiol (starting 
from 7 weeks) showed a reduced difference between MCF-7 cells treated with 10
-8 M 17β-
oestradiol and the non-treated oestrogen deprived cells. Relevant data from the results section 
are summarised in Figures 4.66 and 4.67. Long-term oestrogen deprivation is known to result 
in loss of proliferative response to 17β-oestradiol (Darbre, 2014) and recent work reported 
increased motility of long-term oestrogen-deprived MCF-7 cells (Lewis-Wambi et al., 2008; 
Nguyen et al., 2015). Long-term deprived cells are characterized by hypersensitivity to low 
concentrations of 17β-oestradiol for the proliferative response (Masamura et al., 1995; Song 
et al., 2002a; Santen et al., 2005) and it is possible that there may similarly increase  
sensitivity towards the addition of 17β-oestradiol and UV screens towards cell motility. Our 
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results indicated that 10
-7 
M concentrations of the UV screens gave effects on MCF-7 cell 
motility in the longer term. However, whether this effect built up through the long-term 
exposure or was caused by the increased hypersensitivity of MCF-7 cells due to 17β-
oestradiol deprivation, there is no doubt that MCF-7 cell motility increased in comparison to 
the negative control. It is noteworthy that the increase in MCF-7 cell motility after short-term 
exposure to 10
-5
 M Bp2, which was lost during the long-term exposure, might be due to the 
preserved oestrogenic action caused by this chemical in comparison with the other UV 
screens which gave weaker oestrogenic responses. The long-term oestrogen deprived model 
mimics the post-menopausal scenario in women when oestrogen drops to low levels (Faupel-
Badger et al., 2010) and the risk of breast cancer increases (Ghiasvand et al., 2014). Thus, 
breast cancer cells might become more sensitive toward low oestrogen levels or towards the 
environmental oestrogenic activity of the UV screens.  
Effects of UV screens on MCF-7 cell invasive activity. Results showed that there is an 
increase in the invasive activities of MCF-7 cells after 2 weeks of exposure to 10
-5 
M Bp3, 10
-
5 
M OMC, 10
-5 
M 4MBC and 10
-5 
M HS. Moreover, 31 weeks exposure to 10
-5 
M Bp1, 10
-5
M 
OMC, 10
-5 
M 4MBC and 10
-5 
M HS had significantly increased the invasion of MCF-7 cells 
through matrigel in comparison to the control as determined by the xCELLigence technology. 
Not all of the UV screens tested increased the invasive activity of MCF-7 cells. Neither the 
concentrations tested of Bp2 in the different time points nor Bp3 after 31 weeks of exposure 
showed any effect on MCF-7 cell invasive capability. Invading the  surrounding tissues is one 
of the first steps of cancer cells in the process of metastasis (Nguyen et al., 2009; Hanahan 
and Weinberg, 2011) and the ability of the UV screens to increase MCF-7 cells invasive 
ability might contribute to possible effects of UV screens on breast cancer progression.  
The limited effect of some of the UV screens on MCF-7 cell motility and invasion does not 
negate the potential for them to act within different mixtures after long-term exposure. The 
effect of long-term exposure to mixtures of environmental oestrogens at low concentration is 
a rising concern because it reflects the reality of the exposure to environmental oestrogens in 
daily life (Darbre and Fernandez, 2013) and mixtures of UV screens at low concentrations 
have previously been reported to induce expression of the oestrogen responsive TFF1 gene 
(Heneweer et al., 2005). Thus studying the effect of mixtures of the UV screens must be 
considered in future research. Furthermore, the effect of metabolites of the UV screens should 
not be neglected. In this chapter Bp3 has only increased MCF-7 cell motility after long-term 
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exposure and had no influence on cell invasion after 31 weeks of exposure. On the other 
hand, Bp1 at different concentrations induced both the motility and invasive activity of MCF-
7 cells and Bp1 has been reported to be one of the metabolites of Bp3 (Jeon et al., 2008). 
It is worth noting that long-term exposure to UV screens caused morphological changes in 
MCF-7 cells including the presence of spindle shaped cells and the formation of protrusions 
of pseudopodia and such extensions are known to be related to higher metastatic potential in 
cancer cells (Partin et al., 1989). Change in motility of MCF-7 cells following exposure to the 
UV screens raises the questions of underlying molecular mechanisms. Among the different 
theories that can underly development of motility of epithelial cells, the epithelial–
mesenchymal transition (EMT) was chosen to be investigated.  
Exposure to UV screens reduced levels of E-cadherin and β-catenin. Results showed that 
two of the six UV screens decreased E-cadherin protein and mRNA levels (10
-5 
M Bp1 and 
10
-5 
M HS). 10
-5 
M Bp1 reduced E-cadherin mRNA expression and protein levels in MCF-7 
cells after 24-25 weeks of exposure with no effect on β-catenin. However, 10-5 M HS reduced 
E-cadherin mRNA expression after 1 week and 24-25 weeks of exposure, but decreased E-
cadherin protein levels only after 24 weeks of exposure. It is noteworthy that 10
-5
M HS also 
reduced β-catenin mRNA expression at both time points but only reduced β-catenin protein 
levels in MCF-7 cells after 1 week of exposure. It was reported by Shin and colleagues that 
Bp1 reduces the E-cadherin protein levels in BG-1 ovarian cancer cells after 4 days of 
exposure (Shin et al., 2016), suggesting that the influence of Bp1 on cell motility might be via 
a similar mechanism. In another study of the effects of parabens, Khanna and colleagues 
reported down regulation in protein levels of E-cadherin and β-catenin in MCF-7 cells that 
showed increased motility after more than 20 weeks of exposure (Khanna et al., 2014). 
Repressed E-cadherin is one of the most critical molecular markers of EMT. Further, loss of 
cell-cell adhesion via disturbing the E-cadherin/β-catenin complex is linked to cancer 
progression (Heimann et al., 2000), poor prognosis of breast cancer (Gamallo et al., 1993; 
Hunt et al., 1997) and found to be associated with increase in metastases and invasiveness of  
breast cancer in clinical studies (Oka et al., 1993; Moll et al., 1993; Siitonen et al., 1996; 
Heimann et al., 2000). Experimentally repressing E-cadherin was also linked to an increase in 
MCF-7 cell invasive capacity (Hiscox et al., 2006).  Others of the chemicals caused reduced 
mRNA levels but not the protein. E-cadherin mRNA expression was down-regulated by 
exposure to 10
-5 
M Bp3, 10
-5 
M OMC and 10
-5 
M 4MBC after 24-25 weeks of exposure, but 
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no significant decrease in a protein level was indicated after exposure to these UV screens. E-
cadherin is part of the cell-cell adherens junction (Bazzoun et al., 2013; Martin et al., 2013), 
which functions not only in maintaining the apical shape of the epithelial cells but also as a 
mediator in downstream signalling through its binding to β-catenin (Beavon, 2000; 
Wijnhoven et al., 2000; Vestweber, 2015). The contradictory results of the mRNA levels and 
the protein levels of E-cadherin, might be linked to the lower sensitivity of the western 
blotting technique in detecting small changes compared to other protein detections methods, 
while RT-PCR is a sensitive technique that efficiently amplifies changes of the targeted 
mRNA (Nicholas and Nelson, 2013). In addition, mRNA levels might not reflect protein 
levels (Schwanhausser et al., 2011).  
Levels of β-catenin protein in MCF-7 cells were reduced only by 10-5 M OMC and not by any 
other UV screens after 24-25 weeks of exposure. This UV screen has increased MCF-7 cell 
motility and invasive activity while retaining E-cadherin protein levels which suggests other 
possible pathways in the mechanism of inducing MCF-7 cell motility by 10
-5 
M OMC. It was 
reported that a motile and invasive MCF-7 cell sub-clone expresses E-cadherin at similar 
levels compared to the wildtype cells (Uchino et al., 2010) but the report did not show results 
of levels of β-catenin protein. However, β-catenin down-regulation was reported to be linked 
to increased motility of another breast cancer cell line (MDA-MB-231) (Cai et al., 2014) as 
was observed here in. Down-regulation of β-catenin was also associated with invasion in 
breast cancer (De Leeuw et al., 1997) and more motility and invasion of MCF-7 cells (Yang 
and Kim, 2014).  
Although repressed E-cadherin is an EMT marker and linked to cell motility, retaining E-
cadherin expression and the epithelial morphology can be maintained during cancer cells 
motility (Liu et al., 2014; Shamir et al., 2014) and that might explain the increased MCF-7 
cells motility following exposure to Bp3, OMC and 4MBC without reduction in E-cadherin 
protein levels. Other molecular markers were only studied using RT-PCR and levels of 
protein need to be considered in future work. 
UV screens caused no effect on Snail and Twist-1 mRNA levels. Results showed that 10
-5 
M 
Bp3 induced Snail mRNA levels after 1 week of exposure using RT-PCR and no effects were 
observed after 24-25 weeks of exposure to this chemical or for any of the other UV screens 
tested but it increased by 10
-8
 M 17β-oestradiol. No effect on Twist-1 mRNA level was 
observed. Thus the mechanism of repressing E-cadherin by Bp1 and HS was not found and 
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more research on other transcriptional regulators that suppress E-cadherin such as Snail2 
(Slug) (Hajra et al., 2002) and the Smad interacting protein ZEB2 (SIP1) (Comijn et al., 
2001) might reveal the pathway. Nevertheless, slug and snail protein levels were reported to 
be increased in BG-1 ovarian cancer cells following 96 hours of  exposure to 10
-6 
M Bp1 
(Shin et al., 2016). This difference between the findings of Shin and this work might be 
caused by the difference in the chemical concentration, the different cell line used or the 
endpoint measured by each experiment.  
UV screens reduced the levels of PIK3R1 and BMP7. The underlying molecular pathway 
seems to vary among these chemicals. The search for other molecular markers was conducted 
in order to explain the change in MCF-7 cells to a more motile phenotype. The investigation 
was driven toward two reported motility markers (PIK3R1 and BMP7) that were found in 
MCF-7 sub-cloned motile cells, which retained the expression of E-cadherin (Uchino et al., 
2010). Results from this work showed that 10
-5 
M OMC reduced the mRNA levels of PIK3R1 
after 1 week of exposure and reduced the mRNA levels of both PIK3R1 and BMP7 after 24-
25 weeks of exposure in comparison to un-treated cells, and that is in line with the reduction 
in PIK3R1 and BMP7 mRNA in motile sub-clone of MCF-7 cells as reported by Uchino et al. 
(2010). Moreover, results showed that BMP7 mRNA levels were also reduced in MCF-7 cells 
following 24-25 weeks of exposure to 10
-5 
M Bp3 and 10
-5 
M 4MBC, suggesting a possible 
mechanism underlying their action on MCF-7 cell motility. 
PIK3R1 is a (p86) regulatory subunit of phosphoinositide 3-kinase (PI3K) and the loss of 
control of PI3K signalling by PIK3R1 reduction causes an increase in cancer cell 
proliferation, survival and motility (Luo and Cantley, 2005) and it has been reported to be  
reduced in human invasive breast cancer tissue (Cizkova et al., 2013). BMP7 is a member of 
the 20 bone morphogenetic proteins identified in the human body (Alarmo et al., 2009) and it 
negatively regulates transforming growth factor β (TGF-β) signalling, which when activated 
is found to be involved in breast cancer cell metastasis (Welch et al., 1990; Massague, 2008). 
In motile MDA-MB-231 breast cancer cells PI3KR1 mRNA levels were found to be reduced 
in comparison with levels in epithelial T-47-D cells (Buijs et al., 2007) and MCF-7 cells 
(Uchino et al., 2010). Moreover, BMP7 mRNA is found at greater levels in MCF-7 cells than 
in motile MDA-MB-231 cells (Alarmo et al., 2007). Both markers are reduced in the motile 
MCF-7 cell sub-clone (Uchino et al., 2010). Moreover, overexpressing  PIK3R1 by 
transfection was found to reduce the motility and invasion of MDA-MB-231 and BT-474 
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breast cancer cells (Yan et al., 2016). Thus the ability of 10
-5
M OMC to reduce the mRNA 
levels of PIK3R1 and the reduced levels of BMP7 mRNA caused by the exposure of MCF-7 
cells to 10
-5 
M Bp3 and 10
-5 
M 4MBC might be a possible explanation of the increase in 
MCF-7 cell motility after the exposure to these chemicals. 
UV screens affect the secretion of MMP-9 but not MMP-2. Among the six tested UV 
screens in this research, only 10
-5 
M Bp1 increased MMP-9 secretion as determined by the 
zymogram and increased protein levels of pro-MMP-14 as measured by western 
immunoblotting.  The investigation covered the effect of UV screens on MMP-2, MMP-9 and 
MMP-14 all of which are involved in cancer cells metastasis and invasion (Cockett et al., 
1998; Forsyth et al., 1999; Seiki, 2002; Gupta et al., 2007; Yu and Stamenkovic, 2000; 
Zarrabi et al., 2011) and are known to be expressed by MCF-7 human breast cancer cells (Das 
et al., 2008). Reduction of MMP-2 and MMP-9 activity by 17β-oestradiol was documented 
previously in oestrogen responsive breast cancer cells, while tamoxifen increased MMP-2 and 
MMP-9 activity (Nilsson et al., 2007) and increased individual MCF-7 cell migration 
(Lymperatou et al., 2013). Thus increasing the expression of MMP-9 by 10
-5
M Bp1 might be 
another pathway involved in increased motility of cells exposed to this chemical. It was 
recently reported that MMPs can also be modulated by environmental chemicals. MDA-MB-
231 cells have shown more migration and invasion after long-term exposure to aluminium. 
This shift in motility activity was linked to the increase of MMP-9 activity as measured by 
gelatin zymography and the increase of MMP-14 RNA expression as measured by real time 
RT-PCR assay (Bakir and Darbre, 2015). Whether the effect of the UV screens on MMPs 
activity can be influenced by the presence of ECM material remains to be investigated in the 
future in order to explain the indicated MCF-7 cell invasive activity following exposure to 10
-
5
M OMC, 10
-5
M 4MBC and 10
-5
M HS. 
To conclude, UV screens can change the MCF-7 cell phenotype in vitro. The effect of the 
UV screens on breast cancer cells is not therefore limited to the effect on proliferation but can 
be considered to influence another hallmark of cancer, cell motility and invasion. Until now, 
few studies have investigated the effect of environmental chemicals on cancer cell motility. 
Studies have reported increased motility following exposure to phthalates (Hsieh et al., 2012; 
Yao et al., 2012) and to parabens (Khanna et al., 2014), and the results here show effects of 
the UV screens as well. The variation between the effects of 17β-oestradiol and the UV 
screens after long-term exposure on motility and on the molecular targets raises questions 
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regarding the involvement of the oestrogenic pathways in the increased MCF-7 cell motility 
following exposure to the UV screens. 24-25 weeks of exposure to the UV screen increased 
the motility of MCF-7 cells compared to both the negative control and cells exposed to 17β-
oestradiol. Nevertheless, the effect of the UV screens on the different chosen molecular 
markers in this study did not match with the effects of 17β-oestradiol. Further studies must 
include the use of antioestrogen fulvestrant to confirm the involvement of the oestrogenic 
genomic pathway or the risen sensitivity to those chemicals especially with the recorded 
effect of long-term exposure to 10
-5
 M 4MBC and HS in increasing TFF1 mRNA levels (see 
chapter 3), a gene that is linked to increased MCF-7 cell motility (Prest et al., 2002). Further 
research on the mechanism of action of the UV screens on breast cancer cell motility is 
needed including studies on the non-genomic pathway of the oestrogenic action. 
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Figure ‎4.66 The effect of 17β-oestradiol on MCF-7 human breast cells as determined by 
the xCELLigence technology. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E) or 
with 10
-8 M 17β-oestradiol (+E) for 2 weeks and 10-13 weeks. Media were replenished and cells were 
split each 3-4 days. Cells were analysed for their motility activity on CIM-plate 16 (xCELLigence 
RTCA device). Bar graph represents the percentage increase in cell index calculated from the different 
between 1 hour and 24 hours time points. Values are the average ±SE of triplicate biological 
independent replicates (n=3). * p-value ≤ 0.05 versus no addition by one-way ANOVA Tukey’s test. 
 
218 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7
 w
k
 (
-E
)
7
 w
k
 (
+
E
)
2
0
 w
k
 (
-E
)
2
0
 w
k
 (
+
E
)
1
1 0
1 0 0
W e e k s  o f  e x p o s u re  ( tre a tm e n t)
p
r
e
c
e
n
ta
g
e
 i
n
c
r
e
a
s
e
 i
n
 w
o
u
n
d
 h
e
a
li
n
g
*
Figure ‎4.67 The‎effect‎of‎17β-oestradiol on MCF-7 human breast cells as determined by the 
wound healing assay.  
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E) or 10
-
8 M 17β-oestradiol (+E) for 7 weeks and 20 weeks prior to the experiment. Media were replenished and 
cells were split each 3-4 days. Cells were then reseeded in 12-well plates and once the cells became ≥ 
95% confluent, wound was made and mitomycin c (0.5 µg/ml) was added.  Images were captured at 0 
hour and 24 hours. Cell migration was quantified by analysing minimum 5 images from each well. Values 
are the average ±SE of triplicate wells. Bar graph represents the percentage increase in wound healing 
obtained from 0-24 hours. Values are the average ±SE of triplicate biological independent experiments 
(n=3). * p-value ≤ 0.05 versus no addition one-way ANOVA Tukey’s test. 
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Chapter 5  Effect of UV screens on T-47-D human breast 
cancer cells 
 
5.1 Introduction 
There is variation between breast cancer cell line responses toward anticancer drug therapies 
(Torbett et al., 2008; Heiser et al., 2012; Risinger et al., 2015; Stapf et al., 2016), toward 
growth factors (Ryde et al., 1992; Niepel et al., 2014) and in expressing different molecular 
biomarkers related to cell adhesion and motility (Chekhun et al., 2013). This necessitates the 
use of a panel of breast cancer cell lines to study also potential variation in the effect of 
environmental oestrogens.  
The effect of UV screens on MCF-7 human breast cancer cell proliferation and motility were 
discussed in the previous chapters (chapters 3 and 4). The same cell line has been used as an 
in vitro model by several researchers to estimate the influence of the UV screens on breast 
cancer cell biology (Schlumpf et al., 2001; Heneweer et al., 2005; Kerdivel et al., 2013; 
Jimenez-Diaz et al., 2013; In et al., 2015). Therefore, the effect of the UV screens on 
proliferation and motility was investigated in this chapter using another oestrogen responsive 
cell line which shares some characteristics with MCF-7 cells. 
T-47-D human breast cancer cells (Keydar et al., 1979) were chosen to carry out further 
investigation. Growth of T-47-D cells is not dependent on 17β-oestradiol but responsive to it 
and shows an increase in cell proliferation following exposure to oestrogen (Darbre and Daly, 
1989). Both T-47-D and MCF-7 cells are luminal, epithelial cell lines and express ER (Neve 
et al., 2006; Ford et al., 2011; Holliday and Speirs, 2011). To the best of my knowledge, the 
effect of the UV screens has never been studied on T-47-D human breast cancer cells. 
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5.2 Experimental aim 
The overall aim of this chapter is to study the effect of six UV screens (Bp1, Bp2, Bp3, OMC, 
4MBC and HS) on T-47-D human breast cancer cell proliferation and motility. To achieve 
this aim, the effect of different concentrations of each UV screen on T-47-D cell proliferation 
was determined following 1 week of exposure using the ZBI Coulter counter (as described in 
2.2.1). The wound healing assay (described in 2.4.1) and xCELLigence (described in 2.4.3) 
were used to determine the effect of these chemicals on motility of T-47-D cells investigating 
both collective and individual chemotactic-derived motility following short-term (2 and 3 
weeks) and long-term (13, 21 and 30 weeks) of exposure. 
5.3 Results 
5.3.1 Effects of UV screens on proliferation of T-47-D human breast 
cancer cells  
17β-oestradiol increases the proliferation of T-47-D human breast cancer cells in a dose-
dependent manner. Doses of 10
-12
 M 17β-oestradiol and above simulated the proliferation of 
T-47-D cells with maximum simulation between 10
-11
 M and 10
-8
 M after 7 days (Figure 5.1). 
In this section, the effect of UV screens (Table 2.1) on the proliferation of T-47-D human 
breast cancer cells was investigated after 1 week of exposure. 
T-47-D human breast cancer cells were grown in phenol-red-free-DMEM containing 5% 
DCFCS with 10
-8
 M 17β-oestradiol or with increasing concentrations of UV screens (from 10-
8
 M to 10
-5 
M for 7 days. Cell count experiments were conducted using ZIB Coulter counter 
(as described in section 2.2.1). Cell growth experiments showed that among the tested UV 
screens, 10
-5
M Bp1 (Figure 5.2) (p-value ≤ 0.0001) and 10-5 M Bp2 (Figure 5.3) (p-value ≤  
0.0001) had the highest simulation effect on the proliferation of T-47-D cells and the 
proliferation was stimulated significantly by 10
-8
M Bp1 (Figure 5.2) (p-value ≤ 0.05) and 10-6 
M Bp2 (Figure 5.3) (p-value ≤ 0.001). A lower significant response was found on the 
proliferation of T-47-D cells after short-term exposure to 10
-5 
M Bp3 (Figure 5.4) (p-value ≤ 
0.001). Concentrations of 10
-8 
M to 10
-5 
M OMC did not stimulate the proliferation of T-47-D 
cells (Figure 5.5). Proliferation of T-47-D cells was stimulated significantly by 10
-5 
M 4MBC 
(Figure 5.6) (p-value ≤ 0.001) and 10-5 M HS (Figure 5.7) (p-value ≤ 0.001). 
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Comparisons of the effects of 10
-5
 M benzophenones (Bp1, Bp2 and Bp3) on T-47-D cell 
proliferation with 17β-oestradiol revealed no significant difference. However, the effect of the 
benzophenones and 17β-oestradiol on T-47-D cell proliferation was found significantly 
greater than the effects of concentrations of 10
-5
 M OMC, 4MBC and HS (Figure 5.9). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure ‎5.1 Effect‎of‎17β-oestradiol on proliferation of T-47-D human breast cancer cells 
in monolayer culture. 
T-47-D Cells were grown for 7 days in phenol-red-free-DMEM containing 5% DCFCS with ethanol 
control only (0) or with indicated molecular concentrations of 17β-oestradiol after short-term exposure 
(7 days). Media were replinshed on day 1 and day 4 of the experiment. Values are the average ±SE of 
triplicate independent wells. ** p-value ≤ 0.01 and **** p-value ≤ 0.0001 versus no addition (0) by 
one-way ANOVA Dunnett’s test. 
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Figure ‎5.2 Effect of Bp1 on proliferation of T-47-D human breast cancer cells in 
monolayer culture. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8
 M 17β-oestradiol (+E), with 10-8 M Bp1 (Bp1 (-8M)), 10-7 M Bp1 (Bp1 (-7M)), 10-6 M Bp1 (Bp1 
(-6M)) or 10
-5 
M Bp1 (Bp1 (-5M)) for 7 days. Media were replenished on day 1 and day 4 of the 
experiment. Values are the average ±SE of triplicate independent wells. Where no bars are seen, error 
was too small to be visualized. * p-value ≤ 0.05, ** p-value ≤ 0.01 and **** p-value ≤ 0.0001 versus 
no addition (-E) by one-way ANOVA Dunnett’s test. Two replicate experiments showed similar 
results (n=2). 
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Figure ‎5.3 Effect of Bp2 on proliferation of T-47-D human breast cancer cells in 
monolayer culture. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8
 M 17β-oestradiol (+E), with 10-8 M Bp2 (Bp2 (-8M)), 10-7 M Bp2 (Bp2 (-7M)), 10-6 M Bp2 (Bp2 
(-6M)) or 10
-5
 M Bp2 (Bp2 (-5M)) for 7 days. Media were replenished on day 1 and day 4 of the 
experiment. Values are the average ±SE of triplicate independent wells. Where no bars are seen, error 
was too small to be visualized. *** p-value ≤ 0.001 and **** p-value ≤ 0.0001 versus no addition (-E) 
by one-way ANOVA Dunnett’s test. Two replicate experiments showed similar results (n=2). 
 
           
-E +
E
B
p
2
(-
8
M
)
B
p
2
(-
7
M
)
B
p
2
(-
6
M
)
B
p
2
(-
5
M
)
1 0 3
1 0 4
1 0 5
1 0 6
***
T r e a tm e n t
C
e
ll
s
 p
e
r
 w
e
ll
***
****
224 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure ‎5.4 Effect of Bp3 on proliferation of T-47-D human breast cancer cells in 
monolayer culture. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8
 M 17β-oestradiol (+E), with 10-8 M Bp3 (Bp3 (-8M)), 10-7 M Bp3 (Bp3 (-7M)), 10-6 M Bp3 (Bp3 
(-6M)) or 10
-5
 M Bp3 (Bp3 (-5M)) for 7 days. Media were replenished on day 1 and day 4 of the 
experiment. Values are the average ±SE of triplicate independent wells. Where no bars are seen, error 
was too small to be visualized. *** p-value ≤ 0.001 and **** p-value ≤ 0.0001 versus no addition (-E) 
by one-way ANOVA Dunnett’s test. Two replicate experiments showed similar results (n=2). 
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Figure ‎5.5 Effect of OMC on proliferation of T-47-D human breast cancer cells in 
monolayer culture. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8
 M 17β-oestradiol (+E), with 10-8 M OMC (OMC (-8M)), 10-7 M OMC (OMC (-7M)), 10-6 M 
OMC (OMC (-6M)) or 10
-5
 M OMC (OMC (-5M)) for 7 days. Media were replenished on day 1 and 
day 4 of the experiment. Values are the average ±SE of triplicate independent wells. Where no bars 
are seen, error was too small to be visualized. **** p-value ≤ 0.0001 versus no addition (-E) by one-
way ANOVA Dunnett’s test. Two replicate experiments showed similar results (n=2). 
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Figure ‎5.6 Effect of 4MBC on proliferation of T-47-D human breast cancer cells in 
monolayer culture. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8
 M 17β-oestradiol (+E), with 10-8 M 4MBC (4MBC (-8M)), 10-7 M 4MBC (4MBC (-7M)), 10-6 M 
4MBC (4MBC (-6M)) or 10
-5 
M 4MBC (4MBC (-5M)) for 7 days. Media were replenished on day 1 
and day 4 of the experiment. Values are the average ±SE of triplicate independent wells. Where no 
bars are seen, error was too small to be visualized. *** p-value ≤ 0.001 and **** p-value ≤ 0.0001 
versus no addition (-E) by one-way ANOVA Dunnett’s test. Two replicate experiments showed 
similar results (n=2). 
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Figure ‎5.7 Effect of HS on proliferation of T-47-D human breast cancer cells in 
monolayer culture. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8
 M 17β-oestradiol (+E), with 10-8 M homosalate (HS (-8M)), 10-7 M homosalate (HS (-7M)), 10-6 
M homosalate (HS (-6M)) or 10
-5
 M homosalate (HS (-5M)) for 7 days. Media were replenished on 
day 1 and day 4 of the experiment. Values are the average ±SE of triplicate independent wells. Where 
no bars are seen, error was too small to be visualized. *** p-value ≤ 0.001 and **** p-value ≤ 0.0001 
versus no addition (-E) by one-way ANOVA Dunnett’s test. Two replicate experiments showed 
similar results (n=2). 
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Figure ‎5.8 Comparison and summary of the varying effect of the UV screens on 
proliferation of T-47-D human breast cancer cells in monolayer culture (B). Monolayers 
of T-47-D cells (0.2 x 10
5
 cells/well) were exposed to 10
-8
 M 17β-oestradiol (+E), 10-5 M Bp1 
(Bp1( -5M)), 10
-5
 M Bp2 (Bp2( -5M)), 10
-5
 M Bp3 (Bp3( -5M)), 10
-5
 M OMC (OMC( -5M)), 10
-5
 
M 4MBC (4MBC( -5M)) or 10
-5
 M HS (HS (-5M)) or ethanol control (-E) in phenol-red-free 
DMEM and 5% DCFS for 14 days (B). Values are the average ±SE of 3 independent wells (n=3). * 
p-value ≤ 0.05, ** p-value ≤ 0.01 and **** p-value ≤ 0.0001 versus no addition ( black asterisks), 
17β-oestradiol (green asterisks), Bp1 (blue asterisks), Bp2 (purple asterisks), Bp3 (lime asterisks) 
by one-way ANOVA Tukey’s test. 
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5.3.2 Effects of UV screens on motility of T-47-D human breast cancer 
cells  
5.3.2.1 Effects of UV screens on motility of T-47-D human breast 
cancer cells as measured by wound healing 
The wound healing assay (Liang et al., 2007) was used to determine the effect of short-term 
(3 weeks) and long-term (13 and 30 weeks) exposure to the UV screens on motility of T-47-D 
human breast cancer cells (as described in section 2.4.1). Results showed that after 3 weeks of 
exposure to 10
-5 
M Bp1 or 10
-5 
M OMC the wound healing was higher than the negative 
control. 10
-5 
M Bp1 closed 44.63 ± 2.27% and 10
-5 
M OMC closed 39.09 ± 3.56% of the 
wound, while the closure percentage was 23.35 ± 5.28% in the negative control wells 
(Figures 5.9 - 5.11) (p-value ≤ 0.05). Longer exposure times have shown that after 13 weeks 
of exposure neither 10
-5 
M Bp1 nor 10
-5 
M OMC increased T-47-D cell motility compared to 
the negative control (Figure 5.12). However, after 30 weeks of exposure to 10
-5 
M Bp1 the 
wound healing was significantly higher (33.99 ± 1.95%) than the negative control (23.09 ± 
0.59%) (Figures 5.13 and 5.14) (p-value ≤ 0.05) but with no indicated increase in the wound 
healing percentage in comparison with the results obtained after 3 weeks of exposure to10
-5 
M 
Bp1 (Figure 5.9). 
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Figure ‎5.9 Effect of 3 weeks of exposure to UV screens on motility of T-47-D human 
breast cancer cells as determined by wound healing assay. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control (-E) only, 
with 10
-5
 M Bp1 (Bp1), with 10
-5
 M Bp2 (Bp2), 10
-5
 M OMC (OMC), with 10
-5
 M 4MBC (4MBC) or 
with 10
-5
 M HS (HS) for 3 weeks. Media were replenished and cells were split every 3-4 days. Cells 
were then reseeded in 12-well plates and once the cells became ≥ 95% confluent, wound was made 
and mitomycin c (0.5 µg/ml) was added.  Images were captured at 0 hour and 24 hours. Cell migration 
was quantified by calculating the percentage of wound healing for minimum 3 images of each well 
using Image J software. Values are the average ±SE of triplicate independent wells. * p-value ≤ 0.05 
versus no addition (-E) by t-Test.  
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Figure ‎5.10 Representative images of the effect of 3 weeks of exposure to UV screens on 
motility of T-47-D human breast cancer cells as determined by wound healing assay.  
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control (-E) only, 
with 10
-5
 M Bp1 (Bp1) or with 10
-5
 M Bp2 (Bp2) 3 weeks. Cells were then reseeded in 12-well plates 
and once the cells became ≥ 95% confluent, wound was made and mitomycin c (0.5 µg/ml) was 
added. Images were captured at 0 hour and 24 hours. 
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Figure ‎5.11 Representative images of the effect of 3 weeks of exposure to UV screens on 
motility of T-47-D human breast cancer cells as determined by wound healing assay.  
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control (-E) only, 
with 10
-5 
M OMC (OMC), with 10
-5 
M 4MBC (4MBC) or with 10
-5 
M HS (HS) for 3 weeks. Cells 
were then reseeded in 12-well plates and once the cells became ≥ 95% confluent, wound was made 
and mitomycin c (0.5 µg/ml) was added. Images were captured at 0 hour and 24 hours. 
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Figure ‎5.12 Effect of 13 weeks of exposure to UV screens on motility of T-47-D human 
breast cancer cells as determined by wound healing assay. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control (-E) only, 
10
-8
 M 17β-oestradiol (+E), with 10-5 M Bp1 (Bp1), with 10-5 M Bp2 (Bp2), with 10-5 M Bp3 (Bp3), 
10
-5 
M OMC (OMC), with 10
-5 
M 4MBC (4MBC) or with 10
-5 
M homosalate (HS) for 13 weeks. 
Media were replenished and cells were split every 3-4 days. Cells were then reseeded in 12-well plates 
and once the cells became ≥ 95% confluent, wound was made and mitomycin c (0.5 µg/ml) was 
added.  Images were captured at 0 hour and 24 hours. Cell migration was quantified by calculating the 
percentage of wound healing for minimum 3 images of each well using Image J software. Values are 
the average ±SE of triplicate independent wells.  
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Figure ‎5.13 Effect of 30 weeks of exposure to UV screens on motility of T-47-D human 
breast cancer cells as determined by wound healing assay. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control (-E) only, 
10
-8 
M 17β-oestradiol (+E), with 10-5 M Bp1 (Bp1), with 10-5 M Bp2 (Bp2), with 10-5 M Bp3 (Bp3), 
10
-5 
M OMC (OMC), with 10
-5 
M 4MBC (4MBC) or with 10
-5 
M HS (HS) for 30 weeks. Media were 
replenished and cells were split every 3-4 days. Cells were then reseeded in 12-well plates and once 
the cells became ≥ 95% confluent, wound was made and mitomycin c (0.5 µg/ml) was added.  Images 
were captured at 0 hour and 24 hours. Cell migration was quantified by calculating the percentage of 
wound healing for minimum 3 images of each well using Image J software. Values are the average 
±SE of triplicate independent wells. * p-value ≤ 0.05 versus no addition by t-Test.  
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Figure ‎5.14 Representative images of the effect of UV screens after 30 weeks on motility 
of T-47-D human breast cancer cells as determined by wound healing assay. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control (-E) only or 
with 10
-5 
M Bp1 (Bp1) for 30 weeks. Cells were then reseeded in 12-well plates and once the cells 
became ≥ 95% confluent, wound was made and mitomycin c (0.5 µg/ml) was added.  Images were 
captured at 0 hour and 24 hours. 
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5.3.2.2 Effects of UV screens on motility of T-47-D human breast 
cancer cells as determined by xCELLigence technology 
The movement of T-47-D cells through 8µm pores of a membrane towards a chemotaxis 
stimulus of FCS was observed following the exposure to 10
-8 M 17β-oestradiol or the UV 
screens or no addition for 2, 7 and 21 weeks prior to the experiment which was conducted as 
described previously (in section 2.4.3). 
2 weeks of exposure to 10
-5 
M of the UV screens showed no increase in cell index in 
comparison to the negative control (Figures 5.15 and 5.16). However, 7 weeks of exposure 
increased the individual motility of T-47-D cells after exposure to 10
-5 
M OMC (cell index 
0.27 ± 0.05) (p-value ≤ 0.05) and 10-5 M 4MBC (cell index 0.57 ± 0.05) (p-value ≤ 0.001) in 
comparison to the negative control (cell index 0.04 ± 0.02) (Figure 5.18) and no effect of 
benzophenones was recorded at the same time point (Figure 5.17). 
Longer exposure up to 13 weeks gave no significant increase in T-47-D cell motility (Figure 
5.19), but 21 weeks of exposure increased T-47-D cell motility after exposure to 10
-5 
M Bp2 
(cell index 0.16 ± 0.02) (p-value ≤ 0.05), 10-5 M Bp3 (cell index 0.16 ±0 .01)(p-value ≤ 0.01), 
10
-5 
M OMC (cell index 0.19 ± 0.02) (p-value ≤ 0.01), 10-5 M 4MBC (cell index 0.16 ± 
0.03)(p-value ≤ 0.05) or 10-5 M HS (cell index 0.21 ± 0.04) (p-value ≤ 0.05) in comparison 
with untreated cells (cell index 0.21 ± 0.04) (Figure 5.20). 
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Figure ‎5.15 Effect of 2 weeks of exposure to UV screens on T-47-D breast cancer cell 
migration towards chemotaxis stimulus on an uncoated surface. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 M 17β-oestradiol (+E) 10-5 M benzophenone-1 (Bp1), 10-5 M benzophenone-2 (Bp2), 10-5 M 
benzophenone-3 (Bp3) or ethanol (-E) for 2 weeks in phenol-red-free DMEM supplemented with 5% 
DCFCS. Media were replenished and cells were split every 3-4 days. (A) The relative change in cell 
index of triplicate wells as indicated by the changes in impedance caused by cell migration from upper 
chambers to lower ones through the pores of polycarbonate membrane. Cell index was recorded every 
5 minutes and monitored for 24 hours. (B) Bar graph represents the average of the end point 
measurements (Cell index) of cell migration of triplicate wells at 24 hours. Values are the average 
±SE of triplicate independent wells. 
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Figure ‎5.16 Effect of 2 weeks of exposure to UV screens on T-47-D breast cancer cell 
migration towards chemotaxis stimulus on an uncoated surface. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 M 17β-oestradiol (+E), 10-5 M OMC (OMC), 10-5 M 4MBC (4MBC), 10-5 M HS (HS) or ethanol 
(-E) for 2 weeks in phenol-red-free DMEM supplemented with 5% DCFCS. Media were replenished 
and cells were split every 3-4 days. (A) The relative change in cell index of triplicate wells as 
indicated by the changes in impedance caused by cell migration from upper chambers to lower ones 
through the pores of polycarbonate membrane. Cell index was recorded every 5 minutes and 
monitored for 24 hours. (B) Bar graph represents the average of the end point measurements (Cell 
index) of cell migration of triplicate wells at 24 hours. Values are the average ±SE of triplicate 
independent wells. 
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Figure ‎5.17 Effect of 7 weeks of exposure to UV screens on T-47-D breast cancer cell 
migration towards chemotaxis stimulus on an uncoated surface. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 M 17β-oestradiol (+E), 10-5 M benzophenone-1 (Bp1), 10-5 M benzophenone-2 (Bp2), 10-5 M 
benzophenone-3 (Bp3) or ethanol (-E) for 7 weeks in phenol-red-free DMEM supplemented with 5% 
DCFCS. Media were replenished on day 1 and day 4.  (A) The relative change in cell index of 
triplicate wells as indicated by the changes in impedance caused by cell migration from upper 
chambers to lower ones through the pores of polycarbonate membrane. Cell index was recorded every 
5 minutes and monitored for 24 hours. (B) Bar graph represents the average of the end point 
measurements (Cell index) of cell migration of triplicate wells at 24 hours. Values are the average 
±SE of triplicate independent wells.  
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Figure ‎5.18 Effect of 7 weeks of exposure to UV screens on T-47-D breast cancer cell 
migration towards chemotaxis stimulus on an uncoated surface. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 M 17β-oestradiol (+E), 10-5 M OMC (OMC), 10-5 M 4MBC (4MBC), 10-5 M HS (HS) or ethanol 
(-E) for 7 weeks in phenol-red-free DMEM supplemented with 5% DCFCS. Media were replenished 
on day 1 and day 4. (A) The relative change in cell index of triplicate wells as indicated by the 
changes in impedance caused by cell migration from upper chambers to lower ones through the pores 
of polycarbonate membrane. Cell index was recorded every 5 minutes and monitored for 24 hours. (B) 
Bar graph represents the average of the end point measurements (Cell index) of cell migration of 
triplicate wells at 24 hours. Values are the average ±SE of triplicate independent wells. * p-value ≤ 
0.05 and *** p-value ≤ 0.001 versus no addition by t-Test. 
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Figure ‎5.19 Effect of 13 weeks of exposure to UV screens on T-47-D breast cancer cell 
migration towards chemotaxis stimulus on an uncoated surface. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-E), 
10
-8 M 17β-oestradiol (+E), 10-5 M benzophenone-1 (Bp1), 10-5 M benzophenone-2 (Bp2), 10-5 M 
benzophenone-3 (Bp3), 10
-5 
M OMC (OMC), 10
-5 
M 4MBC (4MBC), 10
-5 
M HS (HS) or ethanol (-E) 
for 13 weeks in phenol-red-free DMEM supplemented with 5% DCFCS. Media were replenished 
every 3-4 days. (A) The relative change in cell index of triplicate wells as indicated by the changes in 
impedance caused by cell migration from upper chambers to lower ones through the pores of 
polycarbonate membrane. Cell index was recorded every 5 minutes and monitored for 24 hours. (B) 
Bar graph represents the average of the end point measurements (Cell index) of cell migration of 
triplicate wells at 24 hours. Values are the average ±SE of triplicate independent wells. 
T-47-D Cells + 10-5 M OMC 
T-47-D Cells+ 10-5 M 4MBC 
T-47-D Cells +Ethanol 
T-47-D Cells + 10-5 M HS 
T-47-D Cells+10-8 M 17β-oestradiol 
T-47-D Cells + 10-5 M Bp3 
T-47-D Cells + 10-5 M Bp1 
T-47-D Cells + 10-5 M Bp2 
-E +
E
B
p
1
B
p
2
B
p
3
O
M
C
4M
B
C
H
S
0 .0 0
0 .0 5
0 .1 0
0 .1 5
1 3  w e e ks
T re a tm e n t
C
e
ll
 i
n
d
e
x
 a
ft
e
r 
2
4
 h
o
u
rs
(A) 
(B) 
242 
 
  
 
 
 
 
 
 
Figure ‎5.20 Effect of 21 weeks of exposure to UV screens on T-47-D breast cancer cell 
migration towards chemotaxis stimulus on an uncoated surface. 
Cells were grown in phenol-red-free-DMEM containing 5% DCFCS with ethanol control only (-
E), 10
-8 M 17β-oestradiol (+E), 10-5 M benzophenone-1 (Bp1), 10-5 M benzophenone-2 (Bp2), 10-5 
M benzophenone-3 (Bp3), 10
-5 
M OMC (OMC), 10
-5 
M 4MBC (4MBC), 10
-5 
M HS (HS) or 
ethanol (-E) for 21 weeks in phenol-red-free DMEM supplemented with 5% DCFCS. Media were 
replenished every 3-4 days. (A) The relative change in cell index of triplicate wells as indicated by 
the changes in impedance caused by cell migration from upper chambers to lower ones through the 
pores of polycarbonate membrane. Cell index was recorded every 5 minutes and monitored for 24 
hours. (B) Bar graph represents the average of the end point measurements (Cell index) of cell 
migration of triplicate wells at 24 hours. Values are the average ±SE of triplicate independent 
wells. * p-value ≤  0.05 and **p-value ≤ 0.01 versus no addition (-E) by t-Test. 
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5.4 Discussion  
This study demonstrated effects of 6 UV screens on proliferation and motility of T-47-D cells 
which demonstrates the effects in MCF-7 cells described in chapter 4 can also be found in a 
second independent breast cell line. Two techniques were used to measure the effects on T-
47-D cell motility following the exposure to the concentrations of the UV screens, which 
caused the highest proliferative response. The first assay used was the wound healing assay 
(Liang et al., 2007) that addresses the collective migration of cells (Friedl et al., 2004) but the 
second assay estimated individual cell motility through 8µm pores of a membrane towards a 
chemotaxis stimulus of FCS using the xCELLigence technology (RTCA DP, ACEA 
Biosciences Inc.). 
UV screens increased cell proliferation. This study demonstrated that exposure to UV 
screens can increase the proliferation of the T-47-D human breast cancer cell line. It also 
confirmed that T-47-D cell is responsive to 17β-oestradiol but not dependent on it (Darbre 
and Daly, 1989), whereas MCF-7 cell depends on 17β-oestradiol (see chapter 3). Compared 
to MCF-7 cells (see chapter 3), the maximal proliferation of T-47-D cell was caused by 10
-5 
M Bp1 and 10
-5 
M Bp2. Also, 10
-5 
M 4MBC and 10
-5 
M HS increased T-47-D cell 
proliferation. However, 10
-5 
M Bp3 increased T-47-D cell proliferation and that was not 
found in the MCF-7 cell line. It is noteworthy that lower concentrations of Bp1(10
-8 
M) 
caused an increase in T-47-D cell proliferation while lower concentrations of 4MBC and HS 
did not increase the proliferation of T-47-D cells and these findings differed from MCF-7 cell 
responses. The benzophenones increased T-47-D cell proliferation to a similar extent of 17β-
oestradiol, which might be linked to their structure and their ligand binding to the ERα pocket 
(as discussed in chapter 3).  
The proliferative response and sensitivity of T-47-D cells toward the UV screens is different 
from MCF-7 cells, and that may be explained by their different sensitivity to 17β-oestradiol 
(Karey and Sirbasku, 1988). Responses to drugs are also known to vary between these cell 
lines which may also be influenced by differences in the experimental conditions (Ryde et al., 
1992; Schafer et al., 2000; Mooney et al., 2002; Radde et al., 2015; Risinger et al., 2015) 
which would be reflected in the response to environmental oestrogens including the UV 
screens. Each cell line possesses unique genomic and proteomic features (Shadeo and Lam, 
2006; Aka and Lin, 2012) and that might not only influence the effect on proliferative 
response of these cells but also the motility response. Further study should be conducted to 
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confirm that the effects of UV screens on T-47-D cell proliferation are via oestrogenic 
pathway including the using of fulvestrant.  
UV screens increased the collective motility of cells. As discussed in the previous chapters, 
breast cancer metastasis is the main cause of mortality of breast cancer patients (Solomayer et 
al., 2000; Schairer et al., 2004; Manders et al., 2006). Thus, the effect of the UV screens on 
the motility of breast cancer cells was investigated using T-47-D cells as well as the MCF-7 
cells. Results have shown that after only 3 weeks of T-47-D cell exposure to 10
-5 
M Bp1 and 
10
-5 
M OMC, collective migration activity was increased. Longer-term exposure (30 weeks) 
caused only a significant increase in wound healing activity following the exposure to 10
-5 
M 
Bp1. 
UV screens increased the motility of individual cells. In contrast to the results with MCF-7 
cells (Chapter 4), the individual motility of T-47-D cells as determined by the xCELLigence 
was not found to be induced following 2 weeks of exposure to the UV screens using the same 
concentrations of the UV screens. However, the effect of OMC and 4MBC on individual cell 
motility was found to be started after 7 weeks of exposure and continued with the similar 
effect after 21 weeks of exposure. Similar to the findings with MCF-7 cells, Bp3 and HS 
induced T-47-D cell motility in the longer term. In contrast to MCF-7 cells, Bp2 induced T-
47-D cell motility after 21 weeks of exposure, while the same chemical had no effect on 
individual MCF-7 cell motility on the longer run. This variation in between the results of both 
cells might be due to their different sensitivity to the UV screens as indicated by their 
different proliferative response to the different concentrations of the UV screens. Another 
possibility is the difference in their biology as MCF-7 cells and T-47-D cells were found to 
express 164 proteins differently including 3% of motility related proteins (Aka and Lin, 
2012). This variation might also be justified by the finding of clinical studies that have 
suggested variation in metastatic potential among oestrogen receptor positive human breast 
cancers (Dai et al., 2005; Lower et al., 2005). 
To conclude, effects of UV screens were observed on both motility of individual and 
collective cell motility. T-47-D human breast cancer cell motility has also been previously 
documented following long-term exposure to parabens (Khanna et al., 2014). In that study, 
the molecular mechanism underlying the motility of MCF-7 cells (loss of E-cadherin) was not 
found in T-47-D cells and that suggested that the induced motility had a different molecular 
mechanism. In this chapter the molecular mechanisms underlying the effect of the UV 
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screens on T-47-D cell motility were not investigated and whether the molecular mechanisms 
are similar or differ between MCF-7 cells and T-47-D cells remains to be determined.  
Since breast cancer is a complex disease, to achieve a total understanding of the effects of UV 
screens on breast cancer progression, different models such as the in vivo model or xenograft 
model are needed to support the in vitro models findings described here (Vargo-Gogola and 
Rosen, 2007). 
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Chapter 6 Effects of UV screens on MDA-MB-231 human 
breast cancer cells 
6.1 Introduction 
The MDA-MB-231 human breast cancer cell line is widely used as an in vitro model for cell 
invasion and metastasis (Holliday and Speirs, 2011). MDA-MB-231 cells are mesenchymal 
motile cells (Rajah et al., 1998) that express low levels of E-cadherin and high levels of 
vimentin (Uchino et al., 2010; Nieva et al., 2012; Zeng et al., 2012; Lin et al., 2014). This cell 
line is described as triple negative for not expressing the oestrogen receptor (ER), 
progesterone receptor (PR) or human epidermal growth factor receptor 2 (HER2) (Holliday 
and Speirs, 2011). However, MDA-MB-231 cells are ERα negative (Lu et al., 2005) but they 
express both ERβ mRNA variant (Vladusic et al., 1998; Kleuser et al., 2008), ERβ protein 
(Hamilton et al., 2015) and ERβ protein variant (Fuqua et al., 1999; AL-Bader et al., 2011) so 
an effect of 17β-oestradiol is still possible on this cell line. Although 17β-oestradiol does not 
alter the proliferation of MDA-MB-231 cells (Cestari et al., 2009; Girgert et al., 2014; Mints 
and Souchelnytskyi, 2014), it increases MDA-MB-231 cell motility (Azios and 
Dharmawardhane, 2005; Zhou et al., 2016), suggesting that environmental oestrogens could 
also influence motility of these cells. 
The influence of environmental oestrogens on breast cancer cell migration is not limited to 
oestrogen responsive cell lines. Phthalates have been reported to increase MDA-MB-231 cell 
migration and invasive activity (Hsieh et al., 2012), Aluminium was found to increase the 
motility of MDA-MB-231 cells (Bakir and Darbre, 2015) and bisphenol A increased the 
migration and invasive capability of MDA-MB-231 and BT-549 triple negative human breast 
cancer cells (Zhang et al., 2016). Therefore the effect of the six UV screens was investigated 
on motility of the MDA-MB-231 cells.  
MMPs are known to be involved in breast cancer cell migration and invasion (Cockett et al., 
1998; Balduyck et al., 2000) (see section 1.3.3.3). The motile and invasive MDA-MB-231 
cell expresses different MMPs. However, silencing MMP-2 or MMP-9 transcription (Mehner 
et al., 2014) or inhibiting their secretion (Kim et al., 2011) decreases both motility and 
invasion of MDA-MB-231 cells. It was previously reported that aluminium salts increase the 
secretion of MMP-9 along with the motility of the MDA-MB-231 cell line (Bakir and Darbre, 
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2015). Thus the effect of the six UV screens on the secretion of MMP-2 and MMP-9 by 
MDA-MB-231 cells was further investigated. 
6.2 Experimental aims 
The overall aim of this chapter is to study the effect of six UV screens (Bp1, Bp2, Bp3, OMC, 
4MBC and HS) on the proliferation and motility of the MDA-MB-231 human breast cancer 
cell line. The experiments of this chapter were not designed to address the oestrogenic 
activity of these chemicals as all the experiment were done using media with phenol-red and 
10% FCS. To achieve this aim, the effect of UV screens on MDA-MB-231 cells proliferation 
was monitored on the xCELLigence machine each hour for 1 week. 
In order to investigate the effect of the six UV screens on MDA-MB-231 cell motility, the 
individual chemotactic derived motility was determined by xCELLigence following 2 weeks 
and 8 weeks of exposure. In addition, live imaging by time-lapse microscopy was used to 
measure the effects on the cumulative length moved by the individual cells following 2 weeks 
and 15 weeks of exposure. Also, the effect of the exposure to these chemicals on cell invasion 
through matrigel coated plates was monitored using the xCELLigence technology after 4 
weeks of exposure. 
Further investigation of molecular mechanisms focused on changes in MMP-2 and MMP-9 
secretion into the media using gelatin zymography and on measuring the levels of the 
intracellular MMP-14 using western immunoblotting. 
6.3 Results 
6.3.1 Effects of UV screens on proliferation of MDA-MB-231 human 
breast cancer cells  
Electrical impedance (cell index) was used to monitor proliferation of MDA-MB-231 cells in 
response to exposure to the UV screens by xCELLigence technology (RTCA-DP, Cambridge 
Biosciences). As described previously (in section 2.2.2), stock MDA-MB-231 human breast 
cancer cells were grown in DMEM containing 10% FCS without or with 10
-5 
M Bp1, with 10
-
5 
M Bp2, with 10
-5 
M Bp3, with 10
-5 
M OMC, with 10
-5 
M 4MBC or with 10
-5 
M HS for 7 
days. Cell index was monitored every hour for one week. Results showed no difference in cell 
index between cells exposed to the UV screens and control cells without exposure to UV 
screens (Figure 6.1).  
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Figure ‎6.1 Effect of UV screens on MDA-MB-231 breast cancer cell proliferation as 
determined by xCELLigence technology. 
Stock MDA-MB-231 cells were grown for up to 7 days in DMEM containing 10% FCS, with 10
-5
M 
benzophenone-1 (Bp1), with 10
-5
M benzophenone-2 (Bp2), with 10
-5
M benzophenone-3 (Bp3), with 
10
-5
M octyl methoxycinnamate (OMC), with 10
-5
M 4-methylbenzylidene camphor (4MBC), with 10
-
5
M homosalate (HS) or no addition ethanol control (-E). Media were replenished on day 1 and day 4. 
Cell proliferation was assessed by seeding 2000 cells in an E-plate 16 and cell index was monitored 
every 30 minutes over the period of 7 days. Each curve shows the average cell index of duplicate 
wells (A). Bar graph shows the average cell index after 7 days (168 hours) (B). 
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6.3.2 Effect of UV screens on motility of MDA-MB-231 human breast 
cancer cells  
The motility of MDA-MB-231 cells was assessed by measuring the movement of cells 
through 8µm pores of a membrane towards a chemotaxis stimulus of FCS as determined by 
the xCELLigence technology and by using live imaging by time-lapse microscopy. 
6.3.2.1 Effects of UV screens on motility of MDA-MB-231 human breast 
cancer cells as measured by xCELLigence technology 
Cells were exposed for 2 weeks to 10
-5 
M of the 6 UV screens or no addition and to 10
-7 
M 
and 10
-5 
M of the 6 UV screens for 8 weeks prior to the experiments. Then the experiments 
were carried out according to the manufacturer’s instructions (as described in section 2.4.3). 
Results showed no alteration to MDA-MB-231 cell chemotaxis driven motility after 2 weeks 
of exposure to 10
-5 
M Bp1, 10
-5 
M Bp3, 10
-5 
M OMC, 10
-5 
M 4MBC or 10
-5 
M HS but reduced 
motility of cells exposed to 10
-5 
M Bp2 (Figure 6.2). Long-term exposure of 8 weeks 
increased the cell motility following the exposure to 10
-5
M Bp2 (cell index 1.04 ± 0.03 with 
p-value ≤ 0.01), 10-5 M Bp3 (cell index 1.15 ± 0.05 with p-value ≤ 0.01), 10-5 M 4MBC (cell 
index 1.22 ± 0.13 with p-value ≤ 0.05) or 10-5 M HS (cell index 1.63 ± 0.21 with p-value ≤ 
0.01) in comparison with the no addition (cell index 0.92 ± 0.02) (Figure 6.3). In contrast, 10
-
5 
M Bp1 reduced the MDA-MB-231 cells index (0.27 ± 0.03 with p-value ≤ 0.001) in 
comparison with no addition (Figure 6.3). 
Results obtained by exposing MDA-MB-231 cells to 10
-7 
M concentrations of Bp1, Bp2, Bp3, 
OMC, 4MBC or HS for 8 weeks showed similar findings to these after exposure to 10
-5
M 
concentrations with no reduction effect of 10
-7 
M Bp1 on MDA-MB-231 cells motility 
(Figure 6.4). Thus 10
-7 
M concentration was chosen to examine the effect of longer exposure 
time in the following experiments using time-lapse microscopy. 
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Figure ‎6.2 Effect of 2 weeks of exposure to 10
-5
M of UV screens on MDA-MB-231 breast 
cancer cell migration towards chemotaxis on an uncoated surface. 
MDA-MB-231 cells were exposed to 10
-5 
M benzophenone-1 (Bp1), 10
-5 
M benzophenone-2 (Bp2), 
10
-5 
M Bp3 (Bp3), 10
-5 
M OMC (OMC), 10
-5 
M 4MBC (4MBC), 10
-5 
M HS (HS) or ethanol (-E) for 2 
weeks in DMEM supplemented with 10% FCS. Media were replenished and cells were split every 3-4 
days. Cells were analysed for their migratory response to chemotaxis in a real time cell migration 
assay by using xCELLigence technology. (A) Curves represent the relative change in cell index of 
duplicate wells as indicated by the changes in impedance caused by cell migration from upper 
chambers to lower ones through the pores of a polycarbonate membrane. Cell index was recorded 
every 5 minutes and monitored for 24 hours. (B) Bar graph represents the average cell index of 
duplicate wells after 24 hours as indicated by the xCELLigence RTCA software.  
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Figure ‎6.3 Effect of 8 weeks of exposure to 10
-5
M concentrations of UV screens on 
MDA-MB-231 breast cancer cell migration towards chemotaxis on an uncoated surface. 
MDA-MB-231 cells were exposed to 10
-5 
M Bp1 (Bp1), 10
-5 
M Bp2 (Bp2), 10
-5 
M Bp3 (Bp3), 10
-5 
M 
OMC (OMC), 10
-5 
M 4MBC (4MBC), 10
-5 
M HS (HS) or ethanol (-E) for 8 weeks in DMEM 
supplemented with 5% FCS. Cells were analysed for their migratory response to chemotaxis in a real 
time cell migration assay by using xCELLigence technology. Media were replenished and cells were 
split every 3-4 days. (A) Curves represent the relative change in cell index of triplicate wells as 
indicated by the changes in impedance caused by cell migration from upper chambers to lower ones 
through the pores of polycarbonate membrane. Cell index was recorded every 5 minutes and 
monitored for 24 hours. (B) Bar graph represents the cell index at 48 hours as calculated by the 
xCELLigence RTCA software. Values are the average ±SE of triplicate independent wells. * p-value 
≤ 0.05 and ** p-value ≤ 0.01 increase versus (–E). #### p-value ≤ 0.0001 decrease versus (–E) by t-
Test. 
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Figure ‎6.4 Effect of 8 weeks of exposure to 10
-7
M concentrations of UV screens on 
MDA-MB-231 breast cancer cell migration towards chemotaxis on an uncoated surface. 
MDA-MB-231 cells were exposed to 10
-7 
M Bp1 (Bp1), 10
-7 
M Bp2 (Bp2), 10
-7 
M Bp3 (Bp3), 10
-7 
M 
OMC (OMC), 10
-7 
M 4MBC (4MBC), 10
-7 
M HS (HS) or ethanol (-E) for 8 weeks in DMEM 
supplemented with 10% FCS. Media were replenished and cells were split every 3-4 days. Cells were 
analysed for their migratory response to chemotaxis in a real time cell migration assay by using 
xCELLigence technology. (A) Curves represent the relative change in cell index of triplicate wells as 
indicated by the changes in impedance caused by cell migration from upper chambers to lower ones 
through the pores of polycarbonate membrane. Cell index was recorded every 5 minutes and 
monitored for 24 hours. (B) Bar graph represents the cell index at 48 hours as calculated by the 
xCELLigence RTCA software. Values are the average ±SE of triplicate independent wells. * p-value 
≤ 0.05, ** p-value ≤ 0.01, *** p-value ≤ 0.001 and **** p-value ≤ 0.0001 versus the control (–E) by 
t-Test. 
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6.3.2.2 Effects of UV screens on motility of MDA-MB-231 human breast 
cancer cells as measured by time-lapse microscopy 
Prior to the experiment MDA-MB-231 human breast cancer cells were exposed for 2 weeks 
or 15 weeks to 10
-7 
M concentrations of  Bp1, Bp2, Bp3, OMC, 4MBC, HS or no addition. 48 
hours prior the experiment, cells were re-seeded in 12-well plates and cell migration was 
analysed using live cell imaging (time-lapse microscopy) (as described in section 2.4.2). 10 
cells were tracked in 3 fields of view per well for 6 hours and the average cumulative length 
moved (total travelled length of cell) was measured for each treatment. 
Results showed no effect of 2 weeks of exposure to the UV screens on the cumulative length 
moved by MDA-MB-231 cells exposed to 10
-7 
M concentrations of Bp1, Bp3, OMC, 4MBC 
or HS (Figure 6.5). However, 15 weeks of exposure caused an increase in cumulative length 
moved by individual MDA-MB-231 cells following exposure to 10
-7 
M Bp1 (135.60 ± 3.57 
microns with p-value ≤ 0.05), 10-7 M Bp2 (169 ± 4.91 microns with p-value ≤ 0.001), 10-7 M 
Bp3 (161.4 ± 4.87 microns with p-value ≤ 0.001) compared to no addition (111.3 ± 3.01 
microns) (Figure 6.6 (A)). There was also an increase in cumulative length moved by 
individual MDA-MB-231cells following the exposure to 10
-7 
M OMC (162.30 ± 8.38 microns 
with p-value ≤ 0.01), 10-7 M 4MBC (139.30 ± 4.85 microns with p-value ≤ 0.05) or 10-7 M 
HS (160 ± 9.57 microns with p-value ≤ 0.01) in comparison with no addition (106.90 ± 3.09 
microns) (Figure 6.6 (B)). 
 
 
 
 
 
 
 
 
 
 
254 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure ‎6.5 Effect of 2 weeks of exposure to UV screens on MDA-MB-231 breast cancer 
cell motility as measured by time-lapse microscopy. 
Effect of exposure to UV screens on MDA-MB-231 human breast cancer cells motility as determined 
by time-lapse microscopy. Cells were exposed to 10
-7 
M Bp1 (Bp1), 10
-7 
M Bp3 (Bp3), 10
-7 
M OMC 
(OMC), 10
-7 
M 4MBC (4MBC), 10
-7 
M HS (HS) or ethanol (-E) for 2 weeks in DMEM supplemented 
with 10% FCS. Media were replenished and cells were split every 3-4 days. Cells were seeded in 12-
well plate at 0.5 x 10
5 
cells/well. Time-lapse images of 3 fields of view per well were recorded every 5 
minutes for 6 hours. Results represent the cumulative length moved. Values are the average of 10 
tracked cells per field of view from 3 fields of view per well and 2 independent duplicate wells. Error 
bars show mean with range of duplicate wells. 
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Figure ‎6.6 Effect of 15 week of exposure to UV screens on MDA-MB-231 breast cancer 
cell motility as measured by time-lapse microscopy. 
(A) Cells were exposed to 10
-7 
M Bp1 (Bp1), 10
-7 
M Bp2 (Bp2), 10
-7 
M Bp3 (Bp3), (B) 10
-7 
M OMC 
(OMC), 10
-7 
M 4MBC (4MBC), 10
-7 
M HS (HS) or ethanol (-E) for 15 weeks in DMEM 
supplemented with 10% FCS. Media were replenished and cells were split every 3-4 days. Cells were 
seeded in 12-well plate at 0.5 x 10
5 
cells/well. Time-lapse images of 3 fields of view per well were 
recorded every 5 minutes for 6 hours. Results represent the cumulative length moved. Values are the 
average of 10 tracked cells per field of view for independent triplicate independent wells ±SE. * p-
value ≤ 0.05, ** p-value ≤ 0.01 and *** p-value ≤ 0.001 versus no addition (-E) by t-Test. 
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6.3.3  Effect of UV screens on invasion of MDA-MB-231 human breast 
cancer cells as determined by xCELLigence technology 
MDA-MB-231 cells exposed to the UV screens for 4 weeks were monitored for their invasive 
activity in real time using xCELLigence technology. According to the manufacturer’s 
instructions (ACEA Biosciences, USA), cells were seeded on matrigel (1:40 dilution) in the 
upper chamber of a CIM-plate 16 (as described in section 2.5). The lower chamber of the 
plate was filled with DMEM without or with 10
-5 
M Bp1, 10
-5 
M Bp2, 10
-5 
M Bp3, 10
-5 
M 
OMC, 10
-5 
M 4MBC or 10
-5 
M HS supplemented with 10% FCS, while the upper chamber 
was filled with the same media without the serum. Invasion was monitored every 5 minutes 
for 48 hours as cells moved through matrigel coated membrane into the lower chamber by 
chemotaxis. 
The experiment showed that only 10
-5 
M Bp2 increased the cell index (1.845 ± 0.017) in 
comparison with no addition (1.238 ± 0.029) (Figure 6.7) (p-value ≤ 0.0001). Investigation of 
the other concentrations and the other different time points was not achieved due to technical 
problems with the xCELLigence machine during the period of MDA-MB-231 cell culture. 
6.3.4  Effect of UV screens on matrix metalloproteinase activity of 
MDA-MB-231 human breast cancer cells as measured by 
zymography 
MMP-2, MMP-9 and MMP-14 were selected for investigating the effect of long-term 
exposure (14-15 weeks) to the UV screens on MDA-MB-231 cells. Secreted MMP-2 and 
MMP-9 were measured in the conditioned media (serum free media) via zymography (as 
described in section 2.8) and the intracellular MMP-14 protein levels were estimated using 
western immunoblotting (as described in section 2.7). 
Results showed a significant increase in MMP-2 secretion following the exposure to 10
-7 
M 
OMC and 10
-7 
M 4MBC but no effect on MMP-2 was indicated following exposure to the 
other the UV screens (Figure 6.8) (p-value ≤ 0.05). MMP-9 secretion was not altered by the 
exposure to the UV screens (data not shown). Also, the UV screens had no significant effect 
on pro and activated MMP-14 levels (Figure 6.9). 
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Figure ‎6.7 Effects of UV screens on MDA-MB-231 human breast cancer cells invasion 
through matrigel coated surfaces. 
MDA-MB-231 cells were exposed to 10
-5 
M Bp1 (Bp1), 10
-5 
M Bp2 (Bp2), 10
-5 
M Bp3 (Bp3), 10
-5 
M 
OMC (OMC), 10
-5 
M 4MBC (4MBC), 10
-5 
M HS (HS) or ethanol (-E) for 4 weeks in DMEM 
supplemented with 10% FCS. Cells were analysed for their migratory response to chemotaxis stimulus 
towards FCS in a real time cell migration assay by using xCELLigence technology. Media were 
replenished and cells were split every 3-4 days. Cells were analysed for their invasive activation 
through matrigel (1:40) coated CIM-plate 16 in a real time cell invasion assay by using the 
xCELLigence technology. (A) Curves represent the relative change in cell index of triplicate wells as 
indicated by the changes in impedance caused by cell migration from upper chambers to lower ones 
through the matrigel coated pores of polycarbonate membrane. Cell index was recorded every 5 
minutes and monitored for 48hrs hours. (B) Bar graph represents the cell index at 48 hours as 
calculated by the xCELLigence RTCA software. Values are the average ±SE of triplicate independent 
wells. **** p-value ≤ 0.0001 versus ethanol control (–E) by t-Test. 
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Figure ‎6.8 Effects of UV screens on secreted MMP-2 of MDA-MB-231 breast cancer 
cells as measured by gelatin zymography. 
MDA-MB-231 cells were exposed to 10
-7 
M Bp1 (Bp1), 10
-7 
M Bp2 (Bp2), 10
-7 
M Bp3 (Bp3), 10
-7 
M 
OMC (OMC), 10
-7 
M 4MBC (4MBC), 10
-7 
M HS (HS) or ethanol (-E) for 14-15 weeks in DMEM 
supplemented with 10% FCS. Media were replenished and cells were split every 3-4 days. Cells were 
exposed to serum free media plus the relative chemicals for 24 hours prior collection. Collected media 
were concentrated using Amicon ultra centrifugal filters prior to gelatin gel zymography. (A) 
Representative scanned image showing the effect of the conditioned media on the activity of MMP-2 
on a 10% gelatin gel. (B) Bar graph represents the band densities of MMP-2 and error bars the 
standard error of triplicate independent experiments (n=3). * p-value ≤ 0.05 versus ethanol control (-
E) by t-Test. 
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Figure ‎6.9 Effect of long-term exposure to UV screens on the protein level of MMP-14 in 
MDA-MB-231 breast cancer cells as determined by western immunoblotting. 
MDA-MB-231 human breast cancer cells were grown for 14-15 weeks in DMEM supplemented with 
10% FCS, with 10
-7 
M Bp1 (Bp1), with 10
-7 
M Bp2 (Bp2) or 10
-7 
M Bp3 (Bp3), with 10
-7 
M OMC 
(OMC), with 10
-7 
M 4MBC (4MBC) or with 10
-7 
M HS (HS) and HeLa human cervical carcinoma 
(HeLa) cells lysate was used as a positive control. Media were replenished and cells were split every 
3-4 days. Cells were exposed to serum free media plus the relative chemicals for 24 hours prior to the 
cell lysate collection. (A)Total cellular protein was loaded at 25µg per track and immunoblotted with 
antibody against pro-MMP-14 (62 kDa) and activated-MMP-14 (50 kDa). (B) Total protein. (C)The 
bar graph shows the level of pro and active MMP-14 relative to total protein. Values are means and 
bars indicate SEM (n=3 independent experiments). 
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6.4 Discussion 
It has been documented that the 6 UV screens studied here interact with the human ER and 
many studies have described oestrogenic action of the UV screens on the oestrogen 
responsive MCF-7 human breast cancer cell line (Schreurs et al., 2002; Gomez et al., 2005; 
Miller et al., 2001; Kunz and Fent, 2006; Schlumpf et al., 2004). To the best of my 
knowledge, the effects of the six UV screens are documented for the first time in this chapter 
in an ERα negative cell line. 
UV screens increase motility but not proliferation of MDA-MB-231 cells. Results showed 
no effect of the UV screens on MDA-MB-231 cell proliferation which is in line with their 
previously reported oestrogen insensitivity (Berthois et al., 1986; Charlier et al., 1995; Jones 
et al., 1998). However, an increase in cell motility was recorded following long-term 
exposure to 10
-7 
M Bp2, 10
-5 
M Bp2, 10
-7 
M Bp3, 10
-5 
M Bp3, 10
-7 
M 4MBC, 10
-5 
M 4MBC, 
10
-7 
M HS and 10
-5 
M HS as measured by the xCELLigence technology and from cumulative 
length moved by MDA-MB-231 cells following 15 weeks of exposure to 10
-7 
M of all of the 
tested UV screens. It is noteworthy that 10
-5 
M Bp1 reduced the motility of MDA-MB-231 
cells and the lower concentration of 10
-7 
M Bp1 had no effect on MDA-MB-231 cell motility 
as indicated by xCELLigence, while this chemical was found to induce the motility of MCF-7 
cells (see chapter 4). In another comparison, 10
-5 
M Bp2 showed no effect on MCF-7 cell 
invasion after long-term of exposure but was the only chemical found to increase the MDA-
MB-231 cells invasion following 4 weeks of exposure. This shows that motility can be 
influenced in ERα-negative cells as well as ERα+ positive cells and suggests that mechanisms 
are not always ER mediated. 
Previous studies have suggested that oestrogens and the environmental oestrogens can 
increase MDA-MB-231 cell motility via non-ER mediated molecular mechanisms. Zhou and 
his colleagues have recently shown that 17β-oestradiol induces the motility of MDA-MB-231 
cells via the ERβ/AKT signalling pathway through increasing the phosphorylation of ezrin a 
member of the actin-binding protein family ERM (ezrin/radixin/moesin) that is involved in 
cytoskeletal rearrangement (Zhou et al., 2016). Another group has reported that phthalates 
can increase MDA-MB-231 cell motility via stimulating the cell surface aryl hydrocarbon 
receptor (AhR), which leads to an increase in the expression of HDAC6 (histone deacetylase 
6) and then facilitate the nuclear assembly of the β-catenin-LEF1/TCF4 transcriptional 
complex and subsequently transactivates the c-Myc gene (Hsieh et al., 2012). It is noteworthy 
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that Bp3 and HS were found to interact with ERβ (Schreurs et al., 2002). Moreover, 4MBC 
was found to bind with high affinity to ERβ in the ER binding assay (Mueller et al., 2003) 
and in vitro to compete with 16α125I-oestradiol to bind with human oestrogen receptor β 
(Schlumpf et al., 2004), which might suggest an ER-β mechanism of Bp3, 4MBC and HS in 
the MDA-MB-231 cells as they expresses ERβ (Fuqua et al., 1999; AL-Bader et al., 2011; 
Hamilton et al., 2015). In order to confirm this assumption, knocking down ERβ by using the 
RNA interference (siRNA) or the oestrogen receptor antagonist fulvestrant, combined with 
using phenol-red-free media and DCFCS should be considered in future studies.  
UV screens increase the secretion of MMP-2 but not MMP-9. The investigation of the effect 
of exposure to UV screens on MMP secretion and expression in MDA-MB-231 cells was 
carried out in this chapter. As described previously (see chapter 4) MMPs have an important 
role modulating the ECM during cancer cell invasion. 10
-7 
M OMC and 10
-7 
M 4MBC 
increased the secretion of MMP-2 by MDA-MB-231 cells after 14-15 weeks of exposure and 
no effect on MMP-14 protein was detected. Both chemicals were found to induce the 
individual cumulative length moved by MDA-MB-231 cells after 15 weeks of exposure. 
MMP-2 is linked to increased invasion, angiogenesis and proliferation of cancer cells 
(Kessenbrock et al., 2010). It is also measured at higher levels in sera of breast cancer patients 
by zymogram (La Rocca et al., 2004).  
Moreover, Zhang and his colleagues have linked the increase in migration and invasive 
capability of MDA-MB-231 and BT-549 triple negative human breast cancer cells after 
treatment with bisphenol A to increases in MMP-2 and MMP-9 expression via oestrogen 
related receptor gamma with the involvement of ERK1/2 and Akt signalling pathways (Zhang 
et al., 2016). Further, MDA-MB-231 cell motility caused by long-term exposure to 
aluminium was linked to an increase of MMP-9 activity as measured by gelatin zymography 
and an increase of MMP-14 mRNA expression as measured by real time RT-PCR assay 
(Bakir and Darbre, 2015). In this work, MDA-MB-231 cell secretion of MMP-9 was not 
altered by the exposure to UV screens. However, MMP-9 secretion from MDA-MB-231 cells 
is believed to be stimulated by the presence of matrigel (Balduyck et al., 2000) which was not 
used in our assays. 
To conclude, UV screens increase the motility of MDA-MB-231 cells but whether the 
mechanism underlying this effect is non-ER mediated or through ERβ remains to be clarified 
in future research. 
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Chapter 7  General discussion  
In this work, the effect of UV screens on proliferation and motility of human breast cancer 
cells was explored. The ability of these chemicals to mimic oestrogen action was assessed in 
terms of oestrogen regulated gene expression and cell proliferation. The chemicals were able 
to induce expression of an ERE-Luciferase reporter gene and to increase the proliferation of 
oestrogen responsive cells. These results are in line with previous reports (Miller et al., 2001; 
Nakagawa and Suzuki, 2002; Schlumpf et al., 2001; Schreurs et al., 2002; Schlumpf et al., 
2004; Gomez et al., 2005; Heneweer et al., 2005; Kunz and Fent, 2006; Kerdivel et al., 2013; 
Jimenez-Diaz et al., 2013) (see chapter 3). 
One strength of this study was the use of three breast cancer cell lines. The MCF-7 cell line 
was used because it possesses ERα, it proliferates in response to oestrogen (Brooks et al., 
1973; Berthois et al., 1986; Darbre and Daly, 1989) and has been used as the basis for the E-
screen used to identify oestrogenic activity of endocrine disrupting chemicals (Soto et al., 
1995). The second cell line is another oestrogen responsive cell line; the luminal epithelial T-
47-D human breast cancer cell line (Keydar et al., 1979; Darbre and Daly, 1989) for which no 
previous work on UV screens has been reported. The third was the ERα negative MDA-MB-
231 human breast cancer cell line (Lu et al., 2005), which was used to investigate any non-
ERα mediated mechanisms of the UV screens. 
Effects of the UV screens in increasing breast cancer cell proliferation were assessed in two 
oestrogen responsive MCF-7 and T-47-D cell lines. MCF-7 and T-47-D cells showed an 
increase in cell proliferation after exposure to Bp1, Bp2, 4MBC and HS but only T-47-D cell 
proliferation increased in response to Bp3 with cell doubling number in 7 days of 2.77 ± 
0.081 compared to MCF-7 cells doubling number of 0.33 ± 0.07 in response to Bp3. The 
highest effects in increasing MCF-7 cell proliferation by Bp1 and Bp2 was decreased by the 
use of the antioestrogen fulvestrant, suggesting that the effect of these chemicals on 
proliferation of breast cancer cells is ERα mediated. The effect of Bp1 and Bp2 is related to 
their structure; both chemicals possess phenolic-rings that are capable of activating ER 
conformation, which is in line with previous studies of docking analysis of Bp2 (Kerdivel et 
al., 2013) and binding affinity of Bp1 (Blair et al., 1999). Although MDA-MB-231 cell 
proliferation was not altered by the exposure to the UV screens, the presence of 10% FCS and 
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the phenol-red in the media would have masked any possible oestrogenic action effects of 
these chemicals on this cell line. 
The effects of long-term chemical exposure are as important to determine short-term effects, 
and might provide different results than the one provided by the acute effect of the short-term 
model. Long-term tissue culture models have been previously used to develop the oestrogen 
deprivation model, which compares proliferation of breast cancer cells in the presence or 
absence of 17β-oestradiol after 6-12 months (Katzenellenbogen et al., 1987; Daly and Darbre, 
1990; Stephen et al., 2001; Shaw et al., 2006). Long-term exposure models have also been 
used to develop the model of antioestrogen resistance by exposing MCF-7 cells for long 
periods in excess of 1 year to tamoxifen or fulvestrant (Lykkesfeldt et al., 1995; McClelland 
et al., 2001; Knowlden et al., 2003; Shaw et al., 2006). The use of the long-term model in 
studying the effect of the exposure to environmental oestrogens was first reported by Khanna 
and co-workers where they have exposed oestrogen responsive MCF-7 cells, T-47-D cells 
and ZR-75 human breast cancer cells to parabens for up to 20 weeks (Khanna et al., 2014). 
This thesis reports the effect of UV screens on breast cancer cells in the long-term model 
which reflects the real-life scenario where effects are in the long-term at low dose levels. 
One of the main findings of this work is that the UV screens caused an increase in breast 
cancer cell motility although with variation between the cell lines used. Motility was assessed 
using three techniques; the wound healing assay, time-lapse microscopy and the 
xCELLigence technology. These methodologies determine different types of motility. During 
this study, different cell lines showed a distinguished type of motility based on the cell line 
biology, and that could explain the contradicting results generated from applying different 
techniques to determine the motility of MCF-7 cell line. The wound healing measures the 
collective cell migration, a type of motility much related to epithelial cells such as MCF-7, 
while the time-lapse is preferred to determined mesenchymal individual cells motility such as 
MDA-MB-231 cells but not suitable for MCF-7 cells. The effects of the UV screens on the 
increased motility of MCF-7 cells started after 2 weeks of exposure as indicated by the 
xCELLigence, while no increases in motility of T-47-D cells or MDA-MB-231 cells were 
indicated using the same technique following the same exposure time. T-47-D cells showed 
less sensitivity to the short-term influence of UV screens in increasing cell motility and it 
needed a longer time of exposure to show an increase in cell motility in comparison to the 
MCF-7 cells. This could be explained given the differences between these cell lines at the 
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genomic and the proteomic levels (Shadeo and Lam, 2006; Aka and Lin, 2012) and their 
variance in response to oestrogen, drugs and experimental conditions (Ryde et al., 1992; 
Schafer et al., 2000; Mooney et al., 2002; Radde et al., 2015; Risinger et al., 2015). 
Moreover, T-47-D cells needed a longer time to lose the proliferative response to oestrogen in 
oestrogen deprived conditions in comparison with MCF-7 cells (Daly and Darbre, 1990).  
This variation in motility observed here might be important in considering the ability of the 
cells to metastasise and might also relate to the finding of clinical studies that have suggested 
a variation in metastatic potential between oestrogen receptor positive human breast cancers 
(Dai et al., 2005; Lower et al., 2005). In parallel with previous reports, the only UV screen 
that has been previously documented to increase the motility of oestrogen responsive cells is 
Bp1, which was reported to increase the motility of MCF-7 cells (In et al., 2015) and the BG-
1 ovarian cancer cell line (Shin et al., 2016).  
Another important point is that the results showed lower concentrations took longer time to 
give a measurable effect. The effect of 10
-7 
M UV screens on motility of MCF-7 cells and 
MDA-MB-231 cells was not observed after 2 weeks of exposure but a longer period of 
exposure (15 weeks for MDA-MB-231 cells and 21 weeks for MCF-7 cells) increased the 
motility of both breast cancer cell lines. This is in line with previous suggestions of the ability 
of low doses of environmental chemicals to cause effects after long-term exposure (Darbre 
and Fernandez, 2013; Goodson et al., 2015). 
The variation in increase in motility among the three breast cancer cell lines following 
exposure to different UV screens can reflect the variation in susceptibility among human 
individuals. The effect on motility of the oestrogen unresponsive MDA-MB-231 cells 
following exposure to the UV screens or the effect caused by weaker oestrogenic chemicals 
such as OMC and 4MBC on MCF-7 oestrogen responsive cells suggest a possible mechanism 
of action other than through ERα. 
Molecular mechanisms underlying the increase in motility of breast cancer cells following 
exposure to the UV screens were further investigated using MCF-7 cells (chapter 4). Bp1 and 
HS reduced the protein levels of E-cadherin suggesting an increase in cell motility through 
phenotypic changing by EMT. A similar finding was linked to the increase of MCF-7 cell 
motility following exposure to parabens (Khanna et al., 2014). OMC reduced the protein 
levels of β-catenin and the mRNA levels of other motility markers of breast cancer cells 
including PIK3R1 and BMP7. Bp2 also reduced the levels of PIK3R1 mRNA while 4MBC 
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and HS have reduced BMP7 mRNA levels. Although the reduction of PIK3R1 and BMP7 
was only studied on mRNA levels, reduction of both markers at an mRNA level is linked to 
increased motility of breast cancer cells (Luo and Cantley, 2005; Uchino et al., 2010). Further 
studies are needed to be conducted on protein levels and further exploration might reveal 
more pathways involved in increasing the motility of MCF-7 cells and the other cell lines (see 
Table 4.7). Another pathway is the increase in the secretion of MMPs as indicated by 
zymography. The increase of the secretion of MMP-9 by MCF-7 cells following the exposure 
to Bp1 and of MMP-2 following the exposure to OMC and 4MBC by MDA-MB-231 cells 
suggests another mechanism of action of these chemicals in increasing motility of these cell 
lines and this mechanism was suggested to be the route of aluminium salts to influence the 
motility of MDA-MB-231 cells (Bakir and Darbre, 2015). 
In this study, the effects of the UV screens on breast cancer cell proliferation have been 
conducted using a range of UV screen concentrations (10
-8 
M to 10
-5 
M) and the 
concentrations used in motility experiments were 10
-7 
M and 10
-5 
M which poses the question 
of whether these concentrations can occur in human samples. Previous work has not 
measured the concentrations of UV screens in human breast tissue. However, when this work 
was started the measurement of the UV screens in human urine, serum (Zhang et al., 2013; 
Janjua et al., 2008), placenta (Vela-Soria et al., 2011; Jimenez-Diaz et al., 2013; Valle-Sistac 
et al., 2016)  and milk (Schlumpf et al., 2010; Rodriguez-Gomez et al., 2015) were published 
by others (see Table 1.4). The range of the UV screens found in human milk (Schlumpf et al., 
2010) were calculated in molarity as the following Bp3 (1.14 X 10
-9 
M to 2 X 10
-8 
M), OMC 
(3 X 10
-10 
M to 1 X 10
-8 
M), 4MBC (1 X 10
-9 
M to 7.6 X 10
-9 
M) and HS (1.7 X 10
-9 
M to 9.33 
X 10
-9 
M). Although the lowest concentration used for motility work (10
-7 
M) is 10 fold 
higher than the highest concentration found in the human milk, these results provide an 
indication of the potential for these chemicals to have adverse effects on breast cancer cell 
biology but for final conclusions measurements of these chemicals are now needed in human 
breast tissue. 
In breast milk more than one UV screen was measured (Schlumpf et al., 2010) and therefore 
the effect of mixtures of UV screens needs to be considered. The exposure to low 
concentrations of mixtures of endocrine disruptors for a long period is a current health 
concern (Darbre and Fernandez, 2013). A previous study has shown that mixtures of parabens 
in concentrations found in the human breast tissue at the no effect concentration levels 
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increased MCF-7 cell proliferation (Charles and Darbre, 2013). In another study, mixtures of 
four UV screens (Bp1, Bp3, OMC and 4MBC) at their mid effect concentration induced the 
oestrogen responsive TFF1 gene mRNA levels in MCF-7 cells similar to levels induced by 
17β-oestradiol (Heneweer et al., 2005). Knowing the levels and concentrations of these 
chemicals in human breast tissue in the future besides the levels measured in human samples 
might inform the exploration of the effect of these chemicals in mixtures especially in 
designing long-term experiments. 
Most reported studies have been carried out using cells grown on plastic culture dishes. 
However, this is not a physiological surface and it is known that cell proliferation and cell 
responses to drugs can vary on different ECM surfaces (Schwartz et al., 1995; Longhurst and 
Jennings, 1998; Sonohara et al., 1998; Woodward et al., 2000; Korah et al., 2004; Ohbayashi 
et al., 2008; Pontiggia et al., 2012). The effect of the ECM materials on the action of the UV 
screens on the proliferation of MCF-7 cells was also explored in this research. To the best of 
my knowledge, this is the first study to explore the effect of ECM materials on the 
proliferation of breast cancer cells in response to any environmental oestrogen (see chapter 
3). A laminin coating increased the proliferation of MCF-7 cells following the exposure to 
OMC which was not observed for MCF-7 cells or for T-47-D cells exposed to OMC on 
plastic. This demonstrates that the effect of these chemicals needs to be studied within the 
context of the complex microenvironment of cancer cells, rather than just using an in vitro 
model on plastic. The ECM components interact with various molecular pathways (Schwartz 
et al., 1995; Burridge and Chrzanowska-Wodnicka, 1996; Longhurst and Jennings, 1998) and 
studying the influence of the presence of different ECM components in combination with 
environmental oestrogens might aid in obtaining closer data to the possible effect of these 
chemicals in vivo. In this work the invasion assays were conducted on matrigel, which is an 
extract driven from the basement membrane of  EHS-mouse tumour (Kleinman and Martin, 
2005) but coating with other components of the ECM might provide different invasion results 
and should be used in future research. 
Because UV screens are mainly used to protect the skin from exposure to UV rays, research 
in this area has been directed towards the role of UV screens in preventing melanoma caused 
by the UV rays (Wolf et al., 1994) rather than the effect of UV screens in terms of causing the 
hallmarks of cancer. Results reported here demonstrate that the UV screens can cause the 
development in human breast cancer epithelial cells of at least 2 of the hallmarks of cancer, 
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namely sustained proliferation and invasion and metastasis. Further studies are now needed to 
investigate whether the UV screens can influence development of any other hallmarks of 
cancer in breast cells. However, in view of the application of UV screens to skin, it would 
also be interesting to investigate any potential for development of hallmarks of cancer in 
keratinocytes. 
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